#version: 0.2
i n
t i
r e
t h
a n
e n
e r
e d</w>
o n
o f</w>
a t
th e</w>
r o
i n</w>
a ti
i t
an d</w>
a r
o n</w>
s t
s i
a l
a l</w>
o r
i c
a s
e c
d i
a c
en t
l o
in g</w>
t o</w>
o r</w>
u r
e r</w>
a s</w>
a m
e s
c o
w it
u l
wit h</w>
o l
d e
s e
u c
in e</w>
re s
p h
en t</w>
l e
l y</w>
ati on</w>
r i
v e</w>
c on
p ati
w as</w>
p ro
e s</w>
o u
T h
d uc
er e</w>
c h
m e
v e
at ed</w>
s .</w>
i d
f f
r a
o s
o c
i s</w>
a n</w>
p er
i c</w>
u s
a t</w>
ent s</w>
a g
i m
o t
a d
h e
w ere</w>
i l
ti on</w>
s u
a p
u n
co m
c e
p a
duc ed</w>
f or</w>
b e
t re
ec t
n e
i s
Th e</w>
t er
e x
b y</w>
re n
in e
p l
pati ents</w>
a b
v er
r at
e ff
t o
e m
in duced</w>
ati on
it y</w>
h i
d o
in c
h y
w e
th at</w>
e n</w>
p res
s ,</w>
n o
re as
t er</w>
h a
c e</w>
t e
a r</w>
re d</w>
m in
a f
u d
m ent</w>
ti on
g n
l i
con t
u t
m a
r an
s y
- induced</w>
i f
an t
p re
v i
l e</w>
h o
c ar
at e</w>
ti c</w>
af ter</w>
ti ve</w>
c a
w h
p or
y .</w>
tre at
ic al</w>
r u
c l
th er
m o
i st
p o
0 .
si on</w>
b e</w>
q u
on e</w>
si gn
m or
no t</w>
g /
or m
as e</w>
) .</w>
e d
y ,</w>
an t</w>
o m
as s
g h
i z
ro u
p ar
inc reas
d a
u m
p i
eff ect
in f
ul ar</w>
u m</w>
th e
) ,</w>
if ic
m on
e t
os e</w>
e v
y l
ther ap
s er
si s</w>
ur e</w>
in t
re ce
in g
ti v
c or
d ru
s e</w>
f i
lo w
i o
d ur
lo g
I n</w>
th er</w>
g en
sign ific
o x
st ud
m ic
an ti
treat ment</w>
ou s</w>
s ho
oc i
b u
ar e</w>
an g
m g/
en ce</w>
o b
e st
u s</w>
u re
ro m</w>
min ist
v ed</w>
ti c
pa th
l l
effect s</w>
lo p
al ly</w>
ec t</w>
to x
e .</w>
ent r
u ro
f rom</w>
in d
be t
res p
ass oci
p t
ad minist
th is</w>
i a</w>
tre ated</w>
di s
us e</w>
g rou
car di
si on
un c
es e</w>
re l
ha d</w>
de ve
ation s</w>
e l
ul t
e ar
e ,</w>
su b
ac tiv
t en
b lo
hy per
ro m
ren al</w>
ar y</w>
am ine</w>
S :</w>
deve lop
ot en
f ol
e p
w i
re por
dur ing</w>
ve l
ti m
associ ated</w>
th an</w>
stud y</w>
cont ro
+ /
ne uro
us ed</w>
rat s</w>
hi b
d ose</w>
y c
pati ent
d er
am in
ag e</w>
d .</w>
t ran
r on
m ent
y s
r ac
a z
O N
ou n
d e</w>
o log
g h</w>
c ur
wi th
tox ic
bu t</w>
si ve</w>
f unc
ut e</w>
d ec
r ation</w>
eff ect</w>
es t</w>
p os
p en
n orm
ma y</w>
l l</w>
es s</w>
es .</w>
ati ve</w>
1 0
in j
in hib
su g
p oten
se s</w>
ec tive</w>
c i
s p
b o
0. 0
fol low
u di
t ed</w>
be en</w>
sug g
g ra
we e
i d</w>
w he
resp on
o d</w>
c entr
pro te
tran s
ha ve</w>
or y</w>
W e</w>
wh o</w>
mg/ k
me th
v en
dec reas
al u
pres s
an ce</w>
a in
l u
increas ed</w>
an c
sho w
g i
ff e
al l</w>
sy n
+/ -</w>
therap y</w>
st udi
in v
en c
rece i
in ter
da y
re qu
ch ang
id e</w>
ation .</w>
y ear
o l</w>
com p
cl in
ul d</w>
signific ant
res ult
i ti
er g
dru g</w>
administ ration</w>
ri s
i r
i a
al l
v er</w>
s ec
mic ro
Th is</w>
rece pt
ar di
pati ent</w>
ac t
a st
ine -induced</w>
ect ed</w>
ac ute</w>
ou t</w>
le vel
l on
ec h
dru g
ob ser
n o</w>
me di
es ,</w>
d er</w>
a il
ot h</w>
significant ly</w>
m y
ic h</w>
h as</w>
( 1
we en</w>
s en
p e
hi gh
c al
wh ich</w>
f orm
bet ween</w>
a k
ve n</w>
grou p
re e</w>
pa red</w>
ine .</w>
p to
i gh
duc tion</w>
ch em
te st
he ar
ch ol
ab le</w>
th ese</w>
int ra
inhib it
id ence</w>
ed .</w>
t w
t ri
di se
si b
ffe ren
es s
activ ity</w>
ar i
develop ed</w>
al o
wee k
re at
ec tion</w>
b ra
com pared</w>
E S
pl ic
tion .</w>
ti al</w>
signific ant</w>
s o</w>
r am
mor e</w>
g lo
al y
c ase</w>
tion s</w>
norm al</w>
b oth</w>
b l
rat e</w>
l im
di fferen
clin ical</w>
re g
p ri
or s</w>
c as
5 -
1 .
v as
m s</w>
do p
blo od</w>
ag on
show ed</w>
s t</w>
m at
an d
u sion</w>
se iz
ris k</w>
pl as
ph a
oc cur
f or
f ail
oc ardi
co ca
b in
toxic ity</w>
rel ated</w>
it s</w>
i t</w>
i al</w>
grou p</w>
con centr
t s</w>
m a</w>
lon g
ex per
st er
ph en
1 0</w>
lo s
he pati
g l
di d</w>
I ON
ti s</w>
t y
sy m
st r
ou r</w>
mor ph
m il
m al
d ys
ch ron
at ing</w>
al so</w>
( 2
se l
rat s.</w>
ol y
level s</w>
fi r
ou s
o ther</w>
mon th
ev alu
E T
A C
' s</w>
se v
ind ic
follow ing</w>
d ro
contro l</w>
C L
ul ation</w>
oun d</w>
m an
ec ti
sy st
mo de
il e</w>
func tion</w>
f requ
day s</w>
ar ter
Th ese</w>
L T
y m
si de</w>
me t
m un
iz ed</w>
erg ic</w>
e -
de f
whe n</w>
th rom
ol d</w>
le v
ech an
d u
cardi a
U S
% )</w>
ver se</w>
ver ,</w>
tw o</w>
su p
re c
or al</w>
ne ph
lo w</w>
d ic
cont in
c ular</w>
blo c
an e
0 0</w>
st o
path y</w>
mg/k g</w>
m g</w>
m echan
olog ical</w>
increas e</w>
b as
al pha
n it
u se
t ac
obser ved</w>
er s</w>
da y</w>
d am
c ri
at ri
2 .
ure s</w>
treat ment
ti g
si st
il ity</w>
hyper ten
th i
sym pto
on ly</w>
l ess</w>
de ter
chron ic</w>
ar k
result s</w>
re f
os t</w>
me as
m er
ar g
US ION
ON CL
ONCL USION
M ET
H O
C ONCLUSION
si a</w>
prote in
o ph
it y.</w>
ine ,</w>
gen er
d y
cas es</w>
I n
5 0</w>
ver y</w>
v ari
us ing</w>
sugg est</w>
s uc
mechan is
hy poten
ex pos
enc y</w>
sib le</w>
sho uld</w>
s ti
r al</w>
hear t</w>
ed ,</w>
decreas ed</w>
com bin
ation ,</w>
al s</w>
ac et
v ing</w>
re t
es tig
de pen
c y
5 %</w>
tion ,</w>
sev ere</w>
s ur
respon se</w>
press ure</w>
n on
contin u
bloc k
ant agon
ac e
a x
3 .
pa in</w>
o di
inv estig
ca used</w>
w e</w>
u b
re ac
my ocardi
l ud
im mun
contro l
am i
U LT
R ES
RES ULT
2 -
with out</w>
pres ent</w>
neph ro
m i
l at
depen d
ar c
RESULT S:</w>
t h</w>
sugg est
ser um</w>
m ost</w>
inc lud
igh t</w>
f ound</w>
we ver,</w>
t e</w>
studi es</w>
sen si
s h
e th
MET HO
METHO D
u p
tion al</w>
th ou
s al
repor t</w>
re co
oc y
in .</w>
en ce
do ses</w>
th ose</w>
pres sion</w>
p at
i r</w>
glo mer
repor ted</w>
recei ved</w>
pro t
li ver</w>
ine -
ce ll
am ph
ad verse</w>
5 0
sec on
recept or</w>
in -
i .
ha vi
f act
cardia c</w>
re duced</w>
p er</w>
in ,</w>
il l
ic i
f e
chang es</w>
trans pl
thou gh</w>
sion .</w>
plas ma</w>
per io
patient s.</w>
p sy
ous ly</w>
is o
fir st</w>
comp le
com m
an aly
v entr
ti s
p le
meth yl
ma in
gi ven</w>
d ing</w>
com plic
c yc
be havi
b io
un der
therap y.</w>
si s.</w>
re ,</w>
ou t
inf usion</w>
g e
do se
d es
d ed</w>
an im
P A
week s</w>
ventr ic
pre v
per form
myocardi al</w>
ing s</w>
gra ph
exper im
car b
vas cular</w>
th ree</w>
ro lim
n ec
hi gh</w>
f ind
d rom
c an</w>
3 0</w>
( A
ur ia</w>
ty p
re duction</w>
ot or</w>
me an</w>
ic ot
for e</w>
ex amin
es the
duc e</w>
du e</w>
d -
- old</w>
tim e</w>
pres ent
os ph
m ac
e red</w>
METHOD S:</w>
L -
2 0</w>
ventric ular</w>
ven ous</w>
syn drom
si mil
se ver
resp ecti
pl ace
p it
m it
e pi
d at
bet a
inj ection</w>
im pro
i p
g res
f lu
ect s</w>
cardi o
a v
- 1
v it
u p</w>
ren t</w>
r h
per id
me n</w>
l it
em ia</w>
dise ase</w>
ati c</w>
amph et
E C
A l
the ir</w>
sion ,</w>
s )</w>
r ine</w>
m ark
inv ol
inc idence</w>
hy po
ex t
dise as
bra in</w>
ac id</w>
4 .
( P
we ll</w>
ur al</w>
ter m</w>
st ri
si de
re ver
por t
ph osph
n icot
in iti
high er</w>
fi b
fail ure</w>
er al</w>
di ag
d s</w>
coca ine</w>
ve l</w>
ur ther</w>
syndrom e</w>
suc h</w>
s tim
s co
respecti vel
m us
li k
g ram
ent ly</w>
el ect
do m
chem o
ce ll</w>
b le
ain ed</w>
administ ered</w>
2 0
ve ly</w>
recei ving</w>
ra di
patient s,</w>
in al</w>
im pa
ia .</w>
hy dro
hi st
d ,</w>
c in
c anc
T I
v alu
ra t</w>
p ul
mic e</w>
ia ,</w>
i ther</w>
e lev
d ra
c ap
at e
ar ac
a ff
( C
throm bo
po st
p y
ol ic</w>
norm al
g en</w>
ence ph
dop amine</w>
az ol
at al</w>
R O
0.0 0
ure .</w>
u red</w>
sub j
re b
re as</w>
psy ch
pre vi
is t</w>
h alo
epi le
en z
en ti
dur ation</w>
dra w
de mon
c lo
ati n</w>
H o
4 -
y -
u al</w>
t ot
simil ar</w>
s ing
re ve
re main
om e</w>
it y,</w>
g e</w>
f t</w>
f er
ent al</w>
b ut
ac tion</w>
a y
U N
N a
I t</w>
1 2</w>
year -old</w>
y si
with in</w>
v al
sion s</w>
se qu
ro le</w>
p r
ox id
occur red</w>
mg/k g
m ents</w>
inf arc
in to</w>
drug s</w>
develop ment</w>
at es</w>
ang io
ad di
ab ility</w>
x im
v ol
ran dom
o p
le ar
l as
in ine</w>
e ither</w>
depend ent</w>
c um
be fore</w>
ad ren
a in</w>
Ho wever,</w>
H B
) -
with draw
w ar
per i
no w
low er</w>
dis or
concentr ations</w>
com par
ca use</w>
a d</w>
T o</w>
N A</w>
A T
2 4</w>
( n</w>
( 3
wh ile</w>
ul t</w>
studi ed</w>
si s,</w>
s ul
reve al
pro long
pro gres
perform ed</w>
ox ic
o ver</w>
month s</w>
mode l</w>
l y,</w>
k now
e u
dat a</w>
centr al</w>
cal c
ass ess
an y</w>
CONCLUSION S:</w>
A n
7 .
treatment .</w>
t ing</w>
sympto ms</w>
rolim us</w>
olog ic</w>
o id
meas ured</w>
l in
id ine</w>
elect ro
eff ective</w>
alpha -
al ge
ab s
a ine</w>
a .</w>
a ,</w>
E :</w>
yc in</w>
v ul
uc le
tox ic</w>
sel ective</w>
poten tial</w>
p ol
n er
ho ur
gh t</w>
f em
en h
decreas e</w>
dam age</w>
con cl
chol est
c is
ar mac
K G
A M
1 9
1 -
- term</w>
w o
syst em
s am
reveal ed</w>
p p
ol er
o f
morph ine</w>
m ul
m in</w>
is h
find ings</w>
c reat
RO UN
KG ROUN
B AC
BAC KGROUN
A f
wee k</w>
transpl ant
t est</w>
sp ec
s on
ren ce</w>
o ver
mic e.</w>
m is
k ine
he pat
f urther</w>
er o
en do
des cri
d os
combin ation</w>
co uld</w>
cl on
beta -
bas el
5 .
3 -
10 0</w>
( P</w>
str uc
st at
sing le</w>
ro s
prolong ed</w>
on t
non -
me mor
mal e</w>
li thi
id ne
ic in</w>
ic ally</w>
hepati tis</w>
de t
con vul
az ep
arac ter
a u
BACKGROUN D
6 0</w>
0 -
se t</w>
reb ral</w>
protein uria</w>
pro l
ph ysi
on g</w>
n a
me dic
lo com
increas es</w>
in -induced</w>
i red</w>
hypoten sion</w>
f our</w>
bl ad
ar b
a use</w>
v id
ti n</w>
t em
po si
par tic
k idne
i l</w>
halo perid
g reat
f ar
ev idence</w>
ec ause</w>
differen t</w>
deter min
concentr ation</w>
ch aracter
anim als</w>
ab ol
T w
BACKGROUND :</w>
Af ter</w>
1 5</w>
year s</w>
tis su
tic al</w>
th al
t u
t oler
s y</w>
s af
pl e</w>
ox y
om a</w>
micro gram
ma j
inj ur
i tion</w>
group s</w>
f u
et y</w>
epile p
car cin
at ten
at ory</w>
ain ing</w>
ac h</w>
P ati
9 5%</w>
0.0 5
ur on
th rou
t ak
si x</w>
seiz ures</w>
s ome</w>
s ed</w>
p .
odi um</w>
nit ro
mode l
int rac
ing ,</w>
im port
fem al
f o
dis continu
di st
comm on</w>
co ur
chang e</w>
cell s</w>
am p
a y</w>
S R
% ,</w>
ve ment</w>
tot al</w>
ri am
re pe
re duc
prote in</w>
per ative</w>
ot oxic
mg/ m
li al</w>
l y
intra venous</w>
inj ec
high -
he mo
gen e
g u
flu o
f ac
ex pression</w>
c ess
bra dy
ap pe
ane ous</w>
a ver
Pati ents</w>
4 0</w>
- 1</w>
w om
u lo
typ e</w>
therap eu
th ere</w>
tac hy
t ra
pro duced</w>
place b
placeb o</w>
p ra
p ac
or t
m b
lo c
l ine</w>
k ed</w>
in ary</w>
il d
h um
experim ental</w>
e t</w>
e m</w>
de s</w>
cardi a</w>
basel ine</w>
assess ed</w>
am ide</w>
P )</w>
C A
whe reas</w>
us ,</w>
ter n
s it
re le
on ary</w>
o id</w>
ne g
n ing</w>
min ut
memor y</w>
medi an</w>
m l
le vel</w>
includ ing</w>
great er</w>
glomer ular</w>
en s
d y</w>
co un
blad der</w>
arter y</w>
ant s</w>
anc ed</w>
an s</w>
am in</w>
am eth
Th ere</w>
TI V
O n
w or
vi v
v ast
su ff
s odium</w>
re gi
re cur
re cor
r in</w>
per c
par t
ne uron
mor rh
mechanis ms</w>
m ou
m ic</w>
inhibit or</w>
inf u
i tive</w>
hyperten sion</w>
he morrh
exper i
er y
d ou
chemo therapy</w>
ch ild
cardio vascular</w>
canc er</w>
ca u
bo dy</w>
arter ial</w>
an esthe
an ce
a vi
EC TIV
A d
therapeu tic</w>
result ed</w>
ph armac
p ine</w>
or g
on e
nicot ine</w>
locom otor</w>
iti es</w>
ing .</w>
indic ate</w>
i ly</w>
hepati c</w>
gl ut
g o
em ent</w>
di ff
de press
da ily</w>
con sist
cl ero
as t</w>
antagon ist</w>
am e
a w
O B
OB J
OBJ ECTIV
I I</w>
1 3</w>
1 2
vit amin</w>
v ac
ud e</w>
tiv ity</w>
struc t
st ro
r hy
rhy th
pri or</w>
poten ti
pos sible</w>
os pit
me mb
m ol
it ed</w>
ish ed</w>
im en
im ag
id oc
he m
he al
expos ure</w>
cont rac
co gn
cis pl
ap p
analy sis</w>
am ong</w>
ab l
CONCLUSION :</w>
Al though</w>
1 ).</w>
( S
% ).</w>
withdraw al</w>
vi e
u res
ti co
sur g
ster one</w>
reco very</w>
recept or
rat s,</w>
r it
pi d</w>
perio d</w>
p tion</w>
on set</w>
o st
o graph
mul ti
mo d
maj or</w>
m R
long -term</w>
l or
k g
k e
in son
in duc
in d</w>
id enti
follow ed</w>
follow -
fi ve</w>
examin ed</w>
evalu ated</w>
c it
b il
b en
atri al</w>
A ll</w>
6 .
( 0.
z e</w>
toxic ity.</w>
throu gh</w>
stim ul
st rat
ser i
s us
re d.</w>
mon it
memb ran
m ine</w>
lik e</w>
le ft</w>
l idoc
know n</w>
iz ation</w>
in s</w>
hear ing</w>
h e</w>
frequ ency</w>
er ,</w>
enceph alo
diag no
cor onary</w>
con di
cogn itive</w>
co ll
cal ci
c at
at ro
ap pro
ag ents</w>
ad j
T R
N e
D e
C I
A N
6 -
1 3
- H
+/ -
( -
v ud
um b
u r</w>
ti s.</w>
the sis</w>
sever ity</w>
remain ed</w>
pro duc
previ ously</w>
prev ent
pres ence</w>
pre gn
ob t
nec ro
met abol
medi ated</w>
los s</w>
ll ed</w>
lithi um</w>
is m</w>
inhib ition</w>
i de
hem oly
ha em
e p</w>
disor der
diseas e.</w>
di vid
cyc lo
cy to
cor rel
con ver
at ed.</w>
ang i
al though</w>
al .</w>
ag ain
ac id
Th e
P ro
M A
C om
C h
yl chol
y l</w>
t r
stud y,</w>
sensi tivity</w>
secon d</w>
s ol
s le
ri b
posi tive</w>
path y.</w>
oten s
on d
na use
mechanis m</w>
m g
m ag
includ ed</w>
impa ir
hour s</w>
heal th
fact or</w>
f ul
f ree</w>
dys kine
di rec
creat inine</w>
b in</w>
ati s
an e</w>
amphet am
al ,</w>
ad riam
ab normal
M D
B A
8 .
1 )</w>
wo men</w>
treatment ,</w>
ti l
ti es</w>
the lial</w>
suggest s</w>
st ar
st and
si m
si c</w>
show n</w>
ro w
recept ors</w>
re sist
psych o
prote ren
ph rine</w>
ph eral</w>
p oly
o ch
m m
m en
is ol
investig ated</w>
in o
immun o
ic ep
ic ac
g am
fluo ro
expos ed</w>
ev o
enz ym
ens ity</w>
dou ble
dose -
dop a</w>
dis c
di a
de l
con f
angi otens
ak e</w>
again st</w>
a th
G rou
C a
2 7
2 ,</w>
- treated</w>
( N
( D
x ameth
ure ,</w>
ti z
ti d
stud y.</w>
stat us</w>
st ra
sen s
py ri
pri m
olog y</w>
n umb
n ucle
ma xim
lo l</w>
le u
k ing</w>
infarc tion</w>
import ant</w>
hum an</w>
he mat
gl yc
fi ed</w>
femal e</w>
ev ents</w>
ery th
dys function</w>
dys func
double -
d oc
cor tico
comple te</w>
ch lor
c es</w>
c er
ar ly</w>
ar d</w>
an emia</w>
amphet amine</w>
ami de
abs ence</w>
ab le
OBJECTIV E:</w>
E P
A c
1 1</w>
( T
( 6
whe ther</w>
ver su
versu s</w>
ty -
tic ally</w>
t en</w>
str ated</w>
seiz ure</w>
s hi
s :</w>
ri al</w>
res ult</w>
present ed</w>
pos sib
pl us</w>
p ent
och ond
oc amp
neuro log
me .</w>
m ia</w>
m as
m .</w>
iso proteren
injur y</w>
inf lu
in ic</w>
hyper alge
h ospit
glut am
gener ation</w>
gen ic</w>
g ran
follow- up</w>
f ic
eff icac
determin ed</w>
deter mine</w>
c re
behavi oral</w>
b ac
ar rhyth
an a
ag ent</w>
ac tin</w>
Tw o</w>
M R
M P
6 %</w>
) ;</w>
wit ch
w il
suggest ed</w>
sub st
s o
s ;</w>
s /
s -
rever sible</w>
reg imen
re s</w>
prot ective</w>
pp ocamp
peri pheral</w>
p ot
on e,</w>
n os
mon ary</w>
ment al</w>
me d
mR NA</w>
m ight</w>
l y.</w>
is on</w>
inhibit ors</w>
hi ppocamp
func tional</w>
ev ent
ep iso
control s</w>
cont aining</w>
calci um</w>
azol e</w>
azep ine</w>
ation s.</w>
associ ation</w>
ami vud
ag es</w>
ag e,</w>
activ ation</w>
ab ly</w>
P G
I V</w>
I I
HB V</w>
1 ,</w>
0 %</w>
we igh
valu es</w>
ur inary</w>
un der</w>
tissu e</w>
suff ici
su al</w>
st atis
sp ont
sign s</w>
se d.</w>
s mo
s m
ri c</w>
rele ase</w>
rat ory</w>
ran ge</w>
pi ratory</w>
otoxic ity</w>
ot on
oc icep
mi gra
los por
lo ro
l ym
l ur
inj ected</w>
health y</w>
g row
experi enc
e ly</w>
e ach</w>
diag nos
demon strated</w>
complic ation</w>
com it
c ul
c an
bio p
b ecause</w>
ate ly</w>
arb it
ap o
and /
and/ or</w>
all y,</w>
al ity</w>
al ine</w>
ag ed</w>
ag e.</w>
ac tive</w>
R e
I m
I N
G F
B C
9 .
. )</w>
( p</w>
x i
v s.</w>
use .</w>
u st
tran si
tim es</w>
tic s</w>
t um
t .</w>
t ,</w>
subj ects</w>
stim ulation</w>
seiz ures
secon d
se x
se en</w>
sam e</w>
s ch
respon ses</w>
res ol
r ati
pul monary</w>
pro p
po sto
pi vac
out com
on ic</w>
ol -induced</w>
obt ained</w>
obser v
ob arbit
mit ochond
m m</w>
lym ph
log ra
lit er
liter at
lidoc aine</w>
leu k
inter v
in duction</w>
in duce</w>
ific ation</w>
i or</w>
hydro x
gam ma
for m</w>
f rac
ex ten
evo ked</w>
er .</w>
em b
elev ated</w>
ear ly</w>
e ven</w>
double- bl
do x
differen ces</w>
cyclo phosph
cyc lospor
cont ra
combin ed</w>
chem ical</w>
ch an
chan ne
ce rebral</w>
carb am
c lear
c es
be ing</w>
amin o
administ r
ad v
ab out</w>
T A
T )</w>
On e</w>
E ff
D )</w>
3 ,</w>
1 7
1 6</w>
1 4</w>
y p
y o
vol um
transpl ant</w>
test ed</w>
t rac
syst olic</w>
syst em</w>
syn dro
sle ep</w>
sign ed</w>
sever al</w>
s a
ret ur
respectivel y.</w>
res piratory</w>
pres su
pre dic
place bo
pi lo
os up
on e.</w>
ocy te</w>
numb er</w>
n am
mus c
me tid
me ,</w>
m an</w>
invol ved</w>
initi al</w>
in ergic</w>
i ed</w>
ho wever,</w>
hi sto
he ad
haloperid ol</w>
fe at
eryth ro
er s.</w>
epilep tic</w>
dose .</w>
do g
disc us
def ici
con comit
ce p
ay s</w>
app ear
ap ine</w>
antagon ist
al one</w>
ag ent
aff ected</w>
ab or
ab il
P re
P ark
N o</w>
C on
C O
6 ,</w>
( n
( 5
% .</w>
% ),</w>
y e
wom an</w>
ur ing</w>
ur ac
under ly
underly ing</w>
tri al</w>
test s</w>
tak ing</w>
sympto m
surg er
sup por
su m
str ic
ster oid
spec if
specif ic</w>
second ary</w>
sec re
saf ety</w>
ri ght</w>
ri g
reac tions</w>
re st
re .</w>
ran g
prol actin</w>
pres sive</w>
pr amine</w>
ph ase</w>
path y,</w>
p ur
neg ative</w>
n ot
ment .</w>
ma int
m ut
l amivud
l am
kidne y</w>
inhibit or
immun osup
im medi
il t
i. p.
hyperten sive</w>
g re
g ast
frequ ent</w>
form ation</w>
far in</w>
fact ors</w>
f oc
efficac y</w>
e qu
dy nam
do es</w>
di aly
de ple
day s.</w>
control s.</w>
ci metid
c ros
atri c</w>
as si
ane ur
ana esthe
adren ergic</w>
ad en
T E
S i
R ec
Park inson
H e
2 1</w>
10 -
1 4
( 4
ye ar</w>
y ro
y oun
vi sual</w>
vast atin</w>
tum or</w>
tre m
ter s</w>
tem por
t ub
t ro
stro k
si rolimus</w>
sensi tive</w>
sco pol
ri ll
re vie
pro b
pre treatment</w>
phen y
p ap
ox if
ocardi ograph
o re
neuro pathy</w>
ner ve</w>
m id
lik ely</w>
impro ved</w>
impa ired</w>
i. v
i f</w>
ho l</w>
group s.</w>
glutam ate</w>
gene sis</w>
fu l</w>
es tim
er ing</w>
effect s.</w>
e very</w>
diagno sis</w>
def ic
de si
cour se</w>
con side
clo z
ci r
ca ffe
c ess</w>
bu pivac
b le</w>
atten u
at h</w>
at eral</w>
at e,</w>
anti depress
aneur ys
amin oph
al co
addi tion</w>
ac cum
S )</w>
O f</w>
K 50
H C
F K50
D O
C R
1 8
1 7</w>
1 ),</w>
tion s.</w>
ti s,</w>
thrombo tic</w>
te d.</w>
t -
system ic</w>
sul f
sub sequ
stri at
st ate</w>
sp inal</w>
si a.</w>
sho w</w>
ser oton
sal ine</w>
s witch
ri pt
ran ial</w>
pro duce</w>
pro ce
pra z
p u
or t</w>
on i
ol e</w>
of ten</w>
o sterone</w>
ne w</w>
ne ed</w>
n ess</w>
multi ple</w>
mou se</w>
mitochond rial</w>
mg/kg )</w>
mg/ d
lit ax
le sions</w>
l arg
it e</w>
is tic</w>
io d
inter sti
inhibit ed</w>
influ ence</w>
inf lam
in divid
im plic
i g
high- dose</w>
hemoly tic</w>
he par
glyc er
fib rill
fail ure.</w>
f low</w>
enh anced</w>
endo thelial</w>
enceph al
ecti vely</w>
e ll
do min
differen ce</w>
de ath</w>
cur rent</w>
contra st
com mon
cholest er
chol inergic</w>
cau ses</w>
calc ification</w>
c T
cT n
b rom
b ed</w>
au to
ati vely</w>
ar th
ap pa
an ic</w>
adj ust
ad e</w>
a thi
W he
T reat
R D
Parkinson 's</w>
P h
A D
5 5
5 ,</w>
2 5</w>
. ,</w>
z ed</w>
ylchol ine</w>
we ight</w>
vari ous</w>
ut aneous</w>
us ers</w>
ur ine</w>
un d
the tic</w>
tachy cardia</w>
t ly</w>
stand ard</w>
st res
si ze</w>
se ven</w>
se g
se d
se .</w>
ri tis</w>
repor ts</w>
reac tion</w>
re comm
pres cri
pre -
pilo car
par tial</w>
ocy to
oc c
no vel</w>
month s.</w>
mis sion</w>
minut es</w>
ma .</w>
m otor</w>
le ad
k in
ist ar</w>
investig ate</w>
intersti tial</w>
indic ating</w>
in sti
imag ing</w>
ic ill
i m</w>
head ac
group .</w>
glomer ul
gl y
experienc ed</w>
enzym e</w>
ent an
en e</w>
en d</w>
ech ocardiograph
e pa
e di
drug .</w>
direc t</w>
contro lled</w>
cont r
complic ations</w>
co -
cispl atin</w>
c h</w>
ay ed</w>
aver age</w>
as e,</w>
ap ri
am oun
al logra
ac hi
a sis</w>
a m</w>
W istar</w>
O ur</w>
I C
D i
D F
D -
C lin
A n</w>
A L
7 -
3 4
2 )</w>
( p
( B
y s</w>
y n
volum e</w>
ver ap
ve ,</w>
um ,</w>
u tive</w>
u s.</w>
u ally</w>
therap y,</w>
ther os
theros clero
the y</w>
th ir
th en</w>
tac rolimus</w>
t es</w>
suggest ing</w>
st on
st e
shi p</w>
s cor
s ),</w>
rever sed</w>
ref o
refo re,</w>
re n</w>
random ized</w>
progres sive</w>
pro v
pro f
posto perative</w>
pl ate
plate le
phen yl
phen obarbit
ph yl
pac litax
p id
or ub
on s</w>
nause a</w>
n or
model s</w>
mo der
min im
micro angio
li f
lev o
l abor
is chem
iod ar
ilt ration</w>
id ity</w>
id al</w>
hyper activity</w>
grow th</w>
glo bin</w>
f ron
ext rac
ex pl
epa m</w>
en ge</w>
e l</w>
di et</w>
descri be</w>
conside red</w>
con sum
comple te
clon idine</w>
child ren</w>
channe l</w>
carcin o
carbam azepine</w>
c ys
be ll
b ar
av oid
ation ship</w>
at ed
an alge
amin ergic</w>
a de
N O
Grou p</w>
D 2</w>
C l
8 0
2 5
(1 0</w>
( V
w ho
who m</w>
vi ral</w>
ve red</w>
ve d.</w>
ve .</w>
val pro
ur b
ud ed</w>
u tion</w>
u pt
transi ent</w>
til ity</w>
struct ural</w>
statis tically</w>
sm all</w>
sh ort
seri ous</w>
se ,</w>
ru s</w>
respectivel y,</w>
repe ated</w>
rel ationship</w>
reg ar
re duce</w>
rat .</w>
ra pid</w>
qu anti
prol act
pr us
perc ent</w>
path o
path ic</w>
partic ip
p ic</w>
p ec
ol ,</w>
ocicep tive</w>
o d
o -
neurolog ical</w>
neuro toxicity</w>
nec ess
n ed</w>
met ast
membran e</w>
med ical</w>
man if
low -
l un
inter ac
ine phrine</w>
increas ing</w>
impair ment</w>
hemorrh age</w>
h er</w>
g est
g ent
frequ ently</w>
feat ures</w>
ext ra
examin ation</w>
evalu ate</w>
ev ed</w>
en ing</w>
en g
ell ular</w>
el der
effect s,</w>
e rebral</w>
drug -induced</w>
double-bl ind</w>
di l
develop ing</w>
cor related</w>
concomit ant</w>
con fir
coca ine-induced</w>
ben e
bas ed</w>
b ul
b enz
ass ess</w>
as one</w>
arg inine</w>
appe a
angiotens in</w>
am ine
ag ic</w>
a therosclero
a re
W ar
Treat ment</w>
T -
PG -
P R
N S
L i
I D
D uring</w>
A t</w>
A S
( O
( H
( E
youn g</w>
wi de
v om
vom it
us ually</w>
um -
tu mor
tion s,</w>
thrombo sis</w>
throm b
th yro
te red</w>
t y</w>
sur viv
sup press
sup ple
secre tion</w>
s k
res h
requ ir
rel ative</w>
reco gn
recei ve</w>
re bell
rati o</w>
qu in
pro sp
prevent ed</w>
prev ent</w>
pit e</w>
physi ological</w>
per sist
pen ia</w>
pa in.</w>
on ucle
ol der</w>
ol ar</w>
o ti
o perative</w>
nitro glycer
n ine</w>
musc le</w>
moder ate</w>
migra ine</w>
metast atic</w>
manif est
man y</w>
mag ne
le s</w>
l ed</w>
iz ed,</w>
int ensity</w>
in suffici
ill ary</w>
i ally</w>
hyperten sion.</w>
hippocamp al</w>
h ic
gran ulo
gra de</w>
gly co
f entan
ext ent</w>
effect .</w>
e de
dyskine sia</w>
disor der</w>
correl ation</w>
convul s
contr ast</w>
cont ri
con sec
compar ison</w>
clear ance</w>
cholester ol</w>
ch o
ch loro
ch all
cardi om
carcin oma</w>
cal e</w>
brady cardia</w>
az ine</w>
ation s,</w>
appea red</w>
ane ously</w>
and ,</w>
an alo
aminoph en</w>
am il
aff ect</w>
adriam ycin</w>
ad ult
activ ity.</w>
abnormal ities</w>
a im</w>
U /
The refore,</w>
Th ir
S t
S P
N -
H g
FK50 6</w>
AT P
A s</w>
A )</w>
5- H
4 %</w>
3 0
2 00</w>
1 %</w>
) -induced</w>
yl line</w>
y r
week s.</w>
urac il</w>
upt ake</w>
to con
ti vi
th resh
te x</w>
t ure</w>
t al</w>
syndro me.</w>
sub c
strat es</w>
sel ected</w>
scor e</w>
resist ant</w>
res t</w>
regi men</w>
ref le
r y</w>
r as
r are</w>
prot ection</w>
pro per
po pul
platele t</w>
perio d.</w>
pec ially</w>
par ame
oxid ative</w>
outcom e</w>
ner v
ne on
maxim um</w>
mat ory</w>
mark ed</w>
lear ning</w>
k .</w>
intra ven
inf ected</w>
ind ing</w>
inc e</w>
impro ve</w>
immunosup pressive</w>
id o
i es</w>
hyperalge sia</w>
hist ory</w>
h orm
gent am
g all
fib ro
f usion</w>
ex hib
et amine</w>
est abl
es pecially</w>
elev ation</w>
dop aminergic</w>
do pa
dist urb
discontinu ation</w>
cys ti
cor tex</w>
contrast ,</w>
contrac ep
consec utive</w>
concl ude</w>
con duc
complete ly</w>
comp oun
co ag
ce rebell
cat al
b or
b ility</w>
at tac
at ed,</w>
an th
amphetam ine-induced</w>
am iodar
all ergic</w>
alco hol</w>
al ized</w>
al apri
addi tion,</w>
acet aminophen</w>
a ud
a em
T M
P O
Ne uro
N O</w>
N MD
I S
F or</w>
F i
D NA</w>
B ecause</w>
B P</w>
7 %</w>
3 )</w>
3 %</w>
20 0
19 9
1 9</w>
0.05 ).</w>
(n =
( M
( 7
y )</w>
wo uld</w>
vi rus</w>
ve hic
v es
um .</w>
ul ative</w>
u ter
u sion,</w>
transplant ation</w>
thromb ocyto
th ase</w>
test osterone</w>
tempor al</w>
syn thase</w>
sus cep
suscep ti
subsequ ent</w>
st ron
st rate</w>
st as
sex ual</w>
s in
s ).</w>
requ ired</w>
repor ted.</w>
recur rent</w>
re x
r o</w>
r in
r he
pyri dam
protein ur
protein s</w>
proce d
pro pi
pro phyl
pro ble
prim ary</w>
previ ous</w>
pressu re,</w>
post -
plic ation</w>
pl ac
pa thetic</w>
over all</w>
or tic</w>
or th
or der</w>
or ation</w>
om ic</w>
oly sis</w>
occur rence</w>
oc ript
ob j
not ed</w>
nitro prus
neuron al</w>
ne w
ne ed
mal i
li po
lead ing</w>
le .</w>
las tic</w>
l ast
l a
l ,</w>
it ory</w>
interv al</w>
ine ster
identi fied</w>
ic e</w>
hypoten sive</w>
hypo thesis</w>
he ad</w>
h al
group ,</w>
gre en</w>
g il
ex er
ex encephal
ex amine</w>
evalu ation</w>
eth yl
est radi
er gen
ent .</w>
em ergen
dynam ic</w>
dox orub
discus sed.</w>
diagnos ed</w>
dia bet
di pyridam
di c</w>
def in
de ath
d- type</w>
continu ous</w>
consist ent</w>
comp on
clon id
ci pi
character ized</w>
catal ep
caffe ine</w>
c al</w>
b one</w>
az epam</w>
av ail
ation al</w>
at in,</w>
as part
anti -
anc y</w>
al s.</w>
al -
adv anced</w>
administr ation.</w>
ab normal</w>
a ro
Whe n</w>
Th ree</w>
SR L</w>
S ub
S E
R es
R D</w>
P er
NMD A</w>
G A
E x
E n
Clin ical</w>
B B
Ac ute</w>
8 %</w>
5-H T
2 %</w>
1 8</w>
1 5
0 ,</w>
- related</w>
- like</w>
- associated</w>
) )</w>
( R
( -1
y ing</w>
xameth oni
wil l</w>
wide ly</w>
w a
vit ro</w>
vi a</w>
ven tion</w>
valu e</w>
use ful</w>
trem or</w>
treat ments</w>
trans por
toler ated</w>
tocon azole</w>
thresh old</w>
th io
t ex
t arg
sympto m</w>
subst anti
stri atal</w>
sti ll</w>
st age</w>
spont aneous</w>
sev of
sevof lur
seroton in</w>
seizures .</w>
se par
scopol amine</w>
s ci
s .
ro ph
rib avi
retur ned</w>
result ing</w>
reg ulation</w>
recomm en
re stric
rat ing</w>
random ly</w>
r ing</w>
r al
psych i
progres sion</w>
prob ably</w>
pro po
pro duction</w>
pilocar p
pi ri
patient 's</w>
path ological</w>
p. o
p as
ox ide</w>
or rh
oph ren
on ce</w>
ol .</w>
occur s</w>
nephro pathy</w>
my o
mus cular</w>
monit or
mon th</w>
mo od</w>
microgram s/
mg/kg ,</w>
meas ure
me g
man ag
m u
m ar
lo p</w>
las t</w>
labor atory</w>
k s</w>
iz ophren
is ed</w>
invol vement</w>
injec tion.</w>
inflam matory</w>
inf orm
in test
id ate</w>
ic ul
hypoten sion.</w>
hydrox y
hepat otoxicity</w>
hemo globin</w>
haem orrh
graph y</w>
foc al</w>
fact or
ev ere</w>
est ro
encephalo pathy</w>
enc es</w>
en alapri
e -induced</w>
drug s.</w>
di et
deve lop</w>
desi pramine</w>
de xameth
de signed</w>
d n
cum ulative</w>
cor tex
convul sive</w>
conver ting</w>
cont ent</w>
con si
co h
cloz apine</w>
clin ically</w>
cimetid ine</w>
cess ation</w>
ce f
ca the
c y</w>
c ent
bu tion</w>
biop sy</w>
bet a</w>
be tic</w>
bar ri
b ri
b inding</w>
atri pt
as pi
as es</w>
anti psycho
ant in
anc es</w>
al tern
agon ist</w>
adren aline</w>
ad ult</w>
acet ylcholine</w>
ac h
W h
U R
S evere</w>
S er
PG- 9</w>
P D</w>
M )</w>
ION :</w>
E Na
CI ,</w>
C )</w>
AN D</w>
AC E</w>
50 %</w>
0 00</w>
(2 )</w>
( mean</w>
( G
y st
we ll
w ent</w>
vol un
volun te
vas o
vas cul
ur g
un chang
um at
ult ra
ul ated</w>
ul arly</w>
u los
toxic ity,</w>
ti l</w>
tak en</w>
syn thesis</w>
suscepti bility</w>
sus p
surviv al</w>
sul ph
subc utaneous</w>
su per
stres s</w>
stra ins</w>
sto pp
st -
sp as
se ly</w>
sco res</w>
sch izophren
s oci
ro w</w>
ri z
rhe umat
re li
re cipi
re al</w>
random ized,</w>
ram idal</w>
ra pid
rapid ly</w>
ra b
r g
py ramidal</w>
psychi atric</w>
pro ces
pre dn
potenti ally</w>
po int
po in
perc ent
percent age</w>
per oxid
pen icill
p ose</w>
p -
ox ic</w>
ot rex
observ ations</w>
o pi
neuron s</w>
nephro tic</w>
morph ine-induced</w>
monit o
mo ve
mo di
min ute</w>
mil d</w>
micro sco
micro g/
mg/m 2</w>
meg al
medic ation</w>
main ly</w>
m ycin</w>
m l</w>
low ing</w>
lim it
level s.</w>
l ac
l .</w>
kg -1</w>
k al
j unc
iz e</w>
iti s</w>
it ation</w>
isoproteren ol-induced</w>
io p
inter val
inter action</w>
injec tions</w>
infarc tion.</w>
inester ase</w>
individ u
in toxic
impro vement</w>
i.v .</w>
hospit al</w>
hist or
h our</w>
gast ric</w>
gamma -
g k
ful ly</w>
fail ed</w>
f ts</w>
f en
ex ce
es s,</w>
episo des</w>
en ci
en .</w>
ec stas
e ph
e f</w>
diseas e,</w>
discontinu ed</w>
dialy sis</w>
dia betic</w>
di stri
demon strate</w>
decreas es</w>
de pression</w>
cyclophosph amide</w>
contracep tiv
consist ed</w>
conf idence</w>
concl uded</w>
coca ine-
chlor ide</w>
child ren
chem ist
character is
ch est</w>
cardiom yo
cardia .</w>
cap sa
brom ocript
bil ateral</w>
b ile</w>
aud itory</w>
as ym
are a</w>
anti bio
anim al</w>
an em
ami l</w>
al k
ak athi
adriam yc
achi eved</w>
ac tic</w>
ac t</w>
ab ine</w>
a reas</w>
a ortic</w>
] o</w>
Z D
Tw ent
T .</w>
S im
N T
N P</w>
L )</w>
I )</w>
H y
Fi ve</w>
Eff ect</w>
E )</w>
D 3</w>
C S
C PA
B oth</w>
B as
9 -
8 0</w>
8 -
5- F
4 00</w>
3 .</w>
2. 5</w>
2 ).</w>
2 %)</w>
10 0
1 6
1 3.
0.05 )</w>
0.00 1).</w>
0. 7
( L
( 95%</w>
( 1</w>
year s.</w>
y cl
y ).</w>
xim ately</w>
week s,</w>
war farin</w>
w all</w>
v inc
v es</w>
us al</w>
ure tic</w>
under went</w>
under go
ulos clero
ul es</w>
uc h</w>
tivi ties</w>
ti tive</w>
the re
th ym
th ia
ten ded</w>
te en</w>
t le</w>
t ain</w>
symptom s.</w>
suppor t</w>
supple ment
subj ect
sub un
su peri
sit es</w>
sit e</w>
sim vastatin</w>
sh e</w>
sensi tiz
se em
s gk
sgk 1
ro ut
riz atript
ribavi rin</w>
ret ro
ret inal</w>
resol ved</w>
ren atal</w>
remain ing</w>
regar ding</w>
recur rence</w>
recor d
receptor s.</w>
reas t</w>
re plac
rat es</w>
rat e.</w>
ran s
radi o
qu es
propo f
propof ol</w>
pro cess
prev al
pol ys
po ster
pheny le
pharmac ological</w>
perform ance</w>
patient ,</w>
pat tern
paclitax el</w>
pa in,</w>
p se
p on
oxy gen</w>
oxif ene</w>
on avi
on ate</w>
ol us</w>
ol i
o pa
nucle us</w>
neuro pathy.</w>
necro sis</w>
n i
n al</w>
mor t
monito red</w>
mod ul
mit ted</w>
microangio pathy</w>
micro g
mic e,</w>
mg/k g/
me tri
mas sive</w>
mali gn
mag nit
m ,</w>
lun g</w>
loc ated</w>
lo z
literat ure</w>
li pid</w>
le sto
lat ency</w>
k g</w>
ist s</w>
is h</w>
intraven ously</w>
intest inal</w>
int ram
int en
insuffici ency</w>
ine ur
induc es</w>
indic ated</w>
in- treated</w>
in do
in dependent</w>
horm one</w>
high ly</w>
hepati tis.</w>
headac he</w>
gram s</w>
glomer ulosclero
gentam icin</w>
gener alized</w>
g um</w>
g ree</w>
g ab
func tion.</w>
fron tal</w>
fibrill ation</w>
fi el
fe w</w>
f y</w>
f iltration</w>
f atal</w>
ex cl
ent ,</w>
en d
elder ly</w>
e pt
e ight</w>
dysfunc tion.</w>
du al</w>
doc um
det ected</w>
del ayed</w>
de x
de pres
de li
de gree</w>
de d.</w>
da ys
da y,</w>
d o</w>
d ensity</w>
cor tis
cor respon
convuls ant</w>
conver sion</w>
conduc ted</w>
con sequ
con sci
common ly</w>
ch arg
but ed</w>
bupivac aine</w>
bo di
block ed</w>
block ade</w>
behavi or</w>
bas al</w>
b reast</w>
b olus</w>
b i
b ec
aw are</w>
ati c
as al
appro ximately</w>
antidepress ant</w>
ance ment</w>
ance .</w>
amoun t</w>
am ne
al ter
al ce
ad ine</w>
act ing</w>
acet am
a ut
a udi
a im
T H
S SR
P T
O n</w>
O R</w>
N one</w>
N S</w>
N R
MR P
L- arginine</w>
Im mun
H g</w>
G ra
G N
F urther</w>
F ol
ES RD</w>
C NS</w>
C I</w>
B D
An ti
ATP ase</w>
7 0</w>
5- fluoro
5 )</w>
4 8</w>
4 0
3 2</w>
2 3</w>
2 .</w>
/ -
(1 5</w>
( 9
wil d-type</w>
wh ere</w>
well -
w ay</w>
vi ous</w>
verap amil</w>
uro mycin</w>
un til</w>
ult ras
tre oti
transplant ation.</w>
tic s.</w>
tic lop
thrombo emb
thir d</w>
ten s
t a</w>
sym pathetic</w>
superi or</w>
sulf ate</w>
strok e</w>
smo king</w>
sion -
side -
si g
sens or
se ve
sch ed
sam ple
s. c
s ing</w>
s c
rit onavi
rig idity</w>
rib ute</w>
res c
reduc ing</w>
recor ded</w>
reco vered</w>
re ten
re si
re se
re p
rang e,</w>
quanti t
pu bl
prophyl actic</w>
prop yl
pro li
proli fer
prevent ing</w>
pra gu
pragu e-
prague- D
prague-D aw
prague-Daw le
prague-Dawle y</w>
poster ior</w>
possib ly</w>
po p
plas tic</w>
plas mic</w>
physi cal</w>
pen s
patho genesis</w>
par acetam
pap aver
p lo
p ep
ot yp
ot er
os f
org an
or ally</w>
onucle o
on omic</w>
on al</w>
ocy an
obser ved.</w>
obj ective</w>
o t</w>
o per
o ff
o d.</w>
nitroglycer in</w>
nerv ous</w>
necess ary</w>
ne ut
n g/
month s,</w>
mol ec
mol /
ml /
minist ration</w>
microgram s</w>
mi x
mg/d L</w>
methyl phen
meth otrex
ment s.</w>
mat ch
mark ers</w>
mark er</w>
mar row</w>
ma z
ma in</w>
m al</w>
los s.</w>
lo x
li g
levo dopa</w>
le ast</w>
le ad</w>
le -
ke toconazole</w>
is ,</w>
ip olar</w>
int ake</w>
infu sions</w>
immun e</w>
i.p. )</w>
hyper kal
hepat oc
hemorrh agic</w>
he x
gra v
gra m</w>
gener al</w>
gall bladder</w>
fic ial</w>
fac ial</w>
f l
exten sive</w>
exhib ited</w>
erg ot
equ al</w>
eph ed
enh ancement</w>
enalapri l</w>
ect om
dyskine si
dose- dependent</w>
disorder s.</w>
diff er</w>
deter i
depress ed</w>
defici ency</w>
de part
de m
d on
cysti tis</w>
cyclophosph amide
creat ine</w>
cour ses</w>
cor ding</w>
cont ribute</w>
condi tions</w>
concl usion,</w>
comp an
coll ag
cerebell ar</w>
cell s.</w>
cTn T</w>
c ult
block ers</w>
bloc k</w>
biop si
bil i
b um
b it
b ipolar</w>
b ing</w>
aut onomic</w>
attenu ated</w>
at tri
at er
at e.</w>
at e-
aspart ate</w>
ari ly</w>
ar rest</w>
appear s</w>
analo gu
an xi
amph oter
amiodar one</w>
amin onucleo
al tered</w>
al le
al bum
aim ed</w>
activ ity,</w>
ac ro
ac compan
a ph
] -
U sing</w>
Th us,</w>
S prague-Dawley</w>
S E</w>
P D
P ,</w>
Na +
N F
L ,</w>
E 1</w>
DO X</w>
C o
C ardi
C ap
C R</w>
B e
B /
Ad ministration</w>
< 0.0
8 ),</w>
7. 5</w>
6 )</w>
3 6</w>
2 7</w>
2 4
2 2</w>
19 8
, 000</w>
( 3.
% ;</w>
wh ite</w>
we ak
viv o</w>
ven tional</w>
us ual</w>
ur ther
ur rent</w>
undergo ing</w>
ul c
typ ical</w>
tre at</w>
toler ance</w>
to pri
to p
to co
ti mo
the m</w>
th ,</w>
tac rolim
syn ap
sup pres
suc cess
star ted</w>
st re
st ained</w>
st able</w>
spont aneously</w>
sion s.</w>
sign al
sh ort</w>
sevoflur ane</w>
sal t-
s he
s al</w>
ro x
ro l
rizatript an</w>
rit er
ris perid
rheumat oid</w>
revie w</w>
resist ance</w>
res on
reson ance</w>
requir e</w>
reg ul
refle x</w>
recogn ized</w>
rec ently</w>
re ly</w>
r ical</w>
r ic
pur pose</w>
pto m
prov ide</w>
propi on</w>
prof ile</w>
pro st
preval ence</w>
predn isol
pre vention</w>
pre treated</w>
pre mat
pre domin
praz ol
pot ent</w>
pot assi
possib ility</w>
pos ed</w>
pilocarp ine-induced</w>
ph r
per me
per it
partic ularly</w>
parame ters</w>
par k
park inson
p ut
p uromycin</w>
p s</w>
p al
p H</w>
over dose</w>
ot ro
ot rans
os ine</w>
org an</w>
ore o
or por
op en</w>
on e-
occur red.</w>
occ ur</w>
oc ular</w>
oc ept
o d-
nor adrenaline</w>
nicot ine-induced</w>
nec k</w>
n oc
my e
mus car
mu co
mort ality</w>
morph ological</w>
monitor ing</w>
mon ke
molec ular</w>
model .</w>
mo re,</w>
mm Hg
methyl -
meth amphetamine</w>
men opa
maxim al</w>
match ed</w>
manag ement</w>
magne tic</w>
m ed</w>
lu co
long er</w>
lon g</w>
lo be</w>
lo ad
lim ited</w>
li gh
lesto lol</w>
le p
le ar</w>
lat er</w>
las ma</w>
lamivud ine</w>
l act
k g/
k etamine</w>
isoproteren ol</w>
isol ated</w>
is ing</w>
insti ll
initi ation</w>
inf ection</w>
in s.</w>
in oma</w>
in contin
immedi ate</w>
if osf
ide ,</w>
id om
ic in-induced</w>
ic ardi
i onic</w>
hy d
h all
graph ic</w>
gene tic</w>
gen ous</w>
g/ d
g em
fol d</w>
fiel d</w>
f lur
f ed</w>
extra pyramidal</w>
ex cre
estim ated</w>
erythro cy
ergot amine
ergotamine /
epilep tic
ephed rine</w>
ent ly,</w>
enci es</w>
emergen cy</w>
el ic
ede ma</w>
ed ly</w>
duc t</w>
dog s</w>
docum ent
dis ru
di ed</w>
di azepam</w>
dexameth asone</w>
det ection</w>
descri bed</w>
descri be
defic its</w>
def ect
day s,</w>
dam age.</w>
cyclospor ine</w>
cros s-
cortex .</w>
consum ption</w>
compoun ds</w>
com pl
co w
car ri
cap illary</w>
ca ref
c riter
block ing</w>
behavi or
barri er</w>
b ur
avail able</w>
atro pine</w>
at tem
at s</w>
appe ti
appe ar</w>
anti gen</w>
anti epileptic</w>
antagonist s</w>
ant s.</w>
am ine.</w>
am ant
alpha- methyl
allogra ft</w>
adjust ment</w>
activ ation.</w>
accum ben
accompan ied</w>
ac u
ac coun
ac cording</w>
a si
War farin</w>
W e
V )</w>
The y</w>
TA M</w>
S he</w>
S e
R en
R )</w>
P lasma</w>
P g
P ain</w>
GA BA
G )</w>
ENa C</w>
D ES
Ca Cl
C D
B y</w>
A R
A ,</w>
9 9
8 ).</w>
50 -
5-fluoro uracil</w>
3 5</w>
3 0-
2 ,
10 (-
1 5-
0. 1</w>
, 4-
(1 .
( AC
( 50</w>
( 10
z e
ze tim
zetim i
year .</w>
yc lo
y :</w>
xamethoni um</w>
war far
w id
vol u
ves sel
ven l
venl af
venlaf ax
vari abl
urther more,</w>
up per</w>
ul l
trans fer
tra in
to in</w>
to ge
ti d</w>
ti ally</w>
thromboemb ol
thrombocyto penia</w>
thia sis</w>
the oph
t or
t oly
t as
syn erg
surger y.</w>
suff ering</w>
sub sti
sub arac
subarac h
subarach no
subarachno id</w>
sub -
stron g</w>
striat um</w>
strat e
ston es</w>
steroid s</w>
ster oid</w>
sp ac
sk in</w>
side -induced</w>
si x
sens ory</w>
seizures ,</w>
se mi
sched ul
sample s</w>
sal t</w>
saf e</w>
s om
s es
s cre
s '</w>
ron id
ri st
reten tion</w>
respectivel y).</w>
res .</w>
rel ap
reg ular</w>
ref l
reac tive</w>
re tic
ran o
ral oxifene</w>
quin ol
pyri dox
publ ished</w>
prop rano
pro por
pro ca
pregn an
pre ad</w>
potassi um</w>
pop ulation</w>
poin t</w>
pl ays</w>
phosph ate</w>
pheny toin</w>
ph thal
pep ti
paracetam ol</w>
par aly
p t</w>
ox et
otro pic</w>
otrans fer
otoxic ity.</w>
oreo ver,</w>
one ph
om as</w>
ol /
occur ring</w>
oc treoti
oc cl
o vari
o ther
no v
no rep
nitroprus side</w>
neuro tens
neuro lep
neg ati
need ed</w>
ne um
n or</w>
n .</w>
mye lo
move ments</w>
mod ulation</w>
min or</w>
min .</w>
mg )</w>
metri c</w>
methylphen idate</w>
met ronid
menopa usal</w>
medic ations</w>
mat ri
magnit ude</w>
m s.</w>
m M</w>
loz enge</w>
lox ac
lo cal
lo ca
loca ine</w>
lit tle</w>
lif e</w>
le gil
larg e</w>
la be
l amin
kidne ys</w>
k e</w>
is e</w>
ir th</w>
intram us
intra renal</w>
interv als</w>
int ro
inhib it</w>
ing s.</w>
ing es
inf er
inf ec
ine- treated</w>
indic ates</w>
inc orpor
implic ated</w>
id ural</w>
id en
hyperten sion,</w>
halo th
group s,</w>
go od</w>
glomerul oneph
gest ation</w>
g luco
g in
g all</w>
fol inic</w>
find ing</w>
f -
experim ent
experi ence</w>
ex ist
ev ent</w>
estradi ol</w>
es cap
er s,</w>
episo de</w>
ep inephrine</w>
ep idural</w>
endo genous</w>
em o
electro cardio
ect ing</w>
e y
e )</w>
dopa -induced</w>
do but
distri bution</w>
disorder s</w>
dipyridam ol
differen tial</w>
diagnos tic</w>
diabet es</w>
di min
der i
demon strates</w>
defici ent</w>
d one</w>
cor tical</w>
control s,</w>
control .</w>
continu ed</w>
consi der
con sti
con i
compon ent</w>
coh ort</w>
clo se</w>
cl assi
cl as
cin ac
cinac alce
chemo therapy.</w>
characteris tics</w>
ch rom
cer tain</w>
cau tion</w>
can n
c li
c ed</w>
bupivac a
bromocript ine</w>
brady kin
bodi es</w>
blo od-
bio chemical</w>
bene ficial</w>
bas ement</w>
bac ter
b asis</w>
b al</w>
avoid ance</w>
attac k</w>
at yp
as ,</w>
arter i
arrhyth mi
arc h</w>
ar m</w>
appeti te</w>
appa rent</w>
apo morphine-induced</w>
anti bodies</w>
ant s,</w>
ant ly</w>
ance ,</w>
analy zed</w>
anaesthe sia</w>
amphoter icin</w>
amin otransfer
am pl
album in</w>
akathi sia</w>
ag gres
ag e
adren ocept
adjust ed</w>
ade qu
addi tional</w>
acro megal
ab o
ab domin
a ort
a k</w>
a c</w>
V P
U n
U -
Twent y-
S cale</w>
S E:</w>
S C
Ren al</w>
R g
Ph armac
Pg p</w>
NR A
NRA 0
MRP 2</w>
METHOD :</w>
M oreover,</w>
M e
M al
L EP
LEP P
L B/
K -
H D
Gra de</w>
Fol lowing</w>
F urthermore,</w>
F K</w>
F )</w>
Eff ects</w>
E P</w>
E D</w>
D ru
D es
C ont
C H
C E</w>
C C
C A</w>
BA LB/
A m
A g
9 ,</w>
8 )</w>
7 5</w>
7 )</w>
5-F U</w>
4 6
4 ,</w>
34 4</w>
3 6
20 -
2 50</w>
2 ),</w>
1. 0</w>
0 %)</w>
/ ml
( range</w>
( I
( +/-
year s,</w>
y et</w>
wor k</w>
wh ose</w>
weigh t,</w>
w at
vomit ing,</w>
vinc rist
vehic le</w>
ve -
vascul itis</w>
vac u
us h
ur ia,</w>
und red</w>
um ar
um -induced</w>
ultras ound</w>
ul f
uc in
typ es</w>
tw ice</w>
tub ular</w>
toxic ities</w>
top ical</w>
to po
to -
ti me,</w>
ti le</w>
thyro id</w>
th us</w>
th .</w>
test ing</w>
te tra
te in
targ et
tachy cardia.</w>
t ut
t ur
t s.</w>
t in
t able</w>
t able
t AM
surger y</w>
ste re
star ting</w>
sp ective</w>
smo k
show s</w>
sh or
separ ate</w>
sec ret
secret ory</w>
se legil
s pi
s over</w>
s ince</w>
s cal
s ar
ru ising</w>
ros s</w>
ro lled</w>
revie w
respon sible</w>
remain s</w>
rele as
rel atively</w>
ref er
reduc es</w>
recommen ded</w>
rec t</w>
re verse</w>
qu e</w>
proper ties</w>
pro vid
pro m
pro fi
pro cess</w>
prim arily</w>
pri ate</w>
prescri bed</w>
pres ents</w>
pregn anc
prednisol one</w>
pre g
preg ulation</w>
polys ac
polysac ch
po or</w>
po d
placebo -
phenyle phrine</w>
phenobarbit one</w>
pharmac o
perit one
patient s)</w>
partic ular</w>
papaver ine</w>
pac t</w>
p- co
p-co umar
p unc
p ron
p renatal</w>
p rac
p .</w>
oxid ant</w>
ox amine</w>
out co
or ity</w>
oph il
one -induced</w>
on in</w>
ol one</w>
ocyan ine</w>
oc ca
o plastic</w>
o ,</w>
nicot inic</w>
neurolog ic</w>
neuro muscular</w>
nause a,</w>
n g
n atri
natri uretic</w>
myo pathy</w>
muscar inic</w>
mus t</w>
mon o
mon g</w>
mo vement</w>
mix ed</w>
mg/ day</w>
mg .</w>
methotrex ate</w>
meth amphetamine-induced</w>
ment ,</w>
medi a</w>
med ull
meas ure</w>
mat o
mark edly</w>
malign ant</w>
maint ained</w>
m ia.</w>
log y</w>
log ical</w>
literat ure.</w>
lin es</w>
lig and
li ght</w>
level .</w>
leuk emia</w>
le t
lat ter</w>
lat er.</w>
las er</w>
lamin a</w>
l ic
l -
k appa
k -
j ects</w>
is ch
intrac erebral</w>
intra peritone
initi ated</w>
infu sion.</w>
inform ation</w>
ind ocyanine</w>
inc id
in st
in de
in ally,</w>
import ance</w>
implic ations</w>
immuno histo
immedi ately</w>
im odi
if ost
idom ide</w>
ici ans</w>
i an</w>
hypoten sion,</w>
hyperkal emia</w>
hist ological</w>
hist amine</w>
high est</w>
hepatoc ellular</w>
hemat oma</w>
h undred</w>
h n
h ab
h ,</w>
granulo mato
glo bul
gl uc
gener ally</w>
gener 's</w>
gen e</w>
gamma -H
g s</w>
g er</w>
g a
fo ot</w>
flu oxet
fic ation</w>
fibro sis</w>
ffe red</w>
fer ri
fail ure,</w>
fac il
f et
f av
expl or
experim ents</w>
exencephal ic</w>
ex cit
ev id
est er
escap e</w>
es tive</w>
epile psy
enh ance</w>
enc y,</w>
en apine</w>
electro n</w>
ed ing</w>
ecstas y</w>
ech ol
ear li
e rec
dos es,</w>
do w
dis charg
di ast
diast olic</w>
di ame
develop mental</w>
des pite</w>
deple tion</w>
defin ed</w>
defic it
de oxy
da y.</w>
d ent
d en
criter ia</w>
confir med</w>
compar able</w>
com pens
coag ulation</w>
co ch
clo sely</w>
chron ically</w>
cholest asis</w>
chall enge</w>
chall eng
ch ic
catalep sy</w>
carcino ma.</w>
canc er.</w>
calc ineur
c ranial</w>
blood- brain</w>
beta- adrenergic</w>
beta 4</w>
behavi ors</w>
b ruising</w>
b re
b irth</w>
b an</w>
auto ph
audi o
atten tion</w>
ation -
at or</w>
asym ptom
ast ro
ast er
ass ay</w>
aspi rin</w>
as signed</w>
as enapine</w>
as c
arth ri
ar t
ar ly,</w>
appro priate</w>
appear ance</w>
antin ociceptive</w>
angio genesis</w>
aneurys m</w>
and ro
analge sic</w>
an ionic</w>
ame li
amant adine</w>
am ine,</w>
am ic</w>
al ox
agon ist
aem ic</w>
ad mitted</w>
acet yl
accumben s</w>
ac ce
abs or
abnormal iti
abil ity,</w>
abdomin al</w>
Y 27
Y27 46
X -
Wh ile</w>
We gener's</w>
W S
W R
UR PO
URPO SE:</w>
U/ L</w>
TR (-
Sub jects</w>
S uch</w>
S /
S .</w>
R ats</w>
Q T</w>
Pre vious</w>
PR L</w>
PA N
P o
P URPOSE:</w>
P <
N G
Me an</w>
MP -
M R</w>
M MP-
M C
M -
M ),</w>
LEPP 1</w>
L Y2746
In trac
In c
H ist
H b</w>
H A
H -
GF R</w>
G SP
G LEPP1</w>
F inally,</w>
F AN
E V
E S:</w>
E NT
E G</w>
E 1
Des pite</w>
Com par
C oc
C G
B ZD
B W
B S
B .</w>
AL F</w>
A s
A rab
A mong</w>
A I
8 00</w>
7 8</w>
7 ).</w>
6 2</w>
5- year-old</w>
5 00</w>
5 .</w>
5 %)</w>
4 4</w>
4 2</w>
4 0-
10 %</w>
1. 5</w>
1 60</w>
1 20</w>
1 ,
0 0
/- )</w>
- free</w>
+ )</w>
(A OR</w>
(2 )-
(+/- )-
( r</w>
( Na
( N</w>
( HB
( 5</w>
( 3</w>
wor sen
wom en.</w>
wit ch</w>
wid es
wides pread</w>
wh ole</w>
wat er</w>
war d</w>
w ays</w>
volunte ers</w>
vi ron
verap amil
venlafax ine</w>
ven til
vast at
vari able
variable s</w>
v s</w>
v oid</w>
v ation</w>
use ,</w>
us ers.</w>
ur able</w>
un usual</w>
un treated</w>
un t</w>
un dic
ult s</w>
ul fi
ucin ations</w>
u do
tri al.</w>
tr ic
toly l</w>
to pro
tiz ed</w>
throu gh
through out</w>
throm bin</w>
ther mia</w>
test .</w>
ter n</w>
ter min
ter but
terbut aline</w>
tacrolim us
t ting</w>
t ory</w>
t onic</w>
t ech
system .</w>
susp ected</w>
sur fac
surfac e</w>
sup pression</w>
suffici ent</w>
substanti al</w>
subj ective</w>
su stained</w>
studi ed.</w>
stre pto
spas m</w>
sol ution</w>
sm all
signal ing</w>
si a,</w>
seri es</w>
seiz ure
secon ds</w>
s qu
s par
s cale</w>
rout ine</w>
ro un
ritonavi r</w>
ri se</w>
retur n</w>
restric ted</w>
resol ution</w>
resi dual</w>
requ i
repe ated
repeated ly</w>
ren tly</w>
ren e</w>
rel ax
regimen s</w>
regimen .</w>
regi ons</w>
reg urg
ref rac
refrac tory</w>
record ings</w>
reco ver
rec ent</w>
re mission</w>
re lev
ra z
ra g
r y
r l</w>
r ho
r e</w>
r TM
ques tion
quantit ative</w>
qu ality</w>
pul se</w>
pse ud
provid ed</w>
proteinur ia.</w>
prot ect</w>
prosp ectively</w>
propor tion</w>
pron oun
pronoun ced</w>
pro toco
pro state</w>
pri locaine</w>
present ing</w>
pregn ant</w>
pre term</w>
pre par
pre dis
praz os
post menopausal</w>
polysacch ar
polysacchar ide</w>
poly morph
placebo ,</w>
pl ied</w>
pl ay</w>
pl atin</w>
pharmac ologic</w>
pha sic</w>
ph a</w>
persist ent</w>
peroxid ation</w>
per icardi
per g
perg ol
pe th
patient .</w>
path oph
pathoph ysi
pat tern</w>
particip ants</w>
parkinson ian</w>
par t</w>
par a
pac em
pacem ak
pa ren
p anic</w>
over dose.</w>
ovari ectom
ovariectom ized</w>
ous ly.</w>
oun d.</w>
ot oc
ost atic</w>
os in
osin ophil
org anic</w>
on g
on 's</w>
odi lat
oc arc
observ ation</w>
ob struc
ob lastic</w>
nov o</w>
normal .</w>
nit ric</w>
nit ed</w>
ng .
ng. /ml
neuro trans
neuro toxicity.</w>
neuro pathic</w>
nephro toxicity</w>
nephro toxic</w>
ne x
n s</w>
n ess,</w>
myocardi tis</w>
monke ys</w>
minut es.</w>
microgram /
microg lial</w>
mi pramine</w>
meth od</w>
metabol ism</w>
met ab
medi ate</w>
me topro
mac roph
ma ,</w>
m L</w>
los art
locom o
loc al</w>
lo l
lipo ic</w>
ligand s</w>
lidoc a
li gi
level s,</w>
le thal
le sion</w>
le d
lat er,</w>
last ing</w>
lamivud ine-
l ing</w>
know led
iti s,</w>
it onin</w>
it h</w>
it ary</w>
ish ing</w>
ischem ic</w>
intrac ranial</w>
intrac or
interval ,</w>
interac tions</w>
insti tu
inhib i
inges tion</w>
ine phr
induc ing</w>
indo l</w>
individ ual</w>
incontin ence</w>
includ e</w>
inc lu
in ity</w>
in a</w>
im pl
im pact</w>
il lu
if edi
identi fi
id ine-induced</w>
ic s</w>
i um</w>
i di
i ble</w>
i -
hypo x
hemat ologic</w>
haloth ane</w>
hal f</w>
haem oly
hab it
h r</w>
glomerulosclero sis</w>
gen ic
gab ap
g y
g e,</w>
find ings.</w>
fentan yl</w>
f ur
ex trem
ex p
evalu able</w>
ev er</w>
estro gen</w>
establ ished</w>
es sen
ergotamine/ caffeine</w>
epileptic us</w>
ence ment</w>
ence .</w>
en viron
en co
em plo
ect ro
ec al</w>
e- control</w>
e ve</w>
drug s,</w>
dow n
dos age</w>
dog s.</w>
doc rine</w>
divid ed</w>
det ect
depend ently</w>
def er
def ects</w>
de generation</w>
de ,</w>
da il
d- generation</w>
cum in</w>
cri tical</w>
cow s</w>
cortico sterone</w>
correspon ding</w>
cor d</w>
contraceptiv es</w>
con ventional</w>
con stric
comple tion</w>
comp ris
comm encement</w>
coll ected</w>
coca ine.</w>
cloz ap
cispl at
cholest atic</w>
chol ine-
children .</w>
chemist ry</w>
character istic</w>
ces sive</w>
cep t</w>
ce ph
cat echol
cas e-control</w>
cardiomyo pathy</w>
cardia ,</w>
cardi otoxicity</w>
cann ab
calcineur in</w>
calc itonin</w>
bu propion</w>
bri ef</w>
bradykin in</w>
ble eding</w>
bili ru
b ron
b ro
b ic
azep am
atro ban</w>
asymptom atic</w>
asal azine</w>
as .</w>
arth ritis</w>
arg atroban</w>
ap ne
anim als.</w>
anesthe sia</w>
an ol</w>
an .</w>
ampl it
amide ,</w>
ameth asone</w>
ameli or
am ine-induced</w>
am ifost
alter ations</w>
allogra fts</w>
al most</w>
af in
adult s</w>
adequ ate</w>
ad ded</w>
acu te
acid .</w>
acid ,</w>
acet ate</w>
abol ished</w>
abo ve</w>
a undic
a ir
Y P
War far
W ith</w>
V N
U- II</w>
U nited</w>
Thir ty-
TR(- )</w>
T est
S u
S ince</w>
S T
S NP</w>
S BP</w>
S ,</w>
Rg 1</w>
Pharmac o
NRA0 160</w>
N I
M y
M or
M A</w>
M ,</w>
L- dopa</w>
L ong
L o
L /
Immun o
IC H</w>
I s</w>
I T</w>
I L-
I -
Hy per
H igh
H er</w>
H e</w>
H IV</w>
Grou ps</w>
FAN F
F rom</w>
ES RD
EP O</w>
Di fferen
De x</w>
D o
CaCl (2)-
CR F</w>
C erebral</w>
C YP
C P
C B
C ,</w>
Bas ed</w>
BALB/ C</w>
B ra
Arab ic</w>
Ad riam
AD AM
A z
9 2
9 )</w>
8 ,</w>
7 2</w>
6 1</w>
6 .</w>
4 0%</w>
4 )</w>
4 ).</w>
3 7</w>
10 3
1. 9</w>
1 4.
1 2.
1 /
1 .</w>
0. 5</w>
/ 8),</w>
- I</w>
( i
( 8
( 2</w>
( 100</w>
ylchol inesterase</w>
yl )
weigh ted</w>
weak ness</w>
war ran
w er</w>
vomit ing</w>
ve in</w>
vast atin,</w>
vari ant</w>
valpro ic</w>
v oc
ure a</w>
urac il
ur ally</w>
up on</w>
up ancy</w>
up .</w>
up -
ultra structural</w>
ulc er</w>
u ti
u pregulation</w>
tumor s</w>
transpor t</w>
trans formation</w>
to b
tissu es</w>
timo lol</w>
tim al</w>
tic -
ti ve,</w>
ti es.</w>
ti az
thromboembol ism</w>
therap y-
theoph ylline</w>
thal idomide</w>
th ors</w>
th or
th en
th ecal</w>
test s,</w>
ter ior</w>
ter .</w>
tein uria</w>
tech ni
tAM CA</w>
t on
t ent</w>
t ardi
tardi ve</w>
t a
syndro me,</w>
synap tic</w>
syn the
switch ing</w>
surg ical</w>
suppor ts</w>
supplement ation</w>
success fully</w>
subject s.</w>
subj ected</w>
su d
studi es.</w>
studi es,</w>
stra in</w>
statis tical</w>
star t</w>
st ret
spec imen
sol u
so me
sle ep
sion s,</w>
sion al</w>
sing le-
simil ar
si z
si dic</w>
si c
si a
short -term</w>
short -
she ll</w>
sgk1 (
sgk1( +/
seve rely</w>
sequ el
sequel a
selegil ine</w>
seem s</w>
sed ation</w>
se em</w>
scre ening</w>
s/ RD
s.c .)</w>
s on</w>
rox ic
rou gh</w>
ron ol
ronol act
rom ol/
ro pi
ri um</w>
rever sib
retic ul
rese arch</w>
requir ing</w>
repor t.</w>
repe titive</w>
ren di
rel ation</w>
regurg itation</w>
regimen s.</w>
regi on
reg res
ref e
refe rence</w>
reduc tions</w>
recipi ents</w>
receptor .</w>
reac h
re sto
re plication</w>
re pa
repa ir</w>
re m
re j
rati o
rat e,</w>
ra re.</w>
punc t
pu t</w>
psycho sis</w>
pseud oli
prov o
prost ag
prostag l
prostagl and
prolifer ation</w>
produc ts</w>
produc t</w>
process es.</w>
proces ses</w>
proble m</w>
pro vi
present ed.</w>
prescri bing</w>
premat ure</w>
predic tive</w>
pre fer
pre ce
prac ti
port al</w>
pod ocyte</w>
po or
pi roxic
physi ci
phosph at
ph y</w>
peth idine</w>
perme ability</w>
per fusion</w>
per azine</w>
pepti de</w>
pen ile</w>
pe ak</w>
pattern s</w>
pathophysi ology</w>
path ology</w>
pas sive</w>
par tially</w>
paclitax el
pacemak er</w>
p ic
p e</w>
p all
oxy gen
out put</w>
ou s,</w>
ou ght</w>
ot al</w>
os sible</w>
os pas
os om
orth ostatic</w>
organ ization</w>
op ic</w>
oni az
ocy tes</w>
occl usion</w>
occ upancy</w>
oc lon
o v
o ro
o pen
norep inephrine</w>
non- selective</w>
nit rendi
ng./ml .</w>
nex t</w>
new bor
neut ro
neurotens in</w>
neuro toxic</w>
neuro protective</w>
neum on
n ociceptive</w>
n imodi
n ight</w>
n ifedi
n ative</w>
n at
n alox
n =
my olysis</w>
mut ations</w>
mul tic
mor b
mod afin
mo tility</w>
mit tent</w>
mis sion.</w>
mid d
microsco pic</w>
microsco p
mic romol/
mg/kg/ day</w>
mechan ical</w>
me ll
mell it
matri x</w>
mas s</w>
manifest ations</w>
man ic</w>
mal tolyl</w>
mal es</w>
maj ority</w>
magne si
ma ze</w>
mR N
m t
m ade</w>
m T
lymph oblastic</w>
low- dose</w>
low ering</w>
losart an</w>
lo od</w>
lithi um-induced</w>
limit ing</w>
ligi ble</w>
li throm
levo dopa-induced</w>
l ing
l ine
l d</w>
know n.</w>
kg )</w>
kappa B</w>
iz ing</w>
isol ated
isolated -H
is oniaz
is on
investig ations</w>
inv a
inva sive</w>
intra thecal</w>
inter mittent</w>
ino gen</w>
injur y.</w>
inhibitor s.</w>
inhibitor ,</w>
inhibit s</w>
infer ior</w>
inf requ
ine 's</w>
ind ol
ind ,</w>
increas ed,</w>
inc t</w>
in te
in si
in ol</w>
impl ant
il l</w>
ifosf amide</w>
identi fy</w>
ide .</w>
i ous</w>
hyper thermia</w>
hyper sensitivity</w>
hydro chloride</w>
ho mo
histo pathological</w>
hippocamp us</w>
high- risk</w>
hi al</w>
hepar in</w>
headac he
he l
haloperid ol-induced</w>
haloperid ol,</w>
hall ucinations</w>
h ol
h en
gra du
glomeruloneph ritis</w>
glo bin
gin ning</w>
gi ven
gast ro
func tion
frequ encies</w>
fo ur
fir st-
fem oral</w>
fe rence</w>
fe ed
f ut
f ound.</w>
f ind</w>
exencephal y</w>
excre tion</w>
ex pres
event s.</w>
evalu ated.</w>
et ax
etax el</w>
estim ate</w>
es s.</w>
es )</w>
erg y</w>
epilep sy</w>
en d-
em ,</w>
elect rical</w>
echocardiograph y</w>
echocardiograph ic</w>
ec it
e zetimi
e ti
e re
e NO
e :</w>
dyskinesi as</w>
drug ,</w>
doxorub icin</w>
dose ,</w>
dos es.</w>
doc etaxel</w>
dobut amine</w>
do myolysis</w>
disturb ance</w>
dist inct</w>
disru ption</w>
dis ulfi
direc tly</w>
dil tiaz
dil ated</w>
di z
determin ation</w>
deteri oration</w>
depart ment</w>
de void</w>
de pri
de n</w>
cyc les</w>
cy tot
cy cl
cros sover</w>
cortico steroid
contri but
consci ous</w>
coni ine</w>
confir m</w>
conf usion</w>
conf oun
condi tion</w>
con junc
con g
con cer
con cent
compar e</w>
collag en
cit abine</w>
cispl atin,</w>
cir cul
cinacalce t</w>
cho w</w>
cas es.</w>
carri ed</w>
carb on</w>
car bo
can not</w>
ca ro
cTn I</w>
c m</w>
bu min
bron ch
block ers.</w>
block er</w>
bl ind</w>
benz yl
aundic e</w>
au thors</w>
atic ally</w>
atherosclero tic</w>
atherosclero sis</w>
at or
at o
at a</w>
as e.</w>
arter io
arrhyth mic</w>
arrhyth mia</w>
ar y,</w>
appro ach</w>
apo pto
apo morphine</w>
ap plied</w>
ap lastic</w>
anti viral</w>
anti tumor</w>
anti body</w>
antagon ized</w>
ant ine
ant .</w>
angiotens inogen</w>
anesthe tic</w>
analy ses</w>
an terior</w>
an ,</w>
amphetam ine.</w>
amp icill
amoun ts</w>
amne sia</w>
aminonucleo side</w>
altern ative</w>
alpha 3</w>
alpha 2
al ter</w>
al s,</w>
al pha</w>
al ong</w>
al one.</w>
al located</w>
al bumin
agent .</w>
ag grav
ag e-
af ety</w>
adrenocept or</w>
aden osine</w>
ac tivities</w>
ac tions</w>
ac ri
able ,</w>
abil ity.</w>
a )</w>
[ Na
[ Ca
X )</w>
WR 24
WR24 25
W O
WO RD
WORD S)</w>
V T
VT E</w>
V PA
V P</w>
UN C
UNC AT
UNCAT ED</w>
Thir ty</w>
TR UNCATED</w>
TR AC
TRAC T</w>
TH P</w>
Si x</w>
Se iz
SSR 103
SC r</w>
S/ Q
S event
S afety</w>
S G
S D
R NA</w>
Q S/Q
Pro teinuria</w>
PD T
P ossible</w>
On co
OBJECTIV ES:</w>
O rg
O C
MET H</w>
M ul
M ost</w>
M ).</w>
Long -term</w>
L ID
L );</w>
J ap
In tra
IL- 3</w>
I GF
H ospit
H 2</w>
GN C
GNC 92
GNC92 H2</w>
GABA (A
G er
F S</w>
EC G</w>
E l
E ight</w>
E M</w>
E EG</w>
Compar ison</w>
Com pared</w>
Cardi ac</w>
CPA P</w>
BS TRACT</w>
B lood</w>
Ad di
A b
A T</w>
A E
< 0.00
9 3</w>
9 3
9 0</w>
9 %)</w>
7 H
7 %)</w>
6 7</w>
6 %)</w>
55 4</w>
5-HT 1
5-HT1 B</w>
5 7
4 9</w>
4 7</w>
4 .</w>
3. 6</w>
3- year-old</w>
3 9</w>
3 4</w>
2. 0</w>
2 8</w>
2 6</w>
2 5%</w>
2 /
14 ,</w>
1 %)</w>
1 %),</w>
0.05 ),</w>
0.0 1).</w>
0. 4
. 0
- dose</w>
- dependent</w>
) :</w>
(A BSTRACT</w>
(2 .
(1 -
(0. 5</w>
(+/-)- PG-9</w>
( range,</w>
( c
( 10-
( 0-
z otoc
z he
zhe im
zheim er
zheimer 's</w>
ym al</w>
yl ating</w>
yl ated</w>
yl ate</w>
yl -
year s)</w>
yc in-
xim al</w>
xi let
xilet ine</w>
x -
x ,</w>
weigh t
week ly</w>
viv o,</w>
vie w</w>
vie w
vi gil
ve d,</w>
vaso press
vaso constric
vas ospas
vas odilat
vacu ol
v ular</w>
v an
uti li
ut ing</w>
ure mic</w>
up- regulation</w>
under taken</w>
under sto
unc lear
unclear .</w>
un known.</w>
un its</w>
un it</w>
un il
ul e</w>
u ses</w>
u l</w>
u e</w>
ty- nine</w>
ty ros
tut es</w>
tub er
tuber c
tuberc ulo
tri ax
tri am
tri al,</w>
treat ing</w>
transplant ation,</w>
trans genic</w>
trans cri
trans amin
tr y
topri l</w>
topo side</w>
toge ther</w>
tiv ari
tivari ate</w>
tis m</w>
tion ally,</w>
tin nit
tinnit us</w>
thrombocyto pen
thi ep
thiep in</w>
there fore</w>
ther ,</w>
then ia</w>
th reat
th at
test ,</w>
ter ato
ter al</w>
tem per
techni qu
te lithrom
te d
targ et</w>
switch ed</w>
sur vi
suppress ed</w>
sug ar</w>
sud den</w>
subsequ ently</w>
sub- T
sub-T en
sub-Ten on's</w>
striat um,</w>
strepto zotoc
strate gi
strategi es</w>
stopp ing</w>
stimul i</w>
stat ins</w>
st one</w>
st aining</w>
st ain
st ages</w>
soci ated</w>
small er</w>
sim ult
signific ance</w>
sign al</w>
sig ma</w>
si s;</w>
show ing</w>
short- acting</w>
sh unt</w>
sgk1(+/ +)</w>
sgk1 (-
sensor ine
sensorine ural</w>
sensitiz ation</w>
sel f-
seem ed</w>
sam ple</w>
sal ine,</w>
sal ic
salic yl
s/RD s</w>
s witch</w>
s lic
s ino
sino atrial</w>
ru m</w>
rou s</w>
ropi um</w>
risperid one</w>
ris ks</w>
ri tis,</w>
rh ab
rhab domyolysis</w>
review ed</w>
rest oration</w>
rest om
respon sive</w>
respon se.</w>
resp ect</w>
res er
repe at</w>
ren in-
relev ant</w>
refer red</w>
recor ds</w>
recor ding</w>
rec all</w>
re uptake</w>
re tri
re presents</w>
ratio s</w>
rat ropium</w>
rac hial</w>
ra re,</w>
rTM S</w>
r yo
r y.</w>
r ar
rar a</w>
r .</w>
r ,</w>
question na
qu ine</w>
pt ed</w>
pseudoli thiasis</w>
provi des</w>
prostagland in</w>
prosp ective</w>
propyl thio
proprano lol</w>
prolact inoma</w>
prolact ine
proces s.</w>
pro min
promin ent</w>
pro chlor
prochlor perazine</w>
press ed</w>
present ation</w>
pregn ancy</w>
predic t</w>
prece ded</w>
pre ci
posto per
post synaptic</w>
post dose</w>
posi ti
polymorph ous</w>
point s</w>
po ison
placebo- controlled</w>
piri form</w>
piri de</w>
pilocar pine</w>
phosph or
phenyl ace
phenyl )
ph y.</w>
perio ds</w>
per son
per for
perfor me
pe g
peg ylated</w>
pe ak
paren teral</w>
p.o .)</w>
p-coumar ate</w>
p us</w>
p ont
p ine,</w>
p el
oxy co
oxif ylline</w>
oxid ase</w>
oxic ill
outcom es</w>
ot opic</w>
os por
or ig
or ide</w>
oper ated</w>
op timal</w>
op tic</w>
on .</w>
of loxac
odi lu
od ds</w>
octreoti de</w>
ocicep tion</w>
oc or
o vascular</w>
o pathic</w>
o me
o ma.</w>
o il</w>
o ds</w>
o 4
o4 36
o436 8
o4368 554</w>
nucle oti
noc k
nock out</w>
no d
neurotrans mit
nephro sis.</w>
nephro pathy.</w>
neph ritis</w>
neon atal</w>
necro sis,</w>
ne ural</w>
n one</w>
n igh
multic ent
modafin il</w>
ml )</w>
minut es,</w>
min )</w>
microgram/ kg/
mg/m (2)</w>
mg/kg ),</w>
mg ,</w>
metronid azol
methyl prednisolone</w>
meth yl</w>
meth ods</w>
metabol it
metab olic</w>
medic ation,</w>
me xiletine</w>
me tic</w>
maz indol</w>
man ia</w>
mal form
magnesi um</w>
m es
m E
mE q
locomo tion</w>
lo we
lipo polysaccharide</w>
lin ked</w>
lif e.</w>
li bit
leuk em
l ate</w>
l )</w>
knowled ge,</w>
k nockout</w>
k ind
it ro
it .</w>
iso flur
is ons</w>
is he
ir rig
ip ratropium</w>
iop am
iopam id
iopamid ol</w>
invol ve</w>
investig ating</w>
investig ated.</w>
intro duction</w>
intrac table</w>
intrac aro
intracaro tid</w>
inter f
interf ere</w>
inten sive</w>
injur y,</w>
injec tion,</w>
inhibit ory</w>
ing u
infu sion,</w>
inf used</w>
induc ible</w>
individu als</w>
indic ation</w>
inde x</w>
incorpor ation</w>
in- converting</w>
in s,</w>
in ess</w>
in ese</w>
in es</w>
in :</w>
in 's</w>
illu strates</w>
if ied</w>
identifi ed.</w>
iden tical</w>
id .</w>
ic k</w>
ic k
ic al,</w>
i.v .)</w>
i. c
i.c .
i.c. v
i gh</w>
hy pe
hy de</w>
hum ans</w>
hour s.</w>
hib ition</w>
hepati tis,</w>
hemoly sis</w>
hemo dynamic</w>
hemo dialy
haemorrh age</w>
ha ving</w>
h is</w>
h er
h ap
gradu ally</w>
glyc ine</w>
glut athi
glutathi one</w>
genic ity</w>
gem citabine</w>
gastro intestinal</w>
gabap enti
gabapenti n</w>
ga ret
g/d l</w>
g reg
g no
frac tion</w>
frac t
fol low</w>
fol ate</w>
fo restom
fo od</w>
flu id</w>
fib rin
fi t</w>
femal es.</w>
feed bac
factor s.</w>
f rag
f lestolol</w>
f if
ey e</w>
extrac ellular</w>
expos ure.</w>
experim ent</w>
exp ected</w>
ex tern
evid ent</w>
et y.</w>
estro gen
establ ish</w>
est er</w>
essen tial</w>
es oph
es :</w>
erec tile</w>
epilepsy .</w>
enc y.</w>
en rolled</w>
en larg
en docrine</w>
em erg
elic ited</w>
elev ations</w>
electro physiological</w>
eff ici
ecit abine</w>
earli er</w>
e titive</w>
e osinophil
e le
e asi
easi ly</w>
dysfunc tion,</w>
dur al</w>
doxorub ic
double-bl ind,</w>
document ed</w>
disturb ances</w>
dis co
dis appeared</w>
dipyridamol e-induced</w>
dipyridam ole</w>
differen ti
diet ,</w>
di d
describe d.</w>
deri v
dem enti
del ta</w>
decreas ing</w>
de hyde</w>
de gre
d P
cytot oxic</w>
cyto plasmic</w>
cycl ic</w>
cy an
coun ts</w>
cortis ol</w>
correl ates</w>
correl ate</w>
convul sions</w>
contrac tility</w>
consequ ences</w>
cong estive</w>
concent rating</w>
con current</w>
complic ation.</w>
compar t
compar ing</w>
comp ound</w>
coll icul
coch lear</w>
cocaine- dependent</w>
co- infected</w>
clin icians</w>
clas s</w>
cir rho
ci garet
choline- devoid</w>
cholest a
chol inesterase</w>
ce .</w>
cathe ter
cas es,</w>
caref ul
cardi otoxicity.</w>
carb ox
car e</w>
capsa icin</w>
cannab is</w>
ca using</w>
c u
bo dy
blad der
bet ter</w>
benz odi
bene fit</w>
be ating</w>
basel ine.</w>
bacter ial</w>
b red</w>
b rachial</w>
b r
b it</w>
ax onal</w>
atyp ical</w>
attri buted</w>
atro phy</w>
ation ;</w>
at es.</w>
aster n</w>
assess ment</w>
as thenia</w>
arthri tis.</w>
arrhythmi as</w>
ar yn
ar tic
ar ch
apne a</w>
ap plication</w>
aort a</w>
antipsycho tic</w>
antin ociception</w>
antidepress ants</w>
antibio tics</w>
anti hypertensive</w>
anth rac
antagonist ,</w>
antagon ism</w>
ant ,</w>
angio graphy</w>
angio graph
aneurys ms</w>
anesthe tized</w>
anem ia.</w>
anem ia,</w>
andro gen</w>
and -
analy sis,</w>
analogu e</w>
anaesthe sia.</w>
an other</w>
an om
an olic</w>
an al
anal ys
an -
amplit ude</w>
amphetam ine,</w>
aminotransfer ase</w>
amino phen
amin es</w>
amifost ine</w>
am oxicill
am e</w>
am bul
am .</w>
alpha-methyl dopa</w>
alpha 2-
alle vi
all y.</w>
all ,</w>
alk ylating</w>
al ospor
al one,</w>
al do
al dehyde</w>
agent s,</w>
agent ,</w>
ag greg
ag es.</w>
aff inity</w>
adv ant
administr ation,</w>
aden ocarc
ad d
activ ated</w>
achi eve</w>
accum ulation</w>
ac ic</w>
ac hol</w>
ac cess</w>
ac c
able .</w>
abl ing</w>
ab und
a y.</w>
a emia</w>
a -
[Na ]o</w>
[Ca ]o</w>
[ 3
[3 H
[3H ]-
Z O
X 3
X3 CR
X ,</w>
Warfar in-induced</w>
VN B</w>
V al
US S
USS ION:</w>
U D
Test osterone</w>
TI ENT
T- cell</w>
T AM
St ud
Sim il
Si rolimus</w>
Ser um</w>
S yst
S even</w>
S O
S M-
S D</w>
S ).</w>
Res ults</w>
Rec urrent</w>
R o4368554</w>
R P</w>
R BC
R AS
RAS T</w>
Pre treatment</w>
Pharmaco kine
Ph ase</w>
PR L-
PG E1</w>
PDT C</w>
PA TIENT
PA N</w>
P O</w>
P N</w>
P -
Org an
Onco logy</w>
O ther</w>
O LT
O HD
NS CL
N- methyl-
N itro
N ine</w>
N icot
N either</w>
N a</w>
Mal e</w>
MP T
M in
M eth
M Z</w>
M T
M M
M K-
LY2746 14</w>
L V</w>
L D
L ),</w>
K etamine</w>
K )-
Inc reas
In ter
In hibition</w>
Immuno histo
IS C
ISC USSION:</w>
ID S</w>
I V
I GN
I D</w>
He al
HO E</w>
HB V
H igh</w>
H S</w>
H 2
H )</w>
GABA(A )</w>
G M</w>
F or
F o
El ectro
E astern</w>
E E</w>
D- penicill
D ata</w>
D a
D ISCUSSION:</w>
D 1</w>
Com bin
Co operative</w>
Ch inese</w>
CG RP</w>
CA SE</w>
CA B
C a</w>
C Y</w>
Be fore</w>
BZD s/RDs</w>
BD 10
BC -
BA EP</w>
B P)</w>
B MC
B 12</w>
Al zheimer's</w>
Addi tionally,</w>
Ad verse</w>
AT T-
A to</w>
A rg
A r
A X</w>
A IDS</w>
A BC-
A -
9 ),</w>
9 %</w>
9 %).</w>
8 2</w>
8 +/-
8 %)</w>
7H 6</w>
7 ,</w>
6- week</w>
6- OHD
6 5</w>
6 0
55 5
5 8</w>
5 5</w>
5 ),</w>
5 %,</w>
4- year-old</w>
4- mg</w>
4 ),</w>
3- 4</w>
3 8</w>
3 3
3 0%</w>
20 %</w>
2 9</w>
2 %.</w>
12 )</w>
1. 3</w>
1. 0
1 ;</w>
1 20
1 2-
1 0.
0.00 1)</w>
0.00 1),</w>
0. 5
/ d
/ J</w>
/ 2
/ -</w>
. (ABSTRACT</w>
,4- di
, K)-
+/ -1
) O
(c )O
(P D)</w>
(P <
(Na ,K)-
(N S
( f
( K
( F
( >
( 5.
( 4.
z ido
zido vud
yl l
yl en
yl ase</w>
year ,</w>
yc in.</w>
x anol</w>
worsen ing</w>
wor king</w>
wor k
withdraw n</w>
withdraw al.</w>
warfar in-
war ds</w>
wa y.</w>
wa ve
w sin
vigil ance</w>
vi r
vi gab
vigab at
vi anolic</w>
ven ess</w>
vehic le
ve ment.</w>
ve lop
velop ment</w>
vasoconstric tion</w>
variabl es.</w>
van ishing</w>
valpro ate</w>
v es.</w>
us t</w>
ures ,</w>
ure th
ur inol</w>
ur ia.</w>
ur aemic</w>
unil ateral</w>
unchang ed</w>
un i
un e</w>
un d</w>
un able</w>
ub ated</w>
u ded.</w>
tyros ine</w>
tw o
tur nal</w>
tric ycl
tri fluoro
transpor ter</w>
trans mission</w>
train ing</w>
train ed</w>
tr ated</w>
toler ated.</w>
toler ability</w>
tob ram
to ward</w>
tion -
ticlop idine</w>
tic- uraemic</w>
tic -like</w>
ti ple</w>
ti me
threat ening</w>
thor acic</w>
that ,</w>
tetra hydro
test s.</w>
ter s.</w>
ter odi
ter fen
ter ,</w>
ten d
te rene</w>
te j
te a</w>
tas k</w>
t witch
t s,</w>
t rou
t es.</w>
synerg istic</w>
syn thetic</w>
symptom s,</w>
symptom atic</w>
surger y,</w>
sur ve
sur roun
surroun ding</w>
suppress ants</w>
suppres sion.</w>
sup ra
sup port
sulph asalazine</w>
subun its</w>
sub group</w>
su xamethonium</w>
su m</w>
su ffered</w>
strok e.</w>
stra ins.</w>
stimul ating</w>
stimul ant</w>
ste in's</w>
st ren
stren g
st radi
stradi ol</w>
st ly</w>
st in
squ am
squam ous</w>
spi ronolact
spac e</w>
sp ectively</w>
sp ect
spect rum</w>
som at
smo oth</w>
slic es</w>
sin us</w>
sim vastat
significant .</w>
sign s.</w>
sig ma
side- effect</w>
side s</w>
si veness</w>
si vely</w>
si rolim
shor ten
sh am
sgk1(- /-)</w>
sex ,</w>
ser ve</w>
sensi tivities</w>
semi -
seizure -
seiz ure.</w>
seg ments.</w>
seg mental</w>
sed ation,</w>
secon d-generation</w>
sec tional</w>
se pt
sept al</w>
se p
schizophren ia</w>
schizophren ia.</w>
schedul ed</w>
sar al
saral as
salt- load
salt-load ed</w>
sal vianolic</w>
s low</w>
s ligh
s ha
s ess
s es.</w>
roph il</w>
ron ic</w>
ro se</w>
ro hn
rohn 's</w>
rig id
ri m
retro spectively</w>
retri ev
resto red</w>
respectivel y)</w>
respecti vely</w>
res s</w>
requi res</w>
replac ed</w>
regres sion</w>
regar d
regard less</w>
reduc ed,</w>
recur ren
recover y.</w>
recomm end</w>
reb ro
reach ed</w>
reac tion.</w>
re produc
re present</w>
re ment</w>
re main</w>
re ad
re -
rang ed</w>
radio therapy</w>
ra ther</w>
ra ised</w>
r rol
qu ired</w>
pyridox ine</w>
py rrol
psycho tic</w>
pse udo
protoco l</w>
proteinur ia,</w>
prot ected</w>
proper ties.</w>
prom ot
progres sed</w>
profi les</w>
proced ures</w>
proced ure.</w>
proce du
procedu res.</w>
proca ine-
proca in
proble ms</w>
prob able</w>
pro ximal</w>
pro mis
pro gno
prev ents</w>
pregnanc y,</w>
pregnan olone</w>
preci pit
pre- treatment</w>
pre- test</w>
pre operative</w>
pre lim
prelim inary</w>
pre clinical</w>
prazos in</w>
prazol am</w>
potenti ated</w>
postoper atively</w>
popul ation
poly drug</w>
pol ar
po real</w>
placebo .</w>
pl ed</w>
pl ayed</w>
pit u
phthal mo
phenylace tic</w>
phen om
phenom en
phen ace
phenace tin</w>
ph on
ph an</w>
perio d,</w>
pergol ide</w>
performe d.</w>
per man
pent ylen
pent oxifylline</w>
pent obarbit
pe di
pati al</w>
path ologic</w>
paraly sis</w>
par alle
pap illary</w>
pap er</w>
p neumon
p ine.</w>
p ed
oxyco done</w>
ox y-
outco me.</w>
ous ly,</w>
ot oxic</w>
ost e
oste o
osom al</w>
os yn
os tig
os mol
org ans</w>
or aph
oraph ob
or able</w>
oph thal
on is
on ic
onic id</w>
olog ically</w>
ograph ic</w>
odilu tion</w>
occa sion
ob ut
o z
o ve
o sis</w>
o metric</w>
not ed.</w>
normal ized</w>
normal -
noc turnal</w>
new er</w>
neuro pathy,</w>
ner .</w>
nephro li
negati ve,</w>
need le</w>
ne arly</w>
n ig
n e</w>
n a</w>
n M),</w>
mut ation</w>
multicent er,</w>
morb idity</w>
month .</w>
monit or</w>
ml/ 100</w>
minim um</w>
minim al</w>
min al</w>
mil li
mil k</w>
microg/ side
mg/kg .</w>
mg/kg ).</w>
metopro lol</w>
metabol ite</w>
metabol is
met h</w>
men ing
membran es</w>
medic ation.</w>
medi al</w>
mechanis m
measure ment</w>
me trial</w>
me f
mef lo
mat ter</w>
manifest ation</w>
man ner.</w>
man ,</w>
maint en
mainten ance</w>
macroph ages</w>
m ia,</w>
m arg
m G
mG lu
mGlu R
lymph oma.</w>
lu x</w>
lu minal</w>
lop urinol</w>
log ic</w>
lev ofloxac
lethal ity</w>
le sions.</w>
le g</w>
le d,</w>
lact am</w>
lac k</w>
l s</w>
l ind
l ess
l er
l eng
kin ase</w>
kidne y,</w>
kg (-1
k et
j ud
j u
iz ol</w>
it s.</w>
it al</w>
isoniaz id</w>
isolated-H IT</w>
ir reversible</w>
ir e</w>
ip )</w>
iop rine</w>
io di
iodi xanol</w>
intraperitone al</w>
intramus cular</w>
intramus cul
intra -
intoxic ation</w>
inter ven
inter fer
interfer on</w>
int ub
instill ation</w>
initi ally</w>
ing ly,</w>
ing est
inf iltration</w>
inf ant</w>
inephr ine.</w>
ine d.</w>
ine ;</w>
ine /
individu als.</w>
indic ative</w>
in yl</w>
in ser
impair ments</w>
immuno deficiency</w>
imag ing.</w>
im in
im al</w>
if y</w>
id ation</w>
ic ally,</w>
ic ,</w>
i.c.v .)</w>
i. p.</w>
i. m.</w>
i ven</w>
i th
i on
i es.</w>
i es,</w>
hyperalge sic</w>
hyperalge sia.</w>
hyper prolactine
hydrox y-
hy p
hour s)</w>
hospit al.</w>
hospit al
homo gen
ho od</w>
histor y,</w>
high ligh
hepat ocyte</w>
hel p</w>
hear t.</w>
h loro
gluco cortico
glomerul i</w>
globul in</w>
given .</w>
gi rl</w>
gener ated</w>
gen otyp
gen e-
gamma-H CH
g r
g on
g li
g ain</w>
g .</w>
fut ure</w>
ful l</w>
fu sidic</w>
frac ture</w>
form e</w>
fluo resc
fibrin olysis</w>
facil it
fac t</w>
f le
f in
f ever</w>
f at
f ast
f asc
expos ure,</w>
exist ing</w>
excl uded.</w>
exce ption</w>
exce ed
ex cessive</w>
ex cept</w>
esoph age
esophage al</w>
erythrocy te</w>
erythro id</w>
eryth em
ere sis</w>
epi thelial</w>
enti re</w>
ent s.</w>
endo plasmic</w>
endo metrial</w>
encephalo pathy.</w>
encephalo pathy,</w>
en ed</w>
emplo y
emo tional</w>
emb ryo
em pha
electro encephalo
electro convulsive</w>
el uc
el imin
effici ent</w>
eff ectively</w>
edi atric</w>
ed :</w>
ecti ve,</w>
ect ed.</w>
ear ch</w>
eNO S</w>
e red.</w>
e ligible</w>
e igh
e f
e .
dynam ics</w>
dy stro
dy ston
dro wsin
don or
disorder .</w>
discus sed</w>
discharg e</w>
dis appearance</w>
diff ic
diet .</w>
dic hloro
di ethyl
determin ation.</w>
det ect</w>
det ail
descri b
describ es</w>
des ferri
depri vation</w>
depres sion.</w>
dent ate</w>
del ay</w>
degre es</w>
defer oxamine</w>
dec line</w>
death s</w>
death .</w>
de pressive</w>
day time</w>
day -old</w>
dP /d
dP/d tej
d s,</w>
d ry</w>
d ram
d ine</w>
d ental</w>
d ap
d ;</w>
cysti tis.</w>
cyclospor in</w>
cyclophosphamide -induced</w>
cur cumin</w>
cor rect</w>
contri bution</w>
contri buted</w>
contrac tions</w>
continu e</w>
consum ing</w>
consider ably</w>
consi der</w>
consci ous
conjunc tion</w>
condi tions,</w>
concomit antly</w>
con st
con duction</w>
compris ed</w>
complic ations.</w>
complic ated</w>
comple x</w>
comple ted</w>
compl ained</w>
compens atory</w>
comp etitive</w>
combin ations</w>
com a</w>
com a,</w>
collicul us</w>
collag en</w>
coh ort
coag ul
clozap ine.</w>
clo mipramine</w>
clin ic</w>
cl im
cl ar
cit rate</w>
cis e</w>
cimetid ine.</w>
chloro procaine-
chemo therapeutic</w>
chang es,</w>
chang ed</w>
ch ymal</w>
ceph alospor
cell ular</w>
cell s,</w>
cef triax
cef onicid</w>
cef az
cefaz ed
cathe ter</w>
careful ly</w>
caref ul</w>
carcino gen
carbo platin</w>
carbam azep
carb achol</w>
carb ach
capsa icin-induced</w>
canc er,</w>
c r
c ent</w>
c all
but able</w>
brady cardia.</w>
bor n</w>
block ade
biopsi es</w>
bio psy
bin o</w>
bic arb
bicarb onate</w>
bet al
benzodi azep
bec ame</w>
be ginning</w>
bar ic</w>
b ular</w>
b stein's</w>
b is
b ine</w>
b h</w>
b est</w>
b al
az ath
avoid ed</w>
autoph agic</w>
attri butable</w>
attenu ation</w>
attem pt</w>
attem pt
attac k.</w>
associ ations</w>
asal az
as p
arb am
ar m
ar d
apopto tic</w>
anxi ety</w>
antine oplastic</w>
antibio tic</w>
anti thyroid</w>
anti oxid
anti hyperalgesic</w>
anti convulsant</w>
anti coagulation</w>
anthrac ycl
anom al
ang es</w>
anc er</w>
analys ed</w>
analy ze</w>
analo g</w>
analge sic
analge sia</w>
an encephal
an e,</w>
an dom
amino glyco
amin o</w>
amil oride</w>
amide .</w>
ambul atory</w>
am izol</w>
am ine-
am ent</w>
alpha2 ABC-
alpha- lipoic</w>
aldo sterone</w>
al ways</w>
al lo
al fentan
air way</w>
ain s</w>
aggres sive</w>
agent s.</w>
ag oraphob
ag ain</w>
adult s.</w>
adj unc
adenocarc inoma</w>
ad mission</w>
acet aminophen
acce ler
acc id
ac tion.</w>
ac ross</w>
ac quired</w>
absor ption</w>
abnormaliti es.</w>
ab use</w>
ab stin
[ CI
[ 2-
ZO -1</w>
X3CR 1</w>
X- 2</w>
X .</w>
W ith
U/ L);</w>
U se</w>
U M
UM MA
UMMA R
U C
UC T
UCT ION:</w>
TR I</w>
TM P</w>
TE T</w>
TE R
TAM -induced</w>
TA F
T ran
T en</w>
T RO
TRO D
TROD UCTION:</w>
T NS
T G
T D
TD P</w>
T ,</w>
Stud y</w>
Si gn
SP EC
SG K
SGK 1</w>
S te
S ou
S ex
S UMMAR
S H</w>
Res earch</w>
Re ver
Re duction</w>
R ep
R S</w>
R AM
R ,</w>
QS/Q T.</w>
PT CR</w>
P L
P A</w>
P 120
P .</w>
OLT X</w>
O ral</w>
O P
O D</w>
O )</w>
NO -
N-methyl- D-
N-methyl-D- aspartate</w>
N ational</w>
N AM
N )</w>
My ocardi
Mul tiple</w>
MK- 80
MD A)</w>
M i
M Hb</w>
L- NAM
L- DO
L e
L abor
L .</w>
J une</w>
Im pro
IN TRODUCTION:</w>
IN TER
IGF -
I ts</w>
I T
I N</w>
I F
I .</w>
Hospit al</w>
Heal th</w>
HC F
HA AR
HAAR T</w>
H z</w>
H is</w>
H aem
GSP E</w>
G iven</w>
G SH</w>
G R</w>
F lestolol</w>
F if
F A
FA N</w>
F ,</w>
E1 8.
E valu
E v
E stradiol</w>
E bstein's</w>
E S</w>
E R
E D
E .</w>
Dru g
De velopment</w>
De li
DES IGN
D op
D ex
D SM-
D S</w>
D N
D CE</w>
Coc aine</w>
Ch ronic</w>
Ch anges</w>
Cap sa
CS S</w>
CPA /
CO X-2</w>
CB Z</w>
CA )</w>
C yclo
C urrent</w>
C ur
C s
C rohn's</w>
C or
C lo
C entr
C ancer</w>
C al
C X3CR1</w>
C T</w>
C N</w>
C M
C 57
C57 B
C .</w>
BC N
B NP</w>
B A</w>
B 2</w>
B )</w>
An gi
An aly
ATT- ALF</w>
AT T</w>
AT P</w>
AC h</w>
A u
A t
A g</w>
A 1</w>
A /J</w>
8. 9</w>
7. 0</w>
7- year-old</w>
6 ).</w>
555 62</w>
5- hydroxy
5- Az
5 9</w>
4 50</w>
3. 3</w>
3. 0
3 1</w>
3 00</w>
3 ,
3 ).</w>
3 %).</w>
27 %</w>
2- chloroprocaine-
2- 3</w>
2 D
17 beta-
15- minute</w>
1/ 2</w>
1. 6</w>
1 6.
1 50</w>
1 5.
1 40</w>
1 -1
0.0 1
0. 6
0. 3</w>
0. 3
-H IV</w>
- positive</w>
- operated</w>
(p H</w>
(S BP)</w>
(S ):</w>
(P =
(O R
(Na,K)- ATPase</w>
(N MDA)</w>
(HB V)</w>
(A D
(9 5</w>
(6 )</w>
(3 ,4-
(2. 0</w>
(2 -
(1 50</w>
( up</w>
( given</w>
( a</w>
( PAN
( MA
( EC
( <
( 40</w>
( 4-
z onis
z ep
z ation</w>
youn ger</w>
yl transfer
year s;</w>
yc in-induced</w>
y- increasing</w>
y tid
ytid ine</w>
y ;</w>
xi ous</w>
x es</w>
x anth
x .</w>
wom en
wh at</w>
weight )</w>
week s)</w>
we l</w>
we l
wel ve</w>
warfarin- drug</w>
wa ve</w>
w ise</w>
w is
w ide</w>
w av
wav es</w>
w ant
want ed</w>
volu me.</w>
volu me,</w>
voc al</w>
vit y,</w>
vit ro
vir tu
vi ation</w>
vessel s</w>
ves se
vesse l</w>
ver .</w>
ventil ation</w>
ven s-
vens- J
vens-J o
vens-Jo hn
vens-John son</w>
vel y,</w>
ve red.</w>
ve loc
vasospas m</w>
vasopress in</w>
variabl es,</w>
vari ety</w>
vari ed</w>
vari ants</w>
vari able</w>
valu es.</w>
valpro e
valproe x</w>
val vular</w>
v or
v ino
vino rel
vinorel bine</w>
v ical</w>
v ar
v age</w>
v ag
uter o</w>
uter ized</w>
uter ine</w>
ut com
ush -
ush- evoked</w>
use d.</w>
us ulf
urg ent</w>
uracil .</w>
ur ic</w>
uni que</w>
understo od.</w>
unchang ed.</w>
unchang ed,</w>
unc ular</w>
unc er
un known</w>
un it
unit ,</w>
un event
un affected</w>
ul cer
uc us</w>
uc hen
uchen ne</w>
u sion-
usion- weighted</w>
u si
usi ve.</w>
u ation</w>
u ary</w>
tw o-
tw in</w>
tur no
turno ver</w>
tumor s.</w>
tuberculo sis</w>
tub ules</w>
tu tion</w>
tro p
tro le
trole andom
tricycl ic</w>
triam terene</w>
tri mo
trimo x
tri gem
tri als</w>
tre n
transplant ed</w>
trans fusion</w>
trac h
trach lor
toler ated,</w>
toge ther,</w>
to m
to genic</w>
tissu es.</w>
tion :</w>
timo lol
ticlop idine-induced</w>
tic s,</w>
tic -induced</w>
ti ve.</w>
ti trated</w>
ti t
thou ght</w>
there af
ther s</w>
the l
thal amic</w>
th us,</w>
th o
th is,</w>
th ick
th es
tern ational</w>
ter ms</w>
tend ency</w>
temper at
telithrom ycin</w>
te trachlor
te d,</w>
target ed</w>
tachy cardia,</w>
table ts</w>
ta il</w>
t ru
tru e</w>
t es,</w>
t al
t ain
t ail
tail -
system s</w>
system ,</w>
susp ected.</w>
sus pen
surve ill
surveill ance</w>
support ing</w>
supple ment</w>
super oxide</w>
sul in
sulin da
sulinda c</w>
suc rose</w>
suc cin
succin ylcholine</w>
substi tution</w>
subst ance</w>
sub set</w>
sub clinical</w>
su ic
struct ures</w>
struct ure</w>
struct urally</w>
stron g
strong ly</w>
stret ch
strate g
stopp ed</w>
sti l
stil be
stilbe stro
stere otyp
stat e.</w>
stand ing</w>
st om
st a
spironolact one</w>
specimen s</w>
spec ific
spas tic
spar te
sp e
some times</w>
sol id</w>
soci al</w>
smok ers</w>
sligh tly</w>
sk ill
simult aneously</w>
side- effects</w>
si zed</w>
si ent</w>
si ci
sici ans</w>
si an</w>
shor ter</w>
sham -operated</w>
sh oc
sh ap
sever ity.</w>
seroton ergic</w>
ser ved</w>
ser ial</w>
sequela e.</w>
sel ectively</w>
sel ection</w>
seg ments</w>
se tting</w>
se ter</w>
scopol amine.</w>
sco re.</w>
salt- deple
salicyl ic</w>
s.c .</w>
s- -
s w
s ought</w>
s lowing</w>
s low
s light</w>
s clero
s can
s atis
s a</w>
s P120
ru sion</w>
ru pt
ro tox
ro striatal</w>
ro d
rit od
ript yl
rib osomal</w>
ri f
rif amp
ri es</w>
rh es
rhes us</w>
reversib ility</w>
rever sal</w>
retro viral</w>
retro spective</w>
retriev al</w>
reticul um</w>
result s.</w>
respon se,</w>
respon ding</w>
respon ded</w>
resp ective</w>
reser pine</w>
rese m
res ,</w>
replac ement</w>
renin- angiotensin</w>
ren zep
ren ovascular</w>
reli ef</w>
releas ing</w>
rel im
rej ection</w>
regi on</w>
reg ist
recommen ded.</w>
receptor s,</w>
receptor -
reas on
reas .</w>
reac tions,</w>
re presented</w>
re organization</w>
re mo
re mark
re ati
raz epam</w>
rang e.</w>
radi ation</w>
rac lon
rab bit</w>
ra rely</w>
ra m</w>
ra dic
ra d
rad ical</w>
r inary</w>
r in.</w>
r in,</w>
r ically</w>
r amine</w>
quinol ine</w>
quin ol</w>
qu ad
pyrrol ate</w>
put ative</w>
punct ate-
punctate- evoked</w>
psych os
provo ked</w>
prot in
prosp ective,</w>
prophyl ax
prolifer ative</w>
progres sion.</w>
prof loxac
proced ure</w>
procain amide</w>
pro thrombotic</w>
pro posed</w>
pro pa
propa fen
pro gn
progn os
prognos tic</w>
pro found</w>
pressu res</w>
present ,</w>
pres um
pres er
premat ure
pregnanc y.</w>
predomin antly</w>
predis posed</w>
predic t
pre- existing</w>
pre treatment.</w>
practi tion
pr ick</w>
pp ing</w>
potenti ation</w>
post ulated</w>
possib le.</w>
posi tion</w>
poor ly</w>
pont ine</w>
polys om
polysom no
poly uria</w>
poin ter</w>
po ro
po i
poi e
pl u
pl at
piroxic am</w>
pilo t</w>
pic rotox
pi renzep
physici an</w>
physi ologic</w>
phenyl) ethyl
pharmaco dynamic</w>
perman ent</w>
perio dic</w>
peri vascular</w>
perc utaneous</w>
per in
pentylen e
pentobarbit al</w>
pent az
pentaz oc
pen ia.</w>
pedi atric</w>
ped uncular</w>
peak ed</w>
patient s;</w>
patient s),</w>
path way</w>
path way.</w>
parame ters.</w>
paralle l</w>
para di
paradi g
par at
par asym
parasym pathetic</w>
par amethasone</w>
pall idal</w>
pal sy</w>
pa rox
pa infu
painfu l</w>
pa fo
pafo x</w>
p.o .,</w>
p.o .
p tive</w>
p ly</w>
p ine-treated</w>
p in
p ill
p g/
p <0.00
p <0.0
oxygen ation</w>
oxy- 4-
ox ant
ox amine.</w>
ov ine</w>
outco me,</w>
out put
ous tic</w>
otoxic ity,</w>
ot s</w>
ot o
ost aining</w>
os ar
oro facial</w>
or i
or bit
orbit al</w>
opi oid</w>
opi oid
oph osph
open -
onucle ar</w>
on ly.</w>
ome prazol
om er
om as
ol ig
ol g
olg i</w>
ograph y</w>
off er</w>
oclon al</w>
occasion ally</w>
obt ain</w>
obstruc tive</w>
ob last
o sis,</w>
o quinol</w>
o d,</w>
nucleoti de</w>
nucle i</w>
nucle ar</w>
non small</w>
no xious</w>
no w</w>
nitroprus side-induced</w>
nitro -
nitrendi pine-treated</w>
nimodi pine</w>
nig rostriatal</w>
ng/ mou
newbor n
neuron s.</w>
neuro psychiatric</w>
neuro physiological</w>
neuro cognitive</w>
nephro toxicity.</w>
nephro toxicity,</w>
nephro pathy,</w>
neon ates</w>
neon ates.</w>
necro sis.</w>
ne ur
ne oplastic</w>
ne ither</w>
nalox one</w>
my asthenia</w>
multi forme</w>
mul tivariate</w>
mt DN
mou th,</w>
mou th
morph ology</w>
morph ine.</w>
mor ning</w>
mon onuclear</w>
mon oclonal</w>
modi fied</w>
model ,</w>
mo thers</w>
mo ther</w>
ml/ min</w>
mitochond ri
mit ral</w>
mit oxant
mis sion,</w>
min ant</w>
min -1</w>
min -1
min ,</w>
mil d-type</w>
migra ine.</w>
midd le-
middle- aged</w>
mid azol
microg/ kg)</w>
microg li
micro vascular</w>
mg/m 2/
mg/m 2,</w>
mg/ day
mg/ K
metronidazol e-induced</w>
metronid azole</w>
methyl ation</w>
meth oxy-4-
meth od.</w>
meth od
meth ac
metabolit es</w>
metabol iz
met oc
met amizol</w>
medull ary</w>
medi um</w>
medi ating</w>
mechanis ms.</w>
meas uring</w>
meas ures</w>
me l
me ans</w>
mat er
mater nal</w>
mas seter</w>
man .</w>
mal e,</w>
mal e
maint ain</w>
mT o
mRN As</w>
mEq /
m uch</w>
m on</w>
m mol/
m im
m L/
m 2</w>
m .,</w>
ly )</w>
lu pus</w>
lowe red</w>
los s,</w>
loc us</w>
lo fen
literat ure,</w>
lim it</w>
lim b</w>
lif e-
life- threatening</w>
lidoca ine.</w>
libit um</w>
leuk o
lead s</w>
le ven</w>
le ,</w>
lat eral</w>
last ed</w>
larg er</w>
lamivudine- resistant</w>
lact ate</w>
la betal
l ay
lay er</w>
l a</w>
l (-1
k- diff
k-diff usion,</w>
k ,</w>
jud g
j o
j aundice</w>
iz ation.</w>
iti al</w>
it y-increasing</w>
it riptyl
it ect
ischem ia</w>
ischem ia.</w>
ischem ia,</w>
is su
ir rit
invol ving</w>
invol ves</w>
invol vement.</w>
investig ation</w>
intracor poreal</w>
intracor onary</w>
intra der
intoxic ation.</w>
inter view
inter peduncular</w>
inten si
int act</w>
inst em</w>
insi pid
initi es</w>
inhibi tion.</w>
ing s,</w>
ing ),</w>
infu sional</w>
inflam ed</w>
infec tion.</w>
ine ly</w>
ine a</w>
ine -</w>
ine )</w>
increas ed.</w>
in- releasing</w>
in- ezetimi
in- based</w>
in z</w>
in nerv
in dependently</w>
in bred</w>
in avi
impair ment.</w>
immunosup press
imag es</w>
im age</w>
ill ing</w>
ific ant</w>
idi opathic</w>
id -
ic in.</w>
ia :</w>
i.p. ,</w>
i.p. ).</w>
i. e
i.e .,</w>
i sual</w>
i dis
i .</w>
hypox ia</w>
hypo the
hyper kine
hyper baric</w>
hyper activity,</w>
hype re
hydroxy phenylacetic</w>
hydro gen</w>
hydro chlor
hy sicians</w>
hist ologic</w>
her bal</w>
hepat ocytes</w>
hepar in-induced</w>
hepar an</w>
hemodialy zed</w>
hemo globin
headache .</w>
hap to
hal f-
haemoly tic-uraemic</w>
haem odilution</w>
habit ual</w>
h or
h il
h )</w>
gy nec
gu inea</w>
group s:</w>
group )</w>
group ).</w>
granulomato sis.</w>
granulomato sis,</w>
granulo cy
gra ft</w>
gra dual</w>
glyco pyrrolate</w>
gluc ar
gi ving</w>
gamma-H C
gamma-HC H</w>
gam ma</w>
g/ day</w>
g/ d</w>
g um.</w>
g ment
g io
g ated</w>
g ,</w>
func tion,</w>
ful minant</w>
fu sion,</w>
frag ment
fract ures</w>
four th</w>
form s</w>
form ed</w>
forestom ach</w>
follow- up.</w>
foc us</w>
fluoxet ine</w>
fluoxet ine-induced</w>
fluoro carb
fluoresc ent</w>
fluo res
fl ush
first- time</w>
fibrill ation.</w>
fib rin</w>
fi x
fet uses</w>
fentan yl
fe ren
fav orable</w>
facil itation</w>
f uro
f re
f low
f il
extrac t</w>
extern a</w>
exten ded</w>
exten d</w>
explor atory</w>
expl ain</w>
experiment s,</w>
exer ts</w>
exer ci
examin ations</w>
ex pressed</w>
ex cess</w>
ex amine
ex amic</w>
eti ology</w>
estrogen -induced</w>
es cal
es /
erythrocy tes</w>
ery l</w>
erg on
er ap
episo d
epile pto
enzym es,</w>
ent h</w>
encephalo path
en tial</w>
en si
en ergy</w>
en ding</w>
en coun
encoun tered</w>
en chymal</w>
emergen ce</w>
emerg ent</w>
em is
em ia.</w>
em ia,</w>
elimin ation</w>
electrocardio graphic</w>
elder ly.</w>
el y,</w>
el l</w>
el ation</w>
effect ,</w>
eff lux</w>
ecti ve.</w>
echocardiograph y.</w>
ec tion.</w>
ec tion,</w>
e toposide</w>
e g
e ated</w>
dystro phy.</w>
dysfunc tions</w>
dysfunc tions.</w>
dram atically</w>
doxorubic in-treated</w>
dou ble</w>
dose- response</w>
dose- limiting</w>
dose- dependently</w>
dose )</w>
dos ing</w>
dos ed</w>
dos ages</w>
dop amine-
don or</w>
disulfi ram</w>
dist ingu
disorder s,</w>
diseas e:</w>
discus s</w>
disco vered</w>
dis played</w>
dis abling</w>
diltiaz em,</w>
diff use</w>
diethyl stilbestro
did an
dichloro phenyl)ethyl
di valproex</w>
di uretic</w>
di ure
di men
dexameth as
deteri or
deter m
describe d,</w>
deri ved</w>
deple tions</w>
depend ency</w>
depen d</w>
depart ment.</w>
demon strat
dementi a</w>
del ine
defect s.</w>
death ,</w>
de viation</w>
de pos
de af
de -induced</w>
days )</w>
dat a,</w>
dam aged</w>
dail y)</w>
dP/dtej c</w>
d or
d in
d )</w>
cyto chrom
cytochrom e</w>
cy t
cur rently</w>
cult ures</w>
creat in
coun ter</w>
coun t</w>
cortis one</w>
corticosteroid s.</w>
cortex ,</w>
control led,</w>
contribut ing</w>
contraceptiv es.</w>
cont ained</w>
const ant</w>
consequ ence</w>
confoun ding</w>
condi tions.</w>
concentr ation.</w>
compon ents</w>
complic ating</w>
compar isons</w>
comp uterized</w>
com pa
coca ine,</w>
co- trimox
co vor
co u
co st-
co lon
co id
clonid ine.</w>
clonid ine,</w>
clo ti
clim bing</w>
cli oquinol</w>
classi fied</w>
clar ify</w>
cit alo
cis apri
cir cum
cigaret tes</w>
ci profloxac
cholesta sis.</w>
cholest eryl</w>
chloro fluorocarb
child hood</w>
chic ks</w>
charg e</w>
channe ls</w>
chang e,</w>
ch elation</w>
cerebell um</w>
cell ulo
ce t
catalep sy
caro ta</w>
cardiom y
cardio respiratory</w>
cardio protective</w>
carcin omas</w>
carbach ol,</w>
carb im
cap ecitabine</w>
cap ac
capac ity</w>
call ed</w>
calc ulated</w>
caffe ine.</w>
c los
c lear</w>
but am
bupivaca ine.</w>
bromocript ine-induced</w>
bre ath
bra in.</w>
bra in,</w>
br ush-evoked</w>
bo y</w>
bo wel</w>
bo th.</w>
block .</w>
bladder .</w>
bl ing</w>
biopsi es
biliru bin</w>
beta- blockers.</w>
beta ENaC</w>
benz o
behavior s.</w>
behavi our</w>
behavi o
bec ome</w>
bac k-diffusion,</w>
b er
azol e.</w>
azepam ,</w>
azath ioprine</w>
az an
azan avi
autoph ag
autophag y</w>
auto antibodies</w>
attenu ate</w>
atherosclero sis.</w>
ate -induced</w>
at ors</w>
at ological</w>
at es,</w>
at azanavi
astro cy
ass ay.</w>
asp ects</w>
as sum
as se
as cit
arth ro
aro und</w>
arch itect
ar ization</w>
aph eresis</w>
ap raclon
ap parat
anxi ety.</w>
antipsycho tic-like</w>
anti- inflammatory</w>
anti retroviral</w>
anti oxidant</w>
anti cholinergic</w>
anti cancer</w>
anti arrhythmic</w>
antagonist s.</w>
ant ly,</w>
ant -induced</w>
angiotens in-converting</w>
angiograph y.</w>
ang ina</w>
aneurys ms.</w>
anesthe sia
anc es,</w>
an uary</w>
ampicill in</w>
amoxicill in</w>
amivud ine</w>
amiodar one,</w>
aminonucleo side-induced</w>
amide -induced</w>
amelior ated</w>
am mon
am itriptyl
alpha ENa
alphaENa C,</w>
alpha 5</w>
alpha 1-
alpha1- adrenergic</w>
alk aline</w>
alfentan il
alco h
albumin uria</w>
al prazolam</w>
al low
al it
al bino</w>
agon ists</w>
ag ing</w>
aff inities</w>
adriamyc in-treated</w>
adriamyc in-induced</w>
administ ered.</w>
adjunc tive</w>
add ress</w>
activ ity-increasing</w>
activ ation,</w>
activ ate</w>
act in
acromegal y</w>
acromegal ic</w>
acid osis,</w>
acet ylcholinesterase</w>
accoun ting</w>
accid ental</w>
ac oustic</w>
ac it
ac cur
abund ance</w>
abs ent</w>
abnormaliti es,</w>
abil ities</w>
ab using</w>
ab use.</w>
a protin
a ine-induced</w>
a .
[2- (3,4-
[2-(3,4- dichlorophenyl)ethyl
Y :</w>
WS R</w>
WS P</w>
WR2425 11</w>
W or
W I</w>
Val pro
VP U</w>
VP A</w>
V isual</w>
V ari
V A
UD Y</w>
U/ l,</w>
U rinary</w>
U T
UT CO
UTCO M
Twent y</w>
Tran sient</w>
Thirty- five</w>
TM A</w>
TI NG
TG ,</w>
TE E</w>
TE )</w>
T rial</w>
T otal</w>
T J
T G</w>
T CR</w>
Syst olic</w>
Sub sequ
Su xamethonium</w>
Ste vens-Johnson</w>
Sou th</w>
Simil arly,</w>
Sign ificant</w>
Sex ual</w>
Seiz ure</w>
SUMMAR Y:</w>
ST UDY</w>
SSR103 800</w>
SO CS
SE .</w>
S yn
S wis
S ul
S odium</w>
S oci
S h
S ch
S T-
S N
S ET
SET TING
S D)</w>
S A</w>
S A
S -
S (c)O
Rep eated</w>
Rec ur
Rec ently,</w>
Rec ent</w>
Re por
RBC s</w>
RAM H</w>
R is
R 13
R13 2</w>
R -
Pharmacokine tic</w>
Ph en
PG- 9
PATIENT S</w>
PA )</w>
P< 0.05),</w>
P renatal</w>
P ost
P hysicians</w>
Organ ization</w>
On ly</w>
O utcom
O phthalmo
O c
O UTCOM
O R
O AE
O -
Nicot ine</w>
Ne ph
Na+ -
NT E</w>
NF kappaB</w>
NF -
Myocardi al</w>
Mor ph
Mi pafox</w>
MT X</w>
MR Is</w>
MP EP</w>
MD MA</w>
MA P</w>
MA IN</w>
M edi
M ar
M any</w>
M P</w>
M D</w>
Li ver</w>
Li thi
Labor atory</w>
L- alpha-
L amivudine</w>
L R132</w>
L H</w>
L A
K e
J anuary</w>
Intrac ranial</w>
Intra venous</w>
Increas ed</w>
In ternational</w>
In itial</w>
IS O</w>
IN G
ING S:</w>
IN D
IND INGS:</w>
II )</w>
IGF- IL-3</w>
IC P</w>
I- S
I U/l,</w>
I II</w>
I CA
I 1-
I ,</w>
He re,</w>
He pati
He inz</w>
HC a</w>
HBV -HIV</w>
HB e
H2 O</w>
H ere</w>
H E
H .</w>
GA BA</w>
G olgi</w>
G la</w>
G en
G 14
G14 5
G145 R</w>
For ty-
Fo od</w>
FANF T</w>
F our</w>
F isch
F e
F an
F L</w>
F L
F INDINGS:</w>
F 344</w>
En do
En d-
ET -1</w>
ESRD ,</w>
E pi
E leven</w>
E lev
E ach</w>
E L
E B
E -
E ),</w>
Drug -induced</w>
Differen tial</w>
Di rect</w>
Dex amethasone</w>
Deli rium</w>
Da ucus</w>
DF P</w>
DESIGN :</w>
D uchenne</w>
D is
D ec
D ays</w>
D WI</w>
D ES</w>
D 4.
Cyclo phosph
Cs A</w>
Combin ed</w>
Ch ol
Centr al</w>
Capsa icin</w>
Cap topril</w>
CaCl(2)- treated</w>
CYP 3
CYP3 A
CYP 2D
CPA/ EE</w>
CH F</w>
CD 4
CD4 +</w>
CD 36</w>
CA 1</w>
C57B L/
C ros
C lon
Bra in</w>
Bas el
BCN U</w>
BB B</w>
BB B.</w>
B io
B R</w>
B P,</w>
B ID</w>
B ,</w>
At ten
Analy sis</w>
An gio
Al pha
Af ric
Ab normal</w>
AI M
AD C</w>
AC h
A ra
A p
A cet
A VP</w>
A E</w>
A A
93 12
9 4</w>
9 0
9 ).</w>
8- year-old</w>
8 6</w>
8 5</w>
8 4</w>
7. 5%</w>
7 6</w>
7 0-
7 %).</w>
6-OHD A</w>
6 7%</w>
6 3</w>
6 0%</w>
6 -induced</w>
6 ),</w>
6 %,</w>
6 %),</w>
50 6</w>
50 6-induced</w>
5. 0</w>
5-hydroxy try
5-F U
5-Az C</w>
5- az
5 ;</w>
5 4</w>
5 1</w>
4 5</w>
4 %)</w>
3. 2</w>
3. 0</w>
3 3</w>
3 2.
3 ,4-di
3,4-di hydroxyphenylacetic</w>
3 %)</w>
3 %),</w>
2. 4</w>
2. 1</w>
2- minute</w>
2, 2,
2 6.
2 4.
2 -</w>
2 %;</w>
2 %).</w>
19 .
19 %</w>
18 0</w>
18 ,</w>
17 %</w>
13 5</w>
13 1
10(- 3)</w>
10 00</w>
10 0-
10 ,000</w>
10 )</w>
1. 4%</w>
1. 1-
1- year</w>
1- 10</w>
1 6,</w>
1 6%</w>
1 5%</w>
1 1,</w>
0.00 0
0. 8</w>
0. 8%</w>
0. 6</w>
0. 5,</w>
0. 4</w>
0. 2
/ M
-1 .</w>
-1 -
- based</w>
+ 2</w>
) ).</w>
) ),</w>
(p =
(R R</w>
(P =</w>
(3 )
(2 0</w>
(10- 40</w>
(10 %)</w>
(1 1</w>
(1 1.
(1 )</w>
(0. 2</w>
(0. 1</w>
(0. 1-10</w>
( one</w>
( median</w>
( i.e.,</w>
( group</w>
( e.
( at</w>
( SR
( 7.
( 60</w>
( 4</w>
( 0.0
( +
( "
' -
zonis amide.</w>
zidovud ine</w>
z one</w>
z en</w>
ys tic</w>
yr ylcholinesterase</w>
yr us,</w>
yr -old</w>
yn ap
ynap tic</w>
yll ine.</w>
yl thio
yl ation</w>
yl )</w>
ycin- mediated</w>
y- stimulating</w>
y- specific</w>
y s.</w>
y ric</w>
y ri
yri dam
y pi
y lo
ylo id</w>
y i
yi el
y g
yg ous</w>
y /
xim ide</w>
xanth ine</w>
xamethoni um,</w>
x ine</w>
x )</w>
worsen ed</w>
work ers</w>
wor k-
weigh ts</w>
we d.</w>
we an
wave forms</w>
warran ted</w>
warran ted.</w>
warfar in.</w>
w k</w>
w all
volunte er</w>
volum es</w>
vit real</w>
vincrist ine</w>
vigabat rin</w>
vi sion</w>
vi ously</w>
vessel s.</w>
verapamil .</w>
ver sion</w>
ver ages</w>
ventil ated</w>
ven ile</w>
veloc ity</w>
ve st
ve )</w>
ve '
vasodilat or</w>
vari ability</w>
var ying</w>
valu e.</w>
val ve</w>
val idity</w>
vacu ous</w>
v x</w>
v ity</w>
v ic
v al</w>
utili zation</w>
ut ri
utri tional</w>
ut ed</w>
ut aneously</w>
ust er</w>
us ti
us h</w>
us ers,</w>
us cit
us -associated</w>
ureth ral</w>
ures .</w>
ure :</w>
ur so
urso deoxy
ursodeoxy chol
ursodeoxychol ic</w>
ur se</w>
ur ium</w>
ur ation</w>
up dat
unevent ful</w>
und us</w>
und le</w>
un wanted</w>
un usually</w>
un ted</w>
un likely</w>
un g
un common</w>
um- 20
um-20 1</w>
um er
ultra -
ultra- short-acting</w>
ulo pathy</w>
ulf on
ul tho
ultho od.</w>
ul es,</w>
ul ate</w>
ul ar
ul anic</w>
udi es</w>
ud a</w>
uc lear
uclear -
uc l
ucl ide</w>
uc asi
ucasi an</w>
ub ular</w>
ub le</w>
u tility</w>
u sive</w>
u propion</w>
u ated</w>
typ es,</w>
ty- five</w>
two ;</w>
twitch ing</w>
tut ed</w>
tum our</w>
trou gh
trough -
trough- concentrations</w>
troleandom ycin-induced</w>
tro ph
tro ke</w>
tri g
tri azol
tri al
trial :</w>
treatment -related</w>
treat ed,</w>
transplant ations</w>
transplant ation
transfer red</w>
transamin ases</w>
trans verse</w>
trans thoracic</w>
tran examic</w>
trac er</w>
tra um
tra n</w>
tr icep
tr amine</w>
tot em
totem por
totempor al</w>
tot ally</w>
tor r,</w>
ton gu
toco ph
tocoph er
tobram ycin</w>
to ol</w>
to o
too k</w>
to mo
tomo graphy</w>
to id</w>
to bac
tobac c
tobacc o</w>
tiz ation</w>
tiz an
tis m.</w>
tim ul
ticlop id
tic ,</w>
ti tion</w>
ti ght</w>
ti es,</w>
thyro idis
thym ocyte</w>
thym idine</w>
thym ic</w>
thromboembol is
thrombo sis.</w>
thir d-generation</w>
thi azol
thereaf ter.</w>
there by</w>
therap y:</w>
theoph ylline.</w>
the ore
thal li
thalli um-201</w>
thal asse
th em
th al</w>
th -
tetrahydro py
tetrahydropy ran
tetrahydropyran yl
tetrachlor ide</w>
tetra z
terfen adine</w>
terato genic</w>
ter s/
ters/ B
ters/B W</w>
ter mat
ter ic</w>
ted ly</w>
te t
te red.</w>
te ar</w>
te -
tas k.</w>
tak e</w>
tacrolimus -associated</w>
tacrolimus )</w>
t one</w>
t ing.</w>
t ation</w>
t ase</w>
t ari
t PA
synerg y</w>
syndrom es</w>
suspen sion</w>
surviv ors</w>
survi val
supra ventricular</w>
suppress ants.</w>
supplement ed</w>
sup ine</w>
sulph ate</w>
sulf asalazine</w>
sul piride</w>
sugg estive</w>
success ful
successful .</w>
suc cessive</w>
suc cess</w>
subun it</w>
substi tutes</w>
substanti ally</w>
subst rate</w>
subject s,</w>
subc utaneously</w>
sub strat
sub ling
sub groups</w>
sub acute</w>
su tism</w>
su mm
stud ying</w>
striat um.</w>
stri p
stret ch</w>
stres s.</w>
strateg y</w>
stopp ed.</w>
ston es,</w>
stimul atory</w>
stimul ation.</w>
stimul ated</w>
steroid al</w>
stere ot
stain ing,</w>
st er</w>
st ep</w>
st ent</w>
st ent.</w>
st en
st ed</w>
st atic</w>
st atic
st ates</w>
st ability</w>
st abil
st .</w>
squ are</w>
spec ies</w>
spec ial</w>
spe ed</w>
spar ing</w>
sp ring</w>
son e-
somat ost
somatost atin</w>
solu tion,</w>
sol uble</w>
sol itary</w>
smok ing,</w>
slow ly</w>
skill ed</w>
sit u
simvastat in-ezetimi
simil arly</w>
sim ple</w>
significant ly.</w>
sigma 1</w>
side ,</w>
si tive</w>
si ded</w>
si as</w>
shorten ed</w>
short ly</w>
shoc k</w>
shi fts</w>
shi ft</w>
shi f
she l
shap e</w>
sevoflur ane,</w>
seve re.</w>
seri es.</w>
sequela e</w>
sequ ential</w>
separ ated</w>
sensitiz ation;</w>
sensi tiv
sens ation</w>
semi- quantitative</w>
sel ecti
selecti ve'
seizure- inducing</w>
seg ment</w>
seg ment
sec tions</w>
se udo
se ts</w>
se en.</w>
se ed</w>
scor ing</w>
sclero sis</w>
schizophren ic</w>
scal e.</w>
scal e,</w>
sc ab
sal vage</w>
sal butam
sa des</w>
sP120 T</w>
s- per
s-per ill
s-perill yl</w>
s patial</w>
s or
s one</w>
s odi
s ati
sati le</w>
s at
s acri
sacri fic
s G145R</w>
s Ag
s -induced</w>
s -1</w>
ry po
rout inely</w>
rod ents</w>
ro zen</w>
ro o
roo m</w>
ro l</w>
ro dent
rodent s.</w>
ritonavi r.</w>
ritod rine</w>
risperid one.</w>
rigid ity,</w>
rifamp in</w>
ri t</w>
ri l
ril men
rilmen idine</w>
rheumat ologic</w>
revie wed.</w>
restric tive</w>
rest or
restor e</w>
rest ing</w>
resem bling</w>
resc en
rescen tic</w>
res uscit
res ection</w>
reproduc i
rem or</w>
reli eved</w>
rele ase,</w>
relap se</w>
regul ation.</w>
regist ered</w>
regimen ,</w>
reg ard</w>
refl ected</w>
refl ect</w>
reduc tase</w>
recogn ition</w>
reco vered.</w>
recipi ents.</w>
recipi ent</w>
rec tom
rec re
recre ational</w>
reas on</w>
re plic
re ments</w>
re ma
rema ind
re ement</w>
re arm</w>
rat s:</w>
rat ings</w>
rat a
rata eg
rataeg us</w>
random ised</w>
ran ulo
ran t</w>
ram -like</w>
radi oph
radi on
radion uclide</w>
radi ographic</w>
radi al</w>
ra p
ra ise</w>
ra i
r un
r ul
r t
r sutism</w>
r one</w>
r ated</w>
r /
r/ ritonavir</w>
questionna ire</w>
questionna i
qu ater
quater n
quatern ary</w>
qu alit
pyri mid
pyrimid in
pul satile</w>
pto phan</w>
psychos timul
psych ological</w>
prote ase</w>
prot ect
proprano lo
prophylax is</w>
propafen one</w>
promis ing</w>
prom pt</w>
progres sively</w>
prof en</w>
produc ts.</w>
produc tion.</w>
produc ing</w>
produc es</w>
process ing</w>
pro thrombin</w>
pro be</w>
pro anth
proanth ocyan
proanthocyan id
previ ously.</w>
previ ously,</w>
pressu re.</w>
press or</w>
preser ved</w>
present ation.</w>
present ation,</w>
pres ynaptic</w>
prepar ations.</w>
premature ly</w>
pregnan -
pregnan- 20-
pregnan-20- one
prefer red</w>
predomin ant</w>
predn is
predis pos
predispos ing</w>
predict ors</w>
pre neoplastic</w>
pre hen
pre ference</w>
pre feren
praz ole</w>
practition ers</w>
pra m</w>
potenti ates</w>
potenti ate</w>
potenti als</w>
post- CAB
post ural</w>
positi vely</w>
port antly,</w>
popul ation.</w>
popul ation,</w>
point es</w>
poie tin</w>
po w
pneumon ia</w>
ple x
ple ural</w>
ple k
plek h
plekh h
ple as
placebo- controlled,</w>
plac em
pl ant</w>
pl ain</w>
pl a
pla sia</w>
pivac aine</w>
pitu itary</w>
piri de-induced</w>
pirenzep ine</w>
pin prick</w>
pi g</w>
physici ans</w>
phthal m
phosphat ase</w>
phenyle phr
phenomen on</w>
phenobarbit al</w>
phenobarbit al.</w>
phen otyp
pharmaco kine
ph ot
ph or
pg/ ml</w>
persist ed</w>
peroxid ase</w>
perid ol</w>
pericardi al</w>
perform ance.</w>
per im
per ce
pepti de
peptide (1-
peptide(1- 4
pentylene tetraz
pentazoc ine-induced</w>
pent one</w>
penicill in</w>
pen ia,</w>
pen et
pel v
pe o
patient s'</w>
path ways</w>
path om
path ies</w>
particip ated</w>
part um</w>
paraly sis.</w>
par i
pari et
par am
param ed
pall id
pallid us</w>
paclitaxel ,</w>
pa rent</w>
pa re
pa in:</w>
pa ediatric</w>
p sy</w>
p ram
p h</w>
p et
p en</w>
p ect
p ast</w>
p anc
panc reati
p an
oxid ation</w>
oxic ity</w>
ox orub
ox carb
oxcarb azepine</w>
ove mb
ovemb er</w>
outcom es.</w>
out patient</w>
out .</w>
out -
ous -
ous- infusion</w>
ou gh</w>
other s</w>
ot otoxic</w>
ostig mine</w>
osteo poro
osmol ality</w>
osar coma</w>
os or
osor b
os ome</w>
os mo
osmo tic</w>
orth otopic</w>
orth o
organ ophosph
or me
or all
or =
or .</w>
opi ate</w>
open- labe
op tical</w>
on to</w>
on ly,</w>
on atal</w>
omas ti
om otor</w>
olog y.</w>
olog ists</w>
oli go
oler ance</w>
ol ute</w>
ol es
ol -
ol )</w>
ocy tic</w>
ocy tes.</w>
ocor tico
ocor tical</w>
ochond rial</w>
occur .</w>
oc tramine</w>
oc rit</w>
oc alce
oc al</w>
obut yric</w>
obser ved,</w>
obj ect</w>
ob vious</w>
ob ses
o- infected</w>
o ventricular</w>
o urable</w>
o side</w>
o plas
o ge
o der
o .</w>
normal- salt</w>
norep inephrine.</w>
nor adrenergic</w>
non- competitive</w>
non compl
noncompl i
no vel
no e
noe a</w>
no de</w>
nitroglycer in.</w>
nitrendi pine</w>
nit ros
nigh t
nifedi pine</w>
ng/ ml</w>
newbor ns</w>
neutro penia</w>
neutro penia,</w>
neut rophil</w>
neurotransmit ters</w>
neurotransmit ter</w>
neurolep tics.</w>
neurolep tic-induced</w>
neuro active</w>
nephroli thiasis</w>
neph ritis,</w>
neg atively</w>
necro tic</w>
necess it
ne ar</w>
nat urally</w>
n utritional</w>
n u
n mol/
n ess.</w>
n er</w>
n as
nas al</w>
n ar
n R
nR H</w>
n M</w>
n M)</w>
n ,</w>
my oton
my oclon
mut ants</w>
musc le.</w>
mun ic
muco sal</w>
muco sa</w>
mt DNA</w>
morph ometric</w>
mor al</w>
month s)</w>
month s).</w>
mon o-infected</w>
mol ind
molind one</w>
modul ators</w>
modul ating</w>
modul ate</w>
modi fy</w>
modi fication</w>
modi fi
model s.</w>
model s,</w>
mo stly</w>
mo fur
mofur -induced</w>
mmHg ;</w>
mmHg .</w>
mm Hg</w>
ml ).</w>
ml ),</w>
mitochondri a</w>
mis sed</w>
minim ize</w>
minim ally</w>
min ox
min o
min ated</w>
min (-1
midd le</w>
mid pontine</w>
microscop y</w>
micrograms/ m
micrograms/m L)</w>
micrograms/ kg</w>
micrograms/ kg/
microgram/kg/ min</w>
microgram s.</w>
microgli a</w>
microg/side )</w>
microangio pathic</w>
micro injected</w>
micro globul
microglobul in
micro g</w>
micro dialysis</w>
mg/m 2.</w>
mg/m (2
mg/kg/ day,</w>
mg/day )</w>
mg/K g</w>
mg/ d</w>
mg/ 24</w>
metri f
metopro lo
metoc lop
metoclop ram
methyl ergon
methyl dopa</w>
meth octramine</w>
meth i
methi azole</w>
metaboliz er</w>
metabol ized</w>
met ry.</w>
mes enchymal</w>
mening e
meninge al</w>
men ,</w>
memor y.</w>
memor y,</w>
membran e.</w>
mellit us.</w>
meflo quine</w>
medull a</w>
mechanism (
mechanism( s)</w>
mechanis m,</w>
measure ments</w>
measure d.</w>
meas urable</w>
me pivacaine</w>
me -
marg in</w>
man ip
man age</w>
mali an</w>
malform ations</w>
mal es,</w>
mal a
maint aining</w>
magnit u
mac ular</w>
mac a
maca que</w>
mTo R</w>
mT c
mTc -
mTc- glucar
mTc-glucar ate</w>
m us</w>
m urine</w>
m um
m e</w>
m ation</w>
m app
m am
mam malian</w>
lymph ocytic</w>
lymph ocyte</w>
lun it
lunit razepam</w>
loz eng
lop inavi
lopinavi r/ritonavir</w>
lop ido
long ed</w>
long -
logra m</w>
log ists</w>
lofen ac</w>
local ized</w>
local ize</w>
local ization</w>
loc i</w>
loc ation</w>
loc ally</w>
load ing</w>
lo st</w>
lo bular</w>
lit termat
lind ane</w>
lin k</w>
lin ed</w>
lim b
li ver.</w>
li pi
li gn
lign oc
li d</w>
leuk in</w>
leu covor
let on</w>
less er</w>
leng th</w>
le tion</w>
le mon</w>
lat ency,</w>
lat encies</w>
lamivud ine.</w>
lac rim
lac k
lack ing.</w>
labe ling</w>
l- arginine</w>
l is
l ine,</w>
l in</w>
l der</w>
l actin</w>
kidne ys.</w>
kg roun
kg -
kg- 1.
k i
ki logram</w>
k es</w>
k ac
k ),</w>
junc tional</w>
judg ement</w>
ju venile</w>
j usti
j ection</w>
iz es</w>
iz ed.</w>
iti s.</w>
iti es,</w>
it ochondrial</w>
it ing</w>
ist er
ister na
issu es</w>
isoflur ane</w>
ishe d.</w>
ishe d,</w>
isch aemic</w>
irrit ability,</w>
ir ar
irar ub
ir CRF</w>
ip yridam
ip ),</w>
intub ation.</w>
intraperitone ally</w>
intramuscul arly,</w>
intrader mal</w>
intra vitreal</w>
intra ventricular</w>
intra vascular</w>
intra hepatic</w>
intoxic ation,</w>
interac tion.</w>
interac t</w>
inter ru
inter leukin</w>
inter ference</w>
institu tion.</w>
inser ted</w>
ino genicity</w>
inhibitor s,</w>
inhibitor .</w>
ing ual</w>
infrequ ently</w>
infrequ ent</w>
inform ed</w>
influ x</w>
inflam mation</w>
infec tions</w>
infarc tion,</w>
inf ilt
inf ant,</w>
ineur in-
ineurin- inhibitor</w>
ine- associated</w>
ine ff
ine :</w>
ine ),</w>
induc ed
indol ent</w>
indo methac
indic ator</w>
ind u
ind ings</w>
ind ed</w>
increas ing
incontin ence.</w>
inclu des</w>
incid ent</w>
inc ubated</w>
in ess,</w>
in direct</w>
in dex
in ating</w>
in adequate</w>
impro ving</w>
implant ed</w>
impa ir</w>
immunosup pression</w>
immunohisto chemist
immunohisto chemical</w>
immun ostaining</w>
immedi ate-
immediate- release</w>
imag es.</w>
im mo
il ine</w>
il d</w>
ig n</w>
ifosf amide,</w>
ide a</w>
ide -induced</w>
ide -
id azol
ic ulation</w>
ia )</w>
i.p. ),</w>
i. e.</w>
i ved</w>
i v
i sian</w>
i pheral</w>
i atro
i als</w>
i =
i )</w>
hypo plastic</w>
hypo methylation</w>
hypo activity</w>
hyperprolactine mia</w>
hyper ammon
hyper activity.</w>
hyp ocalce
hydrox ylase</w>
hydrochlor ide,</w>
hydro gen
hydro cortisone</w>
hydro brom
hum an
human s.</w>
hospital ization</w>
hospit alized</w>
homogen ates</w>
ho me</w>
histor ies</w>
histor ic</w>
highligh ts</w>
high- grade</w>
high- frequency</w>
hi rsutism</w>
hex ach
hepatoc arc
hepatocarc inogenicity</w>
hepati tis
hepat o
hepar in,</w>
hemorrh age,</w>
hemoly sis.</w>
hemoglobin ,</w>
hemo dialysis</w>
hemo di
hemat ological</w>
heal th</w>
he ter
havi oral</w>
hapto globin</w>
haemorrh ages</w>
haemoly tic</w>
ha z
h ind
h ar
h and,</w>
h and
h .</w>
gynec omasti
gy rus</w>
gu n</w>
grow th.</w>
gres sive</w>
great est</w>
grav is</w>
granulo cyto
gran ules</w>
gran ule</w>
gra fts</w>
gra ded</w>
go al</w>
gn ant</w>
gly bur
glutam at
glutamat ergic</w>
glucocortico id</w>
glomerulosclero sis.</w>
glomeruloneph ritis,</w>
glo bu
globu s</w>
gli oblast
gener ation,</w>
gene- targeted</w>
gene sis,</w>
gen it
gen es</w>
gen e,</w>
gen cy</w>
gen ce</w>
gen -
gen- independent</w>
gamma-HCH ,</w>
gamma- amin
gamma-amin obutyric</w>
gamma ENaC</w>
gall stones,</w>
ga ve</w>
g/d l,</w>
g yrus,</w>
g s,</w>
g rypo
g ang
g an
gan ax
g ain
g .,</w>
fur an
func tions</w>
func tions.</w>
fu coid
fron totemporal</w>
frequ ency,</w>
frequ enci
frequenci es.</w>
frac tional</w>
frac tion
form ation.</w>
fo rearm</w>
fluores ce
fluoresce in</w>
fl ut
fix ed
first- line</w>
fin ished</w>
fibro sis.</w>
fib rous</w>
fib er</w>
fet al</w>
ferri tin</w>
femal es</w>
feedbac k</w>
feat ures,</w>
fe wer</w>
fe ver,</w>
fe et
fav ourable</w>
fast er</w>
fasc iculation</w>
factor s,</w>
fac e-
f ying</w>
f rozen</w>
f oci
f its</w>
f inal</w>
f illing</w>
f amil
f all</w>
f action</w>
f a
ezetimi be</w>
extrem e</w>
extrac ts</w>
exten sion</w>
expres sion,</w>
expos ures</w>
explor e</w>
expl ained</w>
experiment ally</w>
experienc ing</w>
exer cise</w>
excre tion,</w>
excl uded</w>
excit ability</w>
exceed ed</w>
exce ed</w>
examin ation.</w>
ex plo
ex o</w>
ex ec
ex ac
exac er
exacer b
event ual</w>
event s,</w>
evalu ations</w>
eth inyl</w>
eth anol</w>
eth ane</w>
et y-
estradi ol.</w>
estradi ol
estim ated.</w>
ester n</w>
est ed</w>
es sed.</w>
erythro poietin</w>
erythem a</w>
ero sive</w>
erg ic
er ul
er ic</w>
er -
equ ina</w>
equ ally</w>
episod es,</w>
epilepsy ,</w>
ep inephr
enzym es</w>
enz y
environ ment</w>
environ ment.</w>
ent ly.</w>
ensi tization</w>
enlarg ement</w>
enh ances</w>
enh anc
enhanc ing</w>
endo thel
end ron
enco ding</w>
enco ded</w>
enc ing</w>
enc ed</w>
en ough</w>
en flur
emplo ying</w>
empha siz
embryo s</w>
emb er</w>
em pi
em ent.</w>
eluc idate</w>
electroencephalo gram</w>
electro ly
elect rom
el uting</w>
el gi
efficac y,</w>
eff ac
ede d.</w>
ec tiv
ear t</w>
e- thallium-201</w>
e w
e rebro
e ous</w>
e metic</w>
e GF
e ).</w>
dyston ia</w>
dyskinesi as.</w>
dys phon
dys p
dynam ic
dur ation,</w>
drug -related</w>
drug -
drom e</w>
dro p</w>
doxorub icin-induced</w>
dos age.</w>
dor sal</w>
dopa .</w>
dog s,</w>
dobut amine-induced</w>
do thiepin</w>
do main</w>
do m</w>
dist ance</w>
dist al</w>
disru ptive</w>
diseas es</w>
diseas es,</w>
discontinu ing</w>
discontinu ed,</w>
dis sociated</w>
dis placem
dimin ished</w>
dimen sion</w>
diltiaz em</w>
diffic ult</w>
differenti ated</w>
diff usion</w>
diff usion-weighted</w>
diff icul
diethylstilbestro l</w>
diet ary</w>
didan osine</w>
diame ters/BW</w>
diame ter</w>
diagno ses</w>
diabet es,</w>
di methyl
di ent</w>
di ed.</w>
di ed,</w>
dexamethas one-induced</w>
dex tran</w>
develop ment.</w>
develop ed.</w>
determ ined.</w>
detect able</w>
detail ed</w>
desi re,</w>
desferri oxamine</w>
des ensitization</w>
deriv ative</w>
deriv ati
depres sion,</w>
dem io
deli very</w>
deli vered</w>
deli rium</w>
defin itive</w>
deficit s,</w>
defic it</w>
decreas ed.</w>
dec lined</w>
dec a
de sign
de red</w>
de mic</w>
de hydrogen
de form
de b
de .</w>
days ).</w>
days ),</w>
dat ab
dap sone</w>
d- release</w>
d- line</w>
d rin
d ri
d one.</w>
d end
d ).</w>
cyt os
cys tic</w>
cyclophosphamide ,</w>
cyclo hex
cyclo he
cyc le</w>
cur ve</w>
cult ured</w>
cross- sectional</w>
cri tically</w>
cre a)</w>
cr yst
coun ter
cou pled</w>
cost- effective</w>
cortis ol-induced</w>
cortico steroids</w>
cor rec
cor e</w>
convuls ants</w>
convul sions.</w>
conver ted</w>
contribut es</w>
contra indication</w>
continu ous-infusion</w>
cont ents</w>
cont act</w>
consum ed</w>
consti tu
consti p
consist ing</w>
consist ently</w>
conside red.</w>
conscious ness,</w>
condi tion.</w>
concl usive.</w>
concer ns</w>
concer ning</w>
concentr ations.</w>
con i</w>
con fusion,</w>
compris ing</w>
comple xes</w>
compart ment</w>
compa red.</w>
comp ul
common est</w>
common ,</w>
com munic
colon y-stimulating</w>
collagen ase</w>
cohort ,</w>
coch le
cocaine- related</w>
coagul ant</w>
co-trimox azole</w>
co- administration</w>
co li
co ld</w>
co erul
co efficient</w>
clos ure</w>
clonid ine's</w>
clon ic</w>
clon ed</w>
cli pping</w>
clear ance.</w>
classi cal</w>
clas sic</w>
cl uster</w>
cl av
clav ulanic</w>
citalo pram</w>
cisplat in.</w>
cis -
cirrho sis</w>
circul ating</w>
cir c
ci um</w>
ci pat
ci es</w>
chron otropic</w>
chol in
chol ec
chlorofluorocarb ons</w>
chlor methiazole</w>
children ,</w>
children 's</w>
chemo therapy-
chem ically</w>
ch ew
cer vical</w>
ceph alo
centr ally</w>
ceftriax one</w>
cefazed one</w>
ce as
catheter ization</w>
cathe ters</w>
catechol amines</w>
catalep togenic</w>
cat ar
catar act
caro tid</w>
cardiomyo pathy.</w>
cardiomyo pathy,</w>
carbamazep ine.</w>
carb ol
cap topri
cap able</w>
can al
calci um.</w>
calc ul
calc ific
caffe ine,</w>
ca us
c isterna
c ing
c ineurin-inhibitor</w>
c )</w>
bupivaca ine-induced</w>
bupivaca ine,</w>
bu tions</w>
bu ffered</w>
bro mo
bro ad
bri ef
breath ,</w>
brady cardia,</w>
bra instem</w>
bor der
blockade .</w>
block ers,</w>
bl unted</w>
bl ingual</w>
bis phosph
bio logical</w>
bio genic</w>
bin ,</w>
bil ater
bi osyn
beta- lactam</w>
beta- blocking</w>
benzodiazep ines</w>
ben ign</w>
behavior .</w>
behavio ural</w>
bec lin</w>
be verages</w>
be li
be gun</w>
be fo
be at
be ag
beag le</w>
be .</w>
be -induced</w>
bas ed,</w>
bacter ials</w>
bac kgroun
b usulf
b undle</w>
b ran
b ral</w>
b ound</w>
azepam -induced</w>
aw a
av oid</w>
auto immune</w>
audio visual</w>
audio grams</w>
audi ologic</w>
au tism.</w>
atten tion.</w>
atro pine,</w>
atri oventricular</w>
ati vely,</w>
ater nal</w>
ate )</w>
atazanavi r</w>
at rac
at ency</w>
at ely,</w>
at ax
aster i
assum ed</w>
ass essed.</w>
ass ays</w>
asalaz ine-induced</w>
as sive</w>
as h
as e-
as cular</w>
aryn x,</w>
artic le</w>
arthro grypo
arterio venous</w>
arteri olar</w>
arrhyth mia.</w>
arm ace
armace u
ari es</w>
arg e</w>
arbam azepine</w>
ar d-
apparat us</w>
appa rently</w>
ap point
ap plic
ap ism</w>
ap ical</w>
antipsycho tics</w>
anti platelet</w>
anti cipat
anti cholinesterase</w>
anti body
anti bacterials</w>
anti bacterial</w>
anthracycl ine-induced</w>
antagonist s,</w>
antagon ize</w>
anim als,</w>
angio edema</w>
ang in
anesthesia -induced</w>
anesthe sia.</w>
anesthe sia,</w>
anencephal y.</w>
ane )</w>
andro gen-independent</w>
anc es.</w>
analy sis.</w>
anaesthe tic</w>
an uria</w>
an other
an ol
an o
an ned</w>
an ine</w>
an e.</w>
ampicill in.</w>
amne sic</w>
amitriptyl ine</w>
aminotransfer ase,</w>
aminoph ylline</w>
ami kac
ami des</w>
am yloid</w>
am ycin</w>
am oxif
altern ate</w>
alter ation</w>
alpha- hydroxy-
alpha- 2</w>
alpha- 2
alpha-2 b</w>
all ergy</w>
alcoh ol,</w>
al- emergent</w>
al tered.</w>
al oxifene</w>
al lopurinol</w>
al gi
al endron
al anine</w>
ak ing</w>
ak en</w>
agoraphob ia</w>
agonist ,</w>
aggres siveness</w>
aggreg ation</w>
ag reement</w>
ag it
aff ecting</w>
af ter
advant ages</w>
adriamyc in.</w>
administ ering</w>
aden ylate</w>
addi tive</w>
ad ulthood.</w>
ad oles
ad mission.</w>
ad mission,</w>
ad ine,</w>
ad ding</w>
ad dic
ad ap
acute ,</w>
activ ator</w>
acit ret
acid :</w>
acetyl salicylic</w>
acetaminophen .</w>
acet aldehyde</w>
accum bal</w>
accoun t</w>
acce pted</w>
ac ytidine</w>
ac tivi
ac tive,</w>
absor p
abs olute</w>
abs ences</w>
a. m.,</w>
a- actin
a reas.</w>
a etiology</w>
a esthe
a e</w>
a di
a ),</w>
] ,</w>
[CI ],</w>
[ 4-
Z y
Wor ld</w>
With in</w>
Whe ther</w>
Whe reas</w>
W il
W estern</w>
VPA -induced</w>
VA S</w>
V erap
V V
V G</w>
Un der</w>
U p
U M-
UM- 27
Twenty- three</w>
Thir teen</w>
Th yro
TNS s.</w>
TJ s</w>
TE OAE
TEOAE s</w>
TAF I</w>
TA C</w>
T welve</w>
T ri
T remor</w>
T oxic</w>
T op
T oge
T ic
T L
T 1</w>
T -induced</w>
Syn drome</w>
Swis s</w>
Sul piride</w>
Sub -
Sub- chronic</w>
Su blingual</w>
St udies</w>
St ates</w>
Soci ety</w>
Sim vastat
Sim ult
Si x
Sevent y-
Ser ial</w>
SSR103 80
SSR10380 0,</w>
SPEC T</w>
SOCS -
SETTING :</w>
SE ).</w>
S we
S ur
S troke</w>
S rl</w>
S ome</w>
S ide</w>
S al
S ),</w>
Rever sible</w>
Recur rence</w>
Rec o
Re g
RO 2</w>
R et
R ating</w>
R aloxifene</w>
R EM</w>
Q u
Q TL
Q RS</w>
Pro t
Pro spective</w>
Pro longed</w>
Pro lactin</w>
Pro gressive</w>
Pre vention</w>
Po sitive</w>
Per me
Per ipheral</w>
PRL- R</w>
PG-9 .</w>
PD .</w>
PA I
P seudo
P ri
P ot
P artic
P ar
P a
P V
P G</w>
P AC
P =
P 450</w>
P -induced</w>
P ).</w>
O vx</w>
O ver</w>
O ver
O p
O lder</w>
O P</w>
O C</w>
O ),</w>
Nitro prus
Neph ro
Ne w</w>
Ne w
Ne onatal</w>
Na Cl
NaCl -treated</w>
NSCL C</w>
NSCL C.</w>
NO- deficient</w>
NG F</w>
NF- kappaB</w>
NF s</w>
N ovember</w>
N or
N ine
N X</w>
N P)</w>
N =
N .</w>
Meth amphetamine</w>
Medi an</w>
MR I)</w>
MPT P</w>
MMP- 9,</w>
MMP- 2,</w>
MM SE</w>
MK-80 1</w>
MA HA
MAHA .</w>
M on
M itochondrial</w>
M g
M et
M ed
M aternal</w>
M an
M MR
M K
MK 80
M HC
MHC -I</w>
M G</w>
M E
ME AS
MEAS UR
M AT
MAT ER
MATER I
MATERI AL
MATERIAL S</w>
M .
M. S.</w>
Lo vastatin</w>
Li -treated</w>
LID s.</w>
LA M</w>
L-DO PA
L- NO
L- NI
L evo
L arge</w>
L PO</w>
L Na</w>
L Na+
L Ca</w>
Ke toconazole</w>
K ing
K S</w>
K +</w>
Jap an.</w>
J aundice</w>
Inc idence</w>
In v
In te
In f
In divid
Impro vement</w>
Immunohisto chemical</w>
Im portantly,</w>
IV -
IV- infected</w>
IS A</w>
INTER V
IN ICA
INICA L</w>
II I-
II E
IF N</w>
ID ,</w>
I-S F</w>
I r
I S</w>
I /
I -H
I ),</w>
Hy dro
Hist ological</w>
Hist o
High -dose</w>
Hg ,</w>
Hepati tis</w>
Haem atological</w>
HCF C
H em
H eart</w>
H P</w>
H IV-infected</w>
H IT</w>
H (3
H(3 )-
Grou p.</w>
Ger many</w>
Ger man
GSP E
G u
G nRH</w>
G ly
G VG</w>
G ),</w>
Fisch er</w>
Fi b
Fan coni</w>
FK50 6)</w>
FANF T-induced</w>
F u
F lu
F indings</w>
F entan
F act
F R</w>
F D
F .</w>
Ex perim
Ex amin
Evalu ation</w>
Ev idence</w>
EL ISA</w>
EC G
E18. 5.</w>
E uro
E stro
E arly</w>
E 40
E 2</w>
E 13.
E -induced</w>
E ,</w>
Dru g</w>
Do thiepin</w>
Di ag
De pression</w>
DSM- IV</w>
DO X,</w>
D-penicill amine</w>
D-penicill amine-induced</w>
D- pen</w>
D ue</w>
D oxorub
D orme
D ipyridam
D el
D bh</w>
D ay</w>
D M
D AM
D A</w>
D ,</w>
Cyclophosph amide</w>
Cur cumin</w>
Cont rolled</w>
Cont rol</w>
Con ventional</w>
Coc aine-induced</w>
Clin icians</w>
Ch rom
Cal cineurin-inhibitor</w>
Ca ucasian</w>
CYP3A 4</w>
CO -
CM RO2</w>
CL INICAL</w>
CI MD</w>
CG I-SF</w>
CC O</w>
CC .</w>
CAB -induced</w>
CA B</w>
CA A</w>
C l</w>
C is
C ase</w>
C arbamazepine</w>
C VP</w>
C T.</w>
C P</w>
C O</w>
C E:</w>
C C</w>
C -
C ).</w>
Bra dy
Be havioral</w>
Basel ine</w>
BZD /
BZD/ RD</w>
BW )</w>
BW ),</w>
BMC s</w>
BC H
B upropion</w>
B ri
B one</w>
B elgi
B PO
B ID,</w>
B 6</w>
As sess
Ara G</w>
Angi osarcoma</w>
An imal</w>
Am iodar
Alpha -
Alpha- lipoic</w>
Al so</w>
Al most</w>
Ag e-
Adriam ycin</w>
Adriam ycin-mediated</w>
AM I</w>
AL L</w>
AA P,</w>
A ff
A .</w>
A ),</w>
<0.0 1)</w>
: 30</w>
99 mTc-glucarate</w>
99 )</w>
9312 9</w>
9- year-old</w>
9 ;</w>
9 9</w>
9 6</w>
9 5</w>
9 2</w>
9 %,</w>
8. 4</w>
8 1</w>
8 -1
8 %).</w>
7 9</w>
7 4</w>
7 ,
6. 7</w>
6. 5</w>
6- year-old</w>
6 7.
6 6</w>
6 4</w>
6 /
50 )</w>
5. 9</w>
5-hydroxytry pt
5-az acytidine</w>
5- day</w>
5 8
5 4.
5 3</w>
5 ,
5 %
5% -
40- year-old</w>
40- 50</w>
4. 8</w>
4. 7</w>
4 6</w>
4 5-
4 +/-
34 ).</w>
30- second</w>
30 .</w>
30 )</w>
30 %).</w>
3. 9</w>
3. 8</w>
3 MA</w>
3 9.
3 7-year-old</w>
3 5%</w>
3 /
3 +/-
3 ),</w>
25 )</w>
20- day-old</w>
2. 2</w>
2-chloroprocaine- CE</w>
2,2, 2-
2 9.
2 6%</w>
2 5-year-old</w>
2 2%</w>
2 %,</w>
199 4</w>
18 -
17beta- estradiol</w>
17 )</w>
100 %)</w>
10- mg</w>
10(- 5)</w>
10 (6)</w>
1. 8</w>
1. 7
1. 6%</w>
1. 3-
1- year-old</w>
1 24</w>
1 2.5</w>
1 19</w>
1 11</w>
1 1.
1 1),</w>
1 %,</w>
0.01 4-
0.00 2).</w>
0.0 7</w>
0.0 3
0.0 1)</w>
0.0 1),</w>
0. 9</w>
0. 50</w>
0. 2</w>
0. 17</w>
0. 16</w>
0. 13</w>
0 /
0 )</w>
0 ),</w>
0 %).</w>
/ N=
. i.
. ).</w>
-H isian</w>
-1 20</w>
- to-
- matched</w>
- containing</w>
- Wh
- /-</w>
, 6
(p <
(n /N=
(i )</w>
(e. g.,</w>
(V TE)</w>
(S N
(S E
(P< 0.05)</w>
(P T
(P R
(O R</w>
(NS CL
(K i=
(H I
(E Na
(E D
(D TI
(D F
(C R
(C I
(C G
(B P)</w>
(AC h)</w>
(AC E)</w>
(A Z
(A R
(A M
(A LT
(7 5</w>
(5 00</w>
(4 %)</w>
(3) H-
(3 2.
(3 00</w>
(3 )</w>
(2 6
(2 00</w>
(2 0%)</w>
(10- 30</w>
(1 20</w>
(1 0.
(1 /
(1 ,
( secondary</w>
( patient</w>
( ne
( initiated</w>
( greater</w>
( days</w>
( but</w>
( both</w>
( as</w>
( all</w>
( W
( MP
( IC
( GF
( FK506)</w>
( EP
( <</w>
( 8</w>
( 80
( 8.
( 7-
( 6</w>
( 5-FU
( 5-
( +)</w>
( '
(' M
% );</w>
" meth</w>
zetimi be</w>
z iness</w>
z er
z ed.</w>
z )</w>
yst ag
ystag mus</w>
ys tis</w>
ys ti
ysti tis</w>
ys mal</w>
yr rol
yrrol idine</w>
ypi es</w>
yp as
ypas s</w>
ym pto
ympto ms</w>
ym panic</w>
yltransfer ase</w>
ylthio uracil</w>
yll ine,</w>
ylchol inester
ylcholinester ases</w>
yl- 2-
yl-2- phen
yl-2-phen oxy
yl-2-phenoxy acet
yl) urea</w>
yl) amino
yl)amino ]
yl ec
ylec gon
ylecgon ine</w>
yl creatine</w>
yl ase,</w>
yl ]-
yl]- form
yl )-
yl)- 2-
yl)-2- thiazol
yl)-2-thiazol yl]-form
yiel ds</w>
year s),</w>
yclo mine</w>
yclo [
yclo[ 4.
yclo[4. 3.0
yclo[4.3.0 ]
yclo[4.3.0] non
ycl in</w>
yc ystic</w>
y on
yon d</w>
y le
yle phrine</w>
y clin
y ?</w>
y -induced</w>
y ),</w>
x- as
x-as sist
x-assist ed</w>
x ure</w>
x is</w>
x io
work- up</w>
wor l
worl d
women ,</w>
women )</w>
wom an.</w>
withdraw n.</w>
withdraw al-emergent</w>
wh il
whil st</w>
wh en
when ever</w>
well- tolerated,</w>
well- known</w>
weight ).</w>
weigh t.</w>
week s).</w>
week s),</w>
week ,</w>
wean ling</w>
we ak</w>
wave form</w>
warfar in-induced</w>
war n
war ding</w>
w rit
w indo
windo w</w>
w ash
w all,</w>
w al
wal k</w>
w ak
wak e
wake ful
w /
w/ v</w>
w .</w>
w -dose</w>
vul ner
vomit ing.</w>
volunte ers.</w>
volum es.</w>
viv o.</w>
vitro .</w>
vitro ,</w>
virtu e</w>
virtu ally</w>
vincrist ine.</w>
vincrist ine,</w>
vi sion.</w>
vi r</w>
vi ol
vi de
vessel s,</w>
verapamil ]o</w>
verapamil ,</w>
ver sely</w>
ver sel
versel y,</w>
ver s</w>
ver ol
verol im
ventric ularly</w>
ventr al</w>
venlafax ine.</w>
vel ed</w>
vehicle /
vehic le.</w>
ve- men
ve-men tion
ve-mention ed</w>
ve- compul
ve- avoidance</w>
ve ti
veti rac
vetirac et
vetiracet am</w>
ve si
ve ments</w>
vasospas m.</w>
vasopress or</w>
vasodilat ory</w>
vascul at
vari ations</w>
vari ation</w>
vari ants,</w>
valu able</w>
val ent</w>
val e</w>
vag al</w>
vacuol es</w>
v is
vis c
visc eral</w>
v ice</w>
v ary</w>
v ant</w>
v .</w>
utili zed</w>
ut rophil</w>
use :</w>
use -
use- and-
use-and- effect</w>
us cular</w>
us age.</w>
us -like</w>
us -
us- maze</w>
uron idation</w>
ure a,</w>
uracil -induced</w>
ur ti
urti car
urticar ia</w>
ur teen</w>
ur red</w>
ur it
urit us</w>
ur ce</w>
ur ate</w>
upt ak
uptak es</w>
up s</w>
up ,</w>
ung -
ung- Con
ung-Con de</w>
understo od,</w>
undergo es</w>
under standing</w>
under st
underst and</w>
under g
uncer tain</w>
uncer tain
uncertain ,</w>
unc tion</w>
un responsive</w>
un rel
un pleas
unpleas ant</w>
un like</w>
un less</w>
un istic</w>
un ine
unine ph
unineph rectom
uninephrectom y</w>
un expected</w>
un diagnosed</w>
umer ous</w>
um- ratio</w>
um- fed</w>
um p</w>
um -treated</w>
um -</w>
um )</w>
ultra structure</w>
ulo pathy.</w>
ulfon amides</w>
ulcer ative</w>
ulcer ation</w>
ulc ers</w>
ulc ero
ulcero genic</w>
ul monary</w>
ul arly,</w>
ul ae</w>
ul a</w>
ud itory</w>
ud ing</w>
uclear- staining</w>
u vant</w>
u sions,</w>
u moral</w>
u ine</w>
u des</w>
u a
u EP
uEP O-
typ ically</w>
ty- two</w>
ty pe
two- step</w>
two .</w>
tw in,</w>
tw ic
twic e,</w>
tumor s,</w>
tumor -free</w>
tuberculo sis.</w>
tub ul
tu res,</w>
tu bu
try ptophan</w>
trop in-releasing</w>
tro py
tropy l</w>
tro pon
tro meth
trometh or
tromethor phan</w>
tro duction</w>
trigem ino
trigemino -
trigemino- parasympathetic</w>
trigem inal</w>
trifluoro ethane</w>
trifluoro acet
trifluoroacet yl</w>
tric us
triam cin
triamcin olone</w>
tri ple</w>
tri phasic</w>
tri meth
trimeth aph
trimethaph an</w>
tri mental</w>
tren ds</w>
treatment ;</w>
treatment :</w>
tre mor
tre me
treme ly</w>
traum a</w>
transpor ter
transporter -1</w>
transplantation ),</w>
transi t</w>
transi ently</w>
transcri ption</w>
transcri pt
trans port
transport -
trans mission.</w>
trans m
transm ural</w>
trans fu
transfu sion-
trans cranial</w>
trac ts</w>
trac t</w>
tra veled</w>
tra pyramidal</w>
tra it</w>
tr y</w>
toxic osis</w>
toxic ologic</w>
toxic it
tox ification</w>
tor sades</w>
tor r</w>
topo side,</w>
tongu e</w>
ton otopic</w>
tocopher ol</w>
tob er</w>
to- left</w>
to wards</w>
to pi
topi ram
to ma</w>
to ins</w>
tizan idine</w>
tiz ing</w>
tiv ation</w>
tissu e.</w>
tissu e-
tion- deficit
tion-deficit /
tion-deficit/ hyperactivity</w>
tion ing</w>
tion /
tion/ ion
tion/ion ization</w>
tin ociceptive</w>
time -dependent</w>
tim ing</w>
tim a</w>
til t</w>
tic ide</w>
tic /
tic/ pharmacodynamic</w>
tic .</w>
tic "</w>
ti ous</w>
ti me.</w>
ti fied</w>
ti ce
thyroidis m</w>
thyro xine</w>
thyro toxicosis</w>
thym ia</w>
thromboembolis m,</w>
thromboemb olic</w>
thrombocytopen ia,</w>
thrombocytopen ia)</w>
throm yc
thresh ol
thir teen</w>
thio per
thio pentone</w>
thick ening</w>
thia sis.</w>
thi oc
thioc arbam
thiocarbam ate</w>
thi az
thi amine</w>
thes e,</w>
therapy- na</w>
therapeu tic"</w>
therap ies</w>
therap ies.</w>
ther mia.</w>
ther mal</w>
theore tical</w>
the toid</w>
the refore,</w>
the li
thalasse mic</w>
thal am
th- inhibited</w>
th re
th em,</w>
tetrahydro cannab
tet an
test ed.</w>
test ;</w>
test ),</w>
terodi line</w>
terodi line,</w>
termin ation</w>
termin ated</w>
termin al</w>
terfen adine,</w>
terato genicity</w>
ter s,</w>
ter one</w>
ter ial</w>
ter ations</w>
tens in-
tensin- II</w>
ten sive</w>
ten der</w>
tempor ally</w>
tempor al,</w>
temperat ure</w>
tem azepam</w>
telithrom ycin.</w>
tein izing</w>
techniqu es.</w>
techniqu e.</w>
te m</w>
te d-
ted- diet,</w>
tari o</w>
target ing</w>
target ,</w>
tail- withdrawal</w>
tacrolimus -induced</w>
tacrolim us.</w>
tachy arrhythmias</w>
tac h
tach ment</w>
tPA ,</w>
t- to-left</w>
t- time</w>
t- avi
t-avi d</w>
t urb
t ting.</w>
t or</w>
t on</w>
t oc
toc in</w>
t ing
ting ling</w>
t amoxif
t al,</w>
t PA</w>
t )</w>
system ic,</w>
system atically</w>
system atic</w>
synthe sis.</w>
synthe sis,</w>
synthe si
synthesi s/
synthesis/ release</w>
syndrom es,</w>
syn chron
synchron y</w>
sym pathom
sympathom i
sympathomi metic</w>
sy ch
sy .</w>
switch es</w>
switch ers</w>
sw ol
swol le
swolle n</w>
sw im
swim m
swimm ing</w>
survival ,</w>
survi ving</w>
surg ery
surgery /
surg e.</w>
sur ia,</w>
supra optic</w>
suppres sion,</w>
suppres s</w>
suppor tive</w>
super ficial</w>
sulph on
sulph ate-
sulphate- associated</w>
sulph asalaz
sulphasalaz ine.</w>
sulf on
sulfon yl
sulf asalazine-induced</w>
sul piride-induced</w>
sul ind
sulind ac
sul in-
sulin- like</w>
suic ide</w>
suic idal</w>
sugg es
subun its.</w>
subun it
subunit s,</w>
substi tuted</w>
substanti ate</w>
subst ances</w>
subst ances.</w>
subj ect</w>
sub- chronic</w>
sub types,</w>
sub therapeutic"</w>
sub sides</w>
sub scale</w>
sub chronic</w>
su xamethonium,</w>
su sta
susta ine
sustaine d-release</w>
su mat
sumat ript
su ed</w>
studi ed:</w>
struct ure.</w>
stron ger</w>
strok es,</w>
strok e,</w>
strip ed</w>
striat ally</w>
stri king</w>
stri al</w>
stres s,</w>
streptozotoc in</w>
streptozotoc in-induced</w>
streptozotoc in-
streng th</w>
stra in-
strain- dependent</w>
str ation.</w>
sto per
stoper atively,</w>
stimul ation-
stimulation- evoked</w>
stereotyp ic</w>
stereotyp ed</w>
stereot ypies</w>
ster one-
sten osis</w>
ste ad</w>
stat us,</w>
stat es.</w>
stand ard
standard -</w>
stabil iz
st- frequent</w>
st ep
st ent
st ay</w>
st ag
st af
staf f</w>
st able.</w>
st able,</w>
st )</w>
spi red</w>
spi ke</w>
specimen s.</w>
specific ity</w>
spec ies,</w>
spastic ity</w>
spas m,</w>
sparte ine</w>
spac e.</w>
sp ots</w>
sp ectro
sor ia
sone- exposed</w>
some what</w>
somat os
somatos ens
somatosens ory</w>
som n
somn ol
solu tions</w>
solu tion.</w>
sol v
sol idation</w>
soci ation</w>
so ver,</w>
so proteren
so on</w>
so as</w>
so -
so- called</w>
so ,</w>
sleep ing</w>
sleep iness</w>
sk in,</w>
siz e,</w>
six ty</w>
six ty-five</w>
six -
situ ations</w>
sit u</w>
sit es,</w>
sit e.</w>
sit e,</w>
sirolim us,</w>
sion :</w>
sion )</w>
single- bl
single- agent</w>
sin ess</w>
similar ity</w>
similar ities</w>
sim vastatin,</w>
significant ly
sign als</w>
side .</w>
sib ility</w>
sia :</w>
si ve-compul
si tis.</w>
si s:</w>
si 's</w>
shorten ing</w>
shif t
shel f</w>
sha red</w>
sha m</w>
sh un
sex -matched</w>
sever ity,</w>
seve re,</w>
sev enth</w>
ser um-ratio</w>
ser ologic</w>
ser o
sequ ently,</w>
separ ation</w>
sensor y-
sensor im
sensorim otor</w>
sensitiz ing</w>
sensi tive.</w>
sens ations</w>
sen se</w>
sen oside</w>
semi de.</w>
self- reported</w>
self- limit
selective' )</w>
sel ec
selec tivity</w>
seizure -induced</w>
segment s,</w>
sed ation.</w>
sed ati
sed /
sed/ refractory</w>
secre tion.</w>
secre tion,</w>
secre ted</w>
secon d-line</w>
sec tions.</w>
sec ticide</w>
se y</w>
se tting.</w>
se minated</w>
se m
sem ide</w>
se ed
seed s</w>
se d,</w>
se arch</w>
se al
seal ants</w>
scre ened</w>
scopol amine
sco red</w>
schedul e</w>
schedul e,</w>
sched ules</w>
scan s.</w>
scal es</w>
scab ies</w>
sc ans</w>
satis faction</w>
saralas in</w>
saralas in-treated</w>
sample .</w>
sam pled</w>
sam pl
salt-deple ted</w>
salt-deple ted,</w>
salt- sensitive</w>
sal t,</w>
sal ine.</w>
sal ine-
saf ety.</w>
saf er</w>
saf e,</w>
sa id</w>
s. kg-1.
s- sectional</w>
s- lim
s-lim on
s-limon ene</w>
s ular</w>
s pro
spro uting</w>
s lud
slud ge,</w>
s lower</w>
s low-
slow- wave</w>
s ent</w>
s ac
s Ag</w>
s ?</w>
s );</w>
rul ed</w>
ru n</w>
rt M
rtM 20
rtM20 4
ronolact one-induced</w>
ron e,</w>
rom ocript
rom bo
rombo tic</w>
ro ute</w>
ro spective</w>
ro sis</w>
ro ots</w>
ro ot</w>
ro om
room .</w>
ro les</w>
ro le.</w>
ro b
rob ust</w>
ris o
ris k.</w>
ris k),</w>
rin )</w>
rim ary</w>
ric ult
ribavi rin.</w>
ri um,</w>
ri tis.</w>
ri gh
righ t-to-left</w>
rhyth mic</w>
rhyth m</w>
rho e
rhoe a,</w>
rex pression</w>
reveal ed.</w>
reve als</w>
reve al</w>
retic ulo
ret e</w>
ret ains</w>
result s,</w>
result ,</w>
restric ted-diet,</w>
resto res</w>
rest less
rest ingly,</w>
respon siveness</w>
respon ses.</w>
respon der
respon d</w>
resol ved.</w>
resi du
residu es</w>
resi d
resc ue</w>
res the
res h</w>
requi rements</w>
requ ested</w>
requ ency</w>
reproduc ible</w>
repor ting</w>
repor tedly</w>
repor ted,</w>
repor t,</w>
replic ation.</w>
renin- -
renin-- angiotensin</w>
ren tal
ren ess</w>
ren dered</w>
ren ch</w>
ren 's</w>
remo ved</w>
remark able</w>
remaind er,</w>
rem ia,</w>
relim inary</w>
relim b</w>
reli ably</w>
reli able</w>
relev ance</w>
releas e.</w>
relax ations</w>
relax ation</w>
relap sed</w>
relap sed/refractory</w>
relap se.</w>
rel ation.</w>
rel ated,</w>
rej ection,</w>
regul ating</w>
regul ates</w>
regres sed</w>
region ,</w>
regi onal</w>
refle x.</w>
refle x-
refl ecting</w>
refer ral</w>
ref ine</w>
reduc tion.</w>
reduc tion,</w>
recurren t,</w>
recurren ces</w>
recur arization</w>
recover y,</w>
record s.</w>
recommen d
recogn ize</w>
receptor- mediated</w>
receptor s)</w>
receptor s).</w>
rec tile</w>
rec tal,</w>
rec ru
rec all
reb ound</w>
reason ably</w>
reason able</w>
read y</w>
reach ing</w>
reac tions.</w>
reac tion,</w>
reac t</w>
reac h</w>
re- exposure</w>
re warding</w>
re started</w>
re o
re in</w>
re fore</w>
re ent
reent rant</w>
re du
redu plication</w>
re do
re combin
recombin ant</w>
re appeared</w>
re activity</w>
re activation</w>
re activation.</w>
re activation,</w>
re absorp
re :</w>
re )</w>
raz os
rat ympanic</w>
rat es.</w>
rat es,</w>
rat e-
rat e)</w>
rat ax
rat :</w>
rat ,</w>
rap amycin</w>
rang ing</w>
ran iti
ram e
rame work</w>
ram -
rai ses</w>
radioph armaceu
radio immuno
radioimmuno assay.</w>
radio active</w>
radi oc
radioc al
radiocal cium</w>
ra y</w>
ra sias</w>
r y,</w>
r indol
r ation
ration al
r ase</w>
r H
rH uEPO-
r 1
r1 (ne
r1(ne o-
r1(neo- /-)</w>
quinol in
quin pi
question ed</w>
ques tions</w>
ques tion</w>
quantit atively</w>
quanti ties</w>
quanti fied</w>
qualit atively</w>
quad ri
qu inine</w>
qu ine.</w>
qu id</w>
qu ick
quick ly</w>
qu i
qu eous</w>
pyrimidin yl-2-phenoxyacet
pyridox ine.</w>
put s</w>
pur pur
pur po
punc ture</w>
pu pi
pupi l</w>
psycho sis,</w>
psych omotor</w>
pseudo acromegaly</w>
provo ke</w>
prov oc
provoc ation</w>
protect ant</w>
prot rusion</w>
prot ects</w>
prot ective.</w>
prost atic</w>
prost ac
prostac yclin</w>
propylthio uracil.</w>
propylthio -</w>
propyl pent
propylpent ano
propylpentano yl)urea</w>
propranolo l.</w>
propor tions</w>
propo fol
propi on.</w>
proper ty</w>
prop ose</w>
prop anol
promot ing</w>
prolong ing</w>
prolong ation</w>
prolact in
prolactin omas</w>
progres sion,</w>
progno sis</w>
progno sis,</w>
profi le.</w>
profi le,</w>
proced ure,</w>
proble m
prob ability</w>
proanthocyanid in</w>
pro ven</w>
pro ved</w>
pro terone</w>
pro per</w>
pro pens
propens ity</w>
pro lin
prolin ic</w>
pro grams</w>
pro gram</w>
pro gest
pro -
prim ate</w>
prim ary,</w>
pri l</w>
pri dil
pri apism</w>
presum ed</w>
press ing</w>
present .</w>
prescri ption</w>
prescri be</w>
prepar ations</w>
prehen sive</w>
pregnan-20-one )</w>
prefer able</w>
predomin ance</w>
prednisol one.</w>
prednis one,</w>
predic ting</w>
predic table</w>
precipit ating</w>
pre- administration</w>
pre treatment,</w>
pre pon
prepon der
preponder ance</w>
pre pared</w>
pre hospital</w>
pre exposure</w>
pre cl
pre cise</w>
pram ine-induced</w>
practi ce.</w>
pra vastatin,</w>
pr uritus</w>
pp ed</w>
pow er
potenti ating</w>
pot ently</w>
pot ence</w>
post-CAB ,</w>
post- operative</w>
post ulate</w>
post switch</w>
post partum</w>
post dose.</w>
pos ure</w>
port unistic</w>
population :</w>
population ).</w>
popul ations</w>
popul ations,</w>
popul ation-
pop ular</w>
poor -
pont aneous</w>
polysomno graphic</w>
polymorph ism</w>
poly ethyl
polyethyl ene</w>
poly di
polydi p
polydip sia</w>
polar iz
polariz ation-
polarization- activated</w>
pol ycystic</w>
pol acri
polacri le
polacrile x</w>
poison ing</w>
poison ing.</w>
po wer</w>
po ison</w>
po doc
podoc aly
podocaly x
pneumon itis,</w>
plu gs</w>
plekhh 2</w>
platele ts</w>
plat form</w>
plas mino
plasmino gen</w>
plas ma,</w>
plas ma
pl us-maze</w>
pl inary</w>
pl er</w>
pl atyp
platyp ne
platypne a-
platypnea- ortho
platypnea-ortho de
platypnea-orthode ox
pl atin,</w>
pl ate</w>
pl anned</w>
pitu it
pituit aries</w>
piroxic am
pilocarp ine-treated</w>
pill s.</w>
picrotox in</w>
pic ture</w>
pi ronolactone-induced</w>
pi perid
pi per
piper az
pi al</w>
physi al-
physial- portal</w>
phyl ax
phyl actic</w>
phosphor ylcholine</w>
phosphor ylation</w>
phosphat emia,</w>
phenylephr ine-induced</w>
phenyl) propi
phenyl )-
phenyl)- 4-
phenotyp e</w>
phen hyd
phenhyd ramine</w>
phen acet
pharmaco dynamics</w>
pharmac ology</w>
ph ys
ph otoc
photoc ell</w>
ph le
phle b
ph ases</w>
pet ec
person ality</w>
persist s</w>
persist ing</w>
peroxid ation,</w>
perme ability.</w>
perio d;</w>
perin uclear-staining</w>
perin atal</w>
perid one</w>
pericardi tis.</w>
pericardi tis,</w>
peri portal</w>
pergol ide.</w>
perce ived</w>
per mit
per ament</w>
per able</w>
peptide(1-4 2
peptide(1-42 )-
peptide(1-42)- infused</w>
pep tic</w>
peo ple</w>
pent ose</w>
penicill amine</w>
pen s</w>
pen ic
penic il
penicil lo
pen i
peni as</w>
pen c
penc il
pencil -
pencil- point</w>
pen ,</w>
pel le
pe bral</w>
pe an</w>
pattern s.</w>
pattern .</w>
patient s:</w>
patient s);</w>
patient :</w>
patient -
path y?</w>
path ologically</w>
pat es</w>
pat ch
patch y</w>
particip ation</w>
particip ate</w>
particip ants.</w>
particip ant</w>
partic ular
partic i
partici pates</w>
parox ysmal</w>
parox et
parkinson ism</w>
pariet al</w>
paramed ics</w>
paraly sis,</w>
paradig m</w>
para ventricular</w>
para hippocampal</w>
par ts</w>
par tition</w>
par ad
parad ox
paradox ical</w>
par ace
parace ll
paracell ular</w>
papaver ine.</w>
pan y,</w>
pal sy.</w>
pal li
palli ative</w>
paclitaxel -
paclitaxel- eluting</w>
pa resthe
pa per
pa ir
pa id</w>
p<0.00 0
p<0.000 1).</w>
p.o. ),</w>
p. m.</w>
p-coumar ate,</w>
p ush</w>
p ump</w>
p tion/ionization</w>
p soria
p ren
p inephrine</w>
p ill</w>
p ful</w>
p assi
passi ve-avoidance</w>
p ass
p ane
pane l</w>
p 24</w>
oz one-
oxy tocin</w>
ox yc
over night</w>
ove rexpression</w>
ovari an</w>
output ,</w>
out- patients</w>
out side</w>
out patients</w>
out patients.</w>
out flow</w>
out ,</w>
oun d,</w>
ou re
otrex ate,</w>
oto protectant</w>
oto acoustic</w>
other wise</w>
ot otoxicity</w>
ot otoxicity.</w>
ot otoxicity,</w>
ot om
ot es</w>
ot ele
ostig m
osorb ide</w>
osom es</w>
os us.</w>
os sy</w>
os ine.</w>
os c
os ,</w>
orth opa
orthopa edi
orthopaedi c</w>
ort y</w>
oro di
orm ation</w>
orig in</w>
orig in.</w>
ori ocarc
organophosph or
organophosphor us</w>
ore ic</w>
or s,</w>
or ption/ionization</w>
or ,</w>
oplas ms</w>
ophthal mo
ophthal mic</w>
oph ob
ophob ia</w>
oper ations.</w>
open-labe l</w>
op tion</w>
op pos
op portunistic</w>
ond ary</w>
on es</w>
on es.</w>
on ec
on di
ondi aldehyde</w>
on co
onco logists</w>
omer ase</w>
omeprazol e.</w>
ome prazole</w>
om y
om pression</w>
om es</w>
om as.</w>
oly tic</w>
olog y,</w>
oligo deoxy
oligodeoxy nucleotide</w>
olig uric</w>
oler ant</w>
ol/ mg</w>
ol s</w>
ol one,</w>
ol ine</w>
ol ide</w>
ol ff
olff -
olff- Parkinson
olff-Parkinson -Wh
olff-Parkinson-Wh ite</w>
ol ed</w>
ol d
ol ;</w>
ol -treated</w>
off spring</w>
off ers</w>
off ending</w>
of -
odilat or</w>
oder ate</w>
ocy tes,</w>
octreoti de,</w>
octreoti de
ocicep tion,</w>
occl usive</w>
occ ult</w>
ocardiograph ic</w>
oc ystis</w>
oc il
ocil pine</w>
oc ep
ocep tive</w>
obut amine</w>
obstruc tion</w>
obses sive-compul
observ ation,</w>
ob viously</w>
ob sc
o- occlusive</w>
o vir</w>
o vale</w>
o th,</w>
o sis.</w>
o protective</w>
o pathy</w>
o p</w>
o gene
o dynamic</w>
numb er,</w>
nucleoti de
nucleotide -
nucleotide- gated</w>
novel ,</w>
normal- salt,</w>
normal ,</w>
norm oten
norm ally</w>
nor mo
noncompli ance</w>
non- small</w>
non- reactive</w>
non- randomised</w>
non- Ho
non-Ho d
non steroidal</w>
non pregnant</w>
non lact
nonlact ating</w>
non episode</w>
non epileptic</w>
nod ules</w>
nod ule</w>
no tic</w>
no sis</w>
nmol/ kg</w>
nitros oure
nitroprus side.</w>
nitroglycer in,</w>
nitro- L-arginine</w>
nitro- 2-
nitro-2- fur
nitro-2-fur yl)-2-thiazolyl]-form
night ma
nigh t-time</w>
nifedi pine.</w>
nifedi pine,</w>
nicot ine,</w>
ni ac
ng/mou se,</w>
neuron es</w>
neurolep tics</w>
neurolep tic</w>
neuro toxicity,</w>
neuro pathological</w>
neuro fil
neurofil ament</w>
neuro chemical</w>
neum ocystis</w>
ner ve.</w>
nephro toxic
nephro sis</w>
neph ritis.</w>
neph rin</w>
negati ve.</w>
neg ligible</w>
necro tizing</w>
necro si
necessit ating</w>
necess arily</w>
ne tic</w>
ne sted</w>
ne ostigmine</w>
ne oplasms</w>
ne l
nel ar
ne eded.</w>
ne a.</w>
ne ,</w>
nause a.</w>
nat ural</w>
nar row</w>
nalox one,</w>
n= 7
n= 4
n ystagmus</w>
n urse</w>
n ous</w>
n on</w>
n ociception,</w>
n ing
ning -
ning- dosed</w>
n ess
n ation
n NO
nNO S</w>
n M).</w>
myoton ia</w>
myoclon us</w>
myocardi um</w>
myo pathy.</w>
myo pathy,</w>
myelo suppression.</w>
my onec
my el
my algi
mut ants,</w>
musc les</w>
mum ol/mg</w>
multi dis
multidis ci
multidisci plinary</w>
muco sitis.</w>
mtDN A-
mtDNA- encoded</w>
move ments.</w>
mouth "
mou th</w>
morph o
morph ine-
morph ine,</w>
mor tem</w>
month -old</w>
month )</w>
mono phasic</w>
mono hyd
monohyd rate</w>
mono amine</w>
monitor ing,</w>
mon ocy
mon ic</w>
mol/ L</w>
mol es/
moles/ glomerul
mol e</w>
modul atory</w>
modul ates</w>
modifi able</w>
mode stly</w>
mode s</w>
mo ving</w>
mo st-frequent</w>
mo graphic</w>
mo de</w>
mmol/ kg)</w>
mmHg ,</w>
mmHg ).</w>
mm 3</w>
mm 2)</w>
mm /
mm )</w>
ml ,</w>
mix ture</w>
mitoxant rone</w>
mitoxant rone,</w>
minut es)</w>
minut es
minox idi
minoxidi l</w>
minim al-
minimal- type</w>
min-1 ),</w>
min(-1 )),</w>
min er
miner al
mineral ocortico
min d</w>
min :</w>
min );</w>
min ).</w>
mim ic</w>
mim ic
mimic king</w>
milli grams</w>
mil der</w>
mil d.</w>
midazol am</w>
mid line</w>
mid -</w>
microscop e.</w>
micromol/ L</w>
micromol/ L,</w>
micromol/ L)</w>
micrograms/ d
micrograms/d l.</w>
microgram/ ml</w>
microgram s.kg-1.
microangio pathy,</w>
micro tubules</w>
micro cryst
micro M)</w>
micro M).</w>
mic ron
mi phen
mg/m(2 ),</w>
mg/m l)</w>
mg/m 2
mg/m2 BS
mg/d L,</w>
mg/d L);</w>
mg/d L),</w>
mg/ h</w>
mg/ 100</w>
mg/ 0.5</w>
mg .
mg ).</w>
metronidazol e.</w>
metrif onate</w>
metoprolo l,</w>
metoclopram ide</w>
methylphen id
methylergon ovine</w>
methyl sulphon
methotrex ate.</w>
method s.</w>
method s,</w>
meth emo
meth amphetamine,</w>
meth ad
metabolis m.</w>
metabolis m,</w>
metab otropic</w>
met ry</w>
met an
met allo
metallo protein
mer ular</w>
mer gency</w>
mer ci
merci ally</w>
ment ation,</w>
ment ary</w>
men .</w>
membran es.</w>
mellit us</w>
mellit us,</w>
mel an
megal y</w>
megal y,</w>
meflo quine.</w>
medic ine</w>
medic ations.</w>
medic ations,</w>
medi um-
mechanism s,</w>
mechanis tic</w>
mechanis m.</w>
meas ures,</w>
maz e.</w>
matri x-assisted</w>
mat ure</w>
mark et</w>
mapp ing</w>
manip ulation</w>
manifest ing</w>
manag ement.</w>
man eu
malign an
malignan cies</w>
malform ations.</w>
male ate</w>
mala i
malai se,</w>
mal ondialdehyde</w>
mal es.</w>
maint ains</w>
magnitu de,</w>
mac y
ma x</w>
ma x)</w>
ma p</w>
mRN A,</w>
mL/ kg</w>
mGluR 5</w>
mGluR 5,</w>
m ossy</w>
m iti
m ist
m ir
mir ro
m ati
m as</w>
m M)</w>
lymph omas</w>
lymph aden
ly ).</w>
lun gs</w>
lu teinizing</w>
lox y
low- dose)</w>
low est</w>
low er,</w>
low .</w>
los ed</w>
loro cyclohex
lorocyclohex ane</w>
lopido gre
lopidogre l</w>
lop idine-induced</w>
long- lasting</w>
long ing</w>
load s</w>
lo vastatin</w>
lo rectal,</w>
lo pregnanolone</w>
lo pathy</w>
lo op</w>
lo merular</w>
lo bul
lo be.</w>
ll ing</w>
ll ergic</w>
littermat es</w>
lithi um-treated</w>
lithi um-
lithi um,</w>
litax el
lis ino
lipi dem
lipidem ia,</w>
ling -induced</w>
line arly</w>
line ar</w>
line )</w>
limb s.</w>
lim its</w>
lik e
lignoc aine</w>
lig ation</w>
lidoca ine-induced</w>
lidoca ine)</w>
libit um-fed</w>
li ving</w>
li quid</w>
li gence</w>
levofloxac in</w>
level ,</w>
leuko encephalopathy</w>
leukem oid</w>
leukem ic</w>
leuk aemia</w>
leucovor in</w>
lethal ity.</w>
lesto lol
le vetiracetam</w>
le thal</w>
le tal</w>
le t</w>
le sions,</w>
le g.</w>
le ep</w>
le ak
leak age</w>
lat e-
lat ation</w>
lamivudine- na</w>
lacrim ation</w>
lac king</w>
labor .</w>
labetal ol</w>
labe l-
label- restricted</w>
la bell
labell ing</w>
l(-1 )</w>
l(-1 ))</w>
l ys
l umb
l s.</w>
l ligence</w>
l ist</w>
l ing.</w>
l ap
l ad
l /
l -treated</w>
l -induced</w>
knowled ge</w>
know n,</w>
kind ling.</w>
kind led</w>
kin ase.</w>
kg -1.</w>
ket amine,</w>
ke y</w>
ke leton</w>
ke letal</w>
kal emia</w>
k s.</w>
k ine</w>
k ind</w>
k in</w>
k ep
kep t</w>
k athi
kathi sia</w>
k app
kapp a</w>
k an
k ain
kain ic</w>
k age</w>
junc tions</w>
jo int
jo in
join t</w>
j it
j er
j aw
jaw -
jaw- stretch</w>
iz ont
iz atript
izatript an</w>
iv )</w>
it sel
it in
itin ase</w>
it ed.</w>
it amin</w>
isoniaz id.</w>
isoflur ane
isoflurane -induced</w>
iso propyl
isch aem
ischaem ia.</w>
is osorbide</w>
is omerase</w>
irrig ations</w>
irrig ation</w>
irarub icin</w>
ip rindol
ip ramine</w>
ip ants</w>
iop soas</w>
ion otropic</w>
invol ved.</w>
investig ator
investig ation.</w>
inv ari
intro duced</w>
intro duc
intraven ously.</w>
intraven ous,</w>
intramuscul arly</w>
intram ural</w>
intrac ellular</w>
intra- arterial</w>
intra- accumbens</w>
intra striatally</w>
intra operative</w>
intra ocular</w>
intra gastric</w>
intra gast
intragast rically</w>
intra arterial</w>
intra -Hisian</w>
intoxic ations</w>
interven tions,</w>
interven tion,</w>
interval :</w>
interval -
interval- prolonging</w>
interac tions.</w>
interac tion
inter im</w>
inter atrial</w>
inte resting</w>
inte gr
int ratympanic</w>
int olerant</w>
int ak
intak e.</w>
insuffici ent</w>
institu tions</w>
instill ations</w>
instill ation,</w>
insti lled</w>
insipid us</w>
insipid us-like</w>
insi gh
insigh ts</w>
ino sis</w>
ino perable</w>
ino ma.</w>
innerv ation</w>
injec tions.</w>
injec tions,</w>
initi ate</w>
inhibi tion,</w>
ingu inal</w>
ingest ing</w>
ingest ed</w>
ing )</w>
inform ation.</w>
influ ences</w>
infilt rate.</w>
infer tility</w>
infec tion,</w>
inf ants</w>
ineff ective.</w>
ine- 3-
ine-3- carbox
ine-3-carbox ylate</w>
ine tic</w>
ine mia</w>
ine mia,</w>
induced )</w>
induc ed.</w>
induc ed,</w>
indu strial</w>
indomethac in</w>
individu als,</w>
indic es</w>
increasing ly</w>
incorpor ating</w>
inclu sion</w>
incid ents</w>
incid ence
incidence ,</w>
incid ed</w>
inc ture</w>
inc rement</w>
in- 1-
in version</w>
in u
in tima</w>
in sulin-like</w>
in stead</w>
in spired</w>
in secticide</w>
in puts</w>
in patients</w>
in patient</w>
in otropic</w>
in oline</w>
in ner</w>
in i
in hal
in ex
in directly</w>
in depend
in complete</w>
in appropriate</w>
in -</w>
in )</w>
impro ved,</w>
import ant.</w>
implant ation</w>
impair ments.</w>
imodi pine</w>
immunosuppress ant</w>
immunosuppress ant.</w>
immunohistochemist ry,</w>
immunohisto chemistry</w>
immuno reactive</w>
immuno modulatory</w>
immuno allergic</w>
immun ological</w>
immun ologic</w>
immun ocyto
immo bil
immobil ization.</w>
im ply</w>
im olar</w>
im mature</w>
im ipramine</w>
im bal
illu strate</w>
ill ness</w>
ill ic
illic it</w>
ild ren's</w>
il tr
il iopsoas</w>
ig er
idom ide.</w>
ido pa
idne y</w>
idi osyn
identifi able</w>
identi fying</w>
identi fication</w>
iden tic
id- inducible</w>
id s</w>
id ine.</w>
id ine,</w>
id ated</w>
icul i</w>
icul ations</w>
icac y</w>
ic yclo[4.3.0]non
ic ular</w>
ic teric</w>
ic ro
ic in,</w>
iatro genic</w>
i- square</w>
i- motor</w>
i- M
i-M ental</w>
i valent</w>
i throm
i s.</w>
i e,</w>
i ar</w>
i /
hypothe sized</w>
hypocalce mia.</w>
hypo thalamic</w>
hypo physial-portal</w>
hypo ph
hypo manic</w>
hypo locomotion</w>
hypo album
hyperkal aemia</w>
hypere mia</w>
hyperammon emia.</w>
hyper thyroidism</w>
hyper thymia</w>
hyper polarization-activated</w>
hyper plasia</w>
hyper cholester
hypercholester ol
hyp notic</w>
hydrobrom ide,</w>
hyd ration</w>
hyd rase</w>
hy bri
hybri diz
hybridiz ation</w>
hy al
horm onal</w>
hor izont
hol e-
hole- bo
hole-bo ard</w>
hol ding</w>
ho w</w>
ho st)</w>
histor ical</w>
hist ology</w>
hippocamp us,</w>
hind -
hind- limb</w>
hil ar</w>
hexach lorocyclohexane</w>
hex y
hex iline</w>
hepato renal</w>
hepatitis -like</w>
hepat otoxicity.</w>
hepat otoxicity,</w>
hepar in.</w>
hemorrh aging</w>
hemorrh age.</w>
hemodi af
hemo dynamics</w>
hemat otoxicity</w>
hemat ocrit</w>
hemat o
hel pful</w>
hear ts</w>
health ,</w>
headache ,</w>
he rein</w>
he ight</w>
he at</w>
har vest
hand ling-induced</w>
haloperid ol.</w>
halo gen
halogen ated</w>
half- life</w>
haemorrh age.</w>
haemorrh age,</w>
haem odynamic</w>
habit uation</w>
habit uated</w>
ha us
h umoral</w>
h r
h ot
h l</w>
h app
h am
ham ar
hamar toma</w>
h ).</w>
gynecomasti a</w>
gu ide
gu e,</w>
gu an
grow th-inhibited</w>
grow ing</w>
group ;</w>
great ly</w>
granulocy te</w>
gran ules,</w>
gram .</w>
gra ph</w>
gra pe</w>
gra ding</w>
gra dient</w>
gon ad
glyco protein</w>
glyco l</w>
glycer in</w>
glybur ide</w>
glucocortico id-inducible</w>
gluco se,</w>
gluc uronidation</w>
gluc onate</w>
glomerul i.</w>
glomer ulopathy</w>
gl ish</w>
gl au
given ,</w>
gest ational</w>
gent ine</w>
gener ative</w>
gene- related</w>
gen uine</w>
gen ically</w>
gen ,</w>
ge al</w>
gang li
ganax olone</w>
gamma- glutam
gamma- carbox
gamma- G
gain .</w>
gabap ent
g/ ml)</w>
g/ ml),</w>
g/ min</w>
g/ m2</w>
g ross</w>
g old</w>
g n</w>
g lial</w>
g ing</w>
g et
g au
gau ge</w>
g ative</w>
furo semide</w>
furo semide.</w>
furan toins</w>
function ally</w>
func tions,</w>
ful ,</w>
fucoid an</w>
fu sions</w>
fu sion.</w>
fron t
frequ ently,</w>
frequ ency.</w>
fre e-
free- field</w>
fragment ation</w>
fragment ation.</w>
frag ility</w>
fraction ated</w>
fract alk
fractalk ine</w>
form er</w>
form ation,</w>
forestom ach
forestomach ,</w>
for t</w>
for ced</w>
for am
foram en</w>
follow s:</w>
foci /
foci/ c
foci/c m2</w>
foc used</w>
fo relimb</w>
flush ing</w>
fle xure</w>
fle xi
fl av
fixed -dose</w>
fir st
find ings,</w>
fin ally</w>
fif ty-
fiel d,</w>
fibro tic</w>
fibrill ation,</w>
fibrill ar</w>
fib res.</w>
fib ers</w>
fi g
fferen t</w>
fentanyl .</w>
femal e,</w>
feet ,</w>
feedbac k,</w>
feat ure</w>
fav or</w>
fat -free</w>
fasc icul
famil iar</w>
fail ure:</w>
factor .</w>
factor ,</w>
facilit ated</w>
facilit ate</w>
face- learning</w>
f undus</w>
f t.</w>
f ru
f resh</w>
f ratax
f ramework</w>
f lunitrazepam</w>
f ist
f ill</w>
f ati
fati gue,</w>
f as
f ar</w>
f ang
fang ch
fangch inoline</w>
ey es</w>
extrem ity</w>
extrac tion</w>
extra hepatic</w>
extra dural</w>
extern al</w>
ext ubated</w>
ext rusion</w>
expres sions</w>
expres sion.</w>
expos ures.</w>
expl oration</w>
expl an
experiment s.</w>
experim ent.</w>
experim ent,</w>
experienc es</w>
exp ect
exist ence</w>
exhib it</w>
exerci se,</w>
exer ted</w>
exec utive</w>
excl usion</w>
excl uding</w>
excit ation</w>
exceed s</w>
examine d.</w>
examine d,</w>
exacerb ated</w>
ex tremely</w>
ex pressing</w>
ex ists</w>
ex ist</w>
ex haus
ex cipi
excipi ents.</w>
ex change,</w>
ex cell
excell ent</w>
ex am
ex act</w>
evid enced</w>
evalu ation.</w>
evalu ating</w>
evalu ates</w>
evalu ated
evalu able.</w>
ev ol
ev ening</w>
eu phor
ety- like</w>
eti ological</w>
eth yl</w>
et ent</w>
estig ation</w>
ester ase</w>
establ ish
est atic</w>
est ami
escal ating</w>
es tic
es -
es- insipidus-like</w>
erythro der
erythroder ma,</w>
erythro bl
erythrobl ast
erythroblast ocyto
erythem at
erythemat osus.</w>
ery thromyc
ergotamine/ caffeine.</w>
erec tion</w>
erebro ventricular</w>
er vation</w>
er sey</w>
er s:</w>
er mal</w>
er ally,</w>
er );</w>
equ ivalent</w>
equ imolar</w>
ept ember</w>
epilepto genesis,</w>
epileptic us.</w>
epi demio
epi demic</w>
ep inephrine.</w>
eosinophil ic</w>
eosinophil ia</w>
eosinophil ia,</w>
enzym es.</w>
entr y</w>
enti ally</w>
ent ries</w>
ent ero
ent ered</w>
ent )</w>
ens ure</w>
ens a</w>
enlarg ed</w>
enflur ane.</w>
endo phthalm
end- systolic</w>
end- stage</w>
end- diastolic</w>
end point</w>
enco de</w>
enalapri l-treated</w>
en s</w>
en ess</w>
en d,</w>
en abling</w>
employ ed.</w>
emphasiz es</w>
empha sis</w>
emis sions</w>
emis sion</w>
emerg ing</w>
emb ry
emb olic</w>
em perament</w>
em ory</w>
em ent,</w>
ell s</w>
elic its</w>
elic it</w>
elev ates</w>
elev ated.</w>
electrom y
electroly te</w>
electrocardio graph</w>
electrocardio grams</w>
electrocardio gram</w>
electro shock</w>
electro physiologic</w>
electro -
electro- diagnostic</w>
ele ments</w>
elder ly,</w>
el se
el ast
efficac ious</w>
effect s;</w>
effect )</w>
effac ement</w>
eff usions,</w>
eff ectiv
effectiv eness</w>
ede ma.</w>
ede ma,</w>
ed ;</w>
ectom y</w>
ectom y,</w>
ecstas y-specific</w>
echocardiograph y,</w>
ech o</w>
ec ondary</w>
ec k</w>
ec d
ecd otal</w>
earli er);</w>
ear s),</w>
ear ning</w>
ear ly.</w>
eNO S)</w>
e z
e verolim
e us</w>
e toposide,</w>
e jection</w>
e ing</w>
e en</w>
e ating</w>
e ;</w>
dyston ia.</w>
dysphon ia</w>
dysp nea.</w>
dys c
dysc rasias</w>
dynamic s,</w>
dur a</w>
drug- drug</w>
drug s:</w>
drug -free</w>
drowsin ess</w>
drowsin ess,</w>
drin king</w>
dri ed</w>
doxorubic in,</w>
down regulation</w>
down -
double- dose</w>
dose- related</w>
dose ),</w>
dos ing.</w>
dos ages.</w>
dos age,</w>
dopa ,</w>
dop amine,</w>
donor )</w>
dog .</w>
document ed.</w>
document ation</w>
docum ents</w>
do g</w>
diz ocilpine</w>
disulfi ram-like</w>
disturb ance,</w>
distri butions</w>
distri buted</w>
distingu ished</w>
displacem ents</w>
disorder :</w>
diseas es.</w>
diseas ed</w>
discharg ed</w>
disc rete</w>
disc rep
disc losed</w>
dis seminated</w>
dis satisfaction</w>
dis play</w>
dis location</w>
dis h</w>
dis cri
discri min
dis com
discom fort</w>
dis appear</w>
dis ability</w>
dis ability.</w>
direc tional</w>
dipyridamol e-thallium-201</w>
dipyridamol e,</w>
din it
dimin ishing</w>
dimin ished.</w>
dimin ish</w>
difficul ties</w>
diffic ult
differenti ation</w>
differen c
did ate</w>
dic yclomine</w>
dic lofenac</w>
diame ters</w>
dialy sis.</w>
diagno sis;</w>
diagno sis.</w>
diagno sis,</w>
diabet es-insipidus-like</w>
di thiocarbamate</w>
di phenhydramine</w>
di oxide</w>
di morph
di latation</w>
di isopropyl
di hydro
di azepam-induced</w>
di ar
dex tromethorphan</w>
dex -H
determin ing</w>
deterior ation.</w>
detect ed.</w>
det ecting</w>
design .</w>
desi re</w>
desi gn</w>
desferri oxamine.</w>
des orption/ionization</w>
der mati
der mat
depri ved</w>
depos its</w>
deple tor</w>
deple ted</w>
depend ing</w>
depend ent.</w>
depend ent,</w>
depend ence</w>
deoxy cortisol</w>
deoxy corticosterone</w>
dend rin</w>
den ervation</w>
demonstrat ing</w>
dementi a.</w>
deline ate</w>
deli ber
deliber ate</w>
dehydrogen ase</w>
deform ations</w>
defin ite</w>
deficit ,</w>
defici ency.</w>
defer oxamine.</w>
defect ),</w>
def ect</w>
deca des</w>
dec rement</w>
dec lines</w>
dec i
dec ade
decade .</w>
deb riso
deaf ened</w>
de x</w>
de trimental</w>
de toxification</w>
de tachment</w>
de position</w>
de polar
de mographic</w>
de letion</w>
de ep</w>
de d,</w>
de al
days '</w>
dat a.</w>
dap sone-exposed</w>
dam age,</w>
dail y.</w>
dail y,</w>
d s.</w>
d rine</w>
d ras
d otes</w>
d ness</w>
d ine-induced</w>
d ensa</w>
d d
dd I)</w>
d ate</w>
d ar
dar k</w>
d ang
d an
d ac
dac arb
dacarb azine</w>
d B</w>
d .)</w>
cytos keleton</w>
cyto static
cyto penias</w>
cyto kine</w>
cyclospor ine.</w>
cyclospor ine-induced</w>
cyclospor ine,</w>
cyclospor in.</w>
cyclohe ximide</w>
cyan amide</w>
cy toly
cur ves</w>
cum ulation</w>
cult ure</w>
cult ure,</w>
cu prolinic</w>
cross- sensitization</w>
cros sover,</w>
cros s
cri sis.</w>
creatin ine.</w>
creatin ine,</w>
cre ati
creati vity,</w>
cow s.</w>
cour ses.</w>
cour se.</w>
cour se,</w>
counter act</w>
coun try</w>
corticosteroid s,</w>
cortico tropin-releasing</w>
cortico steroid</w>
correspon ded</w>
cor tic
cor pus</w>
cor ne
cor n</w>
cor ds</w>
cor d
control ,</w>
contro lling</w>
contrast -induced</w>
contraceptiv es,</w>
contrac ture</w>
contrac tions,</w>
contr ary,</w>
continu ously</w>
cont ain</w>
constip ating</w>
consti tutes</w>
consider ation</w>
conscious ness</w>
confoun der
confir ms</w>
conduc tion,</w>
conduc ting</w>
concl usion</w>
concentr ation,</w>
con solidation</w>
con n
con genit
con cept</w>
compoun ds.</w>
compoun ds,</w>
compoun d,</w>
complic ation,</w>
complete ly.</w>
compens ates</w>
comp uted</w>
comp etent</w>
common .</w>
comit ant</w>
combin ations.</w>
com otor</w>
com mercially</w>
com at
com a.</w>
collagen ase,</w>
collagen as
collagenas e-induced</w>
coll ection.</w>
coll ateral</w>
coli tis.</w>
cogn iti
coerul eus</w>
cochle a</w>
cocaine- associated</w>
coagul ation,</w>
coag ulopathy.</w>
co- infection</w>
co x
co st
co re,</w>
co re)</w>
co pe</w>
co lorectal,</w>
co incided</w>
co c
co arc
coarc tation</w>
co administration</w>
co administered</w>
cloti azepam</w>
cloti azepam,</w>
clonid ine;</w>
clonid ine-
clon us</w>
clo tting</w>
clo miphen
clin ici
clin ical,</w>
clin ic
clear ly</w>
clear ance,</w>
cl aud
claud ic
cisplat in-induced</w>
cisplat in-based</w>
cisapri de</w>
cis- platin</w>
cirrho sis,</w>
circum st
circul atory</w>
circul ation.</w>
circ ulation</w>
ciprofloxac in</w>
cing ulated</w>
cinacalce t.</w>
cimetid ine-associated</w>
cimetid ine,</w>
cigaret te</w>
chrom osome</w>
chrom at
choline- supplemented</w>
cholin ergic
cholester ol.</w>
cholesta sis,</w>
cholec ystitis</w>
cho ose</w>
chloro quine</w>
chic ks.</w>
chic k</w>
chew ing,</w>
chemo therapy,</w>
chemist ry.</w>
chem ically,</w>
chem ical,</w>
character ized.</w>
character ize</w>
character ization</w>
chang es.</w>
chang ed,</w>
chang e.</w>
challeng es</w>
challeng ed</w>
challeng e.</w>
ch oriocarc
ch oreic</w>
ch or
ch ocardiographic</w>
ch ing</w>
ch i-square</w>
ces s.</w>
ces are
cesare an</w>
cer tified</w>
cer tain
cephalo th
centr ations</w>
cent er</w>
cellulo se</w>
cell .</w>
ceftriax one.</w>
ceas ed</w>
ce rebro
ce ,</w>
cau tious</w>
cau tion.</w>
catheter ization.</w>
catechol aminergic</w>
catechol amine</w>
cataract s,</w>
catalepsy ,</w>
cat arac
carri es</w>
carri ers</w>
cardiomy ocyte</w>
cardio pulmonary</w>
cardi c</w>
carcinogen s,</w>
carcino gen</w>
carbol ine-3-carboxylate</w>
carbo platin,</w>
carbim azole</w>
carbim azole.</w>
carb idopa
car mofur-induced</w>
car ious</w>
captopri l-induced</w>
capsa icin.</w>
cap topril</w>
cap sul
cann ulae</w>
canc ers</w>
canc ers.</w>
canc ers,</w>
canal iculi</w>
can didate</w>
calcul us</w>
calcific ation,</w>
calci um,</w>
ca vity</w>
ca vity,</w>
ca use-and-effect</w>
ca usal</w>
ca ud
ca stration.</w>
ca strated</w>
c utaneous</w>
c stas
c rescentic</w>
c left</w>
c am
cam er
c age</w>
c ad
cad aver
cadaver ic</w>
but yrylcholinesterase</w>
busulf an</w>
bur ning</w>
bu propion.</w>
bu metan
bu ff
bronch odilator</w>
bromo phenyl)propi
brom ide</w>
broad -
broad- spectrum</w>
brief ly</w>
brady cardic</w>
brady arrhythmi
bra ins</w>
bra ins.</w>
bra in-
border zone</w>
body weights</w>
bodi an</w>
bo x</w>
bo th,</w>
bo th
bo ard-
board- certified</w>
blockade -induced</w>
block er,</w>
block ,</w>
bl urred</w>
bl inded</w>
bl ac
bisphosph onate</w>
biosyn thesis</w>
biopsy .</w>
biopsies ),</w>
biopsi es,</w>
bio membranes</w>
bio distribution</w>
bio avail
biliru bin,</w>
bili ary</w>
bili ary,</w>
bilater ally</w>
bic uc
bi profen</w>
bi phasic</w>
beta- hydroxylase</w>
beta- blockers</w>
beta- blocker</w>
beta- CC
beta 2-
beta2- adrenoceptor</w>
bet ter,</w>
bet ax
betax o
benzyl penicillo
benzyl iso
benzodiazep in
benzo ylecgonine</w>
bene fits</w>
behavior ,</w>
befo re,</w>
be pridil
be longing</w>
be g
be d
be ats</w>
be at</w>
barri er,</w>
barri er
backgroun d</w>
bac k</w>
b ypass</w>
b ster</w>
b ones.</w>
b ly</w>
b lu
b es
b erg
b .i.
b.i. d.)</w>
b ,</w>
b )</w>
azol amide</w>
az ithrom
az indol</w>
az ab
azab icyclo[4.3.0]non
ay ing</w>
ax ons</w>
ax illary</w>
awa reness</w>
aw ay</w>
avoid ing</w>
aver sive</w>
aver nous</w>
avail able,</w>
av y</w>
auto psy</w>
auto immun
audio gram</w>
au tism</w>
au ses</w>
au gment
au g
atyp ic
atten tional</w>
atten tion-deficit/hyperactivity</w>
attempt s</w>
attempt .</w>
atrac urium</w>
ator vastatin</w>
ation s;</w>
ation :</w>
ation )</w>
atic .</w>
ati ves.</w>
ate ),</w>
at t
at es)</w>
astrocy tes</w>
astro intestinal</w>
astro cyto
asteri xis</w>
associ ative</w>
assess ments.</w>
aspi rin,</w>
aspart ate.</w>
ascit es</w>
ascit es,</w>
asc iculations</w>
asc ending</w>
as yst
as ked</w>
aryn geal</w>
arthri tis,</w>
arterio lopathy</w>
arteri ol
arteri es.</w>
arter y.</w>
are a.</w>
architect ure</w>
arb ox
ar sen
ar rest
ar an
aprotin in</w>
apraclon idine</w>
appro val</w>
appro ach
apopto sis</w>
apo si's</w>
ap noea</w>
ap .</w>
aort a,</w>
aort a
aorta /
aorta/ serum-ratio</w>
anxi ety-like</w>
antipsycho tics.</w>
antioxid ants</w>
antioxid ants,</w>
antine utrophil</w>
antidepress ants.</w>
anticipat ed.</w>
antibody -positive</w>
antibio tics.</w>
anti- oxidant</w>
anti- cocaine</w>
anti- HB
anti thymocyte</w>
anti sense</w>
anti parkinsonian</w>
anti muscarinic</w>
anti dotes</w>
anti convuls
anti cocaine</w>
anti coagulant</w>
anti ang
antiang inal</w>
anti amnesic</w>
anth amine</w>
antagon izing</w>
antagon istic</w>
another ,</w>
anomal y.</w>
angio edema.</w>
angin a,</w>
aneurys m,</w>
anesthe tic,</w>
anencephal y</w>
ane ously.</w>
analy zed.</w>
analogu es</w>
analogu e,</w>
analgesic s</w>
anaesthe sia,</w>
an xio
an uria,</w>
an iti
an icteric</w>
an hydrase</w>
an ese</w>
an ecdotal</w>
an e-
an -induced</w>
amplit udes</w>
amne sia,</w>
aminoph ylline,</w>
aminoglyco sides</w>
amino quinoline</w>
amino glyc
amino acid
amino -
amin es.</w>
amin es,</w>
amikac in</w>
amelior ate</w>
am bodian</w>
am b
am age</w>
altern atives.</w>
alpha2ABC- knockout</w>
alpha2ABC- /-</w>
alpha2- adrenocept
alpha2 -</w>
alpha-hydroxy- 5
alpha- tropyl</w>
alpha- tocopherol</w>
alpha- smooth</w>
alpha ,
alpha, beta-
alpha (2)</w>
alox one</w>
alo peridol</w>
alo id</w>
allow s</w>
allow ed</w>
allogra ft.</w>
allo pregnanolone</w>
all istic</w>
alfentanil -induced</w>
alco hol
albumin uria,</w>
alapri l</w>
al ters</w>
al ready</w>
al low</w>
al ity.</w>
al ine,</w>
al idomide</w>
al er
al anthamine</w>
al "</w>
akathi sia:</w>
akathi sia.</w>
ak inetic</w>
ak e,</w>
air flow</w>
agonist s.</w>
agonist .</w>
aggrav ation</w>
aggrav ated</w>
age- matched</w>
age -</w>
again .</w>
ag ricult
ag netic</w>
after wards</w>
aesthe sia</w>
advant age</w>
adren al
adoles cent</w>
adj uvant</w>
adj ac
adjac ent</w>
adequ ately</w>
adap tive</w>
ad mixed</w>
ad duc
acute ly</w>
acu ity</w>
activi ties.</w>
activ ating</w>
act ual</w>
acromegal y,</w>
acitret in.</w>
acid ity</w>
acid -induced</w>
acid -
acetyl -
acet azolamide</w>
accur ately</w>
accum ul
accoun t,</w>
acceler ated</w>
acceler ate</w>
ac ne,</w>
ac litaxel
ac cent
abund ant</w>
abstin ence</w>
abo ve-mentioned</w>
abnormal ity</w>
ab use:</w>
ab olic</w>
ab ly,</w>
ab bit</w>
a-actin in</w>
a thetoid</w>
a queous</w>
a ined.</w>
a id.</w>
a had</w>
a fferent</w>
a R
] .</w>
] -1
]-1 ,4-di
]-1,4-di azabicyclo[4.3.0]non
] ).</w>
] ),</w>
[CI ]</w>
[4- (5-
[4-(5- nitro-2-furyl)-2-thiazolyl]-form
[3H]- L-arginine</w>
[2-(3,4-dichlorophenyl)ethyl ]-1,4-diazabicyclo[4.3.0]non
[2-(3,4-dichlorophenyl)ethyl ]-
[ verapamil]o</w>
Zy b
ZD V</w>
ZD V
Z ung-Conde</w>
Z )</w>
X O</w>
X )-induced</w>
X ),</w>
With draw
Wil cox
We bster</w>
WR2425 11,</w>
WR -
WR- 27
WR-27 21</w>
W olff-Parkinson-White</w>
W est</w>
Verap amil</w>
Vari ous</w>
Valpro ic</w>
Valpro ate-induced</w>
Val vular</w>
VV H
VVH DF
VPA ,</w>
V max</w>
V itamin</w>
V en
V ascular</w>
V TE
V R
V I
VI P</w>
Up on</w>
Un like</w>
Un it</w>
UM-27 2</w>
U pregulation</w>
U ni
U S</w>
U N</w>
U K</w>
U G
U .</w>
U ,</w>
Twenty- six</w>
Twenty- eight</w>
Top ical</w>
Toge ther,</w>
Tic lopidine-induced</w>
The refore</w>
The ir</w>
Th us</w>
Th rough</w>
Th rombotic</w>
Th ermal</w>
Th alidomide</w>
TI MP</w>
TH E</w>
TAF I,</w>
TA A</w>
T re
T oxicity</w>
T or
T olerance</w>
T im
T est</w>
T emperament</w>
T aken</w>
T ac
T MA
TMA .</w>
T J</w>
T G)</w>
T B
TB O
TBO B</w>
T :
T 2-
T2- weighted</w>
T ).</w>
Syst em
Swe dish</w>
Subsequ ent</w>
St ate</w>
Simult aneous</w>
Simil ar</w>
Sh ort
Sevent y</w>
Sevent een</w>
Ser ologic</w>
Ser ious</w>
Seiz ures</w>
Se ver
ST- segment</w>
SSR Is</w>
SSR I
SR L,</w>
SR ,
SP V</w>
SOCS- 3,</w>
SO N</w>
SN H
SNH L</w>
SE R
SER CA
SE )</w>
SD R
SDR R</w>
SD ).</w>
S(c)O (2)</w>
S(c)O (2
S(c)O(2 ).</w>
S ymptoms</w>
S urg
S up
S ulfonamides</w>
S r
S pontaneous</w>
S pironolactone-induced</w>
S patial</w>
S leep</w>
S kin</w>
S estami
S eptember</w>
S ens
S em
S econdary</w>
S T</w>
S J
Ris k</w>
Ret rospective</w>
Res pon
Res er
Repor ted</w>
Reg ist
Reco very</w>
RBC s.</w>
R s</w>
R ole</w>
R o</w>
R izatriptan</w>
R el
R aniti
R abbit</w>
R P)</w>
R G)</w>
R .</w>
Qu anti
QTL s</w>
Q -
Q- T</w>
Prot ective</w>
Pro te
Pro phylactic</w>
Pro p
Pri locaine</w>
Pre gnant</w>
Pot ter
Post ural</w>
Po stoperatively,</w>
Phen ylephrine</w>
Pharmaco vigilance</w>
Pharmac ological</w>
Perme ability</w>
Partic ipants</w>
PV N</w>
PT Z</w>
PRL- R,</w>
PR ET
PRET AT
PRETAT ION:</w>
PO )</w>
PL L</w>
PG .</w>
PAN -induced</w>
PA R
PA M</w>
PA ),</w>
P< 0.05).</w>
P- glycoprotein</w>
P yrrolidine</w>
P ulmonary</w>
P sych
P rimary</w>
P reliminary</w>
P razos
P neumon
P neumocystis</w>
P irarubicin</w>
P ediatric</w>
P ath
P aclitaxel
P H
P CR</w>
P CO
PCO S</w>
P :</w>
P )-induced</w>
P ),</w>
Over all,</w>
Outcom es</w>
Outcom e</w>
Op tim
On tario</w>
Oc treoti
Oc tober</w>
OUTCOM E</w>
OUTCOM E:</w>
OR T
OC F</w>
OC D-
OCD- like</w>
O X)-induced</w>
O T</w>
O F</w>
O 2-</w>
O 2)</w>
Nor th</w>
Nitroprus side</w>
Nicot ine-induced</w>
New born</w>
Neuro toxicity</w>
Neuro muscular</w>
Neuro logic</w>
Nephro toxicity</w>
Ne gative</w>
Na+- binding</w>
Na+ ,</w>
Na +</w>
NS ,</w>
NS ).</w>
NRA0 16
NO- synthase</w>
NI N</w>
NG ,</w>
N- pyrimidinyl-2-phenoxyacet
N- [4-(5-nitro-2-furyl)-2-thiazolyl]-form
N- (2-
N-(2- propylpentanoyl)urea</w>
N r1(neo-/-)</w>
N on
N imodipine</w>
N iger
N aloxone</w>
N M
N IN
N CE:</w>
N B)</w>
My asthenia</w>
Mul tivariate</w>
Morph ometric</w>
Mor e</w>
Mon it
Min or</w>
Min i-Mental</w>
Mg +2</w>
Meth otrexate,</w>
Met abolic</w>
Med ic
Mar ital</w>
MRP 2-
MRP2- deficient</w>
MR I</w>
MPT P-induced</w>
MP s)</w>
MMR M
MK80 1</w>
METHOD S</w>
MEASUR E
MA PD</w>
MA P,</w>
M yo
M oderate</w>
M od
M ild</w>
M idazol
M icro
M ethyl
M emory</w>
M azindol</w>
M ax
M assive</w>
M agnetic</w>
M ac
M FL</w>
M B</w>
M 1-
M1- selective</w>
M -induced</w>
Lo w-dose</w>
Lo comotor</w>
Lithi um</w>
Li -induced</w>
Levo dopa-induced</w>
Le sions</w>
LY2746 14,</w>
LT X)</w>
LT P</w>
LT :
LNa+ HCa</w>
LID s</w>
LID .</w>
LD L</w>
L-alpha- glycer
L-alpha- GF
L-NO Ar
L-NOAr g</w>
L-NI L</w>
L-NAM E</w>
L-NAM E)</w>
L-DOPA -induced</w>
L-DO PA</w>
L- cholesterol</w>
L idoc
L eu
L ess</w>
L earning</w>
L atency</w>
L ac
L OCF</w>
L Na
L ID</w>
L EV
L Ca
L AM
LAM -
LAM- resistant</w>
L A</w>
L 4-
L ).</w>
King dom</w>
K- MB</w>
K reb
K m</w>
K ing</w>
K idney</w>
K aposi's</w>
K Cl</w>
K BR</w>
K ),</w>
K (Na
K(Na )</w>
Jap anese</w>
J ersey</w>
Inv estigation</w>
Intrac erebroventricular</w>
Intra renal</w>
Inter action</w>
Inte restingly,</w>
Inf arc
Individ ual</w>
In troduction</w>
In sti
In j
In fusions</w>
In fusion</w>
In formation</w>
In duction</w>
In duced</w>
In dex</w>
Immunohisto chemistry</w>
Immun e</w>
Im mediate</w>
INTERV ENT
INTER PRETATION:</w>
II I.</w>
II .</w>
II ,</w>
II ),</w>
IGF -I</w>
IC R</w>
IC :</w>
I/ II</w>
I-H SA</w>
I soproteren
I f</w>
I P)</w>
I K
I H
IH 6
IH6 36</w>
I E
I (f
Hyper sensitivity</w>
Hyper kalemia</w>
Hospit al,</w>
Hist ologic</w>
High er</w>
Hem olysis</w>
He par
He ad
HCFC s</w>
HCF C</w>
HC N</w>
HBe Ag</w>
HBe Ag
HB sAg</w>
H- TBOB</w>
H(3)- receptor</w>
H unt</w>
H ess</w>
H emo
H aloperidol</w>
H PL
H MG</w>
H F)</w>
H EM</w>
H A)</w>
Gu ard</w>
Gly bur
German y,</w>
Gen erally,</w>
GSPE +
GABA -
G ranulo
G ram-
G m.</w>
G astrointestinal</w>
G alanthamine</w>
G P
G OT</w>
G EM</w>
G E
G .</w>
Fu sidic</w>
For ty-nine</w>
Fo urteen</w>
Fif teen</w>
Fentan yl</w>
Fe wer</w>
Fact or</w>
FL AI
FLAI R</w>
FK50 6-
F unction</w>
F requency</w>
F rench</w>
F ran
F orty</w>
F ormation</w>
F ocal</w>
F atal</w>
F asciculations</w>
F ahad</w>
F S.</w>
F EV
FEV 1</w>
F ;</w>
F -
F ),</w>
Experim ental</w>
Examin ation</w>
Ex trapyramidal</w>
Ex posure</w>
Euro pean</w>
Estro gen</w>
Endo thelial</w>
End- systolic</w>
En glish</w>
En docrine</w>
En alapril</w>
Elev ated</w>
Electro n</w>
Electro cardio
Eff icacy</w>
ET -1
ESRD .</w>
ED 50</w>
EC T.</w>
EB F</w>
E40 3
E1 -induced</w>
E toposide</w>
E s)</w>
E rectile</w>
E mergency</w>
E ll
E igh
E cstas
E chocardiographic</w>
E X</w>
E X
E G)</w>
Dru gs</w>
Doxorub icin</w>
Dop pler</w>
Dop amine</w>
Do ses</w>
Do es</w>
Dipyridam ol
Differen t</w>
Differen ces</w>
Diag nosis</w>
Di se
Di ff
Dec reas
De si
De part
Da hl</w>
DF U</w>
DF P-
DF O
DES -treated</w>
DAM P</w>
D up</w>
D obutamine</w>
D ia
D ental</w>
D amage</w>
D S,</w>
D NR
D C</w>
D BP</w>
D BA
DBA /2
Cros sover</w>
Cros s-sectional</w>
Cor relation</w>
Cont rol
Con versely,</w>
Con sequently,</w>
Con fusion</w>
Con comitant</w>
Con centrations</w>
Com pany,</w>
Co A</w>
Clon idine</w>
Clo ti
Cis plat
Chrom osomes</w>
Chol estatic</w>
Ch ildren's</w>
Ch aracter
Cardi ovascular</w>
Cardi oprotective</w>
Cap ecitabine</w>
CaCl(2)- untreated</w>
CaCl(2)- treated,</w>
CaCl (2)</w>
Ca uda</w>
Ca +2</w>
CYP2D 6</w>
CYP2D 6.</w>
CS S
CS F</w>
CR ,</w>
CPA ,</w>
CP K),</w>
CP B</w>
CO C
CO 2</w>
CI S</w>
CI :
CI: 0.
CI -
CI- 9
CI-9 21</w>
CB F</w>
CA N</w>
C57BL/ 6</w>
C57BL/ 6
C57BL/6 J</w>
C rataegus</w>
C r
C ho
C er
C ent
C ells</w>
C auses</w>
C at
C ases</w>
C arb
C ar
C ambodian</w>
C NS,</w>
C M</w>
C K-MB</w>
C K
C E,</w>
C Cl
C -H
Bio chemically,</w>
Belgi um.</w>
Be ginning</w>
Bas al</w>
BMC -treated</w>
BD10 63</w>
BD10 18,</w>
BD L</w>
BD L.</w>
BCH E</w>
BACKGROUND /
BACKGROUND/ AIM
BACKGROUND/AIM S:</w>
BACKGROUN D</w>
B romocript
B oth,</w>
B er
B eck</w>
B Z
B UN</w>
B PO</w>
B F</w>
B E</w>
B E-
B 1</w>
Au to
Atten uation</w>
As sociated</w>
Arg 10</w>
Ar terial</w>
Ar gentine</w>
Anti tuberculosis</w>
Anti -
Angio graphy</w>
Angio edema</w>
An y</w>
An tinociceptive</w>
An t
Amiodar one</w>
Am B.</w>
Al terations</w>
Al lopurinol</w>
Al lopregnanolone</w>
Afric an</w>
Aff ective</w>
Ad ult</w>
Ac tivation</w>
Ac ross</w>
Ac cumulation</w>
AT (-
AT(- /-
AS T:
AS EX</w>
AS A</w>
AS /
AS/ KS</w>
AR T)</w>
AN F</w>
AN CE</w>
AM I
AM ),</w>
AIM :</w>
ADAM -1
ADAM-1 7</w>
ADAM -
ADAM- 10</w>
AD R</w>
AD R
A uditory</w>
A trial</w>
A ortic</w>
A llergic</w>
A kathisia</w>
A ge</w>
A X.</w>
A X-
A S)</w>
A LT:
A KBR</w>
A H
A B
A ART)</w>
A A)</w>
A (2
A(2 A)</w>
> /
>/ =</w>
<0.00 1</w>
: 1</w>
93 17</w>
9. 9</w>
9. 4</w>
9- tetrahydrocannab
9 8</w>
9 8+/-
98+/- 7</w>
9 2,</w>
9 0%</w>
9 +/-
9 %),</w>
80 +/-1
80+/-1 7</w>
8. 6%,</w>
8- fold</w>
8- aminoquinoline</w>
8+/- 4%</w>
8 ]</w>
8 9</w>
8 6
8 5%</w>
8 3</w>
8 0%</w>
8 /
8 .</w>
8 ,000</w>
8 %);</w>
70- year-old</w>
7. 6-
7. 3%),</w>
7. 1%),</w>
7. 0
7 ;</w>
7 8)</w>
7 53</w>
7 3.6</w>
7 2-
72- year-old</w>
7 2%.</w>
7 1.4%</w>
7 00</w>
7 %.</w>
6. 6</w>
6. 6
6.6 %;</w>
6. 2</w>
6. 1</w>
6- year</w>
6- hydroxy
6 8%</w>
6 3-year-old</w>
6 3,</w>
6 1-year-old</w>
6 00</w>
6 0-
6 0%)</w>
50- mg</w>
50- 100</w>
50 %,</w>
5. 4</w>
5. 3</w>
5. 2</w>
5-HT 2</w>
5-HT (6)</w>
5- 15</w>
5 9
5 5.
5 13</w>
5 ).</w>
5 %.</w>
5 %).</w>
45- 12
40- 59
40 4</w>
40 00
4000 Hz</w>
40 %,</w>
4. 4%</w>
4. 1</w>
4- week</w>
4- h</w>
4- DAMP</w>
4 ;</w>
4 7.5</w>
4 4%</w>
4 3-year-old</w>
4 3%</w>
4 2%</w>
4 1</w>
4 /
4 '-
4'- 0-
4'-0- tetrahydropyranyl
4 %,</w>
4 %).</w>
36 %.</w>
34 34
30- year-old</w>
30- min</w>
30- mg</w>
30 00</w>
30 %,</w>
3.0 )</w>
3. 6
3. 1;</w>
3- week</w>
3- methyl
3- day</w>
3- 5</w>
3 N
3 H-TBOB</w>
3 D</w>
3 7%</w>
3 6-year-old</w>
3 5-year-old</w>
3 3.
3 1%</w>
3 1
27 8</w>
27 -
25 3</w>
25 ),</w>
25 %,</w>
200 7,</w>
200 4,</w>
200 3</w>
20 4</w>
20 ,
20 )</w>
20 ),</w>
2. 5)</w>
2. 2,</w>
2. 1;</w>
2. 0,</w>
2-chloroprocaine- CE,</w>
2- DM
2- 3.
2- (p
2-(p -
2-(p- bromophenyl)propi
2,2,2- trifluoroethane</w>
2 PAM</w>
2 E1</w>
2 A</w>
2 ;</w>
2 8-year-old</w>
2 5-
2 40</w>
2 4-h</w>
2 4%</w>
2 3,</w>
2 3%</w>
2 20</w>
2 2,</w>
2 2)</w>
2 2%.</w>
2 19
2 1,</w>
2 1%</w>
2 1
21 days</w>
2 0.0
2 +/-1
2 %),</w>
199 3</w>
199 2.</w>
198 6</w>
198 5</w>
198 5.</w>
198 4</w>
18- month</w>
18 ;</w>
18 0
17beta- Estradiol</w>
17 5</w>
17 .</w>
17 -
17 ,
16 %.</w>
15 4</w>
15 /
15/ 44</w>
15 %,</w>
14. 2</w>
14. 1</w>
14 3</w>
14 0
14 .</w>
131 I-HSA</w>
13. 9</w>
13. 5</w>
13. 2</w>
13 9317</w>
13 7</w>
13 1</w>
13 ,</w>
12. 8</w>
12. 1</w>
12- h</w>
12 6</w>
12 3</w>
12 2</w>
12 10</w>
12 /
12 ,</w>
12 ).</w>
100 ),</w>
100 %.</w>
10. 2</w>
10- month-old</w>
10- 30</w>
10- 20</w>
10(- 8)</w>
10 7</w>
10 ,</w>
10 ).</w>
10 ),</w>
1.1- 8.
1. 4</w>
1. 3
1. 25</w>
1. 2-3.
1. 1</w>
1- deoxycortisol</w>
1, 0
1,0 22</w>
1 8.9</w>
1 7.5</w>
1 30</w>
1 17)</w>
1 13</w>
1 10</w>
1 1-deoxycortisol</w>
1 1-1
1 1)</w>
1 1).</w>
1 1
1 -</w>
1 ,000</w>
00 0
0/ mm3</w>
0.7 ;</w>
0.7 5%.</w>
0.7 2).</w>
0.4 9,</w>
0.014- unit</w>
0.000 1).</w>
0.00 6,</w>
0.00 6).</w>
0.0 5</w>
0.0 2).</w>
0.0 %)</w>
0. 9;</w>
0. 8
0. 7</w>
0. 5%</w>
0. 3,</w>
0. 15</w>
0. 0</w>
0- 5.
0 4
0 2</w>
0 0,</w>
/2 6,</w>
/ cisplatin</w>
.0 1).</w>
. ;</w>
-1- [2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]non
-1 )</w>
- up</w>
- specific</w>
- protective</w>
- pretreated</w>
- negative</w>
- mediated</w>
- enhanced</w>
- B
- 2,2,2-trifluoroethane</w>
- /-)</w>
- -</w>
, "</w>
) ]</w>
) /
) .(ABSTRACT</w>
(p< 0.001).</w>
(p <0.0
(n= 200</w>
(n= 2.
(n= 12)</w>
(i i)</w>
(i e,</w>
(f MRI)</w>
(c)O (2
(c)O(2 ))</w>
(V PA)</w>
(V NB)</w>
(V AS)</w>
(T rental
(T E
(T 3N
(SR L)</w>
(SE ).</w>
(S O
(S D)</w>
(S (c)O(2))</w>
(R P
(PR L)</w>
(PAN ,</w>
(PAN )-induced</w>
(P= 0.3
(P T)</w>
(P D
(P CP
(P <0.01)</w>
(OR s)</w>
(OR :</w>
(O P)</w>
(O LTX)</w>
(NSCL C)</w>
(NS C</w>
(N O)</w>
(N =
(MA P)</w>
(M M
(L Na+
(I V)</w>
(I F
(HI T)</w>
(HB sAg
(H E
(H AART)</w>
(GF R)</w>
(G S
(F S)</w>
(EC T)</w>
(E EG)</w>
(E D)</w>
(DTI C)</w>
(D bh</w>
(D W
(D OX)-induced</w>
(CI P
(CG RP)</w>
(C Y
(C PA
(C P
(C I)</w>
(C CO-
(B Ch
(B BB
(AZ T)</w>
(ALT ,</w>
(AD C)</w>
(A T
(A A
(> or=
(9 7.3%),</w>
(9 6%)</w>
(8 /8),</w>
(6 3%)</w>
(6 2.
(6 %)</w>
(5. 5</w>
(5-FU )</w>
(5 %)</w>
(4 4.
(4 2%)</w>
(4 1%)</w>
(3. 75</w>
(3)H- MK-801</w>
(3 alpha-hydroxy-5
(3 5</w>
(3 -
(2 98+/-7</w>
(2 5%</w>
(2 5%-
(2 4%)</w>
(2 2%)</w>
(2 2%),</w>
(2 00,</w>
(2 00
(2 /8),</w>
(2 )
(2 %)</w>
(10 00</w>
(10 %),</w>
(1. 9</w>
(1. 0</w>
(1 99
(1 5.
(1 5%)</w>
(1 4</w>
(1 4.
(1 2</w>
(1 2%)</w>
(1 )-
(0. 2-
(+ )-
( within</w>
( with</w>
( to</w>
( the</w>
( tacrolimus)</w>
( t
( six</w>
( single</w>
( set</w>
( safety</w>
( placebo</w>
( phase</w>
( not</w>
( max)</w>
( low-dose)</w>
( lidocaine)</w>
( less</w>
( i.v.)</w>
( host)</w>
( from</w>
( eNOS)</w>
( donor)</w>
( defined</w>
( ddI)</w>
( day</w>
( compared</w>
( cTn
( by</w>
( bolus</w>
( and</w>
( an</w>
( alpha-
( alendron
( adj
( X</w>
( TR
( L-NAME)</w>
( IS
( HCFC</w>
( ESRD
( ES
( BC
( ></w>
( 50-100</w>
( 50
( 5-HT
( 30</w>
( +/-</w>
" subtherapeutic"</w>
" )</w>
" ).</w>
zonis amide</w>
zidovud ine.</w>
zidovud ine,</w>
zetimi be-induced</w>
zer o</w>
zer ;</w>
z ygous</w>
z op
zop ic
zopic l
zopicl one</w>
z one,</w>
z ol</w>
z ol
zol e).</w>
z iness,</w>
z ine</w>
z il</w>
z es</w>
z ap
zap ine,</w>
z ).</w>
yst ectomy</w>
ysi s,</w>
ys function</w>
ys 1,</w>
ys )</w>
yro ph
yroph il
yrophil ic</w>
yro idis
yroidis m.</w>
yr ylcholinesterases</w>
yr s</w>
yr s;</w>
yr s),</w>
yr 6
yr6 ]-
yr6]- VIP</w>
yr )</w>
ypi a</w>
yp 3,
yp3, Th
yp3,Th i
yp3,Thi 5,
yp3,Thi5, D-
yp3,Thi5,D- Tic
yp3,Thi5,D-Tic 7,
yp3,Thi5,D-Tic7, O
yp3,Thi5,D-Tic7,O ic
yp3,Thi5,D-Tic7,Oic 8]</w>
youn g,</w>
yo pathy</w>
yo h
yoh im
yohim bine</w>
yo gram.</w>
yn yl)
ynyl) pyri
ynyl)pyri dine</w>
yn u
ynu ren
ynuren ine</w>
ym us</w>
ym uria.</w>
yltransfer ases</w>
yltransfer ase,</w>
ylthio uracil-induced</w>
ylchol ine-induced</w>
ylchol in
ylcholin '
ylcholin' ;</w>
yl- poly
yl-poly -
yl-poly- L-
yl-poly-L- lys
yl-poly-L-lys ine</w>
yl- phosphorylcholine</w>
yl- dexamethas
yl-dexamethas one,</w>
yl- 7-
yl-7- (4-
yl-7-(4- methyl-
yl-7-(4-methyl- piperaz
yl-7-(4-methyl-piperaz in-1-
yl-7-(4-methyl-piperazin-1- yl)
yl-7-(4-methyl-piperazin-1-yl) 1
yl-7-(4-methyl-piperazin-1-yl)1 H-
yl-7-(4-methyl-piperazin-1-yl)1H- indol
yl-7-(4-methyl-piperazin-1-yl)1H-indol e)</w>
yl)amino] phenyl
yl)amino]phenyl ]
yl)amino]phenyl] amino
yl)amino]phenyl]amino ]</w>
yl)amino] -</w>
yl) cyclohex
yl)cyclohex yl
yl)cyclohexyl amine
yl)cyclohexylamine ).</w>
yl salicylic</w>
yl propanol
ylpropanol amine</w>
yl phosphorylcholine</w>
yl ic</w>
yl guan
ylguan idine</w>
yl ated.</w>
yl ate,</w>
yl and,</w>
yl amine</w>
yl ]
yl] pi
yl]pi perazine</w>
yl ,</w>
yiel d</w>
year s).</w>
year s'</w>
year ;</w>
ye lo
yelo suppression</w>
yclo -
yclo- orth
yclo-orth ob
yclo-orthob enz
yclo-orthobenz o
yclo-orthobenzo ate)</w>
yclin es</w>
yclin es,</w>
ycl idine</w>
ycin- induced,</w>
ycin- co
ycin-co lis
ycin-colis tin</w>
ycin- D,</w>
yc lospor
yclospor ine</w>
yc in-treated</w>
yc in,</w>
yc in
ycin ol,</w>
y/ short</w>
y/ injury,</w>
y/ efficacy</w>
y- treated</w>
y- state</w>
y- safe</w>
y- related</w>
y- product</w>
y- isoproteren
y-isoproteren ols</w>
y- dimorph
y-dimorph ic</w>
y- N-
y-N- methyl
y-N-methyl piperid
y-N-methylpiperid ine</w>
y- As
y-As ber
y-Asber g</w>
y- -1
y--1 9</w>
y tren
ytren 's</w>
y ten
yten oid</w>
y sex
ysex ec
ysexec utive</w>
y se
yse al</w>
y s,</w>
y rate)</w>
y r</w>
y py
ypy )</w>
y proterone</w>
y pa
ypa que</w>
y osc
yosc ine
yoscine ).</w>
y ing),</w>
y go
ygo tic</w>
y ch
ych nine</w>
y ad
yad h,</w>
y J</w>
y A),</w>
y .
y. Post
y.Post -
y.Post- mortem</w>
y -old</w>
y ,"</w>
y "</w>
y ").</w>
xim ide-induced</w>
xi s.</w>
xi bility</w>
xanth ines</w>
xamethoni um.</w>
xamethoni um-induced</w>
x- ray</w>
x- mediated</w>
x ton</w>
x sy
xsy m</w>
x ia,</w>
x es.</w>
x ero
xero stom
xerostom ia,</w>
x en
xen on
xenon -1
xenon-1 33</w>
writ ten</w>
writ ing,</w>
world wide</w>
world wide
worldwide .</w>
work- up.</w>
work ers.</w>
work er</w>
wor st</w>
wor se</w>
wor se.</w>
wor ld</w>
wor ds,</w>
wor d</w>
wom an-
woman- years</w>
wom an,</w>
wo ke</w>
withdraw n,</w>
withdraw ing</w>
withdraw al,</w>
with standing</w>
with in-
within- subject
within-subject ,</w>
with holding</w>
witch es</w>
wit z</w>
wit ness
witness ed</w>
wil d-
wild- type
wild-type )</w>
wide -
wide- range</w>
wide ,</w>
wid er</w>
wid ening</w>
wi m</w>
wi an</w>
whe re,</w>
whe re
where by</w>
whe ez
wheez ing.</w>
wh ol
whol e-
whole- body</w>
wh it
whit e-
white- cell
white-cell ,</w>
wh ic
whic h,</w>
wh at
what )</w>
well- tolerated</w>
well- tolerated.</w>
well- recognized</w>
well- established</w>
well- differentiated</w>
well- developed</w>
well- defined</w>
well- characterized</w>
well ing</w>
well ,</w>
week s;</w>
week s'</w>
week s
weeks -old</w>
week ly)</w>
week .</w>
week -old</w>
wean ing</w>
weak ness.</w>
weak ness,</w>
weak ly</w>
weak ,</w>
we ver</w>
we ster
wester n</w>
we d
wed ge</w>
we ating</w>
we ar
wear .</w>
wat ch</w>
wash out</w>
wash out.</w>
warran ts,</w>
warn ings</w>
warn ing.</w>
warfarin- related</w>
war ned</w>
war m</w>
war dam
wardam ang
wardamang ia,</w>
war d.</w>
war .</w>
wall s</w>
wall ;</w>
wall .</w>
wakeful ness</w>
wakeful ness.</w>
wa ve-
wave- to-
wave-to- R-
wave-to-R- wave</w>
w thor
wthor n</w>
w t)</w>
w ris
wris t</w>
w k.</w>
w k
wk )</w>
w ing</w>
w ine.</w>
w in</w>
w in-
win- shift</w>
w illing</w>
w ay
way s.</w>
w ater
water )</w>
w ast
wast age</w>
w as,</w>
w ake</w>
w -
w- pressure</w>
vulner able</w>
vulner ability</w>
vul ation.</w>
volunte ers,</w>
volu metry</w>
volu metric</w>
vol ution</w>
vol t
volt age</w>
vol emia</w>
vol ar</w>
voc ation</w>
voc aly
vocaly ce
vocalyce al</w>
voc al
vocal iz
vocaliz ations</w>
viv al</w>
vit al</w>
vir us,</w>
viol ent</w>
viol ation.</w>
vincrist ine-induced</w>
vincrist ine-
vincristine- induced)</w>
vinc ul
vincul in,</w>
vinc ris
vincris tin</w>
vinc ing</w>
vinc a</w>
vigil ance.</w>
vigabat rin.</w>
vigabat rin)</w>
view ed</w>
view .</w>
vide o</w>
vide o-
video- oc
video-oc u
video-ocu logra
video-oculogra phy.</w>
vid one-
vidone- iod
vidone-iod ine</w>
vid a,</w>
vic ti
victi m</w>
vic inity</w>
vic es</w>
vi x</w>
vi tis,</w>
vi st
vist s</w>
vi sion,</w>
vi sed.</w>
vi re
vire mia</w>
vi ously,</w>
vi als</w>
vi able</w>
vi ability,</w>
vest oc
vestoc k.</w>
vessel .</w>
vesi cul
vesicul ated</w>
vesi co
vesico prostatic</w>
ves ti
vesti bular</w>
ves '</w>
verapamil -related</w>
ver tig
vertig o</w>
ver tic
vertic is</w>
ver thel
verthel ess,</w>
ver te
verte bral</w>
ver t
vert ently</w>
ver sion.</w>
ver sa</w>
ver s.</w>
ver s
vers ity</w>
ver ify</w>
ver ified</w>
ver if
verif ying</w>
ver ging</w>
ver bal</w>
ver atri
veratri dine</w>
ver -
ver- stained</w>
ventric ular
ventricular ly)</w>
ventric les</w>
ventil ation.</w>
ven ular</w>
ven ue</w>
ven tion,</w>
ven ti
venti lat
ventilat or</w>
ven ous,</w>
ven o-occlusive</w>
ven o
veno venous</w>
ven i
veni ent</w>
ven ger</w>
ven ed.</w>
veloc ity.</w>
vel y-safe</w>
vehicle/ vehicle</w>
vehicle/ scopolamine</w>
vehicle -treated</w>
vehicle -</w>
vehicle ,</w>
ve- pressure</w>
ve- enhancing</w>
ve y</w>
ve sic
vesic ally</w>
ve re
vere d,</w>
ve olar</w>
ve ment,</w>
ve lo
velo ci
veloci ties</w>
ve ins</w>
ve ins,</w>
ve in,</w>
ve -like</w>
vasodilat ation</w>
vasoconstric tion.</w>
vaso relaxation</w>
vaso active</w>
vasculat ure.</w>
vasculat ure,</w>
vascul itis.</w>
vascul arly</w>
vascul arization</w>
vas ore
vasore activity</w>
vas omotor</w>
vas cu
vascu log
vasculog en
vasculogen ic</w>
vas ation</w>
variabl es:</w>
vari es</w>
vari ectomy</w>
vari ants.</w>
vari ability.</w>
vari ability,</w>
var us.</w>
van com
vancom ycin</w>
valu es,</w>
valu e,</w>
valpro ate.</w>
valpro ate-induced</w>
valpro ate,</w>
val ves</w>
val idation</w>
val idated</w>
val idate</w>
vag inal</w>
vag ina</w>
vacuol ization</w>
vacuol is
vacuolis ation</w>
vacuol es.</w>
vacuol es,</w>
vac c
vacc ine</w>
v x)</w>
v otal</w>
v ity.</w>
v ised</w>
v inyl</w>
v il
vil li
villi .</w>
v es,</w>
v ec
vec uron
vecuron ium</w>
v ative</w>
v as</w>
v ances</w>
v 2.0</w>
utili zes</w>
uti vely</w>
uter us</w>
uter us.</w>
uter o,</w>
uter i</w>
ut yrylcholinesterase</w>
ut ure</w>
ut ro
utro penia</w>
ut in
utin y.</w>
ut es</w>
ut ations</w>
ut am
utam yltransferase</w>
usulf an-induced</w>
ust om
ustom ed</w>
ush ing
ushing 's</w>
use ly</w>
use d;</w>
us or</w>
us oid
usoid al</w>
us es.</w>
us er</w>
us er,</w>
us c
usc le</w>
us al.</w>
us ac
usac ral</w>
us -induced</w>
us -based</w>
urther ,</w>
uron ate.</w>
uro toxicity</w>
uro toxic</w>
uro tic</w>
uro thelial</w>
uro tensin-II</w>
uro logical</w>
uro dynamic</w>
ureth ra
urethra .</w>
ureth ane-
urethane- anesthetized</w>
ures ).</w>
ure ters,</w>
ure teric</w>
ure ter</w>
ure ter.</w>
ure sis,</w>
ure mia</w>
ure ments</w>
ure less</w>
ure -
ure- P
ure-P rone</w>
ure );</w>
uracil /
uracil/ folinic</w>
ur tic
urtic ation,</w>
ur se.</w>
ur s.</w>
ur n</w>
ur ke
urke y,</w>
ur k
urk inj
urkinj e</w>
ur ingly,</w>
ur ine.</w>
ur in
urin ate.</w>
ur idine</w>
ur i
uri um-
urium- related</w>
ur gency</w>
ur gence</w>
ur ce.</w>
ur bed</w>
ur ated</w>
ur ally.</w>
ur al
ural istic</w>
ur a)</w>
updat ing,</w>
updat ing)</w>
updat ing),</w>
up- regulation.</w>
up ward</w>
up unc
upunc ture</w>
up u
upu ytren's</w>
up ral</w>
up ;</w>
unrel ent
unrelent ing,</w>
unrel ated.</w>
unil ater
unilater ally</w>
uni directional</w>
ung al</w>
unevent ful,</w>
underg one</w>
underg o</w>
under studied.</w>
under line</w>
unchang ed
unchanged .(ABSTRACT</w>
unc lear</w>
un treated,</w>
un t
unt ary</w>
un stable</w>
un sol
unsol ved</w>
un selective</w>
un restricted</w>
un remark
unremark able,</w>
un relieved</w>
un related</w>
un record
unrecord able</w>
un recognized</w>
un recogn
unrecogn ised</w>
un reasonable</w>
un predictable</w>
un orub
unorub icin</w>
un ning</w>
un necessary</w>
un mas
unmas ked</w>
un inten
uninten tional</w>
un ic
unic h
unich -
unich- Wistar</w>
un happ
unhapp iness,</w>
un fractionated</w>
un favorable</w>
un familiar</w>
un dou
undou b
undoub tedly</w>
un ding</w>
un differentiated</w>
un determined.</w>
un desi
undesi ra
undesira ble</w>
un described</w>
un damaged</w>
un conscious</w>
un complicated</w>
un commonly</w>
un common.</w>
un classified</w>
un classi
unclassi fi
unclassifi able.</w>
un aware</w>
un anesthetized</w>
un anesthe
unanesthe tiz
unanesthetiz ed,</w>
un altered.</w>
un acc
unacc ustomed</w>
umer ical</w>
umb er</w>
um- type</w>
um- stimulated</w>
um- depleted</w>
um- dependent</w>
um- associated</w>
um- 3,</w>
um siness</w>
um p
ump ing</w>
um or</w>
um ens</w>
um bil
umbil ical</w>
um :</w>
um ),</w>
ultras ound.</w>
ultras onic</w>
ultras on
ultrason ography</w>
ultra struct
ultrastruct urally.</w>
ultra filtration</w>
ult rac
ultrac ent
ultracent ri
ultracentri fu
ultracentrifu g
ultracentrifug ation</w>
ulos keletal</w>
ulo pathies</w>
ulo in
uloin sular</w>
ull ine,</w>
ulfon yl-7-(4-methyl-piperazin-1-yl)1H-indole)</w>
ulfi ram-like</w>
ulf ate,</w>
ulf asalazine-induced</w>
ul y</w>
ul si
ulsi fication</w>
ul ph
ulph ide</w>
ul n
uln ar</w>
ul line</w>
ul l</w>
ul ati
ulati ve.</w>
ul ated,</w>
ul at
ulat um</w>
ul ant-induced</w>
ul a.</w>
ul a,</w>
udi o
udio grams</w>
ud inal</w>
ud ative</w>
uclear- encoded</w>
ucle ar</w>
ucin ations,</w>
uc tu
uctu ations</w>
uc t
uct ured</w>
uc inosis</w>
uc il</w>
uc ial</w>
uc emia</w>
ub s</w>
ub ital</w>
ub er
uber t
ubert y.</w>
ua ;</w>
ua );</w>
u ximide</w>
u tion.</w>
u tion,</w>
u te
ute )</w>
u t</w>
u reas.</w>
u po
upo rous</w>
u pati
upati onal</w>
u log
ulog en</w>
u ke
uke 's</w>
u itary</w>
u fact
ufact ures</w>
u es</w>
u es,</w>
u bl
ubl ished</w>
u atrial</w>
u ate</w>
u ari
uari al</w>
u ant
uant e</w>
u als</w>
u ally.</w>
u all
uall y-dimorphic</w>
tyros ine-
tyrosine- meth
tyrosine-meth ion
tyrosine-methion ine-
tyrosine-methionine- aspart
tyrosine-methionine-aspart ate-
tyrosine-methionine-aspartate- aspartate</w>
type -1</w>
typ e.</w>
typ e,</w>
ty- six</w>
ty- seven</w>
ty- eight</w>
ty- eigh
ty-eigh t)</w>
two- kidney,</w>
two- dimen
two-dimen sional</w>
twitch ing,</w>
twitch es</w>
tw or
twor k.</w>
tw ins</w>
tw ins.</w>
tw ent
twent y</w>
turb ido
turbido metric</w>
turb ation</w>
tumor s:</w>
tumor .</w>
tumor -protective</w>
tubul es.</w>
tubul es)</w>
tubu log
tubulog lomerular</w>
tubu lo
tubulo -
tubulo- interstitial</w>
tub ules,</w>
tub es.</w>
tu res.</w>
trou bling</w>
trou bl
troubl es
troubles ome</w>
tropon ins</w>
tropon in</w>
troph y,</w>
troph oblastic</w>
troph ic</w>
trop ine-
tropine- MK801</w>
trop in</w>
troleandom ycin</w>
tro phy</w>
trig ger</w>
trig ge
trigge red</w>
trig g
trigg ering</w>
trifluoro acetyl-
trifluoroacetyl- altered</w>
tricycl ics</w>
tricus pid</w>
tricus pid
tricuspid :</w>
tricep s</w>
tricep s.</w>
tricep s,</w>
tric ho
tricho sis</w>
triazol o</w>
triazol am</w>
triazol am.</w>
triax one-
triaxone- associated</w>
tri pt
tript amine,</w>
tri phosphate</w>
tri mipramine</w>
tri me
trime ster
trimester ).</w>
tri hexy
trihexy phen
trihexyphen id
trihexyphenid yl</w>
tri es.</w>
tri ed</w>
tri atal</w>
tri als.</w>
tri ad</w>
tren d</w>
tremor s,</w>
tremor ,</w>
treatment -associated</w>
treatment )</w>
treat ,</w>
tre zol</w>
tre s</w>
tre pto
trepto mycin</w>
tre es.</w>
traum atic</w>
transport- deficient</w>
transport- competent</w>
transpor ters</w>
transplantation :</w>
transplant s</w>
transplant s.</w>
transplant s,</w>
transi tional</w>
transi tion</w>
transi ent,</w>
transfusion- dependent</w>
transfusion- chelation</w>
transfer ase</w>
transfer ase,</w>
transfer .</w>
transcript s</w>
transcript ase</w>
transcri ptom
transcriptom e</w>
transcri p
transcrip tion-
transcription- poly
transcription-poly mer
transcription-polymer ase</w>
transamin ase</w>
transamin ase.</w>
transamin ase,</w>
trans parent</w>
trans mitted</w>
trans mis
transmis sion-
transmission- electron</w>
trans membran
transmembran eous</w>
trans late</w>
trans it.</w>
trans femoral</w>
trans f
transf ected</w>
trans esophageal</w>
trans der
transder mal</w>
tran su
transu re
transure th
transureth ral</w>
tran drine</w>
trac urium</w>
trac t.</w>
trac or
tracor poreal</w>
trac es.</w>
trac ers.</w>
tra it.</w>
tra in</w>
tr ati
trati fication</w>
tr aline,</w>
tr a</w>
toxicit y;</w>
toxicit y)</w>
toxic ological</w>
toxic ations</w>
tox y-N-methylpiperidine</w>
tox ins</w>
tox in</w>
tox in,</w>
tot oxicity</w>
tor vastatin</w>
tor r.</w>
tor ,</w>
topri l.</w>
topri l)</w>
topo isomerase</w>
topiram ate.</w>
topiram ate,</w>
top sy</w>
top ically</w>
tongu e,</w>
ton ic
tonic -
tonic- clonic</w>
ton ,</w>
tom ycin-D,</w>
toler ate</w>
toler ance
tolerance :</w>
toler ability.</w>
tocopher ols</w>
tocon azole.</w>
tocon azol
toconazol e-induced</w>
tobram ycin.</w>
tobram ycin-treated</w>
to- treat,</w>
to- severe</w>
to- acet
to-acet ate
to-acetate /
to-acetate/ 3-
to-acetate/3- hydroxy
to-acetate/3-hydroxy but
to-acetate/3-hydroxybut yrate)</w>
to propi
topropi onic</w>
to pping</w>
to oth</w>
to o</w>
to ma.</w>
to l</w>
to es</w>
to es.</w>
to .</w>
to -treated</w>
to )</w>
tizan idine,</w>
tivi tis</w>
tiv ation
tivation al,</w>
tiv al</w>
tiv a</w>
tit ude</w>
tit ration</w>
tit rating</w>
tit rate</w>
tissue- type</w>
tissue- specific</w>
tissu es,</w>
tis it
tisit e,</w>
tis ing</w>
tis ed</w>
tion- to-treat,</w>
tion- limiting</w>
tion s:</w>
tion na
tionna ire</w>
tion .
tion. A</w>
tion )</w>
tion ).</w>
tion ),</w>
tin ent</w>
timolol -treated</w>
timolol -related</w>
timolol -induced</w>
timolol )</w>
time ly</w>
time -related</w>
time -
time- of-
time-of- f
time-of-f light</w>
tim ulation</w>
tim es:</w>
tim es/
times/ week</w>
tim es,</w>
tim ed</w>
tim ately,</w>
til ity.</w>
til age,</w>
tid al</w>
tico steroids</w>
tico ag
ticoag ulant-induced</w>
ticlopid ine;</w>
ticlopid ine.</w>
ticlopid ine,</w>
tice mia.</w>
tice able</w>
tic- uremic</w>
tic- range</w>
tic s:</w>
tic ity</w>
tic ip
ticip ation</w>
tic ed</w>
tic als</w>
tic ally,</w>
tic al
tical s)</w>
tic -associated</w>
tic )</w>
ti ze</w>
ti vely</w>
ti um</w>
ti ters.</w>
ti ter</w>
ti st</w>
ti st
tist s'</w>
ti re
tire dness</w>
ti p</w>
ti lled</w>
ti lit
tilit y:</w>
ti f</w>
ti d,</w>
ti ce</w>
ti ca
tica emia</w>
ti ally,</w>
thyroidis m.</w>
thyro tropin</w>
thyro ar
thyroar ytenoid</w>
thym us</w>
thym idine-induced</w>
thromboembolis m.</w>
thrombocytopen ic</w>
thrombocytopen ia.</w>
thrombo sis;</w>
thrombo plas
thromboplas tin</w>
thromb us,</w>
thromb i</w>
throm bin,</w>
throm bin
thrombin -
thrombin- activ
thrombin-activ at
thrombin-activat able</w>
threshol ds</w>
threshol d.</w>
threat ened</w>
thre e;</w>
thre e-
three- week</w>
thou gh
though ,</w>
thor a
thora x</w>
tho se,</w>
thir ty-six</w>
thir ds</w>
thir d-line</w>
thioper amide</w>
thioper amide,</w>
thio uracil.</w>
thio b
thiob arbit
thiobarbit uric</w>
thick ness.</w>
thick ness,</w>
thiazol e-
thiazole- 2-
thiazole-2- carbox
thiazole-2-carbox amide,</w>
thiaz ide</w>
thiaz ide-
thiazide- triamterene</w>
thia sis:</w>
thi ot
thiot epa
thiotepa ,</w>
thi en
thien odi
thienodi azepine</w>
thes es,</w>
thes e.</w>
therosclero sis</w>
thereaf ter,</w>
therapy- resistant</w>
therapy- related</w>
therapeu tically</w>
therap y;</w>
therap y.Post-mortem</w>
therap y-induced</w>
therap y)</w>
therap ies,</w>
ther to</w>
ther n</w>
ther mia,</w>
theore tically</w>
then ,</w>
them sel
themsel ves.</w>
them a</w>
them .</w>
theli o
thelio ma,</w>
theli al-
thelial- dependent</w>
the ta</w>
the ory</w>
the l</w>
the ast</w>
the -
the- counter</w>
that :</w>
thalasse mia</w>
thalam us</w>
thalam ocortical</w>
thal idomide.</w>
th- of-
th-of- stay</w>
th ynyl)pyridine</w>
th rac
thrac yclines</w>
th ous
thous and</w>
th ot
thot ri
thotri psy</w>
th ostatic</w>
th on
thon us,</w>
th is
this .
this. A
this.A mino
this.Amino glyco
this.Aminoglyco side</w>
th arg
tharg y,</w>
th an
than ized,</w>
tetrahydropyranyl adriamyc
tetrahydropyranyladriamyc inol</w>
tetrachlor ide-induced</w>
tetra fluoro
tetrafluoro ethane</w>
tetan y.</w>
tetan us</w>
tet anic</w>
test o
testo ster
testoster one,</w>
test ing.</w>
test ing,</w>
test es</w>
test ed;</w>
test )</w>
terodi line
terodiline ).</w>
tern s</w>
termin ing</w>
termin ating</w>
terato genic
teratogenic .</w>
ter us</w>
ter oceptive</w>
ter m
term )</w>
ter in
terin ess
teriness "</w>
tend on</w>
ten sion</w>
ten se</w>
ten of
tenof ovir</w>
ten ed</w>
ten der
tender ness,</w>
tempor ary</w>
tempor arily</w>
tempor al
temporal is</w>
temperat ure.</w>
temperat ure,</w>
temper ament</w>
temper am
temperam ent,</w>
tem pt
tempt s</w>
tem po
tempo rom
temporom an
temporoman di
temporomandi bular</w>
ted ;</w>
ted .(ABSTRACT</w>
ted )</w>
techniqu es</w>
techniqu e)</w>
techni que</w>
tech no
techno logy</w>
te- suppressants</w>
te- derived</w>
te- colon
te-colon y</w>
te trezol</w>
te trandrine</w>
te re
tere ff
tereff ects</w>
te l
tel angi
telangi ect
telangiect a
telangiecta sis.</w>
te grade</w>
te gment
tegment i</w>
te en.</w>
te e</w>
te am.</w>
te am
team s</w>
te ach
teach ing</w>
te -associated</w>
te ,</w>
tas ks</w>
tas k,</w>
tari qu
tariqu id
tariquid ar</w>
target -free</w>
tamoxif en</w>
tamoxif en.</w>
tal ip
talip es</w>
tal "</w>
tak es</w>
tail- fl
tail-fl ick</w>
tail- cu
tail-cu f
tail-cuf f</w>
tacrolim us,</w>
tachy cardi
tachycardi as.</w>
tachy arrhythmia</w>
tachy arrhythmia.</w>
tachy arrhythmi
tachyarrhythmi as.</w>
tac t</w>
table ts.</w>
table ts,</w>
table t</w>
table t,</w>
table )</w>
ta p</w>
ta =
ta= -
ta=- 6.
ta=-6. 7
ta=-6.7 %;</w>
ta -
ta- ro
ta-ro d</w>
tPA ),</w>
tAM CA)</w>
tAM CA
tAMCA .</w>
t- sided</w>
t- line</w>
t- but
t-but yl</w>
t- and-
t-and- a-
t-and-a- half-
t-and-a-half- yr-old</w>
t- acting</w>
t y,</w>
t witch</w>
t welve</w>
t ute</w>
t us</w>
t ures</w>
t ureless</w>
t ure.</w>
t ure,</w>
t rough</w>
t rit
trit an-
tritan- type</w>
t ram
tram uscular</w>
t pro
tpro )</w>
t osomal</w>
t one.</w>
t one-
tone- bur
tone-bur st</w>
t ol
tol ylguanidine</w>
t l
tl and,</w>
t incture</w>
t fold</w>
t estic
testic ular</w>
t enth</w>
t ative</w>
t aro
taro l,</w>
t app
tapp ed</w>
t ap
tap ered</w>
t an
tan de
tande m</w>
t amp
tamp on
tampon ade
tamponade ,</w>
t a.</w>
t :</w>
t .i.
t.i. d.</w>
t .
t. d
t.d .
t.d. s.</w>
t -</w>
t (1/
t(1/ 2)</w>
system s.</w>
system s,</w>
system ically</w>
system :</w>
synthe sized</w>
synerg ism</w>
synerg is
synergis tically</w>
syndro me
syndrome "
syndrome" ,</w>
synap tosomal</w>
synap ses.</w>
synap se.</w>
synap s
synaps es,</w>
syn cope</w>
symptom s;</w>
sym patho
sympatho ad
sympathoad renal</w>
sy no
syno vitis,</w>
switch ing.</w>
switch ing,</w>
switch es.</w>
switch ers.</w>
switch ,</w>
suspen sions.</w>
susp ici
suspici on</w>
susp ect</w>
suscepti ble</w>
suscepti bil
susceptibil ity.</w>
survival /
survival/ repair</w>
surviv ors,</w>
survi ved</w>
surve ying</w>
surgery/ radiotherapy</w>
surgery/ radio
surgery/radio therapy)</w>
sur ge</w>
sur ge
surge on</w>
sur f
surf ace
surface )</w>
sur ance</w>
suppress or</w>
suppress ing</w>
suppress ants,</w>
suppress ant</w>
suppres sible</w>
suppres sed.</w>
support .</w>
suppor ted</w>
suppor ted)</w>
supplement s.</w>
supplement s,</w>
supplement ation.</w>
supple ments</w>
superi ority</w>
super vision</w>
super vision.</w>
super vised</w>
super vened.</w>
super sat
supersat urated</w>
super nat
supernat ants</w>
super im
superim posed</w>
super f
superf ici
superfici ally</w>
sup pressive</w>
sup posed</w>
sup plied</w>
summ ated</w>
summ ary,</w>
summ ar
summar izes</w>
sumatript an</w>
sumatript an.</w>
sulindac .</w>
sulindac ,</w>
sulfonyl ureas.</w>
sulfonyl urea,</w>
sulf ated</w>
sulf ate-
sulfate- treated</w>
sulf ate,</w>
sugges tions</w>
sugges tion</w>
suffici ently</w>
suff ers</w>
sud ative</w>
success ful</w>
suc ce
succe ed
succeed ed</w>
subun it.</w>
substrat um</w>
substrat es,</w>
substrat e,</w>
substi tute</w>
substanti ated</w>
substanti a</w>
subst ance.</w>
subst ance
substance -induced</w>
subling ually</w>
subling ually.</w>
subling ual</w>
subject s)</w>
subject s).</w>
sub- regions</w>
sub- divided</w>
sub types</w>
sub type</w>
sub tle</w>
sub strates</w>
sub sided</w>
sub sets</w>
sub score.</w>
sub scale,</w>
sub regions</w>
sub region,</w>
sub pial</w>
sub mitted</w>
sub membran
submembran ous</w>
sub hypnotic</w>
sub endothelial</w>
sub dural</w>
sub divided</w>
sub cortical</w>
sub cellular</w>
sub cap
subcap sular</w>
sub acute,</w>
su xamethonium.</w>
su vastatin</w>
su tureless</w>
su nit
sunit ini
sunitini b</w>
su n
sun bur
sunbur n.</w>
su it</w>
studi ed,</w>
stud y:</w>
stud y/short</w>
struct ured</w>
struct ure,</w>
struc tures.</w>
struc tions</w>
strok es</w>
strok es.</w>
stro lat
strolat er
strolater ally</w>
strip s.</w>
stric tly</w>
striat al-
striatal- resid
striatal-resid ent</w>
stri ps</w>
stri p</w>
stri kes</w>
stretch ing</w>
stretch es</w>
stretch ed</w>
stretch .</w>
stres sed</w>
stres s-induced</w>
streptozotocin- induced)</w>
streptozotocin- diabetic</w>
strepto mycin</w>
strepto coc
streptococ cal</w>
streng then</w>
streng th.</w>
streng th,</w>
stre ptom
streptom ycin.</w>
stre am</w>
stre am
stream ,</w>
strateg y.</w>
stra ins,</w>
stra in.</w>
str ychnine</w>
str y</w>
str ati
strati fied</w>
stopp ed,</w>
ston es.</w>
ston es
stones ).</w>
stom ati
stomati tis</w>
stom ach</w>
stom ach
stomach s</w>
sto p-
stop- watch</w>
stimul us</w>
stimul us.</w>
stimul us-induced</w>
stimul us,</w>
stimul i-
stimuli- -
stimuli-- the</w>
stimul ates</w>
stimul ate</w>
sti ff
stiff ness</w>
sterone- sensitive</w>
sterone- dependent</w>
steroid s.</w>
steroid -induced</w>
steroid -dependent</w>
steroid -based</w>
stereot ypy)</w>
stere ological</w>
stere o
stereo selective</w>
ster os
steros al
sterosal p
sterosalp ing
sterosalping ography</w>
ster ic</w>
ster g</w>
step wise</w>
step -
step- through</w>
stent s,</w>
stent ing</w>
sten osis.</w>
ste ine,</w>
ste in</w>
ste al"</w>
ste ad
stead y-state</w>
statis tically,</w>
static )</w>
stat in)</w>
stat es,</w>
star vation</w>
star ts.</w>
star tle</w>
star ted.(ABSTRACT</w>
stand ing.</w>
stand ardi
standardi zed</w>
stand ard-
standard- dose</w>
stand ar
standar dis
standardis ed</w>
stain s</w>
stain ings</w>
stain ings,</w>
stag hor
staghor n</w>
stag es,</w>
stabiliz ers</w>
stabiliz er.</w>
stabil ized</w>
sta e)</w>
sta b</w>
st- known</w>
st uporous</w>
st unning</w>
st ration</w>
st rac
strac t</w>
st or
stor age</w>
st ents</w>
st em</w>
st e</w>
st ay.</w>
st ating</w>
st atin</w>
st ances</w>
st an
stan bul
stanbul ,</w>
st age.</w>
st age,</w>
st ability.</w>
st ability,</w>
st ),</w>
spont aneously.</w>
spironolact one.</w>
spectro metry</w>
spectro metry.</w>
specimen .</w>
specific ity,</w>
specific ally</w>
spec ulative.</w>
spec ification</w>
spec ially</w>
spec i
speci men</w>
spe ec
speec h</w>
spastic ity.</w>
spastic ity,</w>
sparte ine/
sparteine/ debriso
sparteine/debriso quine</w>
sparte ine.</w>
spar se.</w>
spac es,</w>
spac es
spaces ;</w>
spac e,</w>
sp on
spon dy
spondy lo
spondylo arthro
spondyloarthro pathy,</w>
sp in</w>
sp ent</w>
sp ection</w>
sp ap
spap er</w>
sor af
soraf en
sorafen i
sorafeni b</w>
sone- associated</w>
son o
sono gram
sonogram s.</w>
son i
soni az
soniaz id</w>
son 's</w>
somnol ence</w>
somnol ence
somnolence /
somnolence/ depressed</w>
some what)</w>
som atic</w>
som an</w>
som al</w>
solv ent,</w>
solv able</w>
sol e</w>
sol ated</w>
sodi um:</w>
sodi um-depleted</w>
sodi um)</w>
soci ations</w>
soci ation.</w>
so urce</w>
so urce.</w>
so on
soon er</w>
so medial</w>
so me,</w>
so ft</w>
smok ing
smoking -related</w>
smok ers.</w>
smo ked</w>
small est</w>
small ,</w>
slow ing,</w>
sligh t,</w>
slic es,</w>
sleep in
sleepin ess.</w>
sleep -
sleep- wake</w>
sleep ,</w>
skill s</w>
sk in.</w>
sk ep
skep tical</w>
siz e.</w>
siz e-
size- dependent,</w>
six- week</w>
six- month</w>
six ty-nine</w>
six ty-eight)</w>
six th</w>
six .</w>
situ ation.</w>
sit es.</w>
sit e
site ?</w>
sist ent</w>
sist ant</w>
sirolim us.</w>
sirolim us-based</w>
sirolim us-associated</w>
sion- produced</w>
sion- mediated</w>
sion- induc
sion-induc er</w>
sion- free</w>
sion- Sexual</w>
sion s;</w>
sion s)</w>
sion ;</w>
single-bl inde
single-blinde d,</w>
single-bl ind,</w>
single- phot
single-phot on</w>
single- cell</w>
single- blind</w>
sing leton</w>
sing ,</w>
sin usoidal</w>
sin uses</w>
sin uatrial</w>
sin om
sinom )</w>
simvastatin-ezetimi be</w>
simvastatin-ezetimi be.</w>
simvastatin-ezetimi be-induced</w>
simvastat ine
simvastatine zetimibe-induced</w>
simvastat in.</w>
simult aneously.</w>
simult aneous</w>
similar ities,</w>
similar :</w>
similar .</w>
sim ply</w>
sim otor</w>
significantly ;</w>
significantly :</w>
significant ly,</w>
significant ly)</w>
significant ,</w>
significant )</w>
signific ance,</w>
signal ing.</w>
signal ing,</w>
signal ing)</w>
sign ment,</w>
sign ified</w>
sign fic
signfic antly</w>
sign al.</w>
sign al,</w>
sigma ST</w>
sigma 2</w>
sig n</w>
side- effects.</w>
side- effects,</w>
side- effect,</w>
side -related</w>
sic k</w>
sib il
sibil ity,</w>
sia ).</w>
si vely,</w>
si ve-like</w>
si ve)</w>
si tis</w>
si ties</w>
si rol
sirol mus</w>
si ologists</w>
si mul
simul ated</w>
si lateral</w>
si lastic</w>
si l
sil ver-stained</w>
si es</w>
si der
sider ing</w>
si as,</w>
si ans</w>
shun ting</w>
shun ting.</w>
short- term)</w>
short ness</w>
short ,</w>
shoc k.</w>
shift ing,</w>
shift ing),</w>
shif ting</w>
shel ves</w>
she ll
shell ,</w>
shap ed</w>
sham "</w>
sha res</w>
sh run
shrun k
shrunk en</w>
sh ou
shou ts</w>
sh ed</w>
sh are</w>
sh ar
shar ply</w>
sgk1(- /-
sgk1(-/- ))</w>
sgk1(+/ +
sgk1(+/+ )).</w>
sex ually-dimorphic</w>
sex -related</w>
sevoflur ane-
sevoflurane- sparing</w>
sever ation</w>
sess ment</w>
sess ing</w>
ses sions</w>
ses sions.</w>
ses sions,</w>
ses sion</w>
ses sion,</w>
ses ses</w>
ses ;</w>
seroton in-
serotonin- dopamine</w>
seroton ergic
serotonergic -</w>
seroton erg
serotonerg ically</w>
sero sitis</w>
sero positive</w>
seri ous,</w>
seri ous
serious "</w>
seri ou
seriou s.</w>
seri ally</w>
ser vices</w>
ser vative</w>
ser um.</w>
ser um-</w>
ser traline,</w>
ser o-
sero- negative</w>
ser ine</w>
ser a</w>
ser ,</w>
sequ entially</w>
sequ encing</w>
sequ ences</w>
separ ately,</w>
sep ticemia.</w>
sep ticaemia</w>
sep sis</w>
sep sis.</w>
sep sis,</w>
sensory- motor</w>
sensory- discrimin
sensory-discrimin ative</w>
sensor ial</w>
sensor i-motor</w>
sensitiz ation.</w>
sensitiz ation)</w>
sensitiv ity.</w>
sensitiv ity,</w>
sensitiv it
sensitivit y).</w>
sens us,</w>
sens or</w>
sens ation)</w>
sen g,</w>
sen apine</w>
semi- quantitatively</w>
semi- invasive</w>
semi quantitatively</w>
semi quantitative</w>
semi pur
semipur ified</w>
self-limit ing.</w>
self-limit ed,</w>
self- limited</w>
self- dosing</w>
selegil ine.</w>
selegil ine,</w>
selective' ),</w>
sel ess</w>
sel ective,</w>
sel ecting</w>
seizures :</w>
seizure- resistant</w>
seizure- pr
seizure-pr one</w>
seizure -associated</w>
segment al,</w>
seg ment.</w>
sedati ves</w>
sedati ves,</w>
sed ent
sedent ar
sedentar y-isoproterenols</w>
sed ated</w>
sed ;</w>
second s),</w>
second -</w>
secon d,</w>
sec tion</w>
sec tion.</w>
sec .</w>
sec ,</w>
se x</w>
se ts.</w>
se t,</w>
se pto
septo -
septo- hippocampal</w>
se n</w>
se eing</w>
se di
sedi mentation,</w>
se c</w>
se arch
search es</w>
se -free</w>
se -dependent</w>
se -
se- controls.</w>
se )</w>
scre en</w>
scopolamine ;</w>
scopolamine -</w>
scopol amine-induced</w>
scopol amine-
scopolamine- injected</w>
sco res,</w>
sco re:</w>
sco pic</w>
sclero sis.</w>
sci enti
scienti f
scientif ic</w>
sci .</w>
schizophren ic
schizophrenic -like</w>
schedul es.</w>
scan ning</w>
scan ,</w>
scal e;</w>
scab ici
scabici des</w>
sc r
scr utiny.</w>
sc ene</w>
sc )</w>
sc )-induced</w>
sc ),</w>
satis fied</w>
satis fac
satisfac tion,</w>
sat uration</w>
sat urable</w>
saralas in.</w>
sar in</w>
sar coma.</w>
sar coma,</w>
sar co
sarco plasmic</w>
sampl ing.</w>
sampl es,</w>
saline- pretreated</w>
saline- infused</w>
salicyl ates</w>
salicyl ate,</w>
salbutam ol</w>
salbutam ol.</w>
salbutam ol,</w>
sal ts.</w>
sal iv
saliv ation,</w>
sal ine-treated</w>
sal ine-</w>
sal ,</w>
saf et
safet y/efficacy</w>
saf ely</w>
saf ely,</w>
sacrific ed</w>
sacrific ed,</w>
sacrific e</w>
sac rine</w>
sac ca
sacca des</w>
sa w</w>
sP120 T,</w>
sAg ,</w>
s/RD s)</w>
s/ min.</w>
s.c .;</w>
s. (ABSTRACT</w>
s-- such</w>
s-- also</w>
s-- a</w>
s-- DFU</w>
s- Webster</w>
s- R
s-R ing
s-Ring er</w>
s wim</w>
s welling</w>
s weating</w>
s ure</w>
s q</w>
s pread</w>
s poro
sporo trichosis</w>
s pl
spl en
splen o
spleno megaly</w>
s paper
spaper ,</w>
s oun
soun d
sound -induced</w>
s or</w>
s old</w>
s me
sme ar</w>
s lop
slop e</w>
s li
sli des</w>
s l
sl ice</w>
s keletal</w>
s ings</w>
s field</w>
s ences</w>
s ect
sect ors</w>
s d)</w>
s chem
schem a</w>
s cat
scat tered</w>
s car
scar ring</w>
s can</w>
s ca
sca venger</w>
s c</w>
s ay</w>
s av
sav ings</w>
s an,</w>
s aminoglyc
saminoglyc an-
saminoglycan- de
saminoglycan-de grading</w>
s agit
sagit tal</w>
s add
sadd le</w>
s a.</w>
s ]</w>
s ]),</w>
s A),</w>
s -1.</w>
ryo precipit
ryoprecipit ate,</w>
ry thema</w>
ry pto
rypto genic</w>
ry pt
rypt ine</w>
rupt ured</w>
rupt ure</w>
rupt ure.</w>
rupt ness</w>
run s</w>
run ning</w>
rul ing</w>
ru sions</w>
ru mentation,</w>
ru di
rudi mentary</w>
rtM204 V)</w>
rtM204 I</w>
rt L
rtL 180
rtL180 M
rtL180M /
rtL180M/ rtM204V)</w>
row siness</w>
row n</w>
row ing,</w>
row .</w>
rout es</w>
rout es.</w>
rou sed.</w>
rou ght</w>
ropi on</w>
roph arynx,</w>
roph age-
rophage- mi
rophage-mi g
rophage-mig ration</w>
ron eph
roneph rosis</w>
ron e
rone ously</w>
rom so</w>
rom pt</w>
rom met
rommet ,</w>
rolim us-associated</w>
rolim us,</w>
rol le
rolle d.</w>
rod ent</w>
ro tid</w>
ro tensin-II</w>
ro ta-rod</w>
ro suvastatin</w>
ro strolaterally</w>
ro sis.</w>
ro sis,</w>
ro se,</w>
ro r
ror s</w>
ro n</w>
ro megaly</w>
ro me-
rome- P450</w>
ro ll
roll ment.</w>
ro lin
rolin a,</w>
ro le,</w>
ro id</w>
ro ad</w>
rizatript an.</w>
rizatript an,</w>
riz on
rizon a</w>
ritonavi r
ritonavir -treated</w>
ritod r
ritodr ine.</w>
rit ,</w>
rist ol-
ristol- My
ristol-My ers</w>
risperid one,</w>
risperid one
risperidone 's</w>
ris k,</w>
ris ingly,</w>
rin sic</w>
rin io
rinio l</w>
rin i
rini ol)</w>
rin ce
rince ton,</w>
rin 's</w>
rill ation</w>
rigid ity.</w>
rigid ,</w>
rig ine,</w>
rifamp in.</w>
ric s.</w>
ric h.</w>
ric h,</w>
ric ally,</w>
ric ,</w>
rib onucle
ribonucle ic</w>
riam terene</w>
ri us</w>
ri um)</w>
ri ses</w>
ri s</w>
ri minated</w>
ri lobular</w>
ri de</w>
ri bo
ribo flav
riboflav in</w>
rhyth ms</w>
rhyth mi
rhythmi as,</w>
rhyth m.</w>
rhe a</w>
rhe a,</w>
rg ent</w>
review s</w>
review ing</w>
review .</w>
reversib ly</w>
reversib le.</w>
reversib le,</w>
rever ted</w>
rever ses</w>
reveal ing</w>
retur ning</w>
retur ne
returne d,</w>
retriev als</w>
retri eved</w>
reticulo endothelial</w>
reticulo -
reticulo- thalamic</w>
reticul um,</w>
reticul ata</w>
reticul ar
reticular is</w>
retic ular</w>
reten tion.</w>
reten tion,</w>
ret rac
retrac tion</w>
ret ard</w>
ret ard
retard ation,</w>
ret ar
retar ding</w>
resuscit ation</w>
resuscit ated</w>
resuscit ate</w>
restric tion</w>
restric t</w>
restless ness</w>
restless ness,</w>
responder s,</w>
responder s)</w>
respon sibility</w>
respon ds</w>
respon der</w>
respon ded,</w>
respectivel y;</w>
resp ects</w>
resol ve</w>
resol ve,</w>
resol ution,</w>
resist ant.</w>
resist ance.</w>
resist ance,</w>
resid ence.</w>
resh -
resh- frozen</w>
reser ved</w>
reser pine.</w>
resem ble
resemble s</w>
rese arch
research .</w>
resc ues</w>
resc ents</w>
res urgence</w>
res sure</w>
res sive</w>
res sed.</w>
res s,</w>
res pi
respi ration</w>
res cent
rescent s,</w>
requi rement</w>
reproduci bly</w>
reproduci bility</w>
reproduci bil
reproducibil ity,</w>
repor ts.</w>
repor ts,</w>
repor ted;</w>
repor t:</w>
replic ated</w>
replac ing</w>
replac ement.</w>
replac ement,</w>
replac e</w>
repe at
repeat ers</w>
reo ver,</w>
reo athetoid</w>
ren s</w>
ren in</w>
ren ally</w>
remo ving</w>
remo ved.</w>
remark ably</w>
remaind er</w>
rem ia:</w>
rem app
remapp ed.</w>
reli eve</w>
reli ably,</w>
reli ability</w>
releas er</w>
releas er,</w>
releas ed</w>
relax ation.</w>
relax ants</w>
relax ant</w>
relax ant,</w>
relap se-free</w>
rel ating</w>
rel ati
relati vely-safe</w>
rel and,</w>
rel .</w>
rel )</w>
rej ection.</w>
regurg it
regurgit ation,</w>
regul atory</w>
regul ator</w>
regul ations</w>
regul ated,</w>
regist ered.</w>
region s.</w>
region s,</w>
region ally</w>
region .</w>
region -specific</w>
regimen :</w>
regimen )</w>
regar ded</w>
reg ulated</w>
reg ularly</w>
reflex- enhancing</w>
reflex- -
reflex-- an</w>
refle xes</w>
refle xes.</w>
refl ects</w>
refl ection</w>
refer r
referr als</w>
ref used</w>
ref ul</w>
ref lux</w>
ref er</w>
reduc ed.</w>
redo x</w>
redo famil
redofamil ial</w>
recurren c
recurrenc es,</w>
recur s</w>
recur .</w>
rectom y,</w>
recru ited</w>
recru ited.</w>
recover .</w>
record ings.</w>
record ing.</w>
recor ded.</w>
recommend ations</w>
recommend ation</w>
recomm enced</w>
recogn ized.</w>
reco vered,</w>
recipi ent
recipient -
recipient- -
recipient-- case</w>
receptor- linked</w>
receptor- blocking</w>
receptor s:</w>
receptor ,</w>
receptor )</w>
recei ves</w>
recall ing</w>
recall ed</w>
rec ur</w>
rec tics,</w>
rec ently,</w>
rebell ar</w>
reb rum</w>
reb oun
reboun ded</w>
reati form</w>
reat h</w>
reas surance</w>
reas sessment</w>
read ings,</w>
read ing</w>
read er</w>
reac tivities</w>
reac tion.A</w>
reabsorp tion.</w>
reabsorp tion,</w>
re- observed</w>
re- infarction,</w>
re- elev
re-elev ate</w>
re vascularization</w>
re tin</w>
re sia</w>
re produced</w>
re presenting</w>
re occur.</w>
re o-
reo- di
reo-di hydroxy
reo-dihydroxy phenyl
reo-dihydroxyphenyl serine</w>
re move
remove d,</w>
re model
remodel ing.</w>
re mode
remode ll
remodell ing.</w>
re mitted</w>
re mission.</w>
re mission,</w>
re min
remin ds</w>
re memb
rememb er</w>
re me
reme dy</w>
re l</w>
re intubation.</w>
re introduction</w>
re introduc
reintroduc ed.</w>
re inf
reinf or
reinfor ce
reinforce ment.</w>
re h
reh abil
rehabil itation</w>
re generative</w>
re distribution</w>
re dient</w>
re considered.</w>
re challenge</w>
re challenge.</w>
re ap
reap pra
reappra is
reapprais al.</w>
re al-
real- time</w>
re al"</w>
re agents</w>
re adi
readi ly</w>
re activator</w>
re acting</w>
re absorption</w>
re ;</w>
raz ol</w>
raz ep
razep am.</w>
rational e</w>
rational e,</w>
ratio .</w>
rati os,</w>
rate- pressure</w>
rate- limiting</w>
rat s;</w>
rat s.(ABSTRACT</w>
rat s--DFU</w>
rat s)</w>
rat ings.</w>
rat ing
rating "</w>
rat es:</w>
rat a.</w>
rat )</w>
rat '</w>
ras y</w>
ras h</w>
ras h,</w>
rap ment,</w>
ranulo cyto
ranulocyto sis</w>
rans plant</w>
rans n
ransn ational</w>
raniti dine</w>
raniti dine-induced</w>
rang es</w>
random -
random- as
random-as signment,</w>
ran ks</w>
ran i
rani otom
raniotom y</w>
ran ge
range ;</w>
ran drine</w>
ran dom</w>
ran as
ranas al,</w>
ran ,</w>
ram ps</w>
ram p
ramp ant</w>
ram ate</w>
ram ,</w>
ral oxif
raloxif en
raloxifen e:</w>
ral ization</w>
ral in</w>
ral gi
ralgi as
ralgias /
ralgias/ myalgi
ralgias/myalgi as</w>
ral azine</w>
rai sed,</w>
rag ments</w>
rag m
ragm atic</w>
radiopharmaceu ticals</w>
radiopharmaceu tical</w>
radioph armac
radiopharmac y</w>
radio therapy.</w>
radio all
radioall erg
radioallerg osorb
radioallergosorb ent</w>
radio activity</w>
radic ulopathy</w>
radic ular</w>
radic als</w>
radic als.</w>
radi us.</w>
radi otele
radiotele me
radioteleme tered</w>
radi ologists</w>
radi ologic</w>
radi olog
radiolog ical,</w>
radi ograph
radiograph ,</w>
radi ation.</w>
rac tice</w>
rac ted</w>
rac lop
raclop ride</w>
rac he
rache al</w>
rab bit
rabbit s.</w>
ra sion</w>
ra pt
rapt or
raptor -containing</w>
ra il</w>
ra bil
rabil is</w>
ra G)</w>
ra -Hisian</w>
rTM S,</w>
rTM S)</w>
rHuEPO- beta</w>
rHuEPO- beta
rHuEPO-beta ).</w>
r usor</w>
r ules</w>
r ule</w>
r uctured</w>
r thostatic</w>
r l)</w>
r ine/
rine/ propofol
rine/propofol /
rine/propofol/ mix
rine/propofol/mix tures</w>
r ich</w>
r icep
ricep s</w>
r ce
rce ase,</w>
r ations</w>
r ary</w>
r a</w>
r =
r= 0.
r=0. 81</w>
quinpi role</w>
quinpi role,</w>
quinolin ium</w>
quinolin es:</w>
quinol ones</w>
quinol one,</w>
quinol ines</w>
quinol ine-
quinoline- 3
quinoline-3 -</w>
quin ine.</w>
quin ine-
quinine- containing</w>
qui v</w>
qui b
quib b</w>
questionnai res</w>
questionnai re.</w>
questionnai re,</w>
ques tion.</w>
quantit ation</w>
quantit ated</w>
quanti ty</w>
quanti fy</w>
quanti fication</w>
qualit ative</w>
quadri ple
quadriple g
quadripleg ic</w>
quadri pare
quadripare sis,</w>
quad riceps</w>
quad rant</w>
qu ire</w>
qu ine/
quine/ sparteine</w>
qu ick</w>
qu ate</w>
qu asi
quasi -
quasi- experimental</w>
q M
qM an</w>
pyrrol id
pyrrolid in
pyrrolidin yl)cyclohexylamine).</w>
pyrimidin es,</w>
pyridox ine-
pyridoxine- dependent</w>
pyridox ine,</w>
pyridox al</w>
py rene</w>
py lo
pylo amin
pyloamin ot
pyloaminot et
pyloaminotet ralin</w>
put amin
putamin al</w>
purpur a</w>
purpur a,</w>
purpo seless</w>
purpo se.</w>
pur suit</w>
pur sued</w>
pur pos
purpos es.</w>
pur inergic</w>
pur ine</w>
pur in
purin ocept
purinocept or</w>
punct ure.</w>
punct ure,</w>
punct ate</w>
pul ses</w>
pul ses;</w>
pul mon
pulmon al
pulmonal e</w>
pul ation-
pulation- based,</w>
publ ished.</w>
publ ished,</w>
pu er
puer ile</w>
pto sis</w>
pt ylate</w>
pt y</w>
pt able</w>
psychostimul ant</w>
psychostimul ant.</w>
psychostimul ant-induced</w>
psychos es,</w>
psycho tic-like</w>
psycho pathology</w>
psychi at
psychiat rically</w>
psych oph
psychoph armac
psychopharmac ological</w>
psy ;</w>
psy ,</w>
psoria sis</w>
psoria sis.</w>
pseudoli thiasis.</w>
pseudo cholinesterase</w>
pseudo allergic</w>
pseudo -
pseudo- allergy</w>
pseud oc
pseudoc ystic</w>
provo k
provok ed:</w>
provid ing</w>
provi ded.</w>
protoco ls</w>
protoco ls.</w>
protoco l.</w>
proteinur ic</w>
proteinur ia:</w>
proteinur ia
proteinuria /
proteinuria/ day.</w>
protein s:</w>
protein s.</w>
protein s,</w>
protein :
protein: creatinine</w>
protein /
protein/ mg</w>
protein .</w>
protein -based</w>
protein ,</w>
protect or</w>
prote omic</w>
prote ome</w>
prote ase-
protease- inhibitor</w>
prote as
proteas ome</w>
prot rusions</w>
prot ection.</w>
prot ection,</w>
prot ecting</w>
prostagland ins</w>
propylthio uracil</w>
propylthio uracil-induced</w>
propyl ene</w>
propyl -
propyl- di
propyl-di eth
propyl-dieth oxy-
propyl-diethoxy- methyl-
propyl-diethoxy-methyl- phosph
propyl-diethoxy-methyl-phosph inic</w>
propranolo l,</w>
proprano lol
propranolol ),</w>
propofol .</w>
prophylax is.</w>
proper ty,</w>
propanol amine.</w>
propafen one,</w>
pron ociceptive</w>
promot es</w>
promot er</w>
promot ed</w>
promis ed</w>
promis e</w>
prom pted</w>
prolong ed,</w>
prolifer ation.</w>
prolactine mia</w>
prolact in.</w>
prolact in-releasing</w>
prolact in-induced</w>
prolact in,</w>
prolact in's</w>
prol ide</w>
prol ap
prolap se</w>
progres sion-free</w>
progres s</w>
progno sis.</w>
progest er
progester one</w>
progest ag
progestag en</w>
prof ound,</w>
prof es
profes sional</w>
produc t.</w>
produc ed.</w>
process or.</w>
process ed</w>
process -specific</w>
proces s,</w>
proce ed</w>
procain amide-induced</w>
problem s,</w>
problem atic.</w>
proble ms.</w>
proble m.</w>
prob es</w>
proanthocyanid ins,</w>
pro- inflammatory</w>
pro- absence</w>
pro ve</w>
pro sy</w>
pro pyloaminotetralin</w>
pro pos
propos al</w>
pro of</w>
pro mi
promi se,</w>
pro maz
promaz ine</w>
pro long</w>
pro gram
program med</w>
pro drug</w>
pro coagulant</w>
pro arrhythmic</w>
prim ed</w>
pri or.</w>
pri or,</w>
pri migra
primigra vida,</w>
pri mi
primi tive</w>
pri mer
primer s,</w>
pri l,</w>
previ ous
previous ly).</w>
prevent ed.</w>
prevent ed,</w>
prevent ability</w>
preval ent</w>
preval ences</w>
presum ably</w>
presum ably,</w>
pressu res.</w>
pressu res,</w>
preser ved.</w>
present ly</w>
present ed:</w>
present ations</w>
present ation;</w>
prescri be
prescribe d.</w>
pres witch</w>
pres sively</w>
pres sion-Sexual</w>
pres ence.</w>
prepar e</w>
prepar ations,</w>
prepar ation;</w>
pren at
prenat ally</w>
pren al
prenal ine-induced</w>
premature ly
prematurely ;</w>
prehen sible</w>
pregnan-20-one ),</w>
pregnan olone,</w>
pregnan cies</w>
preferen tially</w>
preferen tial</w>
preferen ce,</w>
prefer ring</w>
prefer ably</w>
predomin ate</w>
predomin ant.</w>
prednis one</w>
predis pose</w>
predict or</w>
predic ts</w>
predic tive.</w>
predic tion</w>
predic ted</w>
precl uded</w>
precl ude</w>
precipit ated</w>
precipit ate</w>
preci sely</w>
prece de</w>
pre- therapeutic</w>
pre- test),</w>
pre- procedure</w>
pre- papaverine</w>
pre- hypotensive</w>
pre weanling</w>
pre weaning</w>
pre vention,</w>
pre treatment)</w>
pre pulse</w>
pre planned</w>
pre partum</w>
pre part
prepart um.</w>
pre pare
prepare dness</w>
pre pa
prepa re,</w>
pre optic</w>
pre morb
premorb id</w>
pre menopausal</w>
pre load
preload .</w>
pre junctional</w>
pre infusion</w>
pre infu
preinfu sion:</w>
pre frontal</w>
pre fron
prefron tal"</w>
pre exist
preexist ing,</w>
pre excit
preexcit ation,</w>
pre ec
preec l
preecl amp
preeclamp sia.</w>
pre dose</w>
pre cur
precur sor</w>
pre core</w>
pre cor
precor di
precordi al</w>
pre angio
preangio graphic</w>
pre -treated</w>
prazos in.</w>
prazos in-
prazosin- controlled</w>
prazos in,</w>
prazol e)</w>
prazol am.</w>
pram .</w>
practition er
practitioner s;</w>
practi ce</w>
prac tically</w>
prac tical</w>
pr ine.</w>
pr inc
princ i
princi ple</w>
pr ic
pric ed</w>
pr al
pral id
pralid ox
pralidox i
pralidoxi me-
pralidoxime- 2-
pralidoxime-2- chloride</w>
power ful</w>
power ful,</w>
pow der
powder ,</w>
potenti als.</w>
potenti al.</w>
poten sion</w>
poten cy</w>
poten cy
potency :</w>
poten ce.</w>
poten c
potenc y.</w>
potassi um-stimulated</w>
pot onic</w>
pot ent,</w>
postoper atively,</w>
poster o-
postero- lateral</w>
post-CAB ).</w>
post- treatment</w>
post- transplantation</w>
post- transplant</w>
post- receptor</w>
post- exposure</w>
post- exposure.</w>
post- cocaine</w>
post- SNP</w>
post- SCr</w>
post- OLTX</w>
post- CAB</w>
post transplant</w>
post renal</w>
post n
postn atal</w>
post junctional</w>
post injection</w>
post absor
postabsor ptive</w>
possib ly,</w>
possib il
possibil ities</w>
positi ve.</w>
positi ve-pressure</w>
positi ve)</w>
posi tive,</w>
posi tion,</w>
pos sessing</w>
pos sesses</w>
pos ac
posac on
posacon azole</w>
por t</w>
por a
pora dic</w>
population- based</w>
population- based,</w>
population )</w>
poor- risk</w>
poor- metabolizer</w>
poor .</w>
pon tis.</w>
pon tis,</w>
pon s,</w>
pon ents</w>
pon entially</w>
pon ent.</w>
pon at
ponat remia,</w>
polysomno graphy</w>
polysomno graph
polysomnograph y.</w>
polysacch ari
polysacchari de,</w>
poly uria.</w>
poly uria,</w>
poly therapy</w>
poly peptide</w>
poly neuropathy</w>
poly neuropathy.</w>
poly neuropathy,</w>
poly amines</w>
polar ized</w>
pol ip
polip id
polipid aemic</w>
pol ic
polic y</w>
pol ated</w>
pol ;</w>
poison s.</w>
poison ing,</w>
point s,</w>
point s),</w>
poie tic</w>
podocalyx in</w>
podocalyx in,</w>
pod ocytes.</w>
pod ocy
podocy te-associated</w>
po vidone-iodine</w>
po thalamic</w>
po sed,</w>
po polysaccharide</w>
po ore
poore r</w>
po oled</w>
po ol.</w>
po morphine,</w>
po et
poet in-
poetin- 2</w>
plu gs,</w>
plu g</w>
plo pi
plopi a</w>
plic or</w>
plic it</w>
plic ations</w>
plic ation-
plication- competent</w>
plex us</w>
plex us,</w>
plex itis.</w>
plekhh 2,</w>
pleas ed</w>
ple mentary</w>
ple i
plei otropic</w>
ple .</w>
ple ,</w>
platypnea-orthodeox ia,</w>
platypnea-orthodeox ia
platypnea-orthodeoxia -like</w>
platele ts,</w>
plasma ph
plasmaph eresis</w>
plasma /
plasma/ kidney</w>
plas ticity</w>
plas macy
plasmacy toma.</w>
plas ma.</w>
plas m</w>
placebo -treated</w>
placebo -</w>
placebo )</w>
pl ing</w>
pl ified</w>
pl aying</w>
pl ate,</w>
pl ast
plast y,</w>
pl asi
plasi a,</w>
pl ans</w>
pl an</w>
pit al</w>
piroxicam ,</w>
piroxicam )</w>
piroxic am.</w>
pirenzep ine.</w>
piperid in-1-
piperidin-1- yl)</w>
piperaz ine),</w>
pin point</w>
pilocarp ine.</w>
pilocarp ine-
pilocarpine- evoked</w>
pill s</w>
pill s,</w>
pid ural</w>
picrotox in-</w>
picrotox in,</w>
pic ture,</w>
pi votal</w>
pi rical</w>
pi prazole)</w>
pi pet
pipet te</w>
pi pe</w>
pi gs</w>
pi gment
pigment ary</w>
pi es
pies /ml
pies/ml ,</w>
physi ology</w>
physi c
physic ally</w>
phys ostigmine</w>
phys ostigm
physostigm ine.</w>
phylax is</w>
phylax is,</w>
phthalmo s</w>
phthalm itis</w>
phthal mic</w>
phthal im
phthalim ido
phthalimido )
phthalimido) but
phthalimido)but yl]piperazine</w>
phot os
photos timulation</w>
phot ophobia</w>
phosphor ylcreatine</w>
phosphor ine</w>
phosphat ases</w>
phosphat ase,</w>
phosph orodi
phosphorodi am
phosphorodiam ido
phosphorodiamido flu
phosphorodiamidoflu or
phosphorodiamidofluor id
phosphorodiamidofluorid ate),</w>
phosph on
phosphon o
phosphono methyl
phosphonomethyl ]
phosphonomethyl] deca
phosphonomethyl]deca hyd
phosphonomethyl]decahyd r</w>
phosph oli
phospholi pid</w>
phosph o
phospho kinase.</w>
phor ic</w>
phon ophobia</w>
phon ation.</w>
phleb itis</w>
phleb itis,</w>
phenylephr ine,</w>
phenyle thynyl)pyridine</w>
phenylace toxy-N-methylpiperidine</w>
phenyl)-4- [4-
phenyl)-4-[4- (2-
phenyl)-4-[4-(2- phthalimido)butyl]piperazine</w>
phenyl)-4- (4-
phenyl)-4-(4- methylsulphon
phenyl)-4-(4-methylsulphon yl)</w>
phenyl propanolamine.</w>
phenyl al
phenylal amine</w>
phenyl -
phenyl- 2
phenyl-2 (5
phenyl-2(5 H
phenyl-2(5H )-
phenyl-2(5H)- furan
phenyl-2(5H)-furan on
phenyl-2(5H)-furanon )</w>
phenyl )</w>
phenotyp e.</w>
phenomen on.</w>
phenomen a</w>
phenobarbit one.</w>
phenobarbit one-induced</w>
phenobarbit one-
phenobarbitone- primed</w>
phenobarbit one
phenobarbitone -</w>
phenobarbit al-
phenobarbital- containing</w>
phenacet in.</w>
phenacet in,</w>
phen ol
phenol ate</w>
phen idate</w>
phen az
phenaz ine.</w>
pharmacokine tics</w>
pharmacokine tics.</w>
pharmacokine tic/pharmacodynamic</w>
pharmac y</w>
pharmac y.</w>
pharmac y,</w>
pharmac ology.</w>
pharmac olog
pharmacolog ic
pharmacologic all
pharmacologicall y-induced</w>
ph y,</w>
ph ragmatic</w>
ph ore
phore sis</w>
ph oph
phoph or
phophor ylcreatine</w>
ph ent
phent ol
phentol amine</w>
ph enc
phenc yclidine</w>
ph ase,</w>
ph al
phal an</w>
ph agic</w>
ph ag
phag ocyto
phagocyto sis</w>
ph ac
phac o
phaco em
phacoem ulsification</w>
pg/ ml)</w>
peth idine.</w>
petec hial</w>
petec hi
petechi ae</w>
person s.</w>
person ne
personne l</w>
person al</w>
person -
person- years</w>
persist ently</w>
persist ence</w>
persist ed.</w>
peroxid ase.</w>
permit ting</w>
permit s.</w>
perme ability,</w>
perme abil
permeabil it
permeabilit y/injury,</w>
perman ently,</w>
perit ubular</w>
perit ransplant</w>
perio perative</w>
perio d)</w>
perio d).</w>
perid ol.</w>
pericardi tis</w>
peri venular</w>
peri ventricular</w>
peri part
peripart al</w>
peri ence</w>
peri arterial</w>
pergol ide,</w>
performe d,</w>
perform s</w>
perform ing</w>
perce ption</w>
perc uloinsular</w>
per turbation</w>
per tinent</w>
per severation</w>
per oxide</w>
per orally</w>
per one</w>
per mitted</w>
per mis
permis sive</w>
per ine
perine al</w>
per hexiline</w>
per fusion.</w>
per form</w>
per f
perf used</w>
per cep
percep tion.</w>
per -
per- day</w>
peptide(1-4 2),</w>
peo ple.</w>
pentylenetetraz ol</w>
pentylenetetraz ol-induced</w>
pentylenetetraz ol,</w>
pentylene tetrezol</w>
pentylen et
pentylenet razol</w>
pentobarbit al.</w>
pentazoc ine</w>
pent oxy
pentoxy if
pentoxyif ylline</w>
pent o
pento thal</w>
pent am
pentam eric</w>
pens ated</w>
penicill ins</w>
penicill ins.</w>
penicill ins,</w>
penet ration</w>
penet rating</w>
penet rate</w>
pen sive</w>
pen is</w>
pen d
pend age</w>
pen -treated</w>
pen -
pen- shaped</w>
pen )</w>
pelv is</w>
pelv is,</w>
pelv ic</w>
pelle ts</w>
pelle t,</w>
pel vocalyceal</w>
pedi at
pediat rics.</w>
ped ed</w>
pect ori
pectori s.</w>
pect or
pector is</w>
pect edly</w>
pec ific
pecific ally,</w>
pec ia,</w>
peak ing</w>
peak ,</w>
pe tition</w>
pe er-
peer- reviewed</w>
pe dic</w>
pattern s,</w>
pattern ,</w>
patient- reported</w>
patient- controlled</w>
patient s--a</w>
patient s).</w>
patient :
patient: ALT:
patient:ALT: 2
patient:ALT:2 94</w>
patient ).</w>
pati on.</w>
pati ble</w>
pathophysi ologic</w>
pathom echan
pathomechan ism</w>
patho gno
pathogno monic</w>
patho genic</w>
patho genetic</w>
patho genesis,</w>
patho gene
pathogene sis.</w>
patho gen
pathogen es
pathogenes es</w>
path y;</w>
path ology.</w>
path olog
patholog ies.</w>
path ic
pathic a.</w>
pat ent</w>
pass ing</w>
pass ed</w>
pas ses</w>
particular ,</w>
particular )</w>
partic ularly,</w>
part s.</w>
part ly</w>
part ly,</w>
paroxet ine</w>
paroxet ine.</w>
parkinson is
parkinsonis m,</w>
pariet al,</w>
paresthe sias,</w>
paresthe sia</w>
paren ts</w>
paren chymal</w>
pare sis</w>
paramed ical</w>
parame ters,</w>
parame dic</w>
paralle led</w>
paradig m.</w>
paradig m
paradigm ),</w>
paracetam ol/
paracetamol/ day.</w>
paracetam ol.</w>
par tially,</w>
par s</w>
par ity</w>
par inu
parinu x,</w>
par ations</w>
par ath
parath yroidism.</w>
par as
paras om
parasom ni
parasomni as,</w>
par ameth
parameth as
paramethas one.</w>
paper .</w>
papaver ine,</w>
pap il
papil le
papille de
papillede ma</w>
pancreati tis</w>
pancreati tis,</w>
pancreati co
pancreatico biliary,</w>
pan or
panor amic</w>
pal pebral</w>
pal p
palp ation</w>
pal ate</w>
pair s</w>
pair -matched</w>
paclitaxel /cisplatin</w>
paclitaxel .</w>
pacemak ers.</w>
pac king</w>
pac kage</w>
pac ing,</w>
pa z</w>
pa w</w>
pa w-pressure</w>
pa st.</w>
pa st),</w>
pa rotid</w>
pa ired</w>
pa ins</w>
pa in-induced</w>
pa in-
pain- related</w>
pa f
paf ox
pafox -induced</w>
p<0.00 2).</w>
p<0.00 1),</w>
p<0.0 1</w>
p<0.0 1,</w>
p<0.0 1)</w>
p<0.0 1),</w>
p.o. ;</w>
p.o. ).</w>
p.o .</w>
p. m.,</w>
p-coumar ic</w>
p- out</w>
p- enhancing</w>
p- cho
p-cho loro
p-choloro an
p-choloroan iline</w>
p- chloro
p-chloro phenylalamine</w>
p y</w>
p uscular</w>
p us,</w>
p ure</w>
p ups</w>
p uberty.</w>
p tion,</w>
p risingly,</w>
p oun
poun ds,</w>
p ons</w>
p ocamp
pocamp al</w>
p neum
pneum atic</w>
p mol/
pmol/ 10</w>
p m.</w>
p ine-induced</w>
p ine-</w>
p in</w>
p icardi
picardi al</w>
p estic
pestic ide,</w>
p es</w>
p ase</w>
p an</w>
p H
pH ,</w>
p AN
pAN CA
pANCA -positive</w>
p =
p= 0.006,</w>
p <
p< 0.05).</w>
p ,</w>
p ).</w>
p ),</w>
ozone- sparing</w>
ozone- deple
ozone-deple ting</w>
oz ymuria.</w>
oz ygous</w>
oz ide</w>
oxygen ase</w>
oxygen ase-
oxygenase- 2</w>
oxygen ),</w>
oxyco d
oxycod one
oxycodone ).</w>
oxyc ytidine</w>
oxyc anth
oxycanth a),</w>
oxy phenyl)-4-[4-(2-phthalimido)butyl]piperazine</w>
oxy methamphetamine,</w>
oxy glutamate</w>
oxic ity,</w>
oxet ine-induced</w>
ox ious</w>
ox ide.</w>
ox ide-
oxide- redox</w>
ox azepam,</w>
ox az
oxaz a
oxaza phosphorine</w>
ox amine,</w>
ox .</w>
over use</w>
over t</w>
over stimulation</w>
over lap
overlap )</w>
over growth</w>
over dosages.</w>
over dosage</w>
over dosage.</w>
over com
overcom e</w>
over -
over- the-counter</w>
ov ulation</w>
ov ine,</w>
ov ary</w>
output ;</w>
output .</w>
out- patients)</w>
out stretched</w>
out line</w>
out lin
outlin ing</w>
out ine</w>
out bred</w>
ous ?</w>
oun t</w>
oun sfield</w>
oun c
ounc ing</w>
ou ter</w>
ou se</w>
ou h
ouh y</w>
ou ab
ouab ain
ouabain -induced</w>
otro pin</w>
otrans formation</w>
oton ic</w>
oton ergic</w>
otom ies</w>
other s,</w>
other .</w>
otens in-converting</w>
oten tial</w>
oten sion</w>
otele metric</w>
ot withstanding</w>
ot t</w>
ot rigine,</w>
ot racheal</w>
ot ological</w>
ot ation</w>
ot als</w>
ot .</w>
osup pressive</w>
ostigm ine,</w>
osteoporo sis</w>
osteoporo sis.</w>
osteoporo sis,</w>
osteo penia</w>
osteo arthritis</w>
ost ed</w>
ost atic
ostatic s</w>
osph eric</w>
ospas m</w>
osmol ar
osmolar ity,</w>
osmol ality.</w>
osinophil ic</w>
osinophil ia.</w>
osf amide</w>
osc ine)</w>
osar coma,</w>
os yltransferases</w>
os uximide</w>
os s</w>
os ol</w>
os ing</w>
os ine-
osine- 5
osine-5 '-
osine-5'- triphosphate</w>
os ening</w>
os co
osco py</w>
ortho pedic</w>
ort on's</w>
ort al</w>
orpor al</w>
orodi ethyl</w>
oro pyrimidines,</w>
orm one</w>
orm al
ormal izing</w>
orig inating</w>
orig in
origin ,"</w>
ori ent
orient ation.</w>
organophosph ate.</w>
organ s.</w>
organ ogene
organogene sis.</w>
org est
orgest rel)</w>
oreo athetoid</w>
ore xia,</w>
ore pinephrine</w>
ore arm</w>
ore a)</w>
orall y-treated</w>
orall y)</w>
orall y),</w>
or= 2.5</w>
or ted</w>
or rhoea,</w>
or rhea</w>
or on
oron osyltransferases</w>
or k</w>
or ing</w>
or ide,</w>
or i-motor</w>
or der
order ly</w>
or bi
orbi di
orbidi ties</w>
or ang
orang e</w>
or al-
oral- contracep
oral-contracep tive</w>
or adi
oradi ographic</w>
or acic</w>
or -mediated</w>
oppos ite</w>
oppos it
opposit e.</w>
oplas macy
oplasmacy tic</w>
opioid s</w>
opioid s,</w>
opioid ergic</w>
opioid ,</w>
opi ramate</w>
opi ates.</w>
opi ates,</w>
ophthalmo logical</w>
ophthalmo logic</w>
ophthal mia</w>
ophosph ate-induced</w>
ophil ic</w>
oper ations</w>
oper ation</w>
oper ation.</w>
oper ating</w>
open-labe l,</w>
open- chest</w>
open ing</w>
open ia.</w>
open .</w>
op ulation</w>
op tions</w>
op ponent.</w>
op ist
opist o
opisto thonus,</w>
op a</w>
onucle ase-
onuclease- dependent</w>
ont g
ontg omer
ontgomer y-Asberg</w>
onis amide</w>
one- third</w>
one- on
one-on -
one-on- one</w>
one- half</w>
one urotic</w>
one )-
one)- treated</w>
one ),</w>
ond on</w>
onavi r</w>
on volution</w>
on set,</w>
on s.</w>
on otopic</w>
on orgestrel)</w>
on ly).</w>
on line</w>
on le
onle in</w>
on idine</w>
on go
ongo ing</w>
on dro
ondro itinase</w>
on ce
once -
once- per-day</w>
on be
onbe l)</w>
on ates</w>
on ate.</w>
on ate),</w>
omy osarcoma,</w>
omy co
omyco sis.</w>
omer ca
omerca zole).</w>
omeprazol e:</w>
omeprazol e,</w>
omas :</w>
om yopathy</w>
om ycin</w>
om ycin,</w>
om pensated</w>
om men
ommen d
ommend ations</w>
om is
omis sion</w>
om ical</w>
om ers</w>
om b
omb s</w>
om as,</w>
oly tic-uraemic</w>
oly sis,</w>
olog ically,</w>
oligo den
oligoden dro
oligodendro cy
oligodendrocy tes</w>
olig uria.</w>
olig uria,</w>
oli ve</w>
oli .</w>
old stein</w>
old ),</w>
ol- pretreated</w>
ol- controlled</w>
ol ter</w>
ol tarol,</w>
ol ling
olling er-
ollinger- Ell
ollinger-Ell ison</w>
ol labor
ollabor ative</w>
ol l
oll -H
oll-H ypaque</w>
ol ism</w>
ol fact
olfact ory</w>
ol fa
olfa ")</w>
ol ec
olec ularly,</w>
ol e.</w>
ol der
older ).</w>
ol d,</w>
ol ay
olay ers</w>
ol ase,</w>
ol an
olan zapine,</w>
ol a
ola be
olabe ling</w>
ol -associated</w>
oid omycosis.</w>
ograph y,</w>
ograph ical</w>
ogene ity</w>
ofloxac in,</w>
off set</w>
off ,</w>
of iltration</w>
of :</w>
odilu tion.</w>
odi l
odil ating</w>
odi c</w>
oder m</w>
od- risk</w>
od ular</w>
od ocyte</w>
od en
oden e)</w>
ocy tic.</w>
octreotide :</w>
octreotide )</w>
ocortico trophic</w>
och e</w>
och -
och- Sch
och-Sch onlein</w>
occur ,</w>
occl uded</w>
occasion ally.</w>
occa sions</w>
occa sions.</w>
occa sions,</w>
occa sional</w>
occ upational</w>
oc utaneous</w>
oc ryptine</w>
oc rit,</w>
oc ci
occi pital</w>
oc ate</w>
oc arb
ocarb ia</w>
obt unding</w>
obt und</w>
obt ained.</w>
obstruc tion.</w>
obstruc tion,</w>
obsessive-compul sive</w>
obsessive-compul sive-like</w>
obses sive</w>
observ ations,</w>
observ ation.</w>
obser vers</w>
obser vers.</w>
obser ver</w>
obser ve</w>
obsc ure</w>
obsc ure,</w>
oblast oma</w>
obj ectiv
objectiv es</w>
obarbit one-induced</w>
ob lo
oblo tting</w>
ob er
ober ts,</w>
o- ventricular</w>
o- urinary</w>
o- tolylguanidine</w>
o- pathological</w>
o witz</w>
o wing</w>
o vulation.</w>
o urce</w>
o thelioma,</w>
o sterone-dependent</w>
o ropharynx,</w>
o receptor</w>
o proliferative</w>
o pressor</w>
o plasia</w>
o perculoinsular</w>
o pathologic</w>
o men</w>
o iso
oiso quinoline-3-</w>
o int
oint ment</w>
o il
oil s</w>
o ide
oide d.</w>
o hypoph
ohypoph yseal</w>
o h
oh l
ohl and</w>
o gest
ogest rel</w>
o genous</w>
o gen
ogen ously</w>
o ffered</w>
o edema</w>
o )</w>
numb ness</w>
numb ers</w>
numb er.</w>
nucle us.</w>
nucle oside</w>
nucle ation</w>
nu als</w>
nu ally.</w>
nu .</w>
now ,</w>
novel ty</w>
nov o.</w>
nov a</w>
not ed,</w>
not able</w>
not .</w>
nos tics,</w>
normoten sive</w>
normoten sion,</w>
normo thymic</w>
normo chrom
normochrom ic</w>
normal izing</w>
normal izes</w>
normal ized,</w>
normal ization</w>
normal it
normalit y,"</w>
norm ocytic.</w>
norm ocarbia</w>
nor thern</w>
nor pethidine</w>
nor pethidine.</w>
nor met
normet ane
normetane phrine</w>
noncompli ance.</w>
non-Hod gk
non-Hodgk in</w>
non-Hod g
non-Hodg kin
non-Hodgkin 's</w>
non- warfarin</w>
non- valvular</w>
non- users.</w>
non- users,</w>
non- treated</w>
non- steroidal</w>
non- specific</w>
non- smokers.</w>
non- significantly)</w>
non- receptor</w>
non- nephrotoxic</w>
non- necrotic</w>
non- lithium</w>
non- lithium-treated</w>
non- ischemic</w>
non- invasive</w>
non- hypertensive</w>
non- exposed</w>
non- erg
non-erg ot</w>
non- ecstasy</w>
non- dopaminergic</w>
non- depolar
non-depolar izing</w>
non- dapsone-exposed</w>
non- associative</w>
non- PD</w>
non- E-induced</w>
non- CaCl(2)-treated</w>
non- A</w>
non users,</w>
non significantly</w>
non selective</w>
non selective,</w>
non regenerative</w>
non overdose</w>
non organic</w>
non mut
nonmut ant</w>
non lymphocytic</w>
non invasive</w>
non innerv
noninnerv ated
noninnervated )</w>
non hypertensive</w>
non hemorrhagic</w>
non hematological</w>
non hematologic</w>
non f
nonf ilt
nonfilt rating</w>
non cumulative</w>
non cli
noncli pped</w>
nod ular</w>
nod al</w>
no ticed</w>
no ticeable</w>
no ther</w>
nmol/ L</w>
nitrosoure a</w>
nitrosoure a),</w>
nitros ative</w>
nitroglycer in-induced</w>
nitro gran
nitrogran ulogen</w>
nitro gen</w>
nitro gen,</w>
nitro furantoins</w>
nit rous</w>
nit razepam</w>
nit razepam.</w>
nit ol</w>
nimodi pine.</w>
nimodi pine-induced</w>
nimodi pine,</w>
nightma res.</w>
nightma re:</w>
night time</w>
nigh t,</w>
nig ra</w>
nicot ine.</w>
nicot ine's</w>
niac in.</w>
niac in
niacin amide</w>
ni x.</w>
ng/mou se.</w>
ng/mou se)</w>
ng/ mouse</w>
ng/ ml)</w>
ng/ ml).</w>
ng/ ml),</w>
ng/ kg/
ng/kg/ min)</w>
ng./ml .).</w>
ng )</w>
nex pectedly</w>
newborn s?</w>
newborn s.</w>
newborn s,</w>
newborn s'</w>
new spaper</w>
new spaper,</w>
new ly</w>
new ,</w>
neutro penia.</w>
neut ralization</w>
neut ral</w>
neurotrans mission</w>
neurotrans mission.</w>
neurotens inergic</w>
neurotens in.</w>
neurotens in-induced</w>
neuron s:</w>
neuron s,</w>
neurolog ists</w>
neuro toxicity)</w>
neuro surgical</w>
neuro surgery.</w>
neuro sis,</w>
neuro sensorial</w>
neuro radiologists</w>
neuro psychological</w>
neuro protection,</w>
neuro physiology</w>
neuro pharmacological</w>
neuro pathy?</w>
neuro pathy;</w>
neuro pathies</w>
neuro ly
neuroly sis</w>
neuro inflammatory</w>
neuro glial</w>
neuro genic</w>
neuro endocrine</w>
neuro developmental</w>
neuro degeneration</w>
neuro de
neurode generative</w>
neuro biological</w>
neuro -protective</w>
neur one</w>
neur itis</w>
neur algi
neuralgi a,</w>
neur al
neural g
neuralg ia</w>
ness es.</w>
nerv es</w>
nephrotoxic .</w>
nephrotoxic ,</w>
nephroli thiasis:</w>
nephroli thiasis.</w>
nephro tic-range</w>
nephro sclerosis</w>
neph rin,</w>
neph rectomy,</w>
neon ates,</w>
neon ate</w>
neon ate
neonate 's</w>
nelar abine</w>
nelar ab
nelarab ine,</w>
negati vity</w>
negati vity.</w>
negati ve)</w>
need le.</w>
necrosi s?</w>
necrosi s).</w>
necro tising</w>
necro sis;</w>
necro genic</w>
necessit ated</w>
necess ity</w>
necess ar
necessar y.</w>
nec k.</w>
ne y</w>
ne ver</w>
ne twork.</w>
ne t</w>
ne sia</w>
ne ostigmine,</w>
ne oplasia</w>
ne monic</w>
ne mi
nemi us</w>
ne e.</w>
ne )</w>
nause a),</w>
nation wide</w>
nation wide,</w>
nat uralistic</w>
nar rowing,</w>
nam e</w>
nalox one.</w>
na i
nai ve</w>
na di
nadi r</w>
na )</w>
n=7 6)</w>
n=7 4
n=74 8
n=748 ;</w>
n=4 5.</w>
n=4 1;</w>
n= 8
n=8 8</w>
n= 5),</w>
n= 36
n=36 ).</w>
n urse.</w>
n umerous</w>
n umerical</w>
n ull</w>
n uclear-encoded</w>
n s.</w>
n ings</w>
n ing),</w>
n ine
nine ty-nine</w>
n ic</w>
n ia</w>
n d-
nd- week</w>
n ate</w>
n ame
name ly</w>
n alo
nalo zone,</w>
n a.</w>
n a,</w>
n M,</w>
n C
nC i/
nCi/ min</w>
n ACh
nACh Rs</w>
n -Wh
n-Wh it
n-Whit ney</w>
n 's</w>
myoton ia.</w>
myonec rosis</w>
myonec rosis.</w>
myoclon ic</w>
myocardi tis,</w>
myocardi opathy</w>
myo globin
myoglobin uria,</w>
myo fib
myofib re</w>
myelo toxicity</w>
myelo suppression,</w>
myelo peroxidase</w>
myelo pathy</w>
myelo pathy,</w>
myelo ma,</w>
myelo encephalopathy</w>
myelo -
myelo- optic</w>
myel inating</w>
myel in</w>
mye li
myeli tis</w>
myalgi a)</w>
my ocytes,</w>
my ocyte</w>
my dri
mydri asis</w>
my co
myco phenolate</w>
mut ations,</w>
mut ational</w>
mut ation.</w>
mut ase,</w>
mut ants.</w>
mut ant,</w>
muscar ine-induced</w>
muscar in
muscarin ic,</w>
musc uloskeletal</w>
musc le
muscle )</w>
mum ol)</w>
multicent er</w>
multic entr
multicentr e</w>
multi ple,</w>
multi focal</w>
multi factor
multifactor ial</w>
multi f
multif ari
multifari ous</w>
multi drug</w>
multi directional</w>
multi -
multi- organ</w>
mul tisite,</w>
muco us</w>
muco sal,</w>
muco sa.</w>
mu g</w>
mu g/
mug/ g</w>
mu /
mu/ kg)</w>
mu -
mu- opioid</w>
mtDN A.</w>
mtDN A,</w>
move ment.</w>
mouth" :</w>
mouth" ),</w>
mouth .
mouth. "</w>
mouth "</w>
mou se.</w>
mou se,</w>
mort ality.</w>
mort alit
mortalit y:</w>
morpho met
morphomet rical</w>
morpho genesis</w>
morphine- inhibited</w>
morphine- HC
morphine-HC 1</w>
morph ology.</w>
morph ology,</w>
morph ologically</w>
morph ine/
morphine/ Rg
morphine/Rg 1-
morphine/Rg1- treated</w>
morb id
morbid ity,</w>
mor nings</w>
mor ning-dosed</w>
month ly</w>
month ly)</w>
monocy te-derived</w>
monocy cl
monocycl ic</w>
mono therapy</w>
mono therapy.</w>
mono therapies</w>
monke ys,</w>
monke y</w>
monke y.</w>
monitor ing.</w>
monitor .</w>
monito red.</w>
mon oxide.</w>
mon omers</w>
mon olayers</w>
mon ocytes</w>
mon ocyte</w>
mon .</w>
moles/glomerul us</w>
moles/glomerul us,</w>
molec ules</w>
mol/ L.</w>
mol/ L,</w>
modifi es</w>
modi fic
modific ations.</w>
moder ately</w>
moder ate-
moderate- to-severe</w>
modafin il
modafinil ,</w>
mod ulated</w>
mod est</w>
mod ation</w>
mod ality</w>
mod al
modal ities</w>
mo tivational,</w>
mo tion</w>
mo tility.</w>
mo tif</w>
mo reover,</w>
mo re.</w>
mo od,</w>
mo l</w>
mo fe
mofe til</w>
mmol/ d).</w>
mmol/ L,</w>
mmHg )</w>
mm/ year;</w>
mm/ kg</w>
mm as</w>
mm ;</w>
mm 3.</w>
mm 2
mm2 ).(ABSTRACT</w>
mm .</w>
mm ),</w>
ml/ min).</w>
ml/ kg</w>
ml/ 100
ml/100 g/
ml/100g/ min.</w>
ml ess.</w>
ml ;</w>
ml .</w>
mitochondri a.</w>
miti gated</w>
miti g
mitig ating</w>
mit ting</w>
mit tee</w>
mit ted.</w>
mist aken</w>
mist ake,</w>
mis ulfate,</w>
mis sions</w>
mis sed.</w>
mis s</w>
mis judg
misjudg ment</w>
mirro red</w>
mirro r</w>
minutes ).</w>
minutes ),</w>
minox i
minoxi dil
minoxidil .</w>
minim um-type</w>
minim ised</w>
mineralocortico id</w>
mineralocortico id
mineralocorticoid -related</w>
min-1 )</w>
min-1 ).</w>
min(-1 )).</w>
min ute)</w>
min ority</w>
min ium</w>
min ;</w>
milli on</w>
milli metric</w>
milli me
millime tres</w>
mil oride</w>
mil l
mill il
millil it
millilit ers</w>
mil itary</w>
mil i
mili eu
milieu ,</w>
mil der
milder .</w>
mil d,</w>
mil d
mild ly</w>
migra ineur
migraineur s</w>
migra ine:</w>
migra ine-
migraine- inducing</w>
migra ine,</w>
midazol am.</w>
midazol am
midazolam -associated</w>
mid t</w>
mid brain</w>
microscop y.</w>
microscop ical</w>
micron odular</w>
micron .</w>
micromol/ L),</w>
micrograms/kg/ min.</w>
micrograms/kg/ min)</w>
micrograms/kg/ d</w>
micrograms/ mouse</w>
micrograms/ min</w>
micrograms/ kg
micrograms/kg ,</w>
micrograms/ day</w>
micrograms.kg-1. min-1</w>
micrograms.kg-1. min-1).</w>
microgram/kg/ min.</w>
microgram/kg/ min,</w>
microgram/kg/ min)</w>
microgram s)</w>
microgram /ml
microgram/ml .</w>
microgram .
microgram. kg-1.
microgram.kg-1. min-1</w>
microglobulin uria</w>
microglobulin uria.</w>
microglobulin uria,</w>
microgli al-
microglial- specific</w>
microg/side ).</w>
microg/side ),</w>
microg/ side</w>
microg/ rat)</w>
microg/ m
microg/m L),</w>
microg/ kg</w>
microg/ day,</w>
microg ,</w>
microcryst als</w>
microcryst al</w>
microangio pathy.</w>
microangio pathies</w>
micro villi.</w>
micro vessels</w>
micro tubules.</w>
micro somal</w>
micro puncture</w>
micro phthalmos</w>
micro injection</w>
micro graph
micrograph s</w>
micro electro
microelectro de</w>
micro dialy
microdialy sis,</w>
micro b
microb ial</w>
micro M</w>
micro M,</w>
mic ro</w>
mic hol
michol ini
micholini um-3,</w>
mic e:</w>
mic e).</w>
mi rabilis</w>
mi pramine-induced</w>
mi paresis</w>
mi pafox-induced</w>
mi gr
migr ation.</w>
mi ens</w>
mg/m2BS A</w>
mg/m2BS A)</w>
mg/m2/ wk.</w>
mg/m2/ week</w>
mg/m2/ h</w>
mg/m2/ 24</w>
mg/m(2 ).</w>
mg/m l</w>
mg/m 2)</w>
mg/m 2).</w>
mg/kg/ i.p.</w>
mg/kg/ i.p.,</w>
mg/kg/ day.</w>
mg/kg ;</w>
mg/day ).</w>
mg/d l,</w>
mg/d L.</w>
mg/d L).</w>
mg/d )</w>
mg/K g/day</w>
mg/ sq</w>
mg/ l</w>
mg/ l.</w>
mg/ hour
mg/hour .</w>
mg/ day.</w>
mg/ day,</w>
mg/ caffeine</w>
mg/ 50</w>
mg/ 100
mg/100 g</w>
mg. per</w>
mg. kg(-1
mg.kg(-1 )
mg.kg(-1) .
mg.kg(-1). min(-1)),</w>
mg kg</w>
mg ;</w>
mg -
mg- ezetimibe</w>
metrif onate.</w>
metoprolo l.</w>
metoclopram ide.</w>
metoc urine.</w>
metid ine</w>
methylsulphon yl)amino]phenyl]amino]</w>
methylphenid ate.</w>
methylphenid ate,</w>
methylergon ovine,</w>
methyl- 6-
methyl-6- (
methyl-6-( phenylethynyl)pyridine</w>
methyl- 5
methyl-5 alpha-
methyl-5alpha- pregnan-20-one)</w>
methyl- 3-
methyl-3- (3-
methyl-3-(3- fluoro
methyl-3-(3-fluoro phenyl)-4-(4-methylsulphonyl)</w>
methyl xanthines</w>
methyl xanthine</w>
methyl transferase,</w>
methyl quinoline</w>
methyl piperazine),</w>
methyl hist
methylhist amine,</w>
methyl ene</w>
methyl en
methylen edi
methylenedi oxymethamphetamine,</w>
methyl dopa.</w>
methyl dopa-induced</w>
methyl but
methylbut yl)amino]-</w>
methyl ation,</w>
methoxy-4- methylquinoline</w>
methoxy-4- ethyl
methoxy-4-ethyl -B
methoxy-4-ethyl-B -
methoxy-4-ethyl-B- carboline-3-carboxylate</w>
methoxy-4- amino-
methoxy-4-amino- 5-
methoxy-4-amino-5- chloro
methoxy-4-amino-5-chloro benzo
methoxy-4-amino-5-chlorobenzo ic</w>
methoxy-4- [
methoxy-4-[ (
methoxy-4-[( methylsulphonyl)amino]phenyl]amino]</w>
methotrex ate,</w>
methemo globin</w>
methemo glo
methemoglo b
methemoglob inemia</w>
methad one</w>
methad one.</w>
methac in-induced</w>
meth scopolamine</w>
meth oxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine</w>
meth amphetamine.</w>
meth amphetam
methamphetam ine-
methamphetamine- elicited</w>
meth amphet
methamphet amines.</w>
metast asis</w>
metalloprotein ases</w>
metalloprotein ase</w>
metaboliz ers</w>
metabolit es.</w>
metabolit e,</w>
metabolis m
metabolism ).</w>
metabol ised</w>
metabol ic,</w>
met amphetamine</w>
met al</w>
mes othelioma,</w>
mes na.</w>
mes ent
mesent eric</w>
mer sed</w>
mer its</w>
mer ic
meric an</w>
mer cap
mercap topropionic</w>
ment s,</w>
ment alized</w>
ment ]).</w>
ment ;</w>
ment -related</w>
menopa use,</w>
mening itis,</w>
mening es.</w>
memor y:</w>
membran oproliferative</w>
membran e-
membrane- cytoskeleton</w>
membran e,</w>
memb ers</w>
melan oma</w>
melan oma.</w>
mel phalan</w>
mel ag
melag at
melagat ran,</w>
meg aloid</w>
medull as</w>
medull a.</w>
medium- sized</w>
medium- size</w>
medic ine.</w>
medic ations;</w>
medic ated</w>
medic ally.</w>
medi ators</w>
medi ator</w>
medi ates</w>
medi ates,</w>
medi ated.</w>
medi ated,</w>
medi ally.</w>
medi a,</w>
mechan ically</w>
measure ments,</w>
measure ment,</w>
measure d
measured :</w>
measure ),</w>
meas ures).</w>
me- blocking</w>
me x</w>
me t</w>
me sis</w>
me quiv</w>
me prazole</w>
me opathic</w>
me et
meet ing</w>
me at
meat ,</w>
me al</w>
me al.</w>
me AT
meAT P)</w>
me -1</w>
mb le</w>
maz indol
mazindol -treated</w>
maz ind
mazind ol,</w>
maz en
mazen il</w>
maxim um,</w>
maxim ize</w>
matri x,</w>
match ing</w>
mat ter.</w>
mat ous</w>
mat er</w>
mat er.</w>
mas s,</w>
mas k</w>
mas .</w>
mas ,</w>
mark s</w>
mark et
market ed</w>
mark ers:</w>
mark ers.</w>
mark ers,</w>
mark ed
marked ly.</w>
marg ins.</w>
marg in
margin ally</w>
mar row.</w>
mar ital</w>
mar a</w>
mapp ed</w>
manip ulative</w>
manifest ed</w>
manifest ations.</w>
manifest ation.</w>
manifest ation,</w>
manif est</w>
maneu vers</w>
maneu ver</w>
manag ing</w>
manag ed.</w>
man ufactures</w>
man nitol</w>
man ner</w>
man n's</w>
malign ancy</w>
malign anc
malignanc y.</w>
malform ations;</w>
male ate,</w>
male ate)</w>
mala ise</w>
mal tol</w>
mal es)</w>
mal e)</w>
mal ar
malar ia</w>
maj or.</w>
maint ained.</w>
main stay</w>
main s</w>
magnitu de
magnitude :</w>
magnesi um,</w>
mag l
magl utamyltransferase</w>
macroph ages.</w>
macroph age</w>
macroph age-
macrophage- like</w>
mac ulatum</w>
ma y,</w>
ma king</w>
ma kes</w>
ma ke</w>
ma de.</w>
ma ST
maST ,</w>
ma :</w>
ma -
ma- hexachlorocyclohexane</w>
mTo R)</w>
mRN A.</w>
mL/ min)</w>
mL/ 100</w>
mGluR 5)</w>
mEq/ l</w>
mEq/ kg/
mEq/kg/ day,</w>
mEq/ L,</w>
mEq/ L)</w>
mEq .</w>
mEq .).</w>
m sec,</w>
m pirical</w>
m ospheric</w>
m nemonic</w>
m ly,</w>
m io
mio sis;</w>
m ia:</w>
m essen
messen ger</w>
m er</w>
m ec
mec am
mecam ylamine</w>
m ast</w>
m arb
marb le</w>
m ap.</w>
m ant
mant le</w>
m ally</w>
m all
mall -</w>
m M).</w>
m B)</w>
m Ab
mAb s</w>
m 2.</w>
m 2,</w>
m .
m. ),</w>
m -
m- Sestami
m-Sestami b
m-Sestamib i</w>
lys ozymuria.</w>
lymphaden opathy</w>
lymphaden itis,</w>
lymph oplasmacytic</w>
lymph omas:</w>
lymph oma</w>
lymph ocytes</w>
lym ph</w>
ly T
lyT 1)</w>
lur biprofen</w>
lun gs,</w>
lumb usacral</w>
lumb ar</w>
luco cortico
lucocortico id
lucocorticoid -induced</w>
lu tion,</w>
lu ster</w>
lu pus,</w>
lu orodiethyl</w>
lu men</w>
lu ent</w>
lozeng es</w>
lozeng e.</w>
lozeng e,</w>
loxy dine</w>
loxy )-
loxy)- 6-
loxy)-6- methoxy-4-methylquinoline</w>
lowe red.</w>
lowe d,</w>
low- up</w>
low- salt</w>
low- priced</w>
low- osmolality</w>
low- level</w>
low- frequency</w>
low- dose-
low-dose- ADR
low-dose-ADR -associated</w>
low- density</w>
losart an
losartan ),</w>
los al</w>
loro acetaldehyde</w>
lor ide
loride )</w>
lopido g
lopidog rel.</w>
lop ent
lopent yl</w>
lop ec
lopec ia,</w>
long- acting</w>
long it
longit udinal</w>
long et
longet s)</w>
lol )</w>
logra ft</w>
log ous</w>
log istic</w>
log ical,</w>
lofen ac
lofenac .</w>
locomo tion.</w>
locomo tion,</w>
local ised</w>
loc k),</w>
loc ations,</w>
lobul e</w>
lobul e.</w>
lo vastatin,</w>
lo t,</w>
lo sum</w>
lo st.</w>
lo osening</w>
lo id-
loid- osmotic</w>
lo co
loco regionally</w>
lo bal</w>
lo ad</w>
ll ness</w>
ll ation</w>
littermat es.</w>
lithrom ycin</w>
lithium- pilocarpine-induced</w>
lithium- containing</w>
lit er</w>
lisino pril</w>
lisino pril,</w>
lipo protein</w>
lipo polysaccharide,</w>
lipi de
lipide mia</w>
ling ).</w>
lind ane,</w>
lind ane)</w>
lin king</w>
lin kage</w>
lin es.</w>
lin es
lines '</w>
limit s.</w>
limit s,</w>
limit ed.</w>
limit ed,</w>
limit ations</w>
limb s</w>
lim bing</w>
like wise</w>
like li
likeli hood</w>
lik el
likel y.</w>
lignoc a
lignoca ine.</w>
ligi ble
ligible .</w>
ligh t-</w>
ligand s.</w>
lig ent</w>
lic ted</w>
lic king</w>
lic en
licen sed</w>
li vestock.</w>
li ves</w>
li ver,</w>
li ve</w>
li thotripsy</w>
li thiasis</w>
li sted</w>
li p</w>
li oblastoma</w>
li fe
life time</w>
li b
lib ido
libido .</w>
li ability</w>
levofloxac in:</w>
levofloxac in.</w>
levofloxac in,</w>
levo dopa
levodopa /
levodopa/ carb
levodopa/carb id
levodopa/carbid opa</w>
level -dependent</w>
level -I</w>
lev onorgestrel)</w>
leuko penia</w>
leuko encephalopathy.</w>
leukem ia.</w>
leukem ia,</w>
leuk openia.</w>
leuk ocyte</w>
leucovor in,</w>
leu prolide</w>
lethal ities</w>
lestolol :</w>
lestolol -induced</w>
lep tic</w>
leng th.</w>
leng th-of-stay</w>
legil ine-induced</w>
lear ning),</w>
lead s,</w>
le- closure</w>
le xibility</w>
le um</w>
le ucemia</w>
le thargy,</w>
le tes</w>
le ted</w>
le sions)</w>
le prosy</w>
le mon.</w>
le mmas</w>
le i
lei omyosarcoma,</w>
le gs</w>
le gs,</w>
le f
lef t-sided</w>
le d-release</w>
le d-
led- seizures</w>
le av
leav age</w>
le a
lea ving</w>
le /
le/ drugs</w>
late- onset</w>
late- gestation</w>
lat ter,</w>
lat est</w>
lat ele
latele t</w>
lat e,</w>
lat e
late "</w>
lat ,</w>
las h
lash "</w>
las go
lasgo w</w>
larg est</w>
larg ely</w>
lap sed</w>
lamivudine- resistance</w>
lamivudine- containing</w>
lamivud ine,</w>
lamivud in</w>
lamin ar</w>
lam otrigine,</w>
lam matory</w>
lad y</w>
lad der</w>
lacrim ation.</w>
lac ks</w>
labor ator
laborator y,</w>
labor ,</w>
labetal ol-induced</w>
labetal ol,</w>
labe led</w>
labe l</w>
l/ m2,</w>
l/ hour
l/hour /
l/hour/ m2.</w>
l- methylbutyl)amino]-</w>
l- hexy
l-hexy loxy)-6-methoxy-4-methylquinoline</w>
l- based</w>
l- Per
l-Per longets)</w>
l ysis,</w>
l umens</w>
l timately,</w>
l s,</w>
l loid-osmotic</w>
l in,</w>
l ich</w>
l end</w>
l en
len al
lenal idomide.</w>
l arynx,</w>
l aryngeal</w>
l anc
lanc inating</w>
l ability</w>
l ab
lab or</w>
l T)</w>
kine tics</w>
kine sia.</w>
kind ling).</w>
kind led-seizures</w>
kin in</w>
kin es.</w>
kin ase,</w>
kidne ys)</w>
kidne y.</w>
kg(-1 )</w>
kg(-1 ),</w>
kg(-1 ))</w>
kg(-1 )),</w>
ket one</w>
ket olide</w>
ket amine.</w>
ke ys</w>
ke toconazole.</w>
ke to</w>
ke ep
keep ing</w>
kappa B)</w>
kappa -
kappa- beta
kappa-beta .</w>
kan amycin</w>
kan am
kanam ycin-colistin</w>
k- correlated</w>
k- and-
k-and- white</w>
k ynurenine</w>
k ward</w>
k s,</w>
k owitz</w>
k nee.</w>
k its.</w>
k emia</w>
k cros
kcros sing,</w>
k b</w>
k P
kP a</w>
k :</w>
justi fy</w>
justi fic
justific ation.</w>
justi fi
justifi ed.</w>
junc tival</w>
junc tions.</w>
jud ici
judici ously</w>
ju ice</w>
ju g
jug ular</w>
joint s,</w>
joint ly</w>
jit teriness"</w>
jit ter</w>
jer ks,</w>
jer k-correlated</w>
j ust</w>
j umping</w>
j or</w>
j o</w>
j ect</w>
j aundic
jaundic e,</w>
izophren ia</w>
iz ziness</w>
iz ygous</w>
iz ation,</w>
itsel f</w>
itsel f
itself ,</w>
iti l-Perlongets)</w>
it y),</w>
it uitary</w>
it ubular</w>
it ual</w>
it to.</w>
it tle</w>
it s'</w>
it ry</w>
it onavir</w>
it ely</w>
it ch
itch iness,</w>
it 's</w>
ist ructured</w>
issu e</w>
isoproteren ol.</w>
isoproteren ol-treated</w>
isoproteren ol-pretreated</w>
ison ,</w>
isolated-H IT
isolated-HIT ;</w>
isolated-H I
isolated-HI T.</w>
isol ation</w>
isol ated.</w>
isoflur ane,</w>
iso prenaline-induced</w>
iso form</w>
iso enzyme</w>
iso -
iso- osmolality</w>
ish able</w>
ish ,</w>
is panic</w>
is otonic</w>
is odic</w>
is ocortical</w>
is ms</w>
is m.</w>
is let</w>
is -
is- Le
is-Le u</w>
irrit ant</w>
irrig ating</w>
irrig ated</w>
irarub ic
irarubic in)</w>
ir y</w>
ir reversibly</w>
ir respective</w>
ir regular</w>
ir radiation</w>
ir radiation.</w>
ir cum
ircum stances</w>
ir CR
irCR F)</w>
iprindol e-
iprindole- treated</w>
iprindol e,</w>
ip silateral</w>
ip pocampal</w>
ip -H
ip-H is-Leu</w>
ip ,</w>
iop sies</w>
iod ical</w>
io retinal</w>
io prine.</w>
io pentone</w>
io dic</w>
io -
io- al
io-al veolar</w>
invol ved,</w>
invol untary</w>
investigator s,</w>
investigator -
investigator- observed</w>
investig ator</w>
investig ates</w>
investig ated
investigated :</w>
invari ably</w>
invari able</w>
inv ited</w>
inu ous</w>
intub ated,</w>
intub ated
intubated ),</w>
introduc tion,</w>
intraperitone all
intraperitoneall y)</w>
intram ascular</w>
intrader mally</w>
intrac orporal</w>
intrac erebro
intracerebro ventricularly</w>
intrac avernous</w>
intra- arteri
intra-arteri ally,</w>
intra vesically</w>
intra ventricularly)</w>
intra uterine</w>
intra renally</w>
intra patient</w>
intra oral</w>
intra jugular</w>
intest ine</w>
intest ine,</w>
interview ing</w>
interview ed</w>
interview .</w>
interview ,</w>
interven tions.</w>
interval s.</w>
interval .</w>
intersti tium</w>
interru ption</w>
interru pted</w>
interru pt</w>
interaction s;</w>
interaction s--also</w>
interac ted</w>
inter vention</w>
inter oceptive</w>
inter neurons.</w>
inter nal</w>
inter na,</w>
inter na)</w>
inter mediates,</w>
inter mediate</w>
inter ic
interic tal</w>
inter feren
interferen ce.</w>
inter dependence</w>
inter class</w>
inter cellular</w>
inter body</w>
intensi vists</w>
intensi ties</w>
intensi ties,</w>
intensi fy</w>
inten tion-to-treat,</w>
inten se</w>
integr ity,</w>
integr ations</w>
inte rest</w>
inte lligence</w>
inte g
integ rin</w>
int s</w>
int rinsic</w>
int ranasal,</w>
int olerance</w>
insuffici ency.</w>
insuffici ency,</w>
insuffici enc
insufficienc y:</w>
institu tions.</w>
institu tion,</w>
institu ted.</w>
instill ing</w>
instill ation.</w>
inst rumentation,</w>
inst em,</w>
inst ances</w>
inst ances,</w>
inst ance,</w>
insi ght</w>
inser ts</w>
inser tion.</w>
ino varus.</w>
innerv ated</w>
injur y)</w>
injec tion:</w>
injec tion).</w>
inj ected.</w>
initi ation.</w>
initi ation,</w>
initi ating</w>
initi ated.</w>
initi ated,</w>
inhibitor s:</w>
inhibitor s-induced</w>
inhibitor :</w>
inhibitor -1</w>
inhibit ing</w>
inhibi tions</w>
inhibi tion),</w>
inhal ed</w>
inhal ation,</w>
ingest ed.</w>
inges tion.</w>
inges tion,</w>
ing ton</w>
ing redient</w>
ing ing</w>
ing ers</w>
ing eing</w>
ing -induced</w>
ing ).</w>
infu sion-produced</w>
infu sion)</w>
infrequ ent.</w>
inform ative</w>
influ encing</w>
influ enc
influenc es,</w>
infilt rates,</w>
infer red</w>
infec tion:</w>
infarc ts</w>
infarc tions</w>
infarc tions,</w>
infarc tion:</w>
infarc ted</w>
infarc t</w>
infarc t-avid</w>
inf ra-Hisian</w>
inf licted</w>
inf lexibility</w>
inf iltr
infiltr ations</w>
inf ective</w>
inf ants.</w>
inf ants,</w>
inex pensive</w>
inex orable</w>
ineff ective</w>
ine/ Rg1</w>
ine- pretreated</w>
ine- nitric</w>
ine- di
ine-di gluconate</w>
ine zetimibe</w>
ine ligible.</w>
ine d,</w>
induced -
induced- behaviour</w>
indu stry</w>
indomethac in.</w>
individu al
individual 's</w>
indic ator
indicator s.</w>
indic ations</w>
indic ated.</w>
index es</w>
index .</w>
index ).</w>
independ ently.</w>
independ ent)</w>
inde ed</w>
inde ed,</w>
ind led</w>
ind ing.</w>
ind inavi
indinavi r</w>
ind ane</w>
increasing ;</w>
increas e.</w>
incorpor ated</w>
incorpor ate</w>
inclu sion.</w>
inclu ded.</w>
inclu ded,</w>
inc urable</w>
inc riminated</w>
inc rements</w>
inc iting</w>
inc ed</w>
in-ezetimi be-induced</w>
in- untreated,</w>
in- gentamicin</w>
in- clavulanic</w>
in- Po
in-Po ong</w>
in- 1</w>
in versely</w>
in verse</w>
in us</w>
in um,</w>
in sudative</w>
in structions</w>
in spection</w>
in son</w>
in significantly</w>
in senoside</w>
in rcease,</w>
in quire</w>
in patients.</w>
in patients,</w>
in patient,</w>
in one,</w>
in omic</w>
in ol.</w>
in nate</w>
in ine-nitric</w>
in ed</w>
in distingu
indistingu ishable</w>
in consistently</w>
in conclusive.</w>
in concl
inconcl usive</w>
in com
incom prehensible</w>
in atal</w>
in amide-induced</w>
in adequately</w>
in ad
inad vertently</w>
in activation</w>
in activating</w>
in activated</w>
in ac
inac tive.</w>
in ability</w>
in ]</w>
in ).</w>
impro vements</w>
impro vement.</w>
impro vement,</w>
impro ved.</w>
impro ve,</w>
import ance,</w>
implic ations.</w>
implic ates</w>
implic ate</w>
implant able</w>
implant -
implant- supported)</w>
impl ies</w>
impair ment]).</w>
impair ment,</w>
impa i
impai red.</w>
immunohistochemist ry.</w>
immunohisto chemical,</w>
immunocyto chemistry.</w>
immunocyto chemical</w>
immuno therapy</w>
immuno therapy:</w>
immuno histological</w>
immuno globulin</w>
immuno globul
immunoglobul ins.</w>
immuno com
immunocom promised</w>
immuno chemically</w>
immuno assay</w>
immuno -
immuno- suppressive</w>
immun olabeling</w>
immun oblotting</w>
immun e-
immune- mediated</w>
immo bility</w>
immedi ately,</w>
imen sions</w>
imbal ance</w>
imbal ance.</w>
imag ing,</w>
imag es,</w>
imag e)</w>
im um</w>
im pressively</w>
im potence</w>
im potence.</w>
im perative</w>
im peded</w>
im ozide</w>
im mersed</w>
im ited</w>
im idazol
imidazol ine</w>
im als</w>
iltr ation.</w>
ill nesses.</w>
ill ness,</w>
ill aries</w>
ill ain
illain -B
illain-B ar
illain-Bar r</w>
ill ,</w>
il itation</w>
il d.</w>
il d-
ild- up</w>
il ateral</w>
il .</w>
igh tened</w>
ig y</w>
ig ab
igab at
igabat rin</w>
ifost ine</w>
ifosf amide.</w>
ific ation.</w>
ifedi pine</w>
if i
ifi er</w>
if est
ifest ations</w>
ido thymidine</w>
ido thymidine-induced</w>
ido acetate</w>
idiosyn cr
idiosyncr atic</w>
idiosyn c
idiosync rasy</w>
identic al.</w>
identic al,</w>
iden tically</w>
iden e)</w>
ide- effects</w>
ide n</w>
ide al</w>
id- stimulating</w>
id s,</w>
id rosis,</w>
id ine-treated</w>
id ine-digluconate</w>
id ine-associated</w>
id din
iddin ess.</w>
id ated.</w>
id :</w>
icardi tis</w>
icardi al,</w>
ic tus</w>
ic terus</w>
ic oll-Hypaque</w>
ic loxydine</w>
ic lofenac</w>
ic in-untreated,</w>
ic in-treated</w>
ic e.</w>
ic e
ice berg
iceberg ?</w>
ic ation</w>
ic ag
icag o,</w>
ic .</w>
iatro genically</w>
ia ?</w>
i/ AR
i/AR B</w>
i.v .;</w>
i.v .,</w>
i.v .).</w>
i.p. ))</w>
i.c.v .</w>
i. m.),</w>
i- structured</w>
i yadh,</w>
i ver</w>
i v</w>
i ron</w>
i p</w>
i on</w>
i mex</w>
i metidine</w>
i melagatran,</w>
i leum</w>
i led,</w>
i ine,</w>
i i)</w>
i gnant</w>
i gn
ign ,</w>
i ent
ient ation</w>
i ed.</w>
i dic</w>
i bu
ibu profen</w>
i b
ib rating"</w>
i atric</w>
i ans</w>
i ,</w>
hypox ic,</w>
hypox ia.</w>
hypox emia</w>
hypox aem
hypoxaem ia,</w>
hypothe tic.</w>
hypothe size</w>
hypoten sion-mediated</w>
hypoph arynx,</w>
hypocalce mia</w>
hypoalbum inemia</w>
hypoalbum inemia,</w>
hypo volemia</w>
hypo ventilation</w>
hypo thyroidism.</w>
hypo thyroid</w>
hypo thermia</w>
hypo thermia.</w>
hypo thermia,</w>
hypo thalamus</w>
hypo phosphatemia,</w>
hypo mania</w>
hypo locomotion.</w>
hypo gon
hypogon a
hypogona dis
hypogonadis m</w>
hypo aesthesia</w>
hyperprolactine mic</w>
hyperprolactine mia.</w>
hyperkine tic</w>
hyperkine sis.</w>
hyperkine sis,</w>
hyperkine sias</w>
hyperkal emia.</w>
hypere osinophilia.</w>
hypere mic</w>
hypercholesterol emia</w>
hypercholesterol aemia</w>
hyperammon emia,</w>
hyperalge sia,</w>
hyperalge sia).</w>
hyper trophy</w>
hyper trophy,</w>
hyper thymic</w>
hyper thermia.</w>
hyper salivation,</w>
hyper plasia,</w>
hyper phosphatemia,</w>
hyper parathyroidism.</w>
hyper locomotion</w>
hyper lipidemia</w>
hyper lipidemia,</w>
hyper intense</w>
hyper h
hyperh idrosis,</w>
hyper filtration</w>
hyper cal
hypercal ce
hypercalce mia,</w>
hyper biliru
hyperbiliru b
hyperbilirub inemia,</w>
hyper acute</w>
hyper active</w>
hyper CK
hyperCK aemia</w>
hyper -
hyper- reactivity</w>
hype remia:</w>
hype remia,</w>
hydroxy- di
hydroxy-di propyloaminotetralin</w>
hydroxy- 3-methyl
hydroxy-3-methyl glut
hydroxy-3-methylglut ar
hydroxy-3-methylglutar yl</w>
hydroxy quinolines</w>
hydroxy quinolines:</w>
hydrox ylase,</w>
hydrox yl)</w>
hydrox y</w>
hydrochlor ide.</w>
hydrobrom ide</w>
hydro chlorofluorocarbons</w>
hydro chloro
hydrochloro thiazide-triamterene</w>
hyd ronephrosis</w>
hyd ralazine</w>
hyal uronate.</w>
hyal inosis</w>
hy potonic</w>
hy ponatremia,</w>
hy polipidaemic</w>
hy oscine)</w>
hy gi
hygi en
hygien e,</w>
hy dra
hydra zine</w>
hum an-
human- cit
human-cit rated</w>
hr lich</w>
hr ),</w>
hour s,</w>
hour s),</w>
hour ,</w>
hour ),</w>
hot plate</w>
hot -
hot- plate,</w>
hospital ization,</w>
hospital ised</w>
hospit als</w>
hospit al,</w>
horm ones</w>
horm one,</w>
horizont ally</w>
horizont al</w>
hor ns.</w>
homogen ates.</w>
homogen ates)</w>
homo zygous</w>
homo logous</w>
ho wever</w>
ho pes</w>
ho meopathic</w>
ho c</w>
ho arsen
hoarsen ess</w>
ho ard
hoard ing,</w>
ho ,</w>
histor ies.</w>
histo pathologic</w>
histo chemistry</w>
histo chemistry.</w>
hist ology,</w>
hist ologically</w>
hist aminergic</w>
hippocamp us.</w>
hind limb</w>
hil us</w>
hil us.</w>
highligh ting</w>
highligh ted.</w>
high- salt</w>
high- resolution</w>
high- pressure</w>
high- flu
high-flu x</w>
high- dose)</w>
high- amplitude</w>
high light</w>
high er,</w>
high ,</w>
hic le/drugs</w>
hic c
hicc ups</w>
hi therto</w>
hi p</w>
hi p.</w>
hi on.</w>
hi m</w>
hexach loride)</w>
hex idine-digluconate</w>
hex af
hexaf luorodiethyl</w>
heter ozygous</w>
heter ogenously</w>
heter ogeneity</w>
her nia</w>
her b
herb als,</w>
hepato megaly,</w>
hepatitis -
hepatitis- B</w>
hepat otoxic</w>
hepat ocytes.</w>
hepat ocytes,</w>
hepat ectomy,</w>
hepar itinase</w>
hepar in]</w>
hemoly tic-uremic</w>
hemoly sis,</w>
hemoglobin uria</w>
hemodialy sis;</w>
hemodialy sis.</w>
hemodiaf iltration</w>
hemodiaf iltration.</w>
hemodi lution,</w>
hemo dynamics,</w>
hemo dil
hemodil uting</w>
hemato poietic</w>
hemato pathology</w>
hemat uria</w>
hemat omas,</w>
hemat ologically</w>
hemat ocrit,</w>
hem lock),</w>
hem izygous</w>
hem ical</w>
hear ing,</w>
health y,</w>
health food</w>
health .</w>
heal ed</w>
headache )</w>
headac h
headach es,</w>
head .</w>
head -up</w>
head ,</w>
head ")</w>
he xamethonium</w>
he xamethonium,</w>
he rence</w>
he re.</w>
he ptylate</w>
he misulfate,</w>
he miparesis</w>
he micholinium-3,</w>
he ightened</w>
he avy</w>
haz ard</w>
haz ard
hazard ous?</w>
haz ar
hazar dou
hazardou s.</w>
harvest ed.</w>
harvest ed,</w>
har mless.</w>
hapto globin
haptoglobin .</w>
happ iness</w>
hap s</w>
hap pens</w>
hand s,</w>
haloth ane.</w>
haloth ane)</w>
haloperid ol;</w>
haloperid ol-controlled</w>
haloperid ol)</w>
hall ucinosis</w>
hall ucinations,</w>
hall marks</w>
hall eng
halleng e,</w>
half- life.</w>
hal ide</w>
hal f
half ).</w>
haemorrh agic</w>
haemorrh ages.</w>
haemoly sis.</w>
haem ofiltration</w>
haem odilution.</w>
haem atological</w>
haem at
haemat ocrit</w>
hab domyolysis</w>
ha wthorn</w>
ha ir</w>
h s).</w>
h r,</w>
h ost</w>
h old</w>
h ero
hero ine</w>
h ere</w>
h arm
harm ful</w>
h and-
hand- foot</w>
h ancement</w>
h Es)</w>
h C
hC G</w>
h ;</w>
h -1</w>
h -1)</w>
h )
h) U
h)U V</w>
gynecomasti a.</w>
gynec ologic</w>
gy rata.</w>
guide lines</w>
guide d,</w>
guan idoacetate</w>
gu aran
guaran a</w>
group s;</w>
group :</w>
group ),</w>
grav ity</w>
grav is,</w>
granulomato sis:</w>
granulocyto sis</w>
granulocyto penia</w>
granulocyto penia.</w>
granulocy tes</w>
granulocy te-colony</w>
granulo mas</w>
granulo mas.</w>
gran ulated,</w>
gran ular</w>
gradu al,</w>
gra ine</w>
gra des</w>
gra d
grad ation</w>
gr and</w>
gr /d
gr/d l.</w>
gonad otropin</w>
gonad ally</w>
go t</w>
go od.</w>
go od-risk</w>
go od,</w>
go al.</w>
gn itive</w>
gn ition</w>
gn aw
gnaw ing</w>
glyco suria,</w>
glyco saminoglycan-degrading</w>
glyco l,</w>
glyco aminoglyc
glycoaminoglyc ans</w>
glybur ide,</w>
glutam ate,</w>
glut amine</w>
gluco suria,</w>
gluco se</w>
gluco se.</w>
glucar ic</w>
gluc oronosyltransferases</w>
glomerulosclero tic</w>
glomerulosclero sis,</w>
glomerul us</w>
glomerul i,</w>
glomer ulopathies</w>
globin uria</w>
glo bal</w>
glioblast omas</w>
glioblast omas.</w>
glioblast oma</w>
gli omas</w>
gli omas.</w>
glau comat
glaucomat ous</w>
glau coma</w>
gl as
glas ses</w>
gl and</w>
gl and,</w>
gl an
glan d.</w>
gin senoside</w>
gin seng,</w>
gin a</w>
gi ves</w>
gi ve</w>
gi tized</w>
gi t</w>
gi onal</w>
get ting</w>
get s</w>
gest odene)</w>
gest ations</w>
gest ation.</w>
gest ants,</w>
gentam icin.</w>
gentam icin-treated</w>
gentam icin-induced</w>
gentam icin,</w>
genotyp es</w>
genotyp es.</w>
genotyp ed</w>
genotyp e</w>
genotyp e,</w>
genit o-urinary</w>
genic -</w>
gener ations</w>
gener ation.</w>
gener ating</w>
gener ated.</w>
gener al
general ized,</w>
gene tically</w>
gen s</w>
gen omic</w>
gen ital</w>
gen es.</w>
gen ec
genec ity</w>
gen dered</w>
gen der</w>
gen der
gender -dependent</w>
gen -positive</w>
gem fibro
gemfibro zil</w>
ge ographical</w>
ge l</w>
gastro c
gastroc nemius</w>
gast ric,</w>
gangli on</w>
gangli a</w>
gang rene</w>
ganax olone,</w>
gamma-glutam yltransferase</w>
gamma-glutam yltransferase,</w>
gamma-carbox ylation</w>
gamma-carbox ylated.</w>
gamma-HCH .</w>
gamma-HCH ),</w>
gamma-G T</w>
gamma-G T)</w>
gamma- vinyl</w>
gamma- hexachlorocyclohexane</w>
gamma- en
gamma-en olase,</w>
gamma- carb
gamma-carb oxyglutamate</w>
gamma- V
gamma-V inyl</w>
gam maglutamyltransferase</w>
gall stones</w>
gall stone</w>
gain ,</w>
gabapent in-induced</w>
gabapent in,</w>
g/d l)</w>
g/d L</w>
g/ day
g/day );</w>
g ust</w>
g um,</w>
g um),</w>
g rommet,</w>
g p),</w>
g out,</w>
g oscopy</w>
g o</w>
g maST,</w>
g iddiness.</w>
g edly</w>
g av
gav aged</w>
g as
gas -
gas- liquid</w>
g ap.</w>
g ained</w>
g ag
gag /
gag/ pol;</w>
g A</w>
g ;</w>
g )</w>
g ).</w>
fut ure.</w>
fut ure,</w>
function ing</w>
function ing,</w>
function al
functional /
functional/ physiological</w>
function :</w>
function )</w>
ful fill</w>
ful );</w>
fucoid an,</w>
fu simotor</w>
fru ste</w>
fru it</w>
front ocortical</w>
front ally</w>
fron t-line</w>
frequ ently.</w>
frequ ent.</w>
frequ ent,</w>
frequ enc
frequenc y)</w>
fre ez
freez e-
freeze- fracture</w>
fre ely</w>
fratax in.</w>
fratax in,</w>
fraction ).</w>
frac tures,</w>
frac tions</w>
frac tion,</w>
four teen</w>
four ;</w>
four ,</w>
form ulation</w>
form ula,</w>
form s,</w>
form ers</w>
form er.</w>
form ation
formation ally</w>
form al</w>
for ward</w>
for ty-two</w>
for nix.</w>
for getting</w>
for ce
force d-
forced- swimming</w>
follow- up;</w>
follow- up,</w>
fol lowed,</w>
fol ic</w>
fol d.</w>
fol d)</w>
fol d).</w>
foci .</w>
foc using</w>
foc i</w>
foc ally</w>
fo ot.</w>
fo am
foam y</w>
flut ter</w>
flut ter.</w>
flut amide,</w>
flush ing,</w>
flush ed</w>
flur biprofen</w>
flur amines,</w>
fluoxet ine.</w>
fluoro quinolone,</w>
fluoro phosphate</w>
fluoro phenyl)</w>
fluoro cit
fluorocit rate,</w>
fluoro benzyl
fluorobenzyl idene)</w>
fluoro acetyl-
fluoroacetyl- adduc
fluoroacetyl-adduc ted</w>
fluoro acetate</w>
fluoresc ence</w>
fluores cent
fluorescent -
fluorescent- labeled</w>
fluo rene</w>
flu vastatin,</w>
flu phenazine.</w>
flu ids</w>
flu id:</w>
flu ency,</w>
flu ence</w>
flow s</w>
flow metry.</w>
flow ,</w>
flow )</w>
flexi on</w>
flexi bly</w>
fle x</w>
flav ine</w>
fl uctuations</w>
fl are</w>
fixed -
fixed- salt</w>
fix ed</w>
fist ula</w>
fist ula.</w>
first ;</w>
first ,</w>
fir mly,</w>
fir m</w>
fil m</w>
fil am
filam ent)</w>
fig uring</w>
fig uration</w>
fifty- three</w>
fifty- one</w>
fif ty-five</w>
fif th</w>
fif teen</w>
fif teen.</w>
fic its</w>
fic ations,</w>
fibro sis,</w>
fibro proliferative</w>
fibrin olysis,</w>
fibrill ary</w>
fib er,</w>
ffe ine-induced</w>
ff spring</w>
fet us</w>
fet us.</w>
ferri oxamine</w>
fer tility</w>
fer tility:</w>
fentanyl :</w>
fentanyl ,</w>
fentan yl-dexamethasone,</w>
fen fluramines,</w>
femal e.</w>
feet .</w>
feedbac k.</w>
feed ing,</w>
feat ures.</w>
fe ver.</w>
fe et</w>
fe el
feel ing</w>
fe eding</w>
fe bri
febri le</w>
fe a
fea sibility,</w>
fat ty</w>
fat ality</w>
fat al,</w>
fast ing.</w>
fast ing,</w>
fascicul ations.</w>
fascicul ation,</w>
fas hion.</w>
fas ci
fasci otomies</w>
far mer</w>
far .</w>
fail s</w>
fail ing</w>
factor .(ABSTRACT</w>
fact s</w>
facilit atory</w>
face- name</w>
fac ies,</w>
fac ed</w>
fac e,</w>
fa ther</w>
fa iled,</w>
f urther,</w>
f ungal</w>
f resh-frozen</w>
f rail</w>
f p).</w>
f ound,</w>
f osfamide</w>
f lestolol-induced</w>
f lat,</w>
f lash"</w>
f its.</w>
f ited</w>
f ish,</w>
f ingers</w>
f inely</w>
f ine</w>
f ile</w>
f ell</w>
f ed.</w>
f ects</w>
f ecal</w>
f ast</w>
f air
fair ly</w>
f ad
fad ed</w>
f MRI</w>
ey es.</w>
ey el
eyel ids,</w>
extrem ity.</w>
extrem ities</w>
extrem ities,</w>
extrac tion.</w>
extrac ted</w>
extrac t.</w>
extrac t,</w>
extrac erebral</w>
extra vasation</w>
extra striatal</w>
extra renal</w>
extra polated</w>
exten sively</w>
exten sively,</w>
exten ds</w>
ext ent.</w>
expos ure:</w>
expos ure);</w>
expos ing</w>
explor ation.</w>
explor ation,</w>
explo red</w>
explo red.</w>
explo ited</w>
explan ations,</w>
explan ation</w>
experiment ;</w>
experienc es.</w>
experi ence.</w>
expect ation</w>
expect ancy</w>
exist ed</w>
exist .</w>
exhib its</w>
exhib iting</w>
exhib ite</w>
exhaus tion</w>
exhaus tion.</w>
exerci se.</w>
exerci se-controls.</w>
exer ting</w>
exer t</w>
exer cis
exercis ed</w>
exec ution</w>
excre tion.</w>
excl ude</w>
excit ement</w>
excit atory</w>
excit ation.</w>
exce eded.</w>
examin ing</w>
examin es</w>
examin ations.</w>
examin ations,</w>
examin ation,</w>
examin able</w>
exam s,</w>
exam ple</w>
exacerb ation</w>
ex udative</w>
ex teroceptive</w>
ex t</w>
ex posed,</w>
ex ponentially</w>
ex piratory</w>
ex itil-Perlongets)</w>
ex it</w>
ex enceph
exenceph aly
exencephaly ;</w>
ex em
exem plified</w>
ex change</w>
ex cess.</w>
ex anth
exanth em
exanthem a,</w>
ex act
exact ly</w>
ex )-induced</w>
evol ution</w>
evol ution.</w>
evo kes</w>
evo ke</w>
evid ences</w>
everolim us</w>
everolim us.</w>
event ually</w>
event s:</w>
event .</w>
event ,</w>
evaluated ;</w>
evaluated :</w>
evalu ations.</w>
evalu ations,</w>
evalu ation,</w>
ev ofloxacin,</w>
ev inced</w>
ev es</w>
euphor ia</w>
euphor ia,</w>
eu tic</w>
eu thymic</w>
eu thanized,</w>
eu s.</w>
ety- Sch
ety-Sch midt</w>
eti tive,</w>
ethyl ]</w>
ethyl )
ethyl) -1-
ethyl)-1- nitrosourea),</w>
eth osuximide</w>
eth nic</w>
eth idine-associated</w>
eth anolic</w>
eth anol
ethanol ).</w>
et ween</w>
et uses</w>
et randrine</w>
et ari
etari ans</w>
et amine,</w>
et ail
etail s</w>
estrogen -
estrogen- testosterone</w>
estrogen ,</w>
estro genic</w>
estradiol :</w>
estradiol -dependent</w>
estradiol -</w>
estim ates</w>
estim ated,</w>
esthe tics.</w>
esthe siologists</w>
ester s)</w>
ester ification</w>
ester ases</w>
ester :</w>
establish ment</w>
establish es</w>
establ ishing</w>
est or,</w>
est ing</w>
est ers</w>
est er,</w>
est ).</w>
essen tially</w>
esoph ag
esophag itis,</w>
escap e,</w>
escal ations</w>
escal ation</w>
es/ person-years</w>
es ulfonyl-7-(4-methyl-piperazin-1-yl)1H-indole)</w>
es tionnaire</w>
es tion.</w>
es enchymal</w>
es citalopram</w>
erythromyc ins</w>
erythromyc ins,</w>
erythrocy tes.</w>
erythrocy tes,</w>
erythroblastocyto penia</w>
erythroblastocyto penia.</w>
erythro phagocytosis</w>
erythro n</w>
ero ded.</w>
ergotamine/ caffeine,</w>
ergot amine</w>
ergon ovine</w>
erg y"</w>
erg olide</w>
erg ocryptine</w>
erg mann's</w>
erec tions</w>
ere sis.</w>
ere d,</w>
erap eutic</w>
er- 344</w>
er y</w>
er rors</w>
er roneously</w>
er rations</w>
er ous</w>
er osol</w>
er ocutaneous</w>
er but
erbut aline,</w>
er ad
erad ication</w>
equ inovarus.</w>
equ ential</w>
episod es.</w>
epinephr ine:</w>
epinephr ine-induced</w>
epinephr ine),</w>
epilepto genic</w>
epilepto genecity</w>
epileptic us-associated</w>
epidemio logical</w>
epidemio logic</w>
ephed rine/propofol/mixtures</w>
eph alospor
ephalospor in</w>
ep sy</w>
ep letion</w>
ep isodic</w>
ep icardial,</w>
ep at
epat ocyte</w>
ep -
ep- tendon</w>
enzym atically</w>
enzy me.</w>
enzy me-blocking</w>
enzy me-1</w>
enz ylthiouracil</w>
enz berg
enzberg ,</w>
environ ments.</w>
environ ment,</w>
entr icular</w>
enti ties</w>
entero pathica.</w>
entero colitis.</w>
ent s)</w>
ent s'</w>
ent ropion</w>
ent rapment,</w>
ent oxifylline</w>
ent ory</w>
ent erocutaneous</w>
ent ering</w>
ent am
entam icin</w>
ent ally</w>
ensi tivity</w>
enlarg ed,</w>
eng aged</w>
enflur ane</w>
endothel in</w>
endothel in-converting</w>
endothel in-1</w>
endophthalm itis.</w>
endophthalm itis,</w>
end- tidal</w>
end points</w>
end otracheal</w>
end onuclease-dependent</w>
end ings</w>
end ar</w>
encephalopath y:</w>
encephalopath y--19</w>
encephalopath y)</w>
encephalopath y").</w>
encephal y</w>
ence ).</w>
enc es.</w>
enalapri l.</w>
en uresis,</w>
en tion</w>
en sued</w>
en rollment.</w>
en rolled.</w>
en orrhea</w>
en och-Schonlein</w>
en ing,</w>
en gendered</w>
en esulfonyl-7-(4-methyl-piperazin-1-yl)1H-indole)</w>
en ergy"</w>
en dos
endos co
endosco pic</w>
en cour
encour age</w>
en abl
enabl ed</w>
employ ed</w>
employ ed:</w>
employ ed
employed ),</w>
empi rically</w>
empi rically,</w>
empi rical</w>
emphasiz ed.</w>
emo val</w>
emergen cy
emergency -
emergency- department</w>
embryo s.</w>
embryo .</w>
embry onic</w>
embry o</w>
emb olism</w>
emb oli.</w>
em pty</w>
em it</w>
em ents</w>
em citabine</w>
eluc idated</w>
eluc idated.</w>
else where</w>
else where,</w>
ell ation</w>
elimin ated</w>
elic ited.</w>
elev enth</w>
elev ations,</w>
elev ating</w>
elev ated,</w>
electromy ography</w>
electromy ographic</w>
electrom yogram.</w>
electroly tes,</w>
electroencephalo graphy</w>
electroencephalo graphic</w>
electro phoresis</w>
electro grams</w>
electro gram</w>
electro diagnostic</w>
electro des</w>
ele ven</w>
elast olysis</w>
elast in.</w>
el usive.</w>
el ta=-6.7%;</w>
el son</w>
el les</w>
el itto.</w>
el as
elas tic</w>
eigh th</w>
eigh tfold</w>
eigh t.</w>
eigh t-and-a-half-yr-old</w>
eg etarians</w>
effici ency</w>
effect s--such</w>
effect s).</w>
effac ement,</w>
eff usion</w>
eff ort</w>
eff er</w>
eff e
effe rent</w>
ef triaxone-associated</w>
ef ly,</w>
edi onbel)</w>
ed ing.</w>
ed er</w>
ed ation</w>
ect rical</w>
ect opic</w>
ect oderm</w>
ect ed,</w>
ecstas y.</w>
ecstas y-related</w>
ecstas y).</w>
ecit ab
ecitab ine:</w>
echol amine-induced</w>
echocardiograph y:</w>
echan isms</w>
ech -
ech- R
ech-R af
ech-Raf a
ech-Rafa elson</w>
ec ubital</w>
ec tions</w>
ec ho,</w>
ec ate,</w>
ec arbox
ecarbox amide
ecarboxamide )</w>
ec ar
ecar in</w>
earli est).</w>
ear s</w>
ear s)</w>
ear .</w>
eGF P</w>
eGF P-
eGFP- microglia</w>
eGF P)</w>
e. g.</w>
e- like</w>
e- 140</w>
e y</w>
e tic</w>
e ther</w>
e rens</w>
e rebellar</w>
e mesis</w>
e lithromycin</w>
e iver</w>
e igy</w>
e hicle/drugs</w>
e as
eas y</w>
e ach
each .</w>
e ),</w>
dystro phy,</w>
dysphon ia.</w>
dysp noea</w>
dyskinesi as,</w>
dyskinesi a,</w>
dyskine tic</w>
dyskine sia.</w>
dysfunc tioning</w>
dysfunc tional</w>
dysfunc tion:</w>
dys rhythmias,</w>
dys phoric</w>
dys chrom
dyschrom ato
dyschromato psy,</w>
dys arthri
dysarthri a</w>
dynamic )</w>
dy e</w>
dy az
dyaz ide</w>
dur ing,</w>
dur ations</w>
dur ation:</w>
drug- eluting</w>
drug s-induced</w>
drug 's</w>
drug '
drug' .</w>
drowsin ess.</w>
dro pped</w>
dro p-out</w>
dro p,</w>
drin k</w>
draw n</w>
draw back</w>
dras tically</w>
dras tic</w>
dram atic</w>
dra parinux,</w>
down- regulation</w>
down- regulation.</w>
down stream</w>
down regulates</w>
down regulated</w>
down ,</w>
dow n</w>
double-bl inded</w>
double- immunolabeling</w>
double- ar
double-ar med</w>
double -</w>
dou bl
doubl ed</w>
dose- intensity</w>
dose- dependent,</w>
dose- comparison</w>
dose- and</w>
dose :</w>
dos ing).</w>
dor somedial</w>
dopamine- mediated</w>
dopamine- lesion</w>
dopamine- beta-
dopamine-beta- oxidase</w>
dopamine- antagonistic</w>
dopa -
dopa- estrogen</w>
dop amine.</w>
donor s.</w>
donor .</w>
donor -
donor- derived</w>
don ors</w>
don ation.</w>
don a</w>
domin ance</w>
dom peridone</w>
dom .</w>
dog :</w>
document ed,</w>
do methacin-induced</w>
do men</w>
do medially.</w>
do mains</w>
dn a</w>
diz ziness</w>
diz ziness,</w>
diz ygotic</w>
diure tics</w>
diure tics.</w>
diure tics,</w>
diure sis</w>
disulfi ram,</w>
disturb ances.</w>
disturb ances,</w>
distingu ish</w>
dist urbed</w>
dist ress</w>
dist ress,</w>
dist racted</w>
dist orted</w>
dist ant</w>
dist ance.</w>
dist ally</w>
disru ption,</w>
displacem ent,</w>
disor ientation</w>
diseas e-like</w>
discrimin ate</w>
discrep ant</w>
discrep ancy</w>
discontinu ous,</w>
discontinu ed.</w>
discontinu ation.</w>
discontinu ation,</w>
discontinu ance</w>
disco vered.</w>
disco id</w>
discharg es</w>
discharg es.</w>
dis ulphide</w>
dis tilled</w>
dis solvable</w>
dis solution</w>
dis solution,</w>
dis sociation</w>
dis sociation.</w>
dis plays</w>
dis playing</w>
dis parity</w>
dis mutase,</w>
dis missed.</w>
dis kinesia.</w>
dis integrin</w>
dis integrations</w>
dis inhibition</w>
dis figuring</w>
dis appoint
disappoint ing</w>
dis appear
disappear ing</w>
dis advantages</w>
direc tion</w>
direc t-acting</w>
dinit rate</w>
dinit rate.</w>
din ecarboxamide)</w>
dimorph ism</w>
dimin ished,</w>
dimethyl propranolol),</w>
dimethyl hydrazine</w>
dimethyl -</w>
dil uted</w>
diisopropyl phosphorodiamidofluoridate),</w>
diisopropyl fluorophosphate</w>
dihydro uracil</w>
dihydro ergocryptine</w>
difficult y</w>
difficult -to-
difficult-to- treat</w>
difficul ties,</w>
differenti ate</w>
differenc es.</w>
differenc es,</w>
differen tly</w>
differen tially</w>
differen t.</w>
differen ce,</w>
diff usely</w>
diff ers</w>
diff er.</w>
diethylstilbestro l.</w>
diethyl amino
diethylamino )
diethylamino) ethyl</w>
diet s,</w>
didan osine.</w>
dichloro -2,2,2-trifluoroethane</w>
dic lofenac.</w>
diar rhoea,</w>
diar rhea,</w>
diame ter,</w>
dialy zer;</w>
diagnos ing</w>
diagno sed;</w>
diagno sed.</w>
diabet es:</w>
dia phragmatic</w>
di verse</w>
di verging</w>
di ps</w>
di plopia</w>
di phosphate</w>
di phenylacetoxy-N-methylpiperidine</w>
di opathic</w>
di oidomycosis.</w>
di methyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl)</w>
di methoxy-4-ethyl-B-carboline-3-carboxylate</w>
di luent</w>
di ligent</w>
di lemmas</w>
di gitized</w>
di e</w>
di dat
didat es</w>
di d,</w>
di azepam,</w>
di ari
diari es,</w>
di acetate</w>
di -
di- o-tolylguanidine</w>
dex-H T.</w>
dex-H T).</w>
dex .</w>
dex -treated</w>
dex ),</w>
develop s</w>
develop ment;</w>
develop .</w>
determin ant</w>
determ ined,</w>
deterior ation,</w>
deterior ated</w>
deteri otation</w>
detect able.</w>
detect able,</w>
detect ,</w>
detail s</w>
detail ing</w>
det rusor</w>
det ection,</w>
design ated</w>
describe d;</w>
des ogestrel</w>
des min</w>
des at
desat uration</w>
des -
des- Arg
des-Arg 10
des-Arg10 HOE</w>
dermati tis</w>
dermati tis,</w>
dermat omes</w>
dermat ologic</w>
derivati ves</w>
derivati ves.</w>
derivati ve.</w>
der ang
derang ements</w>
depress ant-induced</w>
depress ant
depressant -like</w>
depres sions</w>
depres sion:</w>
depres sion-inducer</w>
depres sion)</w>
depres s</w>
depos its.</w>
depos ited</w>
depolar ization</w>
deple tor,</w>
deple tion)</w>
depend s</w>
depend ently.</w>
depend ency.</w>
depend ence.</w>
depend ed</w>
depart ment,</w>
dent ate,</w>
dend rin,</w>
den sities</w>
den sely</w>
den sed</w>
den se</w>
den ied.</w>
den ial</w>
demonstrat ed.</w>
demonstrat ed,</w>
demon stration</w>
demio logical</w>
dem and</w>
deline ated</w>
deline ated.</w>
deli rium,</w>
deli rium)</w>
del toid</w>
del ay.</w>
del ay
delay ed.</w>
dehydrogen ase,</w>
degre es.</w>
deform ities,</w>
defin itely</w>
defin ing</w>
deficit s.</w>
deficit .</w>
defici ency,</w>
defer oxamine,</w>
defect s:</w>
defect s,</w>
defect s),</w>
defect .</w>
defect ).</w>
def ovir</w>
def erens</w>
def end</w>
def ecate,</w>
decreas ed;</w>
decreas ed,</w>
decreas e,</w>
deci sion</w>
deci be
decibe ls.</w>
dec onvolution</w>
dec ompression</w>
dec ompensated</w>
dec hallenge,</w>
dec ayed</w>
dec arbox
decarbox ylase</w>
dec ade</w>
debriso quine/sparteine</w>
deb ated.</w>
death s.</w>
death s,</w>
deal t</w>
deal ing</w>
deaf ness</w>
deaf ening,</w>
de vice</w>
de quate</w>
de myelinating</w>
de liver</w>
de leted</w>
de hydration</w>
de gradation</w>
de generated</w>
de ad</w>
de activation,</w>
de activated</w>
de activ
deactiv ations,</w>
de )</w>
days ;</w>
day time,</w>
day <
day< 10,</w>
day )</w>
day ).</w>
datab ase</w>
datab ase.</w>
datab ase,</w>
dat e,</w>
dang erous</w>
dang er</w>
dan azol
danazol .</w>
dan az
danaz ol</w>
dam s.</w>
dam pens</w>
dam aging</w>
dam ages</w>
dam ages.</w>
da unorubicin</w>
da iry</w>
dP/dtej c)</w>
dP .</w>
d- on.</w>
d- amphetamine</w>
d- amphetamine,</w>
d- 1</w>
d- 1)</w>
d one,</w>
d ing.</w>
d ging</w>
d ence</w>
d en.</w>
d ds</w>
d ark
dark ness</w>
d ant</w>
d actin
dactin omycin</w>
d P)</w>
cytot oxicity,</w>
cytostatic s.</w>
cytostatic s,</w>
cytos ol</w>
cytoly tic</w>
cytoly tic)</w>
cyto static</w>
cyto protective.</w>
cyto protection</w>
cyto plasm</w>
cyto penia.</w>
cyto pathy?</w>
cyto metry.</w>
cyto logy</w>
cyto kines.</w>
cyto ch
cytoch rome-P450</w>
cyto architect
cytoarchitect ural</w>
cyt osine</w>
cyclospor ine-</w>
cyclospor in,</w>
cyclophosphamide .</w>
cyclophosphamide -related</w>
cyclophosphamide -pretreated</w>
cyclophosphamide -based</w>
cyclohe ximide-induced</w>
cyclo oxygenase-2</w>
cycl es,</w>
cyc lopentyl</w>
cyc le.</w>
cyan osis.</w>
cyan ide</w>
cyan amide.</w>
cyan amide,</w>
cy te</w>
cy steine,</w>
cy proterone</w>
cur ves.</w>
cult ure.</w>
cu tis</w>
cu itry</w>
cryst al
crystal in,</w>
cross- reactivity</w>
cross- reactivities</w>
cross- reacting</w>
cross- react</w>
cross- over</w>
cross- linking</w>
cross matching</w>
cross link</w>
cros s</w>
criter ia,</w>
criter ia)</w>
cri stae)</w>
cri bed</w>
cre ening</w>
cre ative</w>
cre ation</w>
cr ucial</w>
cow s;</w>
covor in</w>
counter parts.</w>
coun ty</w>
coun ts.</w>
coun tries.</w>
coun ted</w>
coun t,</w>
cou pling</w>
cost- savings</w>
cost s,</w>
cost );</w>
corticosteroid s:</w>
cortico striatal</w>
cortico id.</w>
cortic es</w>
cortic es.</w>
correspon ds,</w>
correspon dence</w>
correspon d</w>
correl ations</w>
correl ation.</w>
correl ated,</w>
correc tion</w>
correc ted</w>
correc table</w>
corne al</w>
corne a,</w>
cord ingly,</w>
cord ance</w>
cor puscular</w>
cor nu.</w>
convul sions;</w>
convul sions,</w>
convul sion</w>
convul se</w>
conver sion.</w>
conver sely</w>
control s)</w>
control led-release</w>
control ).</w>
contri butions</w>
contrast s</w>
contrast ed</w>
contrast -enhanced</w>
contracep tive,</w>
contracep tion,</w>
contrac tures,</w>
contrac ture.</w>
contrac tion</w>
contrac tile</w>
contra indicated</w>
contr al
contral ateral</w>
continu ously.</w>
continu ous,</w>
continu es</w>
continu ation</w>
continu ance</w>
contin ence</w>
cont ext</w>
cont ention</w>
cont ains</w>
consum ers</w>
constric tion.</w>
constric tion,</w>
constitu tively</w>
constitu tive</w>
constitu ent</w>
constip ation</w>
consti tuted</w>
consti pation.</w>
const ellation</w>
consist s</w>
consider ing</w>
consider ations.</w>
consider able</w>
consequ ently</w>
consequ ent</w>
consequ ences.</w>
consec utively</w>
consci ous,</w>
conn ective</w>
conn ection</w>
conjunc tivitis</w>
conjunc tiva</w>
coni ine-treated</w>
coni ine-induced</w>
coni 's</w>
congenit a</w>
congenit a.</w>
cong estion.</w>
confounder s.</w>
confounder s,</w>
confoun ding.</w>
confir matory</w>
conf used</w>
conf ocal</w>
conf ined</w>
condi tions:</w>
condi tioning</w>
condi tion,</w>
concomit antly,</w>
concer n</w>
concentr ations,</w>
concentr ation-
concentration- blood</w>
concentr ation
concentration s:</w>
concent ric</w>
con vincing</w>
con venient</w>
con sent</w>
con sensus,</w>
con gestants,</w>
con genital</w>
con fusion.</w>
con formed</w>
con figuration</w>
con densed</w>
con cordance</w>
con ce
conce al
conceal ed</w>
compul sive</w>
compon ent.</w>
compon ent,</w>
complic ations,</w>
complete ly,</w>
comple x-mediated</w>
compl ished</w>
compl aining</w>
compl a
compla ints</w>
compens ation</w>
compens ated</w>
compart ments</w>
compart mentalized</w>
compart ment.</w>
compar ison,</w>
compar atively</w>
compa res</w>
comp rises</w>
comp etitive,</w>
communic ation</w>
communic ation.</w>
communic ated</w>
common ly,</w>
comm encing</w>
combin ation.</w>
combin ation,</w>
combin ation
combination -induced</w>
comat ose</w>
com promising</w>
com promise,</w>
com pression</w>
com pressed</w>
com prehensive</w>
com position</w>
com posed</w>
com patible</w>
com orbidities</w>
com modation</w>
com ment</w>
com b
comb ating</w>
com a
coma '
coma' ,</w>
collicul us,</w>
coll ecting</w>
coll ected,</w>
coll ater
collater al-
collateral- CA1</w>
coll ap
collap sed.</w>
coli tis,</w>
coid an
coidan -treated</w>
cohort s.</w>
cohort .</w>
cogniti ve-enhancing</w>
cogniti ve,</w>
coerul eus.</w>
cochle a.</w>
cocaine- kindled</w>
cocaine- injected</w>
cocaine- abusing</w>
coca ine;</w>
coca ine-</w>
coca ine's</w>
coc ci
cocci dioidomycosis.</w>
coag ulated</w>
co-trimox azole.</w>
co- treatment</w>
co- primary</w>
co- morbidity</w>
co- morbidity,</w>
co- infection:</w>
co- agonist</w>
co st.</w>
co re.</w>
co pies/ml,</w>
co localized</w>
co lloid-osmotic</w>
co incident</w>
co il.</w>
co herence</w>
co existed</w>
co enzyme</w>
co asse
coasse mble</w>
co arsen
coarsen ing</w>
co al</w>
clozap ine-treated</w>
clozap ine,</w>
clozap ine),</w>
clos ed</w>
clonidine- suppressible</w>
clonidine- like</w>
clonid ine-induced</w>
clon us,</w>
clon es</w>
clon es.</w>
clomiphen e</w>
clomiphen e-induced</w>
clo t</w>
clinici an</w>
clinici an-
clinician- assessed</w>
clinic opathologic</w>
clinic o-pathological</w>
clin ically,</w>
clim ati
climati zation</w>
cli p</w>
cli ent</w>
clear .</w>
claudic ation.</w>
claudic ation,</w>
classi fications,</w>
classi fication</w>
clas s,</w>
clar ification.</w>
cl usion</w>
cl umsiness</w>
cl ues,</w>
cl ubs</w>
cl es,</w>
cl aimed</w>
citalo pram.</w>
cit onin</w>
cisterna e</w>
cisterna e.</w>
cisterna e,</w>
cisplat inum,</w>
cisapri de,</w>
cisapri de)</w>
cis- N-
cis-N- [2-(3,4-dichlorophenyl)ethyl]-
cis-N-[2-(3,4-dichlorophenyl)ethyl]- 2-
cis-N-[2-(3,4-dichlorophenyl)ethyl]-2- (1-
cis-N-[2-(3,4-dichlorophenyl)ethyl]-2-(1- pyrrolidinyl)cyclohexylamine).</w>
cirrho sis.</w>
circumst anti
circumstanti al,</w>
circumst ances,</w>
circum flex</w>
circum ference</w>
circ le</w>
cir cular</w>
cir cuitry</w>
cir cles,</w>
ciprofloxac in:</w>
ciprofloxac in.</w>
cing ulate</w>
cinacalce t,</w>
chron ology</w>
chromat ography</w>
chromat ography,</w>
choriocarc inomic</w>
choriocarc inoma.</w>
chor ioretinal</w>
chor ionic</w>
cholinergic s.</w>
cholinergic s)</w>
cholin olytic</w>
cholec ystectomy</w>
chol ine</w>
cho w.</w>
cho sen</w>
cho roid</w>
cho osing</w>
cho ice</w>
cho ice.</w>
cho constriction.</w>
cho an
choan al</w>
chlorofluorocarb ons.</w>
chloro ethyl)-1-nitrosourea),</w>
chloro acetaldehyde</w>
chloro -2,2,2-trifluoroethane</w>
chloro -1
chloro-1 ,
chloro-1, 2,2,2-
chloro-1,2,2,2- tetrafluoroethane</w>
chlor promazine</w>
chlor hexidine-digluconate</w>
chlor amb
chloramb ucil</w>
chic k.</w>
chew ing</w>
chemotherapy- treated</w>
chemotherapy- responsive</w>
chemotherapy- naive</w>
chemo therapies.</w>
chemo prevention</w>
chemist ries</w>
characteris tics:</w>
characteris tics.</w>
characteris tics,</w>
characteris e</w>
channe ls,</w>
channe l.</w>
chang es:</w>
chang ed.</w>
challeng ing</w>
challeng ing.</w>
challeng e,</w>
ch oreoathetoid</w>
ch onic</w>
ch ondroitinase</w>
ch ild</w>
ch ild.</w>
ch es</w>
ch ar
char coal</w>
ch ance</w>
ch amb
chamb er</w>
ch ain</w>
ch ain
chain ,</w>
ch a
cha perone</w>
ch -to-
ch-to- bed
ch-to-bed side</w>
ch )</w>
cess ory</w>
cess (R
cess(R )</w>
certain ly</w>
certain ly,</w>
cerebro spinal</w>
cerebro cortical</w>
cerebell um.</w>
cer vix</w>
cer ns</w>
cephaloth in</w>
cephaloth in-gentamicin</w>
cephalospor ins</w>
cephalospor ins,</w>
cephalospor in</w>
cephalospor in-induced</w>
cephalospor in,</w>
cephalo pathy</w>
centr e</w>
centr al-
central- c
central-c ity</w>
centr al
central )</w>
cent rilobular</w>
cent er.</w>
cellulo se.</w>
cellulo se,</w>
cell s'</w>
cell ing</w>
cefazed one.</w>
cefazed one)-treated</w>
ceas ing</w>
ce rebrum</w>
ce ived</w>
caus es.</w>
caus ative</w>
caus ality</w>
caud ate</w>
caud ate.</w>
cau tion,</w>
cau domedially.</w>
catheter ized</w>
cathe ter.</w>
catechol amines,</w>
cataract s</w>
catarac togenic</w>
catarac t</w>
catalepsy :</w>
catalepsy .</w>
catal ase</w>
cat s.</w>
cat aly
cataly tic</w>
cat abol
catabol ism.</w>
cas pase</w>
cas es/person-years</w>
cas e.</w>
cas ca
casca de,</w>
cas c
casc ade</w>
careful ly.</w>
cardiomy ocytes</w>
cardiomy ocytes.</w>
cardio version</w>
cardio version.</w>
cardio vascularly</w>
cardio megaly,</w>
cardi otoxic</w>
cardi ology</w>
cardi ologic</w>
carcinogen s</w>
carcinogen -treated</w>
carcinogen ,</w>
carcino ma:</w>
carcino genicity</w>
carcino genic</w>
carcino genesis</w>
carcin ostatics</w>
carbox ylic</w>
carbol ine-induced</w>
carbidopa /
carbidopa/ levodopa</w>
carbidopa -
carbidopa- levodopa</w>
carbamazep ine-induced</w>
carbamazep ine,</w>
carbam ylcholin';</w>
carbach ol.</w>
carb onic</w>
carb onate</w>
car tilage,</w>
car sinom)</w>
car ry</w>
car ies</w>
captopri l.</w>
capsul es.</w>
capsul es,</w>
capsa icin-untreated,</w>
cap ture</w>
cap illaries</w>
cap ecitabine:</w>
canc ers:</w>
canal icular</w>
can didates</w>
camer a</w>
camer a.</w>
call s</w>
calcul i.</w>
calcineur in-based</w>
calcific ation.</w>
calci um-dependent</w>
calc ulation</w>
calc ified</w>
cal losum</w>
cal losal</w>
cal ibrating"</w>
cal endar</w>
cal e.</w>
ca uda</w>
ca re;</w>
ca re.</w>
ca inamide-induced</w>
cTn T,</w>
c ryptogenic</w>
c ryoprecipitate,</w>
c rescents</w>
c rescents,</w>
c raniotomy</w>
c ramps</w>
c or</w>
c on</w>
c lopidogrel.</w>
c leavage</w>
c ited</w>
c ents</w>
c ent.</w>
c ation
cation ic</w>
c ame</w>
c ages</w>
c ages.</w>
c age.</w>
c DNA</w>
c B
cB yJ</w>
c 99
c99 m-Sestamibi</w>
c .</w>
c ,</w>
butam ol</w>
but yrylcholinesterases</w>
busulf an-induced</w>
bur ying),</w>
bur den</w>
bumetan ide</w>
bumetan ide,</w>
bul b,</w>
buff ering</w>
buff er.</w>
bu te,</w>
bu ild-up</w>
bu d</w>
bu b
bub ble</w>
bronch ospasm</w>
bronch orrhoea,</w>
bronch odilating</w>
bronch itis</w>
bronch io-alveolar</w>
bron choconstriction.</w>
bromo -1-
bromo-1- chloro-2,2,2-trifluoroethane</w>
brom peridol</w>
brom peridol.</w>
brom ide,</w>
broad ly</w>
bro aden
broaden s</w>
bro ad</w>
brief ,</w>
bri dging</w>
breath s.</w>
bre eder</w>
bre ast
breast ,</w>
bre aking</w>
bre ak</w>
bre ak
break s),</w>
bran ching</w>
bran ches</w>
bran ch</w>
brain- dissociated</w>
brain- barrier</w>
bradykin in,</w>
bradykin in).</w>
bradyarrhythmi as.</w>
bradyarrhythmi as
bradyarrhythmias ;</w>
brady arrhythmic</w>
bra instem,</w>
br ush</w>
br inging</w>
both ;</w>
both ).</w>
border line</w>
bor ns</w>
bor e</w>
body weight</w>
bodi es,</w>
bo ys</w>
bo osted</w>
blu e</w>
blu e.</w>
blood- brain-barrier</w>
block s</w>
block ing.</w>
block er.</w>
block ed.</w>
blo tting</w>
blo t</w>
blo t.</w>
ble omycin,</w>
ble eding.</w>
ble ed,</w>
bladder s.</w>
bladder ,</w>
blac k</w>
blac k-and-white</w>
bl inding</w>
bl an
blan ching</w>
bit ter</w>
bisphosph onates</w>
bis benzyliso
bisbenzyliso quinoline</w>
bis -
bis- (2-
bis-(2- chloroethyl)-1-nitrosourea),</w>
biosyn theses,</w>
biopsy -
biopsy- proven</w>
biopsy )</w>
biopsy ).</w>
biopsies ).</w>
biopsies ").</w>
biopsi es)</w>
bioavail ability</w>
bioavail ability,</w>
bio tic-associated</w>
bio logical,</w>
bio feedback,</w>
bin d</w>
bin .</w>
biliru bin.</w>
bilater al.</w>
bicuc ulline</w>
bicuc ulline,</w>
bic yclo-orthobenzoate)</w>
bi weekly</w>
bi ventricular</w>
bi otransformation</w>
bi ol.</w>
bi -
bi- SPEC
bi-SPEC T
bi-SPECT /
bi-SPECT/ dobutamine</w>
betaxo lol</w>
betaxo lol)</w>
betal ol</w>
beta-CC M</w>
beta-CC M),</w>
beta- thalassemic</w>
beta- thalassemia</w>
beta- pregnan-20-one)</w>
beta- methyl-5alpha-pregnan-20-one)</w>
beta- hCG</w>
beta- estradiol</w>
beta- crystalin,</w>
beta- carboline-induced</w>
beta- carboline-3-carboxylate</w>
beta- blockers,</w>
beta- adrenoceptor</w>
beta- adrenocept
beta-adrenocept or-mediated</w>
beta =
beta= 0.49,</w>
bet es</w>
bet ami
betami metic</w>
bes ylate,</w>
bes art
besart an</w>
ber ries</w>
bepridil .</w>
bepridil )</w>
benzylpenicillo yl-poly-L-lysine</w>
benzylpenicillo ate,</w>
benzyliso quinolinium</w>
benzyl thiouracil.</w>
benzyl penicillin</w>
benzodiazepin es.</w>
benzodiazepin es,</w>
benzodi azepine</w>
benzo [
benzo[ a
benzo[a ]-
benzo[a]- pyrene</w>
benz enesulfonyl-7-(4-methyl-piperazin-1-yl)1H-indole)</w>
benz ene</w>
bene fited</w>
ben ign,</w>
ben ch-to-bedside</w>
beli eved</w>
beli eve</w>
beli ef</w>
behavior al,</w>
behavior :</w>
behavio urs.</w>
behavi orally</w>
beg in</w>
beg an</w>
befo re.</w>
bed time</w>
bec omes</w>
beat s/min.</w>
beat ing,</w>
beat -to-
beat-to- beat</w>
be yond</w>
be st-known</w>
be low</w>
be it</w>
be ings</w>
basel ine,</w>
bas ophilic</w>
barrier ;</w>
barrier /
barrier/ density</w>
bal anced</w>
bal ance</w>
bal ance.</w>
bacter ia.</w>
backgroun ds</w>
bac kcrossing,</w>
b y-product</w>
b viously,</w>
b rown</w>
b rought</w>
b reath</w>
b pm.</w>
b ox.</w>
b ouncing</w>
b ought</w>
b ott</w>
b one,</w>
b ingeing</w>
b inding.</w>
b bott</w>
b ath
bath ing</w>
b ase</w>
b aro
baro receptors.</w>
b are</w>
b ar</w>
b anned</w>
b and</w>
b allistic</w>
b ad</w>
b a
ba sic</w>
b .</w>
azol amide-induced</w>
azol am
azolam -induced</w>
azithrom ycin.</w>
azithrom ycin-induced,</w>
azepam -
azepam- ,</w>
azath ioprine.</w>
az idothymidine-induced</w>
ax ol;</w>
ax is.</w>
awa iting</w>
aw ful);</w>
aw aking</w>
aw ake</w>
aw ake,</w>
avoid ance,</w>
avoid able</w>
avoid .</w>
aver ine</w>
aver aged</w>
avail ability</w>
av oided.</w>
av an,</w>
autoimmun ity,</w>
autoimmun ity),</w>
auto psy;</w>
auto antibody-positive</w>
aut oradiographic</w>
augment ed</w>
augment ation</w>
aug ments</w>
aug ment</w>
audio genic</w>
audi ological</w>
aud i</w>
au )</w>
au ).</w>
atypic als,</w>
atypic al
atypical '</w>
attri bute,</w>
attenu ating</w>
attenu ates</w>
atten tion,</w>
atten ding</w>
atten dant</w>
atten d</w>
attempt ing</w>
attem pted</w>
attac ks</w>
attac k:</w>
att aining</w>
att ained</w>
atro pine.</w>
atro phy.</w>
atro genically</w>
atri um</w>
atri o-ventricular</w>
atri a</w>
atri a.</w>
atrac urium-related</w>
ator ies,</w>
atis faction</w>
ation ).</w>
atherosclero sis,</w>
ath letes</w>
ath ioprine</w>
atazanavi r.</w>
atax ic</w>
atax ia</w>
atax ia.</w>
at ypia</w>
at ures</w>
at ure</w>
at ubular</w>
at titude</w>
at terns</w>
at resia</w>
at omical</w>
at mospheric</w>
at m,</w>
at ins</w>
at ever</w>
at encies</w>
at ab
atab ase</w>
at .</w>
at -
at- risk</w>
asyst ole</w>
asyst ole.</w>
asymptom atic.</w>
asym metric</w>
astrocyto mas</w>
astrocyto mas,</w>
astrocy tic</w>
astrocy tes.</w>
astro glial</w>
asteri xis.</w>
ast ric</w>
ast ly,</w>
ast er</w>
assum ption</w>
associ ation,</w>
assi um</w>
assess ments</w>
assess ing</w>
assess able</w>
ass uringly,</w>
ass ayed</w>
ass a
assa ults</w>
aspi rin.</w>
aspi rin)</w>
aspi rin's</w>
aspi rated</w>
aspart ate,</w>
asp ect</w>
ash ington</w>
as urements</w>
as opressor</w>
as d</w>
as cribed</w>
aryn goscopy</w>
arthrogrypo sis</w>
arthrogrypo sis.</w>
arthrogrypo sis,</w>
arth ralgias/myalgias</w>
arteriol es</w>
arteriol es,</w>
arterio pathic</w>
arterio graphy</w>
arteri es,</w>
arteri al,</w>
arter y,</w>
arter ies</w>
arrhythmi as,</w>
arrhyth mia:</w>
arrhyth mia,</w>
arrest ed</w>
arrest .</w>
aro used</w>
aro usal</w>
aro usal.</w>
aro se</w>
armaceu ticals)</w>
arm rest</w>
ark ers</w>
ari ses</w>
ari piprazole)</w>
arg yrophilic</w>
arg inine-nitric</w>
are a,</w>
architect ure,</w>
arc uate</w>
aran jo</w>
ar thel</w>
ar t.</w>
ar ms</w>
ar ms.</w>
ar m.</w>
ar ising</w>
ar ise</w>
ar avan,</w>
ar )</w>
aprotin in.</w>
aprotin in,</w>
apraclon idine.</w>
apraclon idine-treated</w>
approach es,</w>
approach .</w>
appro ved</w>
appoint ments</w>
appoint ment</w>
applic ations</w>
applic ation,</w>
applic able,</w>
appeti te-suppressants</w>
appear ances</w>
appear ances,</w>
appear ance,</w>
appea red.</w>
apparat us.</w>
app ly</w>
app iness</w>
apo morphine.</w>
apne a.</w>
apne a,</w>
aph eresis.</w>
ap topril)</w>
ap sone-associated</w>
ap position,</w>
ap pendage</w>
ap onidine</w>
ap averine</w>
ap art.</w>
anxio genic</w>
anxio genic-</w>
anxi olysis</w>
antioxid ant,</w>
antidepress ants,</w>
antidepress ant-induced</w>
anticonvuls ants.</w>
anticonvuls ant
anticonvulsant s),</w>
anticipat ed,</w>
antibody -mediated</w>
antibio tic,</w>
anti-HB s,</w>
anti-HB c,</w>
anti- nuclear</w>
anti- dementia</w>
anti- arrhythmic</w>
anti- amnesic</w>
anti- MP
anti-MP O</w>
anti- CN</w>
anti tumour</w>
anti thrombotic</w>
anti thrombosis</w>
anti sympathetic</w>
anti proliferative</w>
anti phospholipid</w>
anti oxidative</w>
anti muscarine-induced</w>
anti microbial</w>
anti luminal</w>
anti inflammatory</w>
anti hyperalgesia</w>
anti globulin</w>
anti gen-positive</w>
anti gen,</w>
anti estrogenic</w>
anti epileptogenic</w>
anti diuretic</w>
anti convulsive</w>
anti convulsants</w>
anti coagulation,</w>
anti coagulated</w>
anti cholinergics.</w>
anti -HIV</w>
anthracycl ine</w>
anthracycl ine.</w>
anthrac yclines,</w>
antagonist .</w>
antagon izes</w>
ant ecubital</w>
ant adine</w>
another .</w>
anomal y</w>
anomal y,</w>
anomal ies.</w>
anom aly
anomaly :</w>
ano rectics,</w>
anim al.</w>
angiotens in-releasing</w>
angiograph y,</w>
angiograph ically</w>
angio poetin-2</w>
angio plasty,</w>
angio pathy</w>
angio pathic</w>
angio grams</w>
angio gram.</w>
angio degeneration</w>
angin a.</w>
angi oneurotic</w>
ang le-closure</w>
aneurys mal</w>
aneurys m.</w>
aneur ymal</w>
anesthesia :</w>
anesthe tize</w>
anesthe tics</w>
anesthe tics.</w>
anesthe tic-induced</w>
anem ia?</w>
anem ia:</w>
ane ously,</w>
ane ),</w>
andom ized,</w>
and- Re
and-Re sistant</w>
and all
andall -
andall- S
andall-S elitto.</w>
analys ing</w>
analy tical</w>
analy ser,</w>
analy sed.</w>
analogu e).</w>
analogu e),</w>
analo gs</w>
analgesic s,</w>
analgesic -induced</w>
analgesic ,</w>
analge sia.</w>
anaesthe tized</w>
anaesthe tist</w>
anaesthe tised</w>
ana x</w>
ana phylaxis,</w>
ana emia</w>
ana emia.</w>
ana emia,</w>
an- Wistar</w>
an tegrade</w>
an orexia,</w>
an ophthalmia</w>
an nually.</w>
an ish</w>
an atomical</w>
an )</w>
ampl ifier</w>
ampl ified</w>
amphoter icin.</w>
amphoter icin,</w>
amphetam ine;</w>
amoxif en</w>
amoxicill in.</w>
amoxicill in-clavulanic</w>
amoun ted</w>
amne sia.</w>
ammon ium</w>
amitriptyl ine.</w>
amiodar one-induced</w>
aminotransfer ase.</w>
aminophen -induced</w>
aminonucleo side,</w>
aminoglyco side</w>
aminoglyco side-related</w>
aminoglyco side-induced</w>
aminoacid uria.</w>
aminoacid uria,</w>
amino- l-methylbutyl)amino]-</w>
amino steroid-based</w>
amino propyl-diethoxy-methyl-phosphinic</w>
amino fluorene</w>
amine 4</w>
amin 1
amin1 A</w>
amin ,</w>
amil oride,</w>
amil -induced</w>
amikac in.</w>
amifost ine,</w>
amifost ine)</w>
amelior ates</w>
amelior ated,</w>
ameli oration</w>
ame ters</w>
ambul ate</w>
amant adine,</w>
amant ad
amantad ine.</w>
am ylase</w>
am ylase,</w>
am sacrine</w>
am ple</w>
am ma-hexachlorocyclohexane</w>
am enorrhea</w>
am -operated</w>
alu minium</w>
altern ations</w>
altern ation</w>
altern ating</w>
alter ing</w>
alter ations.</w>
alpha2ABC- /-
alpha2ABC-/- ).</w>
alpha2-adrenocept ors</w>
alpha2-adrenocept ors,</w>
alpha2- receptor</w>
alpha2- adrenoceptor</w>
alpha2- adrenergic</w>
alpha2- /
alpha2-/ I1-
alpha2-/I1- receptor</w>
alpha-methyl tyrosine</w>
alpha-methyl histamine</w>
alpha-methyl dopa.</w>
alpha-methyl dopa-estrogen</w>
alpha-methyl dopa,</w>
alpha-hydroxy- 3
alpha-hydroxy-3 beta-methyl-5alpha-pregnan-20-one)</w>
alpha- receptor</w>
alpha- pregnan-20-one),</w>
alpha- mediated</w>
alpha- mediated,</w>
alpha- haemolytic</w>
alpha- blocker,</w>
alpha- atrial</w>
alpha- adrenoceptor</w>
alpha- adrenergic</w>
alpha- TA
alpha-TA c</w>
alpha- T</w>
alpha- 1</w>
alpha,beta- methylene</w>
alpha,beta- meATP)</w>
alpha beta-crystalin,</w>
alpha ENaC</w>
alpha 3,</w>
alpha 1</w>
alpha ,</w>
alpha )-
alpha)- methylhistamine,</w>
alpha (1)</w>
alo pecia,</w>
alo id.</w>
allo cortical</w>
allevi ation</w>
allevi ating</w>
allevi ates</w>
allevi ated</w>
allevi ated,</w>
allevi ate</w>
alle gedly</w>
all ucinations</w>
all enge</w>
alk aloid</w>
alk aloid.</w>
alge sic</w>
alfentanil .</w>
alfentanil ,</w>
alfentan il</w>
aler ted</w>
aler t</w>
alendron ate,</w>
aldo sterone-sensitive</w>
alcohol ic.</w>
alcohol -
alcohol- na</w>
alcoh olic</w>
albumin ,</w>
al- constriction,</w>
al though,</w>
al prazolam.</w>
al pebral</w>
al one),</w>
al epsy</w>
al beit</w>
aim s</w>
agricult ure</w>
agricult ural</w>
agoraphob ia.</w>
agoraphob ia,</w>
agonist s,</w>
agonist )</w>
agon ism</w>
agit ation.</w>
agit ation,</w>
aggres sive)</w>
aggres sion;</w>
aggreg ations</w>
aggreg ation.</w>
aggreg ated</w>
aggrav ation.</w>
aggrav ates</w>
aggrav ate</w>
agent s),</w>
age- interaction</w>
age- dependency</w>
age- adjusted</w>
age ous</w>
age ing-induced</w>
age ;</w>
ag ressive</w>
ag ranulocytosis</w>
ag itation</w>
after discharges</w>
afin il</w>
aff ects</w>
aff ective</w>
af tereffects</w>
aesthe tists'</w>
advant ageous</w>
adv ocate</w>
adv ised</w>
adv ise</w>
adv ance</w>
adult s;</w>
adult s:</w>
adult s,</w>
adult :</w>
adult .</w>
adriamyc inone,</w>
adriamyc in,</w>
adrenal ine.</w>
adrenal ectomy,</w>
adren oreceptor</w>
adren ocorticotrophic</w>
adoles cents</w>
administr ation;</w>
administr ation:</w>
administr ation).</w>
administr ated</w>
administ ered,</w>
administ er</w>
adjust ments</w>
adjunc t</w>
adj ust</w>
adi otelemetric</w>
adenocarc inoma.</w>
aden osine.</w>
aden osine-5'-triphosphate</w>
aden oma</w>
aden ohypophyseal</w>
aden ine</w>
ade oxycytidine</w>
ade mic</w>
adduc ts</w>
addic tive,</w>
addic tion</w>
addic tion,</w>
addi tion.</w>
add ressed.</w>
adap tation</w>
ad y</w>
ad vised.</w>
ad versely</w>
ad n</w>
ad mitted.</w>
ad missions</w>
ad d</w>
ad d-on.</w>
acute ly,</w>
acute -
acute- onset</w>
acute "</w>
acu ity.</w>
activi ties,</w>
activ ations</w>
activ ates</w>
activ ated,</w>
act uarial</w>
act s</w>
acro megaloid</w>
acro dermatitis</w>
acri flavine</w>
acri dinecarboxamide)</w>
acitret in-induced</w>
acit retin</w>
acid- transmitted</w>
acid- base</w>
acid osis</w>
acid B</w>
achi eves</w>
acetyl transferase</w>
acetyl salicylate,</w>
acetyl cysteine,</w>
acetyl aminofluorene</w>
acetaminophen -induced</w>
acetaminophen )</w>
acetam ol-associated</w>
acet ylcholinesterases</w>
acet ylcholine-induced</w>
ace to-acetate/3-hydroxybutyrate)</w>
accur ate</w>
accur ate,</w>
accumul ation.</w>
accumul ating</w>
accumben s.</w>
accumben s,</w>
accum ulated</w>
accoun ts</w>
accoun ted</w>
accompan ying</w>
accid entally</w>
accent uated</w>
accent uante</w>
acceler ating</w>
acce ptable</w>
ac upuncture</w>
ac tion,</w>
ac ted</w>
ac ne</w>
ac kward</w>
ac ine's</w>
ac ilitation</w>
ac idic</w>
ac he</w>
ac complished</w>
ac commodation</w>
ac climatization</w>
ac cessory</w>
ac cess.</w>
ac cept</w>
ac ademic</w>
abstin ent</w>
abstin ence.</w>
abstin ence).</w>
absorp tion-limiting</w>
abs cess</w>
abol ished,</w>
abol ish</w>
abnormal ity.</w>
abnormal ity,</w>
abnormal .</w>
abl ation</w>
abl ation,</w>
abdomin al-constriction,</w>
ab users</w>
ab users.</w>
ab used</w>
ab ruptness</w>
ab road</w>
ab rasion</w>
ab normally</w>
ab itual</w>
ab errations</w>
ab domen</w>
aR S-
aRS- 6-
aRS-6- [
aRS-6-[ phosphonomethyl]decahydr</w>
aR S
aRS ,6
aRS,6 SR,
aRS,6SR, 8
aRS,6SR,8 aRS-6-[phosphonomethyl]decahydr</w>
a. m.</w>
a-actin in,</w>
a wian</w>
a vascular</w>
a ura)</w>
a roused.</w>
a re,</w>
a qMan</w>
a phylaxis</w>
a jor</w>
a ine's</w>
a ids</w>
a f</w>
a etiological</w>
a erosol</w>
a effer</w>
a defovir</w>
a betalol</w>
a Cl
aCl (2)
aCl(2) )-induced</w>
] o,</w>
] o)</w>
] I
]I BZ
]IBZ M</w>
] )</w>
] );</w>
[Na ]o,</w>
[Ca ]o)</w>
[3H]- naloxone</w>
[3H]- l-arginine</w>
[3H]- dihydroergocryptine</w>
[3H]- 5-az
[3H]-5-az adeoxycytidine</w>
[2-(3,4-dichlorophenyl)ethyl]- 4-
[2-(3,4-dichlorophenyl)ethyl]-4- methylpiperazine),</w>
[2- methoxy-4-[(methylsulphonyl)amino]phenyl]amino]</w>
[ optical</w>
[ leuprolide</w>
[ [2-methoxy-4-[(methylsulphonyl)amino]phenyl]amino]</w>
[ W
[W HO
[WHO ]</w>
[ SSRI
[SSRI s]),</w>
[ SERCA
[SERCA 2
[SERCA2 ]),</w>
[ SD
[SD ]</w>
[ S
[S I
[SI OP</w>
[ R
[R R
[RR ]</w>
[ Neuro
[Neuro biol.</w>
[ N
[N at.</w>
[ MTX</w>
[ L
[L ys1,</w>
[ IV
[IV A
[IVA ]).</w>
[ H
[H yp3,Thi5,D-Tic7,Oic8]</w>
[ AN
[AN F
[ANF ]</w>
[ A
[A OR
[AOR ]</w>
[ <</w>
[ 95%</w>
[ 8/
[8/ 33
[8/33 ]);</w>
[ 36
[36 %
[36% ]</w>
[ 26</w>
[ 2-</w>
[ 12
[12 3
[123 I
[123I ]IBZM</w>
[ 1.5</w>
[ +/-1
[+/-1 5.
[+/-15. 8]</w>
[ (4-
[(4- amino-l-methylbutyl)amino]-</w>
[ (+/-)-
[(+/-)- PG-9
[(+/-)-PG-9 ]</w>
Zyb an,</w>
Zyb an)</w>
Zy ban</w>
ZO -1
ZO-1 ,</w>
ZDV -induced</w>
ZDV )-induced</w>
ZD s/RDs)</w>
Z onisamide</w>
Z ollinger-Ellison</w>
Z W
ZW /
ZW/ Lac
ZW/Lac J</w>
Z T
ZT -treated</w>
Z .</w>
Z -induced</w>
Y ork</w>
Y PR
YPR E
YPRE N-
YPREN- trial:</w>
Y MD
YMD D)</w>
Y HA)</w>
Y 5
Y5 Y</w>
X3CR 1)</w>
X- ray</w>
X- rats</w>
X imelagatran,</w>
X a</w>
X O),</w>
X :</w>
X -related</w>
X +
X+ HP</w>
Wor king</w>
Withdraw al</w>
Withdraw al-emergent</w>
Wilcox on</w>
Wilcox on's</w>
Wil son's</w>
Wh ole</w>
Wh atever</w>
Wh at</w>
Warfar in-treated</w>
Warfar in,</w>
WS P)</w>
WR2425 11).</w>
W omen</w>
W ashington</w>
W U
WU BR</w>
W P
WP W</w>
W I
WI L
WIL L</w>
W HA
WHA T</w>
W H
WH O</w>
W ES
WES T)</w>
W :</w>
Verap amil-induced</w>
Ven ous</w>
Ven o-occlusive</w>
Vari ations</w>
Vari ant</w>
VVHDF ,</w>
VVHDF ).</w>
VV HD
VVHD F</w>
VTE .</w>
VTE ,</w>
VR T</w>
VR T)</w>
VPA -associated</w>
VPA -
VPA- therapy</w>
VP /
VP/ CP
VP/CP M
VP/CPM .</w>
VP ),</w>
VN B,</w>
VN )</w>
VA :
VA: D
VA:D A)</w>
V igabatrin</w>
V entricular</w>
V ehicle/drugs</w>
V egetarians</w>
V asopressor</w>
V SD</w>
V P)</w>
V II
VII a)</w>
V G)</w>
V FD
VFD S.</w>
V ER
VER ED</w>
V B/
VB/ n</w>
V ,</w>
V ),</w>
Up per</w>
Uni versity</w>
Uni -</w>
Un usual</w>
Un treated</w>
Un til</w>
US ,</w>
US )</w>
UR ES:</w>
UR E:</w>
UR ,</w>
UM-27 2.</w>
UG T</w>
UG T)</w>
UD CA</w>
UD CA)</w>
U- exposed</w>
U- II)</w>
U rotensin-II</w>
U rine</w>
U rgent</w>
U p</w>
U nexpectedly</w>
U ltimately,</w>
U K
UK PD
UKPD RG)</w>
U C</w>
U ;</w>
U )</w>
Twenty- two</w>
Twenty- four</w>
Twenty- five</w>
Tw in</w>
Tri mipramine</w>
Tri fluoroacetyl-adducted</w>
Tri azolam-induced</w>
Treat ments</w>
Treat ment-related</w>
Treat ment,</w>
Tre ated</w>
Tre at</w>
Tran examic</w>
Tor sades</w>
Tor onto</w>
Top con</w>
Toge ther</w>
Tim es</w>
Tim e</w>
Thyro xine</w>
Thyro id</w>
Thyro id-stimulating</w>
Thirty- two</w>
Thirty- six</w>
Thirty- nine</w>
Thirty- four</w>
Th ymus</w>
Th reo-dihydroxyphenylserine</w>
Th ose</w>
Th oracic</w>
Th is,</w>
Th iopentone</w>
Th erapeutic</w>
Test osterone-dependent</w>
Test ,</w>
Tac rolimus</w>
Tac rolimus,</w>
TR(- ))</w>
TR P</w>
TR IS</w>
TR I.</w>
TR )</w>
TNS s</w>
TNS s,</w>
TJ -associated</w>
TIV E-
TIVE- W</w>
TI s</w>
TI O
TIO N</w>
TI MPs)</w>
TI CI
TICI PA
TICIPA NT
TICIPANT S:</w>
TI CE:</w>
TH P.</w>
TH P
THP -1</w>
TH IS</w>
TH C</w>
TG .</w>
TE M</w>
TAM ,</w>
TA K
TAK E</w>
TA B,</w>
TA -
TA- T1</w>
TA ).</w>
T- lymphocytic</w>
T- PCR</w>
T- AL
T-AL F)</w>
T yr6]-VIP</w>
T urkey,</w>
T umor</w>
T romso</w>
T riniol</w>
T riamterene</w>
T ransnational</w>
T ouhy</w>
T otals</w>
T opiramate</w>
T onotopic</w>
T issues</w>
T issue</w>
T incture</w>
T etrandrine</w>
T erbutaline,</w>
T elithromycin</w>
T dP.</w>
T c99m-Sestamibi</w>
T aqMan</w>
T amoxifen</w>
T aking</w>
T X),</w>
T UR,</w>
T O</w>
T MP
TMP ,</w>
T HC
THC ,</w>
T H</w>
T DF
TDF S</w>
T CR,</w>
T C)</w>
T Ac
TAc )</w>
T 4</w>
T 30</w>
T 2</w>
T 1-
T1- weighted</w>
T )-induced</w>
T )-
T)- associated</w>
T ),</w>
System ic</w>
System atic</w>
Syn thesis</w>
Swis s-Webster</w>
Swe den.</w>
Surg ical</w>
Surg ery</w>
Sur vival</w>
Sur vey</w>
Sur prisingly,</w>
Sup pression</w>
Sup port</w>
Sul piride-induced</w>
Subsequ ently</w>
Subsequ ently,</w>
Su xamethonium-induced</w>
Stud y.</w>
Ste ady</w>
St atins</w>
St ates,</w>
St ates)</w>
St age</w>
Sr l-based</w>
Sr l,</w>
Sou theast</w>
Soci al</w>
Six ty</w>
Six ty-seven</w>
Six -</w>
Simvastat inezetimibe</w>
Simvastat in-induced</w>
Simvastat in-ezetimibe-induced</w>
Simult aneously,</w>
Sim vastatin</w>
Sim vastatin,</w>
Sign s</w>
Si rolimus-associated</w>
Si rius</w>
Si gmaST,</w>
Short ly</w>
Short -
Short- latency</w>
Sh in-Poong</w>
Sh am-operated</w>
Sex ,</w>
Sever ity</w>
Sever al</w>
Seventy- three</w>
Seventy- one</w>
Seventy- five</w>
Sestami bi-SPECT/dobutamine</w>
Ser um-</w>
Ser otonergic</w>
Sens ori-motor</w>
Sens ation</w>
Sem istructured</w>
Sem i-structured</w>
Seiz ure-Prone</w>
Se x</w>
Se legiline-induced</w>
Sch izophrenia</w>
Sch aeffer</w>
Sal vage</w>
Sal ine-pretreated</w>
Sal butamol</w>
SUMMAR I
SUMMARI ES:</w>
ST- segment.</w>
ST- T</w>
ST R</w>
ST OP</w>
ST AT
STAT 5</w>
SSRI s.</w>
SSR I</w>
SSR I.</w>
SR, 4
SR,4 aRS,6SR,8aRS-6-[phosphonomethyl]decahydr</w>
SR S,</w>
SR I),</w>
SR 4
SR4 86
SR486 92</w>
SR ,</w>
SR )</w>
SPEC T.</w>
SP ECTIV
SPECTIV E:</w>
SP E)</w>
SOCS- 3</w>
SOCS -1</w>
SN P.</w>
SN P,</w>
SM- IV</w>
SJ L</w>
SJ L,</w>
SG PT
SGPT ,</w>
SG O
SGO T,</w>
SETTING ,</w>
SERCA 2</w>
SE X),</w>
SE M)</w>
SE M).</w>
SE -induced</w>
SE ),</w>
SD H-
SDH- fp).</w>
SD ,</w>
SC r.</w>
SC r,</w>
SC H</w>
SA R</w>
SA G)</w>
SA G
SAG E:</w>
SA ).</w>
S/ M
S/M S).</w>
S/ KS</w>
S- III-
S-III- R</w>
S- (-
S-(- )-
S-(-)- ET-1
S-(-)-ET-1 2
S-(-)-ET-12 6.</w>
S- (+)-
S-(+)- cis-N-[2-(3,4-dichlorophenyl)ethyl]-2-(1-pyrrolidinyl)cyclohexylamine).</w>
S witches</w>
S ulfasalazine-induced</w>
S triatal</w>
S treptomycin</w>
S tratification</w>
S topping</w>
S t.</w>
S quibb</w>
S pread</w>
S poradic</w>
S pecifically,</w>
S pan</w>
S ource</w>
S mall-</w>
S inus</w>
S ide-effects</w>
S equential</w>
S ensitivity</w>
S edation</w>
S creening</w>
S ch</w>
S cale.</w>
S audi</w>
S atisfaction</w>
S Y5Y</w>
S V,</w>
S URE:</w>
S S),</w>
S R</w>
S M</w>
S K
SK F</w>
S IGN
SIGN IF
SIGNIF ICA
SIGNIFICA NCE:</w>
S H-
SH- SY5Y</w>
S C</w>
S BP,</w>
S A,</w>
S .)</w>
S -induced</w>
S -1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]non
S-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]non ane),</w>
S );</w>
S ):</w>
S (
S( h)UV</w>
Ris peridone</w>
Ris ks</w>
Rg 1,</w>
Rever sibility</w>
Rever sal</w>
Ret urn</w>
Respon ses</w>
Respon se</w>
Reser pine</w>
Reser pine-</w>
Res piratory</w>
Repor ts</w>
Repor t</w>
Rep etitive</w>
Ren ally</w>
Rel ative</w>
Rel ationship</w>
Regist er</w>
Regist er,</w>
Reg ular</w>
Recur arization</w>
Reco gnition</w>
Rec ommendations</w>
Rec ently</w>
Rec eiver</w>
Re view</w>
Re plication-competent</w>
Re gional</w>
Re duced</w>
Re bound</w>
Re assuringly,</w>
Re administration</w>
Re active</w>
Re actions</w>
Raniti dine</w>
Raniti dine-induced</w>
RO Is</w>
RESULT (S):</w>
RAM H.</w>
R- wave-to-R-wave</w>
R- R</w>
R- (
R-( alpha)-methylhistamine,</w>
R s,</w>
R s)</w>
R outine</w>
R oberts,</w>
R iyadh,</w>
R itonavir</w>
R habdomyolysis</w>
R esting</w>
R emoval</w>
R emission</w>
R ed.</w>
R c</w>
R are</w>
R andomized,</w>
R andall-Selitto.</w>
R adiotelemetric</w>
R acine's</w>
R T</w>
R T-PCR</w>
R S.</w>
R S,</w>
R R)</w>
R P
RP N.</w>
R N
RN ase</w>
R H-
RH- A)</w>
R EV
REV IE
REVIE W:</w>
R EP
REP ORT
REPORT :</w>
R EL
REL EV
RELEV ANCE</w>
R E
RE AD
READ E
READE R</w>
R D)</w>
R AT
RAT ION
RATION AL
RATIONAL E:</w>
R .,</w>
R -1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]non
R-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]non ane)</w>
R ,
R, 2
R,2 S-(+)-cis-N-[2-(3,4-dichlorophenyl)ethyl]-2-(1-pyrrolidinyl)cyclohexylamine).</w>
R ),</w>
Quanti tative</w>
Quanti fying</w>
Qu estionnaire</w>
QTL s)</w>
QS/Q T,</w>
QS/Q T)</w>
Psych ologists</w>
Psych iatric</w>
Pseudo acromegaly</w>
Pseudo acromegaly,</w>
Pseudo -
Pseudo- allergic</w>
Prote us</w>
Prote omic</w>
Prot ection</w>
Prop ylthiouracil</w>
Prop ylthiouracil-induced</w>
Pro ximal</w>
Pro vocation</w>
Pro ject</w>
Pro cainamide-induced</w>
Pro 2,
Pro2, 5,</w>
Pri apism</w>
Pre viously</w>
Pre parations</w>
Pre operative</w>
Pre clinical</w>
Pre -</w>
Prazos in</w>
Prazos in-induced</w>
Potter -
Potter- type</w>
Potter 's</w>
Pot assium</w>
Post mortem</w>
Po pulation-based,</w>
Po oled</w>
Po isons</w>
Pneumon itis</w>
Pneumon itis,</w>
Phen ylpropanolamine</w>
Phen obarbitone-induced</w>
Pharmacokine tics</w>
Pharmacokine tic/pharmacodynamic</w>
Ph armaceuticals)</w>
Ph arm.</w>
Pg p-enhancing</w>
Perme ability,</w>
Per sistent</w>
Per itubular</w>
Per iodical</w>
Per iodic</w>
Per inatal</w>
Per icarditis</w>
Per hexiline</w>
Per haps</w>
Per ceived</w>
Pati ents'</w>
Pati ent</w>
Path ologically,</w>
Path ological</w>
Partic ular</w>
Park inson</w>
Par tial</w>
Par ameters</w>
Par acetamol-associated</w>
Paclitaxel /cisplatin</w>
Paclitaxel ,</w>
Pa ir</w>
Pa O
PaO 2</w>
Pa CO2</w>
PV ),</w>
PT Z-induced</w>
PT X</w>
PT T),</w>
PT ION:</w>
PT CR
PTCR .</w>
PRL- positive</w>
PR AC
PRAC TICE:</w>
PO SURE:</w>
PO 2</w>
PO -
PO- PL
PO-PL L),</w>
PH NO</w>
PH ,</w>
PG E1-induced</w>
PDT C
PDTC -treated</w>
PD ).</w>
PATIENT S:</w>
PATIENT (S):</w>
PAR gamma</w>
PAR TICIPANTS:</w>
PAN .</w>
PAN ,</w>
PAI -1</w>
PAI -1.</w>
PAI -1)</w>
PAC .</w>
PAC -induced</w>
PAC -containing</w>
PA S</w>
PA M)</w>
PA C</w>
PA .</w>
PA ,</w>
PA ).</w>
P= 0.03
P=0.03 ;</w>
P= 0.01).</w>
P= 0
P=0 .</w>
P< 90
P<90 mmHg)</w>
P< 0.001)</w>
P< 0.001).</w>
P120 T</w>
P- stimulated</w>
P uromycin</w>
P ublished</w>
P rompt</w>
P rinceton,</w>
P ressure</w>
P ractice</w>
P otential</w>
P ost</w>
P ortal</w>
P opulation</w>
P olfa")</w>
P odocyte</w>
P latelet</w>
P ituitary</w>
P imozide</w>
P icloxydine</w>
P ethidine-associated</w>
P ergolide</w>
P enzberg,</w>
P entoxifylline</w>
P atterns</w>
P atency</w>
P ast</w>
P assive</w>
P apaverine</w>
P anax</w>
P alpebral</w>
P U)</w>
P SA</w>
P S.</w>
P R</w>
P PARgamma</w>
P PA.</w>
P MA</w>
P I)</w>
P ER
PER SPECTIVE:</w>
P EG</w>
P CR,</w>
P CP
PCP .</w>
P CA</w>
P C</w>
P C
PC 02</w>
P =</w>
P <0.01)</w>
P <0.0
P<0.0 1),</w>
P 58</w>
P 5
P5 8,</w>
P 4
P4 50
P450 /
P450/ CCl
P450/CCl 4</w>
P 02</w>
P /
P/ O</w>
P +
P+ NX</w>
P (+)</w>
Over all</w>
Organ ophosphate-induced</w>
Organ elles</w>
Org anic</w>
Optim ization</w>
Optim ising</w>
Ophthalmo logy</w>
Ophthalmo logists</w>
Ophthalmo logical</w>
Ophthalmo logic</w>
Op timal</w>
Onco paz</w>
Octreoti de-induced</w>
Octreoti de,</w>
ORT ANCE</w>
OR (adj
OR(adj )</w>
OP s</w>
OP S).</w>
OP AC
OPAC :
OPAC: DA</w>
OP -induced</w>
OP ),</w>
ON )</w>
OLT X,</w>
OC s).</w>
OC F),</w>
OC D</w>
OAE s)</w>
O- methylation</w>
O- inhibited</w>
O variectomy</w>
O ut</w>
O totoxicity</w>
O sterg</w>
O s]</w>
O rthostatic</w>
O phthalmic</w>
O perative</w>
O pen,</w>
O mitting</w>
O mission</w>
O meprazole</w>
O ffspring</w>
O dds</w>
O cular</w>
O bviously,</w>
O X)</w>
O L
OL D)</w>
O F
OF H.</w>
O CD
OCD .</w>
O 2.</w>
O .</w>
O ).</w>
O )-induced</w>
Nor adrenergic</w>
Non pharmacologic</w>
Non hematologic</w>
Nitroprus side-induced</w>
Nitro glycerin</w>
Nitro furantoins</w>
Nitro -
Nitro- L-arginine</w>
Nine ty</w>
Nine ty-nine</w>
Nine teen</w>
Niger ians</w>
Niger ian</w>
New borns</w>
Neuro sci.</w>
Neuro psychological</w>
Neuro psychiatric</w>
Neuro protective</w>
Neuro protection</w>
Neuro plasticity</w>
Neuro inflammation</w>
Neuro image</w>
Neuro filament)</w>
Neuro active</w>
Nephro lithiasis</w>
Neph rin</w>
Ne vertheless,</w>
Ne utropenia</w>
Na+- extrusion</w>
Na+- K+</w>
Na+ /</w>
Na +/
Na+/ K+</w>
Na ),</w>
NS s)</w>
NS Z.</w>
NS AI
NSAI D</w>
NS ),</w>
NRA016 0,</w>
NRA016 0
NRA0160 :</w>
NR )-
NR)- containing</w>
NO S)</w>
NO -induced</w>
NO ,</w>
NMD A-
NMDA- receptor</w>
NM BA</w>
NM BA
NMBA s</w>
NIN CD
NINCD S).</w>
NIN -induced</w>
NI ;</w>
NI ,</w>
NI )-
NI)- based</w>
NF- M</w>
NF -H
NF-H ,</w>
N-pyrimidinyl-2-phenoxyacet amides</w>
N-pyrimidinyl-2-phenoxyacet amide</w>
N-methyl- N-
N-methyl-N- nitrosourea</w>
N-[4-(5-nitro-2-furyl)-2-thiazolyl]-form amide</w>
N-[4-(5-nitro-2-furyl)-2-thiazolyl]-form amide-induced</w>
N- dimethylpropranolol),</w>
N- acetylcysteine,</w>
N umerous</w>
N umber</w>
N uclear</w>
N oxious</w>
N otwithstanding</w>
N ormalizing</w>
N orepinephrine</w>
N ifedipine</w>
N ested</w>
N early</w>
N ative</w>
N aranjo</w>
N ZW/LacJ</w>
N X+HP</w>
N TION</w>
N S)</w>
N J
NJ )</w>
N I</w>
N 4</w>
N ,</w>
N ,
N, 5-
N,5- dimethyl-</w>
N (G
N(G )-
N(G)- nitro-L-arginine</w>
N (6
N(6 )-
N(6)- cyclopentyl</w>
N '-
N'- diisopropylphosphorodiamidofluoridate),</w>
Myocardi tis</w>
Myo pathy,</w>
Myo globinuria</w>
Morph ological</w>
Morph ine/Rg1</w>
Mor ris</w>
Mor ning-dosed</w>
Monit oring</w>
Monit or</w>
Mon keys</w>
Mod est</w>
Mod afinil</w>
Min utes</w>
Min imal</w>
Midazol an</w>
Midazol am</w>
Micro scopic</w>
Micro angiopathic</w>
Mi graine</w>
Mg (2
Mg(2 +
Mg(2+ )-
Mg(2+)- free</w>
Methyl phenidate</w>
Methyl ergonovine</w>
Meth amphetamine-induced</w>
Met amizol</w>
Medic ines</w>
Medic ations</w>
Medi ation</w>
Med ical</w>
Me asurements</w>
Max imum</w>
Max imal</w>
Mar yland,</w>
Mar mara</w>
Man n-Whitney</w>
Man ifestations</w>
Man ia</w>
Mal tolyl</w>
Mal ta.</w>
Mal ignant</w>
Mal awian</w>
Mac ula</w>
Mac rophage-migration</w>
MT X.</w>
MT X,</w>
MRP 2)</w>
MR M),</w>
MR I
MRI ).</w>
MR ,</w>
MR )</w>
MPT ),</w>
MP ORTANCE</w>
MP EP
MPEP ,</w>
MP ),</w>
MMRM ;</w>
MMRM .</w>
MMR M</w>
MMP- TIMP</w>
MMP- 9</w>
MMP- 2</w>
MM T</w>
MM SE.</w>
MM F,</w>
MK80 1.</w>
MK-80 1)</w>
MK-80 1
MK-801 -induced</w>
MK- 4
MK-4 86</w>
MET H.</w>
MET H)</w>
MET H
METH -induced</w>
MEASURE M
MEASUREM ENT
MEASUREMENT S</w>
MEASURE (S):</w>
MEASUR E:</w>
MD MA
MDMA -free</w>
MD M,</w>
MD ,</w>
MD )</w>
MD ),</w>
MC s)</w>
MC M,</w>
MC M),</w>
MA P-induced</w>
MA O-inhibited</w>
MA H
MAH A</w>
MA )</w>
MA ),</w>
M yelosuppression</w>
M utations</w>
M uscle</w>
M unich-Wistar</w>
M ouse</w>
M otor</w>
M orton's</w>
M ontgomery-Asberg</w>
M olecularly,</w>
M ice</w>
M esenchymal</w>
M en</w>
M echanisms</w>
M ature</w>
M arkers</w>
M anic</w>
M ajor</w>
M ain</w>
M S</w>
M S,</w>
M PA,</w>
M P)</w>
M I
MI F</w>
M F
MF )]</w>
M ES
MES SAGE:</w>
M E</w>
M C</w>
M BA
MBA s)</w>
M AC
MAC )</w>
M 4),</w>
M 4
M4 /M
M4/M 1</w>
M 3</w>
M 2,</w>
M 1,</w>
M 0)</w>
M 0
M0 )]</w>
Long -
Long- Ev
Long-Ev ans</w>
Lo w</w>
Lithi um-induced</w>
Lithi um-associated</w>
Lidoc aine</w>
Lidoc aine-induced</w>
Li popolysaccharide</w>
Li pid</w>
Li Cl</w>
Li Cl
LiCl .</w>
Li -pretreated</w>
Li )-induced</w>
Levo dopa</w>
Leu kemia</w>
Leu covorin</w>
Le iden</w>
Le ft</w>
Lac k</w>
Labor atories,</w>
LY2746 14.</w>
LT P.</w>
LT P)</w>
LNa+ LCa</w>
LNa .</w>
LNa ,</w>
LEV E
LEVE L</w>
LEV ,</w>
LEPP 1)</w>
LD L.</w>
LD L-cholesterol</w>
LD H</w>
LD :</w>
LCa .(ABSTRACT</w>
LCa )</w>
LA .</w>
L4- 5</w>
L4- 3
L4-3 Del
L4-3Del ta</w>
L-alpha-glycer ylphosphorylcholine</w>
L-alpha-glycer yl-phosphorylcholine</w>
L-alpha-GF C</w>
L-alpha-GF C)</w>
L-NO Arg
L-NOArg ;</w>
L-NI L
L-NIL ;</w>
L-NAM E,</w>
L-DOPA .</w>
L- dopa.</w>
L- dopa,</w>
L- arginine-nitric</w>
L- Threo-dihydroxyphenylserine</w>
L- R)</w>
L- Dop
L-Dop a</w>
L- 3)</w>
L- 1.</w>
L uke's</w>
L oss</w>
L ong</w>
L one</w>
L ondon</w>
L ittle</w>
L indane</w>
L imited</w>
L ight</w>
L i</w>
L evofloxacin,</w>
L atencies</w>
L ate</w>
L ate,</w>
L astly,</w>
L aryngoscopy</w>
L aryngeal</w>
L abetalol</w>
L S</w>
L L)</w>
L F
LF B,</w>
L E
LE V</w>
L C
LC a,</w>
L AI
LAI R)</w>
L :
L: (W
L:(W I
L:(WI )
L:(WI) WUBR</w>
L 6
L6 /J</w>
L 4</w>
L 3-
L3- L4</w>
L 1210</w>
L .,</w>
Kreb s</w>
Kreb s-Ringer</w>
King dom.</w>
Ke toconazole-induced</w>
KG )</w>
K- variant</w>
K- 80
K-80 1,</w>
K orea)</w>
K indled</w>
K i</w>
K ety-Schmidt</w>
K etamine,</w>
K G</w>
K B
KB R,</w>
K 2
K2 93</w>
K -</w>
K (+)</w>
Jap an</w>
Jap an,</w>
J uly</w>
J s),</w>
J ,</w>
Isoproteren ol</w>
Isoproteren ol-treated</w>
Ir win</w>
Ir reversible</w>
Ir besartan</w>
Inv entory</w>
Intrac erebral</w>
Intrac ellular</w>
Intrac avernous</w>
Intra -
Intra- arterial</w>
Inter view</w>
Inter view.</w>
Inter active</w>
Inter -
Inter- observer</w>
Inte lligence</w>
Insti tutes</w>
Insti llation</w>
Inj ections</w>
Inj ected</w>
Infarc ts</w>
Infarc t-avid</w>
Inf lammatory</w>
Individ uals</w>
Increas ing</w>
Increas e</w>
In tramuscular</w>
In toxications</w>
In tensive</w>
In tense</w>
In take</w>
In patient</w>
In jection</w>
In fluence</w>
In domethacin-induced</w>
In dependent</w>
In correct</w>
In appropriate</w>
Impro vements</w>
Impro ved</w>
Immunohisto chemical,</w>
Immuno localization</w>
Immuno fluorescence</w>
Immun osuppressive</w>
Immun ostaining</w>
Immun ological</w>
Im pression-Sexual</w>
Im potence</w>
Im paired</w>
Im pact</w>
IV I
IVI G</w>
IV )-
IV)- infected</w>
IT T</w>
IT T)</w>
IT S</w>
IT S)</w>
IS T</w>
IS .</w>
ION (S):</w>
INTERVENT ION:</w>
INTERVENT ION(S):</w>
INTERV E
INTERVE NTION</w>
IN WEST)</w>
IN CM
INCM NSZ.</w>
IN :</w>
IN )</w>
IL- 3.</w>
IK r</w>
IK r,</w>
III- V</w>
III- R.</w>
IIE F</w>
IIE F.</w>
IIE F),</w>
II a</w>
II I/
III/ IV</w>
II /
II/ III-V</w>
IGF- IL-3.</w>
IF X.</w>
IE LD:</w>
ID s)</w>
ID E
IDE NCE:</w>
ID ),</w>
IC H.</w>
IC 50</w>
I1- receptors.</w>
I1- receptor-mediated</w>
I1- imidazoline</w>
I-S F;</w>
I-H SA).</w>
I- albumin</w>
I(f )-
I(f)- generating</w>
I(f ),</w>
I stanbul,</w>
I soniazid</w>
I solated</w>
I reland,</w>
I llness</w>
I gA</w>
I fosfamide</w>
I draparinux,</w>
I diopathic</w>
I atrogenically</w>
I U</w>
I PTION:</w>
I P).</w>
I MPORTANCE</w>
I L).</w>
I G
IG N</w>
I F)</w>
I D)</w>
I 1-</w>
I )-induced</w>
Hyper tensive</w>
Hyper tension</w>
Hyper prolactinemia</w>
Hyper baric</w>
Hydro gen</w>
Hydro cortisone</w>
Hydro chlorofluorocarbons</w>
Hy sterosalpingography</w>
Hy pothalamic</w>
Hy potension</w>
Ho e-140</w>
Histo pathology</w>
Histo pathological</w>
Histo pathologic</w>
Hist ology</w>
High ly</w>
High est</w>
High -
High- signal</w>
Hg :</w>
Hg .</w>
Hg )</w>
Hg ),</w>
Hepati c</w>
Hepar in</w>
Hepar an</w>
Hemo globin</w>
Hemo dynamic</w>
Hem olytic</w>
Heal th,</w>
Head ache</w>
Head -up</w>
He redofamilial</w>
He avy</w>
Haem olytic-uraemic</w>
Haem odilution</w>
HPL C</w>
HPL C-
HPLC- mass</w>
HO ME</w>
HO L</w>
HO ),</w>
HE OPS).</w>
HE M-induced</w>
HE K293</w>
HE ,</w>
HD L-cholesterol</w>
HD .</w>
HD ).</w>
HCFC s)</w>
HC l</w>
HC l.</w>
HC a.</w>
HC N4</w>
HC N)</w>
HC ).</w>
HC ),</w>
HBeAg -positive</w>
HBeAg -negative</w>
HBV .</w>
HBV ,</w>
HB sAg,</w>
HB s</w>
H2 O2.</w>
H2 O),</w>
H(3)- receptors.</w>
H z)</w>
H z).</w>
H ounsfield</w>
H ormone</w>
H olter</w>
H ispanic</w>
H ippocampal</w>
H ester,</w>
H epatocyte</w>
H enoch-Schonlein</w>
H b,</w>
H b)</w>
H appiness</w>
H an-Wistar</w>
H allucinations</w>
H abitual</w>
H YPREN-trial:</w>
H VA:DA)</w>
H V</w>
H US</w>
H US,</w>
H U</w>
H T4</w>
H S-induced</w>
H S).</w>
H RH-A)</w>
H R,</w>
H P.</w>
H P+NX</w>
H P)</w>
H L),</w>
H ITT</w>
H FD
HFD E-induced</w>
H D</w>
H Ca
HCa ).</w>
H 3</w>
H 3-
H3- receptor</w>
H 2-
H2- receptors</w>
H .,</w>
H ).</w>
H ),</w>
Gu illain-Barr</w>
Granulo matous</w>
Granulo cyte</w>
Gram- positive,</w>
Gram- negative,</w>
Gra ves'</w>
Gra pe</w>
Gra ded</w>
Glybur ide</w>
Glybur ide-induced</w>
Gly T1</w>
German y).</w>
Ger man</w>
Gen etic</w>
Gen eral</w>
GSPE+ drug</w>
GSPE+ drug.</w>
GSPE 's</w>
GSP E.</w>
GP T</w>
GP T.</w>
GF R.</w>
GF P(+)</w>
GF )</w>
GE M,</w>
GE 1)</w>
GABA- transaminase.</w>
GABA- A</w>
GABA(A ))</w>
GABA .</w>
GABA )</w>
GA IN:</w>
G wardamangia,</w>
G lucocorticoid-induced</w>
G lomerular</w>
G lobal</w>
G lioblastoma</w>
G lasgow</w>
G insenoside</w>
G entamicin</w>
G emcitabine</w>
G eigy</w>
G astric</w>
G aravan,</w>
G amma-hexachlorocyclohexane</w>
G all</w>
G M-induced</w>
G M),</w>
G I</w>
G H</w>
G F</w>
G E1
GE1 )-induced</w>
G D</w>
G C-H
GC-H T</w>
G 20
G20 2
G202 10
G20210 A</w>
G /
G/ VP/CPM.</w>
G .,</w>
Fu coidan-treated</w>
Fran ce</w>
Fran ce.</w>
Forty- two</w>
Forty- three</w>
Forty- six</w>
Forty- four</w>
Fol low-up</w>
Fol ey</w>
Fol ate</w>
Flu oxetine-induced</w>
Flu oropyrimidines,</w>
Flu mazenil</w>
Fisch er-344</w>
Fif ty</w>
Fif ty-two</w>
Fif ty-eight</w>
Fib rous</w>
Fib rin</w>
Fib rillation</w>
Fentan yl,</w>
Fe w</w>
Fe atures</w>
Fan coni's</w>
Fact ors</w>
FL A-
FLA- 63,</w>
FL ):</w>
FK506- nephropathy</w>
FK506- associated</w>
FD E)</w>
FANF T)</w>
FAN )</w>
F- dependent.</w>
F- 344</w>
F uture</w>
F undus</w>
F ragments</w>
F orearm</w>
F lurbiprofen</w>
F lunitrazepam</w>
F low</w>
F lestolol:</w>
F kappaB)</w>
F icoll-Hypaque</w>
F etuses</w>
F aster</w>
F acilitation</w>
F VB/n</w>
F Rs</w>
F Rs,</w>
F IELD:</w>
F I),</w>
F H).</w>
F F</w>
F E
FE AT
FEAT URES:</w>
F D)</w>
F C
FC s).</w>
F <
F< 4
F<4 5%)</w>
F 2</w>
Experim ents</w>
Examin ations,</w>
Ex tracorporeal</w>
Ex tra</w>
Ex plicit</w>
Ex perience</w>
Ex ogenous</w>
Ex clusion</w>
Evalu ations.</w>
Evalu ation,</w>
Ev ents)</w>
Euro pe</w>
Estro gens</w>
Epi thelial</w>
Epi leptic</w>
Epi demiological</w>
Epi demic</w>
Endo thelial-dependent</w>
Endo phthalmitis</w>
End- stage</w>
End- diastolic</w>
En hancement</w>
En cephalopathy</w>
Ell man</w>
Elev ations</w>
Elev ation</w>
Electrocardio graphy</w>
Electrocardio graphic</w>
Electro physiological</w>
Electro physiologic</w>
El ectrical</w>
Eigh ty-nine</w>
Eigh teen</w>
Ecstas y</w>
Ecstas y-specific</w>
EX POSURE:</w>
EX ).</w>
EV IDENCE:</w>
EV 1)</w>
EV )-induced</w>
ET-1 ),</w>
ET )</w>
ES -
ES- D</w>
ES ,</w>
ES ).</w>
EP s)</w>
EP S,</w>
EP O.</w>
EP M</w>
EP ;</w>
ED s),</w>
ED ITS</w>
ED ,</w>
ECG s</w>
ECG -enhanced</w>
ECG ,</w>
EC T</w>
EC E
ECE -1</w>
EC 50</w>
EB FF</w>
EB F.</w>
E403 1.</w>
E403 1,</w>
E40 31</w>
E18. 5</w>
E18. 5,</w>
E13. 5</w>
E13. 5.</w>
E13. 5,</w>
E1 5.
E15. 5,</w>
E- LFB,</w>
E zetimibe</w>
E very</w>
E specially</w>
E s</w>
E s).</w>
E rythema</w>
E pinephrine</w>
E pidural</w>
E picardial</w>
E osinophilic</w>
E mpirical</w>
E ither</w>
E i/ARB</w>
E hrlich</w>
E ating</w>
E MG</w>
E M)</w>
E KG</w>
E I)</w>
E G.</w>
E F</w>
E EG.</w>
E E.</w>
E E)</w>
E D)</w>
E A
EA S</w>
E 2,</w>
E 1)</w>
E -1
E-1 ),</w>
Drug -associated</w>
Doxorub icin-induced</w>
Dorme x</w>
Dorme x.</w>
Dorme x,</w>
Do se-dependent</w>
Dise ases</w>
Dise ase</w>
Dis ulfiram-like</w>
Dis sociated</w>
Dis continuance</w>
Dis .,</w>
Dipyridamol e-thallium-201</w>
Dipyridamol e-induced</w>
Dipyridam ole</w>
Diff usion-weighted</w>
Diff use</w>
Diag nostics,</w>
Dia betic</w>
Dia betes</w>
Di git</w>
Di azepam-,</w>
Dex -treated</w>
Desi pramine</w>
Desi pramine-induced</w>
Des ferrioxamine</w>
Depart ment</w>
Depart ment,</w>
Deli rium,</w>
Del aying</w>
Del ayed</w>
Decreas es</w>
Decreas e</w>
Dec ompression</w>
Dec ember</w>
De termining</w>
De termination</w>
De sign</w>
De pressed</w>
De ficits</w>
De fects</w>
De ep</w>
De ep-tendon</w>
De ath</w>
DSM- III</w>
DSM- III-R.</w>
DO X:</w>
DO X.</w>
DO X-rats</w>
DNR -containing</w>
DNR ,</w>
DN A.</w>
DM S-III-R</w>
DFP- atropine</w>
DFP- atropine,</w>
DFO ,</w>
DFO 's</w>
DF U.</w>
DF U-exposed</w>
DF U,</w>
DF S);</w>
DF P.</w>
DF P,</w>
DF O</w>
DF -I</w>
DESIGN ,</w>
DES IGN</w>
DES CR
DESCR IPTION:</w>
DES -induced</w>
DES -
DES- exposed</w>
DBA/2 J</w>
DBA/2 J,</w>
DAM P)</w>
D4. 7</w>
D4. 4</w>
D4. 2</w>
D4. 2,</w>
D- pen-treated</w>
D- pen,</w>
D- Arg
D-Arg -
D-Arg- [Hyp3,Thi5,D-Tic7,Oic8]</w>
D- 6
D-6 8,</w>
D ysfunction</w>
D ysexecutive</w>
D upuytren's</w>
D rowsiness</w>
D izziness</w>
D imensions</w>
D iclofenac</w>
D etails</w>
D epletion</w>
D atabase</w>
D apsone-associated</w>
D anish</w>
D W</w>
D TIs</w>
D SM</w>
D RR)</w>
D P)</w>
D MCM,</w>
D L-Threo-dihydroxyphenylserine</w>
D L)</w>
D C
DC E.</w>
D BP,</w>
D AT(-/-
DAT(-/- )).</w>
D A-
DA- innervated</w>
D A,</w>
D 50)</w>
D 4</w>
D 3)</w>
D 2/
D2/ D3</w>
D 2-3</w>
D 2-
D2- receptor</w>
D 2
D2 L</w>
D 1/
D1/ D2</w>
D 1).</w>
D 1
D1 =
D1= plug</w>
D .</w>
D -treated</w>
Cyclophosph amide,</w>
Cyclo oxygenase</w>
Cur ve</w>
Cur rently</w>
Cs A,</w>
Cr )</w>
Cr (ED
Cr(ED TA).</w>
Cor ticosteroids</w>
Cor responding</w>
Cor onary</w>
Control s</w>
Control s,</w>
Cont rary</w>
Cont inuous</w>
Con tact</w>
Con sidering</w>
Con servative</w>
Con junctival</w>
Con ium</w>
Con iine,</w>
Con fusion,</w>
Con formationally</w>
Con current</w>
Con cerns</w>
Compar isons</w>
Compar ative</w>
Combin ing</w>
Combin ation</w>
Com pression</w>
Com prehensive</w>
Com position</w>
Com ponents</w>
Com plications</w>
Com plementary</w>
Com petition</w>
Com mon</w>
Com mittee</w>
Coc aine's</w>
Co urse</w>
Co ombs</w>
Co gnitive</w>
Co .,</w>
Cloti azepam</w>
Cloti azepam-induced</w>
Clon idine-induced</w>
Clon idine,</w>
Clo se</w>
Clo mipramine</w>
Clo mipramine-induced</w>
Clin ically</w>
Clin ically,</w>
Cl ,</w>
Cl ).</w>
Cisplat in.</w>
Cisplat in-based</w>
Cis platin</w>
Chrom osome</w>
Chol inesterase</w>
Chol inergic</w>
Cho reoathetoid</w>
Cho reatiform</w>
Character ization</w>
Character istic</w>
Ch loroacetaldehyde</w>
Ch icago,</w>
Ch allenge</w>
Ch E</w>
Cer vical</w>
Cer tain</w>
Centr ally</w>
Cent re.</w>
Cent er</w>
Cat echolamine-induced</w>
Cat alepsy</w>
Cardi omyopathy</w>
Carb onic</w>
Carb achol</w>
Car mofur-induced</w>
Car dona</w>
Capsa icin-induced</w>
Cap topril.</w>
Cal cium</w>
Cal citonin</w>
CaCl 2
CaCl2 -induced</w>
Ca rolina,</w>
Ca reful</w>
Ca ffeine-induced</w>
CYP3A 4.</w>
CSS 18</w>
CSS 10</w>
CS -1</w>
CR L:(WI)WUBR</w>
CR F,</w>
CR ).</w>
CR ),</w>
CPA/ EE.</w>
CONCLUSION (S):</w>
COC s</w>
COC s.</w>
CO- I,</w>
CO X</w>
CO VERED</w>
CO S).</w>
CO HOL</w>
CO .</w>
CO -I</w>
CO ),</w>
CM F</w>
CK .</w>
CI:0. 7-
CI:0.7- 2.
CI:0.7-2. 4)</w>
CI:0. 3-
CI:0.3- 1.
CI:0.3-1. 2)</w>
CI S.</w>
CI S,</w>
CI PS.</w>
CI MD,</w>
CH C</w>
CD 1</w>
CCl 4.</w>
CC U</w>
CC ,</w>
CB F,</w>
CA SE:</w>
CA 3</w>
CA 3-
CA3- C</w>
C57B L6/J</w>
C-H T)</w>
C- type</w>
C- 90
C-90 8
C-908 9)</w>
C yproterone</w>
C yclosporine</w>
C ushing's</w>
C rescentic</w>
C ranial</w>
C ollaborative</w>
C luster</w>
C lopidogrel</w>
C limbing</w>
C ircumstances</w>
C imetidine</w>
C hemical</w>
C erebellar</w>
C ephalosporin</w>
C ellular</w>
C ell</w>
C eftriaxone-associated</w>
C ause</w>
C are</w>
C an</w>
C VVHDF</w>
C VVHDF,</w>
C NP</w>
C K</w>
C ES-D</w>
C E)</w>
C DF-I</w>
C D-68,</w>
C D)</w>
C CO-I</w>
C CO-I,</w>
C 219
C219 ,</w>
C /M
C/M S/MS).</w>
C /
C/ BC
C/BC P),</w>
C )-
C)- dependent</w>
C ),</w>
C (max)</w>
Bromocript ine</w>
Bromocript ine-induced</w>
Bri xton</w>
Bri efly,</w>
Bri ef</w>
Brady kinin</w>
Brady cardia</w>
Brady cardia,</w>
Bra instem</w>
Bio logical</w>
Bio chemical</w>
Ber lin,</w>
Ber kowitz</w>
Belgi um</w>
Be yond</w>
Basel ine,</w>
BZ ),</w>
BW /
BW/ 3</w>
BW .</w>
BW ).</w>
BPO ;</w>
BPO .</w>
BPO -
BPO- PLL</w>
BMC -
BMC- transplanted</w>
BE- Injected</w>
BE- Induced</w>
BD10 63,</w>
BD10 18</w>
BD L,</w>
BD 103
BD103 1</w>
BD 100
BD100 8</w>
BCN U.</w>
BCH E)</w>
BC s)</w>
BC P</w>
BC HE,</w>
BC C,</w>
BB B,</w>
BALB/ cByJ</w>
BALB/ C,</w>
BA EPs)</w>
B/ 1
B/1 D)</w>
B utyrylcholinesterase</w>
B usulfan-induced</w>
B ristol-Myers</w>
B ovine</w>
B ladder</w>
B irth</w>
B iopsies</w>
B inding</w>
B ile</w>
B ilateral</w>
B etween</w>
B enzylthiouracil</w>
B ech-Rafaelson</w>
B allistic</w>
B ackward</w>
B S</w>
B N.</w>
B MC</w>
B K</w>
B H</w>
B H)</w>
B F;</w>
B F-dependent.</w>
B F)</w>
B E.</w>
B E-induced</w>
B ChE</w>
B 6.</w>
B 6,</w>
B ).</w>
B ),</w>
Az rin</w>
Az idothymidine</w>
Az athioprine</w>
Auto phagic</w>
Auto antibodies</w>
Au topsy</w>
Au tism</w>
Au gust</w>
Atten tional</w>
Atten tion</w>
At tempts</w>
Assess ments</w>
Assess ment</w>
Assess ing</w>
As sociations</w>
As sociation</w>
As say</w>
Arg 3,
Arg3, 4,</w>
Arab ia,</w>
Ara G/VP/CPM.</w>
Ap plication</w>
Ap parent</w>
Ap amin</w>
Ap amin,</w>
Anti- oxidant</w>
Anti- epileptic</w>
Anti tumor</w>
Anti thymocyte</w>
Anti psychotic-like</w>
Anti hypertensive</w>
Anti emetic</w>
Anti depressant-induced</w>
Anti convulsant</w>
Anti biotic-associated</w>
Anti bacterial</w>
Ant agonists</w>
Ant agonism</w>
Angi otension</w>
Angi otensin-converting</w>
Analy ses</w>
An ticoagulant-induced</w>
An ticipation</w>
An thracyclines</w>
An san,</w>
An nuals</w>
An imex</w>
An imals</w>
An gina</w>
An esthesiologists</w>
An encephaly</w>
An d</w>
An aphylaxis</w>
An algesic</w>
An aesthetists'</w>
An aesthesia</w>
Amiodar one-induced</w>
Am plicor</w>
Am ount</w>
Am nesia</w>
Am ifostine</w>
Am antadine</w>
Alpha 2
Alpha2 ABC-
Alpha2ABC- /-</w>
Al so,</w>
Al prazolam</w>
Al pha</w>
Al lograft</w>
Al bino</w>
Age- related</w>
Age- matched</w>
Age- dependent</w>
Ag es</w>
Ag )</w>
Afric an.</w>
Afric a,</w>
Aff inity</w>
Adriam ycinol,</w>
Adriam ycin-induced</w>
Addi tional</w>
Ad vances</w>
Ad ults</w>
Ad mission</w>
Acet ylsalicylic</w>
Acet azolamide-induced</w>
Acet aminophen</w>
Acet aminophen-induced</w>
Ac tomycin-D,</w>
Ac tivity</w>
Ac romegaly</w>
Ac cordingly,</w>
Ac cording</w>
Ac cess(R)</w>
Ac c)</w>
Ab stract</w>
Ab sences</w>
AX- allergic</w>
AX- PLL</w>
ATT- AL
ATT-AL F.</w>
ATP ases</w>
ATP ase.</w>
ATP .</w>
ATP -
ATP- binding</w>
ATP ,</w>
AT(-/- ))</w>
AST: 27
AST:27 4</w>
AST: 111</w>
AS ).</w>
AS ),</w>
AR EAS</w>
AR E)</w>
AR +
AR+ CR</w>
AN P</w>
AN G</w>
AN CA)</w>
AN )</w>
AMI :</w>
AMI -induced</w>
AM HS</w>
AM H)</w>
AM CA</w>
AM )</w>
ALT: 122</w>
AL T</w>
AL F,</w>
AL COHOL</w>
AI D)</w>
AH F</w>
AH F,</w>
AE s</w>
AE s,</w>
AE D,</w>
ADR -induced</w>
ADAM 17</w>
ADAM 17
ADAM17 ,</w>
ADAM 10</w>
ADAM 10,</w>
AD P/O</w>
AD P-stimulated</w>
AD HD</w>
AD HD.</w>
AD A
ADA M</w>
ACh Rs)</w>
ACh Es</w>
ACh E</w>
AC h,</w>
AC TIVE-W</w>
AC TH</w>
AC Ei/ARB</w>
AC ),</w>
AB C</w>
AB )-induced</w>
AA PH,</w>
A- variants.</w>
A xsym</w>
A udiograms</w>
A typical</w>
A tropine-MK801</w>
A tracurium</w>
A torvastatin</w>
A to-treated</w>
A therosclerosis</w>
A sians</w>
A sian</w>
A sia.</w>
A senapine</w>
A rizona</w>
A pril</w>
A pomorphine,</w>
A part</w>
A nother</w>
A miloride</w>
A miens</w>
A merican</w>
A lopecia,</w>
A im</w>
A granulocytosis</w>
A dequate</w>
A ZT-treated</w>
A X-related</w>
A X,</w>
A VRT</w>
A V</w>
A UC</w>
A P<90mmHg)</w>
A FI),</w>
A 2A</w>
A 10</w>
A ).</w>
A (1)-
A(1)- adenosine</w>
> or=2.5</w>
> 50</w>
> 5.0</w>
> 2.5</w>
> 1.
>1. 27</w>
> 0.4</w>
= cigarettes</w>
= 65</w>
= 5),</w>
= 4</w>
= 4),</w>
= 20</w>
= 20%</w>
= 2),</w>
= 10</w>
= 0.7
=0.7 9)</w>
= .0
=.0 2),</w>
= .
=. 000
=.000 6)</w>
<0.00 1)</w>
<0.0 25),</w>
<0.0 2).</w>
< 9
<9 0%)</w>
< 60
<60 )</w>
< 200</w>
: 64</w>
: 00</w>
99 ;</w>
99 6,</w>
9312 9),</w>
93 ;</w>
92 6</w>
90 4+/-
904+/- 4
904+/-4 34</w>
90 %,</w>
9. 9
9.9 %;</w>
9. 8%</w>
9. 8%)</w>
9. 8
9.8 8)</w>
9. 7%</w>
9. 7%).</w>
9. 6</w>
9. 6%</w>
9. 5</w>
9. 5%).</w>
9. 4,</w>
9. 4%</w>
9. 2%;</w>
9. 1</w>
9. 1),</w>
9. 1%),</w>
9. 0</w>
9-tetrahydrocannab inol</w>
9-tetrahydrocannab inol.</w>
9- year</w>
9- week</w>
9- month</w>
9- [[2-methoxy-4-[(methylsulphonyl)amino]phenyl]amino]</w>
9- 9.1),</w>
9- 9
9-9 5,</w>
9- 51</w>
9- 2003</w>
9- 10-
9-10- weeks-old</w>
9+/- 36</w>
9+/- 10</w>
9 th</w>
9 ].</w>
9 9.0</w>
9 62</w>
9 6-
96- h</w>
9 6),</w>
9 5
95 7</w>
9 4).</w>
9 4
94 1).</w>
9 3,</w>
9 25</w>
9 2%)</w>
9 1</w>
9 17
917 ]</w>
9 10</w>
9 10
910 +/-
910+/- 7
910+/-7 70</w>
9 0,</w>
9 /26,</w>
9 .</w>
9 -1
9-1 78)</w>
86 8</w>
80 8</w>
80 3,</w>
80 +/-
80+/- 58
80+/-58 7)</w>
8/ 18;</w>
8. 95%</w>
8. 8),</w>
8. 7</w>
8. 6%</w>
8. 5%)</w>
8. 3</w>
8. 35</w>
8. 3,</w>
8. 3%</w>
8. 2%</w>
8. 1%</w>
8. 0
8.0 ;</w>
8-1 4</w>
8-1 33
8-133 9).</w>
8-1 2</w>
8- week-old</w>
8- hour</w>
8- [(4-amino-l-methylbutyl)amino]-</w>
8- 10</w>
8- 1.
8-1. 1),</w>
8- ,</w>
8+/- 1.0
8+/-1.0 9)</w>
8+/- 0.2</w>
8 9.7%</w>
8 7</w>
8 7.1%),</w>
8 7%</w>
8 6)</w>
8 6%</w>
8 6%),</w>
8 50</w>
8 5.
85. 4%).</w>
8 40</w>
8 4-year-old</w>
8 4
84 ])</w>
8 34).</w>
8 3
83 93</w>
8 27</w>
8 21</w>
8 20</w>
8 2,2,
82,2, 803,</w>
8 2
82 +/-
82+/- 24
82+/-24 5</w>
8 18
818 8).</w>
8 1.6</w>
8 1%</w>
8 0-
80- yr-old</w>
8 );</w>
8 %,</w>
7H 6,</w>
70- unit,</w>
70- 80%</w>
7.6- fold</w>
7.6- fold.</w>
7.0 5</w>
7.0 5)</w>
7. 9,</w>
7. 8</w>
7. 8),</w>
7. 7,</w>
7. 6</w>
7. 6),</w>
7. 6
7.6 %.</w>
7. 5,</w>
7. 44</w>
7. 3%</w>
7. 25
7.25 ;</w>
7. 2%</w>
7. 1</w>
7. 1%,</w>
7. 1%)</w>
7- year</w>
7- y-old</w>
7- hydroxy-dipropyloaminotetralin</w>
7- dimethoxy-4-ethyl-B-carboline-3-carboxylate</w>
7- NI</w>
7- NI,</w>
7- 85.4%).</w>
7- 25</w>
7- 2
7-2 3.
7-23. 5),</w>
7- 10</w>
7- 1.
7-1. 3),</w>
7, 7
7,7 0
7,70 5</w>
7, 10
7,10 ,
7,10, 17,
7,10,17, 27
7,10,17,27 ,
7,10,17,27, 41</w>
7 beta-estradiol</w>
7 :30</w>
7 9.6</w>
7 9)</w>
7 9%,</w>
7 8-year-old</w>
7 8%,</w>
7 74</w>
7 7-y-old</w>
7 7%</w>
7 7
77 .</w>
7 63</w>
7 6-year-old</w>
7 6%</w>
7 5.
75. 9%</w>
7 5,</w>
7 5%,</w>
7 38</w>
7 3.
73. 5%</w>
7 3),</w>
7 3%</w>
7 1</w>
7 1.4</w>
7 1%</w>
7 0%</w>
7 /
7/ 23</w>
7 -1
7-1 5.
7-15. 0
7-15.0 8)</w>
7 ),</w>
7 %,</w>
67. 66</w>
67. 4</w>
67. 3%</w>
60- 90</w>
60- 4.
60-4. 18
60-4.18 )</w>
60 .</w>
60 -120</w>
60 +/-
60+/- 9%,</w>
60 ),</w>
60 %.</w>
6/ 4
6/4 9)</w>
6/ 24</w>
6/ 20</w>
6. 9</w>
6. 8</w>
6. 7%</w>
6. 4</w>
6. 4%</w>
6. 3</w>
6. 2)</w>
6. 2%).</w>
6. 0</w>
6. 0),</w>
6. 0
6.0 8</w>
6-hydroxy dopamine</w>
6-hydroxy dopamine-lesion</w>
6-OHD A,</w>
6-OHD A)</w>
6- hr</w>
6- hour</w>
6- g/d</w>
6- 87.1%),</w>
6- 40</w>
6- 35</w>
6- 32.
6-32. 4%).</w>
6 ;</w>
6 9</w>
6 9-95,</w>
6 9).</w>
6 8.35</w>
6 75</w>
6 7-year-old</w>
6 7,</w>
6 7%.</w>
6 6.6</w>
6 6%</w>
6 6
66 ,6
66,6 80</w>
6 50</w>
6 5.</w>
6 5-year-old</w>
6 44</w>
6 4.
64. 1,</w>
6 4-year-old</w>
6 4%</w>
6 30</w>
6 3.
63. 8%</w>
6 22</w>
6 2/
62/ 92</w>
6 2.
62. 0)</w>
6 2)</w>
6 2%,</w>
6 19</w>
6 19
619 )</w>
6 1,</w>
6 1%</w>
6 ,000</w>
6 ,
6, 7-dimethoxy-4-ethyl-B-carboline-3-carboxylate</w>
58 ].</w>
58 2)</w>
57 %.</w>
57 %,</w>
555 62)</w>
55. 6-87.1%),</w>
55. 3%</w>
55 1</w>
55 )</w>
55 %,</w>
54. 7%</w>
54. 6%</w>
54. 2%</w>
50- year-old</w>
50- unit</w>
50- 80</w>
50- 60</w>
50- 55</w>
50- 20
50-20 0%</w>
50- 0.7
50-0.7 5</w>
50 9</w>
50 6,</w>
50 6)</w>
50 4</w>
50 00</w>
50 0/mm3</w>
50 .</w>
50 +/-
50+/- 5
50+/-5 61,</w>
50 ),</w>
50 %),</w>
5. 7%</w>
5. 7%)</w>
5. 6</w>
5. 6),</w>
5. 5)</w>
5. 4)</w>
5. 4).</w>
5. 3)</w>
5. 3%),</w>
5. 2%)</w>
5. 1),</w>
5. 1%</w>
5-hydroxytrypt amine4</w>
5-hydroxytrypt amine,</w>
5-hydroxytrypt amin1A</w>
5-hydroxytry ptophan</w>
5-hydroxy triptamine,</w>
5-fluoro uracil/folinic</w>
5-fluoro uracil.</w>
5-HT P</w>
5-HT 6</w>
5-HT (1
5-HT(1 B/1D)</w>
5-H T</w>
5-H T)</w>
5-FU ,</w>
5-Az C)</w>
5- year</w>
5- week</w>
5- min</w>
5- micrograms/kg</w>
5- mg</w>
5- dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl)</w>
5- T</w>
5- 96),</w>
5- 8</w>
5- 6</w>
5- 5.4</w>
5- 47.5</w>
5- 4.
5-4. 1),</w>
5- 3.
5-3. 58].</w>
5- 27
5-27 )</w>
5- 13</w>
5- 11)</w>
5- 10</w>
5- (
5-( l-hexyloxy)-6-methoxy-4-methylquinoline</w>
5, 7,10,17,27,41</w>
5, 5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl)</w>
5%- 60%)</w>
5 th</w>
5 mg)</w>
5 g</w>
5 HT4</w>
5 93</w>
5 9-year-old</w>
5 9,</w>
5 9%</w>
5 80</w>
5 8.9</w>
5 8.6%,</w>
5 8.3</w>
5 8-year-old</w>
5 8).</w>
5 8%</w>
5 70</w>
5 7.9,</w>
5 7-year</w>
5 6%</w>
5 5-year-old</w>
5 5%</w>
5 47</w>
5 40-
540- 840</w>
5 4/
54/ 94</w>
5 4-year-old</w>
5 4-
54- 67</w>
5 4%</w>
5 37</w>
5 32</w>
5 3.</w>
5 3.9</w>
5 3)</w>
5 3
53 ))</w>
5 2</w>
5 27
527 +/-
527+/- 509</w>
5 2%</w>
5 2%,</w>
5 14</w>
5 1-year-old</w>
5 +/-1
5+/-1 6</w>
46 %)</w>
45-12 6,</w>
45-12 6).</w>
45- 120</w>
40-59 67</w>
40-59 67,</w>
40 0-
400- 500</w>
40 0),</w>
40 ,
40, 60</w>
40 %)</w>
4/ 4
4/4 5)</w>
4. 93</w>
4. 9).</w>
4. 6</w>
4. 6;</w>
4. 6,</w>
4. 6%</w>
4. 5</w>
4. 47</w>
4. 40</w>
4. 4.</w>
4. 3</w>
4. 33
4.33 6,</w>
4. 3.</w>
4. 3+/-
4.3+/- 1.9</w>
4. 2;</w>
4. 17)</w>
4. 1)</w>
4. 1%</w>
4- fold</w>
4- diphenylacetoxy-N-methylpiperidine</w>
4- acridinecarboxamide)</w>
4- 5.1),</w>
4- 21</w>
4- 2
4-2 2).</w>
4+/- 6.1</w>
4+/- 0.7
4+/-0.7 )</w>
4'-0-tetrahydropyranyl adriamycin</w>
4'-0-tetrahydropyranyl adriamycin.</w>
4 :64</w>
4 :30</w>
4 941).</w>
4 9.2%;</w>
4 9-year-old</w>
4 9%)</w>
4 8-hour</w>
4 8,</w>
4 8+/-4%</w>
4 7.3%</w>
4 7-year-old</w>
4 7).</w>
4 7),</w>
4 7%</w>
4 58</w>
4 54</w>
4 51</w>
4 5.9</w>
4 5-year-old</w>
4 5,</w>
4 47</w>
4 4.1%</w>
4 3</w>
4 39</w>
4 32</w>
4 3.3</w>
4 3-
43- 78</w>
4 3)</w>
4 24</w>
4 2.5</w>
4 2-
42- day-old</w>
4 2%.</w>
4 2%).</w>
4 14</w>
4 1.5</w>
4 1.4</w>
4 1%</w>
4 1
41 %).</w>
4 0.8</w>
4 0.3</w>
4 0,</w>
4 /2
4/2 6)</w>
4 -</w>
4 -1
4-1 2</w>
4 ,000</w>
4 )),</w>
4 %;</w>
39. 9%</w>
39. 6</w>
39. 3</w>
3434 99;</w>
3434 99)</w>
34 6%,</w>
34 3)</w>
34 %,</w>
34 %),</w>
33. 67%</w>
33. 3%).</w>
33 90,</w>
33 ).</w>
33 %.</w>
32. 7%</w>
32. 3</w>
32. 3%</w>
31 I-HSA).</w>
31 %.</w>
30- year</w>
30- 60</w>
30 th,</w>
30 0
300 -1
300-1 500</w>
30 );</w>
30 ).</w>
30 ),</w>
3/ 99)</w>
3/ 50)</w>
3/ 4</w>
3.6 7-15.08)</w>
3.6 -</w>
3.0 ),</w>
3. 82</w>
3. 7</w>
3. 7;</w>
3. 75</w>
3. 5</w>
3. 5)</w>
3. 4</w>
3. 4;</w>
3. 4-fold</w>
3. 4),</w>
3. 4%;</w>
3. 32</w>
3. 2;</w>
3. 1</w>
3-methyl adenine</w>
3- year</w>
3- mercaptopropionic</w>
3- hydroxy-3-methylglutaryl</w>
3- hour</w>
3- bis-(2-chloroethyl)-1-nitrosourea),</w>
3- aminopropyl-diethoxy-methyl-phosphinic</w>
3- 7</w>
3- 6</w>
3- 60</w>
3- 60%</w>
3- 5.3</w>
3- 20</w>
3- 2.
3-2. 7).</w>
3- -
3-- a</w>
3, 774</w>
3, 5,7,10,17,27,41</w>
3, 424</w>
3+/- 43</w>
3+/- 3.6</w>
3 alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one)</w>
3 SR,4aRS,6SR,8aRS-6-[phosphonomethyl]decahydr</w>
3 9-51</w>
3 9%,</w>
3 9%).</w>
3 8393</w>
3 81</w>
3 80+/-587)</w>
3 8+/-4%</w>
3 8)</w>
3 74</w>
3 7).</w>
3 7%.</w>
3 7%,</w>
3 6.3</w>
3 6-40</w>
3 6%</w>
3 58</w>
3 50</w>
3 504</w>
3 500</w>
3 50)</w>
3 5%,</w>
3 5%)</w>
3 40</w>
3 4.3</w>
3 4-year-old</w>
3 3)</w>
3 3%</w>
3 22</w>
3 20</w>
3 2.5</w>
3 2),</w>
3 2%)</w>
3 1.</w>
3 1.4%</w>
3 1).</w>
3 1),</w>
3 0.4
30.4 %;</w>
3 0.0
30.0 mg/kg</w>
3 0.
30. 1%,</w>
3 -1
3-1 996,</w>
3 );</w>
3 %,</w>
3 %);</w>
2D 6.</w>
29. 8%).</w>
29. 2,</w>
29. 0
29.0 +/-
29.0+/- 2.1</w>
27- year</w>
27- 73),</w>
27 2</w>
27 0</w>
27 0,</w>
27 .</w>
26. 6%</w>
26. 5%</w>
26. 3+/-3.6</w>
26. 0%</w>
25- mg/m2</w>
25- gauge</w>
25 /26,</w>
25 /
25/ 100</w>
25 ).</w>
24. 9</w>
24. 6%</w>
24. 3%</w>
24. 2</w>
24 :1</w>
24 3</w>
24 1</w>
24 ).</w>
219 ]</w>
200 9,</w>
200 8.</w>
200 6,</w>
200 5</w>
200 4</w>
200 3--a</w>
200 3,</w>
200 2</w>
200 1</w>
200 0-
2000- 2002</w>
200 ,</w>
20.0 mg/kg</w>
20.0 )</w>
20- year-old</w>
20- mg</w>
20- fold</w>
20- 30%</w>
20, 40,60</w>
20, 000
20,000 fold</w>
20 66</w>
20 3</w>
20 00</w>
20 .</w>
20 );</w>
20 ).</w>
2/ 3</w>
2. 9%</w>
2. 9%).</w>
2. 8</w>
2. 8-fold</w>
2. 8).</w>
2. 7</w>
2. 7;</w>
2. 7-23.5),</w>
2. 7)</w>
2. 7%).</w>
2. 6</w>
2. 6-32.4%).</w>
2. 6,</w>
2. 6).</w>
2. 5;</w>
2. 58</w>
2. 53</w>
2. 5,</w>
2. 5%</w>
2. 4;</w>
2. 45</w>
2. 32</w>
2. 3);</w>
2. 3%).</w>
2. 21</w>
2. 20</w>
2. 2),</w>
2. 1-
2.1- 53)</w>
2. 0%)</w>
2-DM H</w>
2-DM H)</w>
2-(p-bromophenyl)propi onate</w>
2-(p-bromophenyl)propi onate),</w>
2- year</w>
2- week</w>
2- methyl-6-(phenylethynyl)pyridine</w>
2- methoxy-4-amino-5-chlorobenzoic</w>
2- kg</w>
2- h</w>
2- fold</w>
2- fold).</w>
2- dimethylhydrazine</w>
2- adrenoreceptor</w>
2- acetylaminofluorene</w>
2- Hz</w>
2- 62.0)</w>
2- 4</w>
2- 199
2-199 4)</w>
2- 126</w>
2- ,</w>
2- )</w>
2- (
2-( diethylamino)ethyl</w>
2, z)</w>
2, 820</w>
2+/-1 5</w>
2+/-1 3</w>
2 nd-week</w>
2 a</w>
2 E1)</w>
2 C,</w>
2 <90%)</w>
2 :00</w>
2 9th</w>
2 99</w>
2 9-year-old</w>
2 9),</w>
2 9%).</w>
2 89</w>
2 84</w>
2 82</w>
2 80</w>
2 80+/-17</w>
2 8.2%</w>
2 8-1339).</w>
2 8)</w>
2 8).</w>
2 8%</w>
2 64</w>
2 60</w>
2 60.</w>
2 50%</w>
2 5.6</w>
2 5.2</w>
2 48</w>
2 4-year-old</w>
2 39%,</w>
2 38</w>
2 37</w>
2 36</w>
2 34</w>
2 3390,</w>
2 30%,</w>
2 3.6</w>
2 3.3</w>
2 3-year-old</w>
2 3+/-43</w>
2 28)</w>
2 23</w>
2 2.9%</w>
2 2-fold).</w>
2 17</w>
2 16</w>
2 15</w>
2 13,</w>
2 10</w>
2 1.6</w>
2 1.5</w>
2 1.3</w>
2 1-
21- 59</w>
2 1)</w>
2 0.4
20.4 %,</w>
2 0.3</w>
2 0.1</w>
199 9-2003</w>
199 6.</w>
199 5</w>
199 5,</w>
199 3-1996,</w>
199 2</w>
199 1</w>
199 1,</w>
199 0</w>
198 7</w>
198 1</w>
198 1.</w>
198 1).</w>
19. 9</w>
19. 4</w>
19. 3</w>
19. 2</w>
19 77.</w>
19 69-95,</w>
19 67</w>
19 6)</w>
19 3.9</w>
19 2</w>
19 0</w>
19 .</w>
19 %),</w>
180 ).</w>
18- gauge</w>
18 3</w>
18 1</w>
18 .</w>
18 +/-
18+/- 5</w>
18 %</w>
18 %,</w>
17- year-old</w>
17- day-old</w>
17, 2</w>
17 th</w>
17 7</w>
17 7.8</w>
17 0</w>
16. 619)</w>
16. 4</w>
16. 4+/-6.1</w>
16. 213,</w>
16. 1
16.1 %;</w>
16 9</w>
16 95</w>
16 7</w>
16 5</w>
16 4</w>
16 3</w>
16 3)</w>
16 0%</w>
16 /
16/ 20</w>
16 .</w>
15. 7</w>
15. 6</w>
15. 5</w>
15. 3%</w>
15. 2%,</w>
15- yr-old</w>
15- year-old</w>
15- mm</w>
15- day</w>
15- 41%).</w>
15- ,</w>
15 79</w>
15 6</w>
15 4:64</w>
15 3</w>
15 20</w>
15 2+/-15</w>
15 .</w>
15 )</w>
15 ).</w>
15 ),</w>
140 ;</w>
140 .</w>
14. 8</w>
14. 3</w>
14. 3%</w>
14. 0</w>
14 th</w>
14 9</w>
14 6</w>
14 /
14/ 92,</w>
14 )</w>
14 ).</w>
14 %</w>
131 I-albumin</w>
131 +/-
131+/- 22</w>
13. 8</w>
13. 5g</w>
13. 5),</w>
13. 1</w>
13. 0%</w>
13 th</w>
13 9+/-36</w>
13 9)</w>
13 78</w>
13 6</w>
13 4).</w>
13 3</w>
13 28-1339).</w>
13 1.0
131.0 8</w>
13 ,000</w>
13 ).</w>
13 %</w>
13 %;</w>
13 %.</w>
120 ),</w>
12/ 30</w>
12/ 27</w>
12. 7</w>
12. 6%</w>
12. 5%</w>
12. 4%,</w>
12- wk</w>
12- week,</w>
12- month</w>
12- lead</w>
12 weeks,</w>
12 h,</w>
12 8</w>
12 6,</w>
12 5).</w>
12 4).</w>
12 3)</w>
12 23</w>
12 .</w>
12 %</w>
11. 8%</w>
11. 5%</w>
11. 2%).</w>
11-1 7</w>
11-1 3</w>
11 th</w>
11 :30</w>
100- mm</w>
100- micrograms</w>
100- 582)</w>
100- 10,000</w>
100 0/mm3</w>
100 /
100/ 65</w>
100 ,000</w>
100 )</w>
10. 9</w>
10. 8</w>
10. 6</w>
10. 3%</w>
10- year-old</w>
10- second</w>
10- month</w>
10- keto</w>
10- fold)</w>
10- 40</w>
10- 37</w>
10(- 7)</w>
10(- 4)</w>
10 9</w>
10 82+/-245</w>
10 8.9</w>
10 6</w>
10 65</w>
10 4</w>
10 2+/-13</w>
10 1.7
101.7 4)</w>
10 1),</w>
10 .</w>
10 (9
10(9 )/
10(9)/ L)</w>
10 (7
10(7 )</w>
10 (3)</w>
10 (2)</w>
10 %.</w>
10 %,</w>
10 %),</w>
1/ s,</w>
1/ 2)</w>
1.7 3</w>
1.7 /
1.7/ 100,000</w>
1.3- 8.8),</w>
1.3- 7.6),</w>
1.3- 5.6),</w>
1.3 ;</w>
1.3 5-3.58].</w>
1.2-3. 9).</w>
1.2-3. 8).</w>
1.1-8. 8)</w>
1.1-8. 5,</w>
1.1- 5.4).</w>
1.1- 3.4),</w>
1.0 ;</w>
1.0 4</w>
1.0 2</w>
1.0 1-
1.01- 1.
1.01-1. 53))</w>
1. 9;</w>
1. 98</w>
1. 9-9.1),</w>
1. 86%</w>
1. 84</w>
1. 8-fold</w>
1. 60-4.18)</w>
1. 6.</w>
1. 6,</w>
1. 5-T</w>
1. 5)</w>
1. 5%,</w>
1. 48</w>
1. 4%)</w>
1. 35</w>
1. 34</w>
1. 3,</w>
1. 2</w>
1. 26</w>
1. 2%;</w>
1. 19</w>
1. 131</w>
1. 1-1
1.1-1 2.2),</w>
1. 0-5.
1.0-5. 9),</w>
1-1 5</w>
1-1 50</w>
1- month</w>
1- mm</w>
1- dichloro-2,2,2-trifluoroethane</w>
1- chloro-1,2,2,2-tetrafluoroethane</w>
1- bromo-1-chloro-2,2,2-trifluoroethane</w>
1- 4)</w>
1- 4)),</w>
1- 3</w>
1- 31).</w>
1- 30</w>
1- 2</w>
1- 1</w>
1- 10,000</w>
1- -
1-- 9</w>
1- (2-
1-(2- methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine</w>
1, 821</w>
1, 800</w>
1, 340</w>
1, 200</w>
1, 2-dimethylhydrazine</w>
1, 2-DMH</w>
1, 1-dichloro-2,2,2-trifluoroethane</w>
1 M0)]</w>
1 A,</w>
1 :1</w>
1 8.4</w>
1 8.1%</w>
1 7.6-fold</w>
1 6-week</w>
1 55)</w>
1 50.</w>
1 5,</w>
1 4-year-old</w>
1 4-21</w>
1 3-year-old</w>
1 3-60%</w>
1 17</w>
1 15).</w>
1 100</w>
1 1.4%</w>
1 1%</w>
1 0.7;</w>
1 0.1</w>
1 );</w>
04 8).</w>
04 5;</w>
00 8).</w>
0/ 99)</w>
0.8 9),</w>
0.8 %.</w>
0.7 5;</w>
0.7 5%</w>
0.7 5%,</w>
0.7 4,</w>
0.7 045;</w>
0.6 9</w>
0.6 75</w>
0.6 5;</w>
0.6 4)</w>
0.6 2,</w>
0.5 M</w>
0.5 6,</w>
0.5 3,</w>
0.5 3).</w>
0.5 %.</w>
0.5 %
0.5% /
0.5%/ 12h,</w>
0.4 8,</w>
0.4 45</w>
0.4 4).</w>
0.3 8%).</w>
0.3 50-unit</w>
0.3 2).</w>
0.2 8+/-0.2</w>
0.2 62</w>
0.2 25</w>
0.2 2,</w>
0.05 ;</w>
0.05 .</w>
0.05 ,</w>
0.05 );</w>
0.05 )).</w>
0.03 5),</w>
0.03 %,</w>
0.014- unit,</w>
0.01 1).</w>
0.01 ).(ABSTRACT</w>
0.000 1,</w>
0.000 1)</w>
0.00 8</w>
0.00 8).</w>
0.00 7)</w>
0.00 7).</w>
0.00 5)</w>
0.00 5).</w>
0.00 31.</w>
0.00 3).</w>
0.00 3),</w>
0.00 24).</w>
0.00 1</w>
0.00 1;</w>
0.00 12).</w>
0.0 93;</w>
0.0 8</w>
0.0 75%,</w>
0.0 70-unit,</w>
0.0 7).</w>
0.0 6%</w>
0.0 4</w>
0.0 49</w>
0.0 47).</w>
0.0 4).</w>
0.0 3</w>
0.0 343)</w>
0.0 34).</w>
0.0 3,</w>
0.0 3)</w>
0.0 3).</w>
0.0 25).</w>
0.0 228)</w>
0.0 2)</w>
0.0 2%</w>
0.0 19</w>
0.0 15%,</w>
0.0 13).</w>
0.0 11</w>
0. 90</w>
0. 9)</w>
0. 85</w>
0. 8-1.1),</w>
0. 7-1.3),</w>
0. 50-0.75</w>
0. 5-4.1),</w>
0. 5%)</w>
0. 4-5.1),</w>
0. 4%</w>
0. 33).</w>
0. 3-2.7).</w>
0. 27</w>
0. 25</w>
0. 25)</w>
0. 25),</w>
0. 25%</w>
0. 24:1</w>
0. 23</w>
0. 2,</w>
0. 2%</w>
0. 2%.</w>
0. 2%)</w>
0. 15%,</w>
0. 12</w>
0. 125).</w>
0. 11</w>
0. 11),</w>
0. 1,</w>
0-5. 7)</w>
0- 32</w>
0- 2</w>
0 M0)</w>
0 50+/-561,</w>
0 3</w>
0 13</w>
0 -120</w>
/M (5
/M(5 )-
/M(5)- selective'),</w>
/M (3)
/M(3) /M(5)-selective'),</w>
/2 ))</w>
/ EE)</w>
/ D)</w>
/ 8).</w>
/ 4),</w>
.0 5,</w>
.0 4).</w>
.0 2).</w>
.0 1)</w>
. S.)</w>
. 14).</w>
. 008).</w>
-1 9.4,</w>
- pen)</w>
- negative)</w>
- Tacrolimus</w>
- N,5-dimethyl-</w>
- MK801</w>
- A)</w>
- 9.6%</w>
- 5.0</w>
- 4.6%</w>
- 3</w>
- 3.7</w>
- 24.6%</w>
- 0.5-4.1),</w>
- (4-
-(4- fluorophenyl)</w>
,6 82,2,803,</w>
, N-dimethylpropranolol),</w>
, 957</w>
, 250</w>
+/- )</w>
+ 4.1</w>
)/ A(2A)</w>
)- alpha-methylhistamine</w>
) 2A</w>
) /M(3)/M(5)-selective'),</w>
(t 1/2)</w>
(t (1
(t(1 /2))</w>
(p= 0.025).</w>
(p= 0.01)</w>
(p= 0.008</w>
(p= 0.006,</w>
(p<0.0 21)</w>
(p<0.0 2),</w>
(p< 0.05).</w>
(p g/ml)</w>
(p g/ml),</w>
(p ANCA)</w>
(p <0.001</w>
(p <0.001)</w>
(ne ar)</w>
(n=2. 8+/-1.09)</w>
(n=2. 4+/-0.7)</w>
(n= 94).</w>
(n= 92,</w>
(n= 834).</w>
(n= 6,</w>
(n= 6)</w>
(n= 25)</w>
(n= 12,</w>
(n= 11),</w>
(n= 10</w>
(n= 101),</w>
(n= 100),</w>
(n/N= 9/26,</w>
(n/N= 62/92</w>
(n/N= 25/26,</w>
(n g/ml)</w>
(n g/ml),</w>
(n NOS)</w>
(n AChRs)</w>
(n =</w>
(i ii)</w>
(f MRI).</w>
(f ))</w>
(e. g.</w>
(cTn T)</w>
(cTn I)</w>
(c lopidogrel</w>
(alpha- TAc)</w>
(alpha- T)</w>
(alendron ate</w>
(alendron ate)</w>
(adj ))</w>
(W SR)</w>
(W HO),</w>
(V upral</w>
(V oltarol,</w>
(V ohland</w>
(V d)</w>
(V SD)</w>
(V PU)</w>
(V PA).</w>
(V P)</w>
(V IP)</w>
(V FD)</w>
(V AS),</w>
(Trental )</w>
(Trental ),</w>
(TR P)</w>
(TR I),</w>
(TE OAEs)</w>
(TE M).</w>
(T3N 1M0)]</w>
(T3N 0M0)</w>
(T riniol)</w>
(T dP)</w>
(T axol;</w>
(T T)</w>
(T NSs)</w>
(T MP)</w>
(T MA)</w>
(T Js),</w>
(T HP)</w>
(T HC),</w>
(T G)</w>
(T ET)</w>
(T DP)</w>
(T DFS);</w>
(T D)</w>
(T CR),</w>
(T AM),</w>
(T AFI),</w>
(T AA)</w>
(T 60),</w>
(T 30),</w>
(T 180).</w>
(T 120),</w>
(T 0)</w>
(SR S)</w>
(SR )</w>
(SO CS-1</w>
(SO 2<90%)</w>
(SN P,</w>
(SN P)-induced</w>
(SN HL),</w>
(SE M)</w>
(S rl)</w>
(S edionbel)</w>
(S ch)</w>
(S V),</w>
(S TR)</w>
(S SRI),</w>
(S PV),</w>
(S ON)</w>
(S E)</w>
(S DRR)</w>
(S Cr)</w>
(S C)</w>
(S AP<90mmHg)</w>
(S )</w>
(RP P)</w>
(RP N)</w>
(R oche</w>
(R c)</w>
(R T)</w>
(R S)</w>
(R BCs)</w>
(R AS).</w>
(R AMH)</w>
(R )-alpha-methylhistamine</w>
(R (2)
(R(2) =0.79)</w>
(PT Z)</w>
(PT X)</w>
(PT CR).</w>
(PR L-R)</w>
(PD TC)</w>
(PD ).</w>
(PCP )-induced</w>
(PCP ),</w>
(PAN )</w>
(P=0.3 9),</w>
(P=0.3 7).</w>
(P= 0.44).</w>
(P= 0.11),</w>
(P= 0.05).</w>
(P< 0.05).</w>
(P< 0.05),</w>
(P< 0.001).</w>
(P urkinje</w>
(P tpro)</w>
(P irarubicin)</w>
(P gp),</w>
(P VN)</w>
(P R)</w>
(P PI)</w>
(P PA),</w>
(P O2)</w>
(P O)</w>
(P N)</w>
(P GE1)</w>
(P GE1)-induced</w>
(P G),</w>
(P EG</w>
(P COS).</w>
(P CO2</w>
(P CA)</w>
(P C/BCP),</w>
(P C)</w>
(P AC),</w>
(P <</w>
(P <0.02).</w>
(P <0.001</w>
(P 58).</w>
(P 450</w>
(P "</w>
(OR (adj))</w>
(O vx)</w>
(O FH).</w>
(O D)</w>
(O CD)</w>
(O C)</w>
(O 2-)</w>
(O -A)</w>
(Na,K)- ATPase.</w>
(Na Cl).</w>
(NSCL C).</w>
(NS AID)</w>
(N= 10)</w>
(N= 10),</w>
(N estor,</w>
(N YHA)</w>
(N X)</w>
(N TE)</w>
(N MBAs)</w>
(N L4-3Delta</w>
(N IN)</w>
(N GF)</w>
(N G),</w>
(N FkappaB)</w>
(N F)</w>
(N E),</w>
(N Acc)</w>
(N ,N-dimethylpropranolol),</w>
(N ,</w>
(N ).</w>
(MP O).</w>
(MP EP;</w>
(MP ),</w>
(MM SE)</w>
(MM SE).</w>
(MA PD).</w>
(MA P).</w>
(MA HA)</w>
(M exitil-Perlongets)</w>
(M Z)</w>
(M TX),</w>
(M S).</w>
(M PA),</w>
(M MRM),</w>
(M MPs)</w>
(M K-801,</w>
(M IF)</w>
(M Hb)</w>
(M FL</w>
(M FL):</w>
(M ES).</w>
(M ED</w>
(M .S.)</w>
(LNa+ LCa)</w>
(LNa+ HCa).</w>
(L S)</w>
(L PO)</w>
(L OCF),</w>
(L Na),</w>
(L IDs)</w>
(L ID)</w>
(L HRH-A)</w>
(L EV)-induced</w>
(L D50)</w>
(L C/MS/MS).</w>
(L AM)</w>
(L A)</w>
(Ki= 39</w>
(Ki= 237</w>
(Ki= 180</w>
(K )</w>
(K (i)</w>
(K (+)</w>
(IS T)</w>
(IS O)-induced</w>
(IF X)</w>
(IF N)</w>
(IC P)</w>
(IC H)</w>
(IC 30)</w>
(I S)</w>
(I OP),</w>
(I L-3)</w>
(I GF</w>
(I /D)</w>
(I (f))</w>
(HI V)</w>
(HE V)</w>
(HE M,</w>
(HBsAg -negative)</w>
(HBsAg -</w>
(HB s</w>
(HB SAG)</w>
(H yoscine).</w>
(H ip-His-Leu</w>
(H b)</w>
(H US)</w>
(H S)</w>
(H R)</w>
(H R),</w>
(H P)</w>
(H IV)-infected</w>
(H ITT)</w>
(H FDE)</w>
(H E-LFB,</w>
(GS H)</w>
(GS H),</w>
(GF P)</w>
(G oldstein</w>
(G lyT1)</w>
(G VG)</w>
(G SPE)</w>
(G R</w>
(G M)</w>
(G LEPP1)</w>
(G I)</w>
(G EM)</w>
(G D1=plug</w>
(G C-HT)</w>
(G :</w>
(F R)</w>
(F LAIR)</w>
(F L)</w>
(F EV1)</w>
(ESRD ).</w>
(ESRD ),</w>
(ES RD)</w>
(ES )</w>
(EP S),</w>
(EP O)</w>
(EP M)</w>
(ENa C)</w>
(ENa C).</w>
(ENa C)-dependent</w>
(ED ITS)</w>
(ED (50
(ED(50 ))</w>
(EC T).</w>
(EC G)</w>
(EC E-1),</w>
(E P)</w>
(E KG)</w>
(E F<45%)</w>
(E F)</w>
(E E)</w>
(E BF)</w>
(E 8188).</w>
(E 2),</w>
(E 13.5),</w>
(DW I)</w>
(DW )</w>
(DTI s)</w>
(DF U;</w>
(DF P),</w>
(DF O)</w>
(D ex)-induced</w>
(D elta=-6.7%;</w>
(D TG)</w>
(D SM-IV</w>
(D S),</w>
(D RG)</w>
(D OPAC:DA</w>
(D NR)-containing</w>
(D MCM),</w>
(D I)</w>
(D EX).</w>
(D ES,</w>
(D CE)</w>
(D BP)</w>
(D BH)</w>
(D AT(-/-))</w>
(D A)</w>
(D A).</w>
(D -pen)</w>
(CY P)</w>
(CY )</w>
(CR F</w>
(CR F)</w>
(CR ;</w>
(CPA P)</w>
(CPA /EE)</w>
(CP M)</w>
(CP B).</w>
(CIP S)</w>
(CIP S):</w>
(CI MD),</w>
(CG I-SF;</w>
(CCO- IV</w>
(CCO- I)</w>
(C yA),</w>
(C sA),</w>
(C rataegus</w>
(C r</w>
(C lT)</w>
(C aptopril)</w>
(C aCl(2))-induced</w>
(C X3CR1)</w>
(C VVHDF).</w>
(C VP),</w>
(C T)</w>
(C SS),</w>
(C R,</w>
(C R)</w>
(C PA)</w>
(C P</w>
(C OX)</w>
(C OCs).</w>
(C O2)</w>
(C O),</w>
(C NS)</w>
(C NS),</w>
(C NP)</w>
(C NI)-based</w>
(C N)</w>
(C MF)]</w>
(C M)</w>
(C HF)</w>
(C HEOPS).</w>
(C HC).</w>
(C FCs).</w>
(C EI)</w>
(C CO),</w>
(C C).</w>
(C BZ),</w>
(C ARE)</w>
(C AN)</w>
(C AB)-induced</w>
(C AA)</w>
(BCh Es).</w>
(BCh E),</w>
(BC P)</w>
(BC C),</w>
(BBB )</w>
(BBB ).</w>
(B ergmann's</w>
(B asd</w>
(B arthel</w>
(B ZDs/RDs)</w>
(B S</w>
(B R</w>
(B PO-PLL),</w>
(B OLD)</w>
(B NP)</w>
(B MCs)</w>
(B ID),</w>
(B F)</w>
(B E),</w>
(B DL)</w>
(AZ T)-induced</w>
(AT T-ALF)</w>
(AT T)-associated</w>
(AR V)</w>
(AR B)</w>
(AR ;</w>
(AM I)-induced</w>
(AM HS).</w>
(AM CA)</w>
(ALT )</w>
(AD R)</w>
(AD HD).</w>
(AD AM),</w>
(AC hEs)</w>
(AC E),</w>
(AC C-9089)</w>
(AC C)</w>
(AC )</w>
(AA P:</w>
(AA P)-induced</w>
(A trial</w>
(A to)</w>
(A raG)</w>
(A mB)</w>
(A bbott</w>
(A X)</w>
(A VRT)</w>
(A VP)</w>
(A SEX),</w>
(A SA</w>
(A SA,</w>
(A S/KS</w>
(A PTT),</w>
(A NP)</w>
(A MP),</w>
(A LL)</w>
(A KBR,</w>
(A HF)</w>
(A Es)</w>
(A EDs),</w>
(A ED)</w>
(A E)</w>
(A 1)</w>
(A (1
(A(1 )/A(2A)</w>
(>or= 26</w>
(>or= 10.8</w>
(> 60%)</w>
(> 5mg)</w>
(> 100</w>
(> 1.0</w>
(< 60</w>
(< 5</w>
(< 150</w>
(< 12</w>
(< 10</w>
(9 0</w>
(9 0%).</w>
(9 %).</w>
(80 mg/kg/day</w>
(80 -120</w>
(80 %)</w>
(8. 8</w>
(8. 7%</w>
(8. 5</w>
(8 9.1%),</w>
(8 6.2%).</w>
(8 5</w>
(8 2%).</w>
(8 0.0%)</w>
(8 /8).</w>
(7. 6%)</w>
(7. 2%)</w>
(7. 1%)</w>
(7. 1%),</w>
(7- NI;</w>
(7- 49</w>
(7- 350)</w>
(7 9.4%</w>
(7 8%)</w>
(7 7.1</w>
(7 6</w>
(7 6.6%;</w>
(7 6%)</w>
(7 5.9</w>
(7 4%</w>
(7 3/99)</w>
(7 0</w>
(7 0/99)</w>
(7 0%)</w>
(7 /8),</w>
(62. 8%)</w>
(62. 5%)</w>
(6 9.9</w>
(6 9.8%)</w>
(6 9%),</w>
(6 7.1%,</w>
(6 6</w>
(6 6%)</w>
(6 5+/-16</w>
(6 48</w>
(6 3%);</w>
(6 3%),</w>
(6 1</w>
(6 17</w>
(6 1.6</w>
(6 1%),</w>
(6 00</w>
(6 0-120</w>
(6 /8),</w>
(6 ))</w>
(50 %).</w>
(5. 8%)</w>
(5. 7%)</w>
(5. 6</w>
(5. 2%)</w>
(5-HT )2A</w>
(5-HT (6))</w>
(5-FU ),</w>
(5- 20</w>
(5 <</w>
(5 9%)</w>
(5 8%)</w>
(5 7.1%)</w>
(5 7%)</w>
(5 5</w>
(5 5.2%)</w>
(5 5%-60%)</w>
(5 5%).</w>
(5 4</w>
(5 4.4%</w>
(5 3</w>
(5 2</w>
(5 26</w>
(5 2.7%).</w>
(5 1</w>
(5 0.0</w>
(5 )</w>
(44. 2</w>
(44. 1%),</w>
(4. 8%);</w>
(4. 7)</w>
(4. 3)</w>
(4. 2</w>
(4. 1</w>
(4. 1%),</w>
(4- DAMP)</w>
(4 9%),</w>
(4 8%</w>
(4 6</w>
(4 50</w>
(4 4%,</w>
(4 4%)</w>
(4 3%)</w>
(4 3%).</w>
(4 1.8</w>
(4 1.4%)</w>
(4 0%)</w>
(4 /8),</w>
(4 ,957</w>
(4 )</w>
(4 %</w>
(3alpha-hydroxy-5 beta-pregnan-20-one)</w>
(3alpha-hydroxy-5 alpha-pregnan-20-one),</w>
(32. 9%)</w>
(32. 87</w>
(32. 2-62.0)</w>
(3. 7</w>
(3. 75,</w>
(3. 7%)</w>
(3. 6</w>
(3. 5</w>
(3. 5-5.4</w>
(3. 45</w>
(3. 3</w>
(3. 3%).</w>
(3. 2</w>
(3- benzenesulfonyl-7-(4-methyl-piperazin-1-yl)1H-indole)</w>
(3,4- methylenedioxymethamphetamine,</w>
(3)H- haloperidol</w>
(3 alpha-tropyl</w>
(3 S-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane),</w>
(3 R-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane)</w>
(3 MA),</w>
(3 9.7%).</w>
(3 9+/-10</w>
(3 9%)</w>
(3 9%).</w>
(3 8.6%,</w>
(3 7.1%),</w>
(3 6</w>
(3 6%),</w>
(3 5.7%)</w>
(3 5%)</w>
(3 4/45)</w>
(3 3</w>
(3 3%)</w>
(3 23+/-43</w>
(3 2%)</w>
(3 1</w>
(3 1%)</w>
(3 000</w>
(3 0.5%)</w>
(3 0.0</w>
(3 /4),</w>
(26 5.2</w>
(26 0,</w>
(26 %).</w>
(25%- 35%)</w>
(25%- 30%).</w>
(200 6),</w>
(200 4),</w>
(2. 7</w>
(2. 7%)</w>
(2)- selective')</w>
(2 PAM)</w>
(2 9</w>
(2 9%)</w>
(2 9%).</w>
(2 80+/-17</w>
(2 8%)</w>
(2 6%</w>
(2 6%)</w>
(2 5</w>
(2 5%)</w>
(2 40%</w>
(2 3</w>
(2 2</w>
(2 1.6</w>
(2 1.0</w>
(2 1%</w>
(2 000</w>
(2 0.2%)</w>
(2 0.0%)</w>
(2 0%).</w>
(2 ,682,2,803,</w>
(2 ,250</w>
(2 ),</w>
(199 5-96),</w>
(199 2-1994)</w>
(15. 9%).</w>
(15. 6%),</w>
(14. 9</w>
(14. 3%).</w>
(11. 7)</w>
(11. 7%).</w>
(11. 6%),</w>
(11. 2,</w>
(10. 7%</w>
(10. 2)</w>
(10. 1%)</w>
(10 4)</w>
(10 1</w>
(10 0,</w>
(1/ 8).</w>
(1/ 2,z)</w>
(1. 7%)</w>
(1. 5</w>
(1. 46%)</w>
(1. 2),</w>
(1. 2%)</w>
(1. 1)</w>
(1. 03</w>
(1- [2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine),</w>
(1- 5</w>
(1- 10,000</w>
(1, 800</w>
(1, 3-bis-(2-chloroethyl)-1-nitrosourea),</w>
(1, 2-DMH)</w>
(1)- selective')</w>
(1 R,2S-(+)-cis-N-[2-(3,4-dichlorophenyl)ethyl]-2-(1-pyrrolidinyl)cyclohexylamine).</w>
(1 92%)</w>
(1 90</w>
(1 9%)</w>
(1 8%);</w>
(1 8%).</w>
(1 7beta-estradiol</w>
(1 78</w>
(1 7.5%</w>
(1 7.2%</w>
(1 6/49)</w>
(1 6%</w>
(1 6%)</w>
(1 5%,</w>
(1 35</w>
(1 31I-HSA).</w>
(1 30</w>
(1 3/50)</w>
(1 28</w>
(1 25</w>
(1 2.9%).</w>
(1 2.5</w>
(1 2.1</w>
(1 2.0</w>
(1 10</w>
(1 1.5</w>
(1 1),</w>
(1 1%)</w>
(1 0.1</w>
(1 /8),</w>
(1 ,</w>
(1 )/M(3)/M(5)-selective'),</w>
(1 ).</w>
(1 ),</w>
(0.2- 1.0</w>
(0.2- 0.9)</w>
(0.0 8)</w>
(0.0 3</w>
(0.0 1-1</w>
(0.0 1%</w>
(0. 96</w>
(0. 9%)</w>
(0. 8</w>
(0. 86</w>
(0. 7%).</w>
(0. 675</w>
(0. 5-47.5</w>
(0. 4</w>
(0. 38</w>
(0. 35</w>
(0. 34%),</w>
(0. 25</w>
(0. 15</w>
(0. 135</w>
(0- 9.88)</w>
(0- 30)</w>
(0- 30);</w>
(0- 270</w>
(0- 220</w>
(0- 100)</w>
(0- 0.3</w>
(-1 6.2)</w>
(-1 5.4)</w>
(-1 4.6;</w>
(-1 0.7;</w>
(- 49%)</w>
(- 40%)</w>
(- 32%)</w>
(- 21.3</w>
(- 20.0)</w>
(+/-)- amphetamine</w>
(+/- )</w>
(+)- 7-hydroxy-dipropyloaminotetralin</w>
(+ 6.6</w>
(+ -MK801</w>
('M (2)-selective')</w>
('M (1)/M(3)/M(5)-selective'),</w>
('M (1)-selective')</w>
(" valproate</w>
(" protocol</w>
(" meth</w>
(" empty</w>
( without</w>
( wild-type)</w>
( while</w>
( which</w>
( vincristine-induced)</w>
( vigabatrin)</w>
( vestibular</w>
( ventricular</w>
( vehicle</w>
( values</w>
( usually</w>
( ua);</w>
( twice</w>
( tryptophan</w>
( tricuspid:</w>
( total</w>
( timolol)</w>
( thyroarytenoid</w>
( thirteen</w>
( tests</w>
( terfenadine,</w>
( tPA),</w>
( tAMCA)</w>
( t-butyl</w>
( such</w>
( streptozotocin-induced)</w>
( statin)</w>
( static)</w>
( standard</w>
( stage</w>
( some</w>
( sixty-eight)</w>
( since</w>
( short-term)</w>
( sgk1(-/-))</w>
( sgk1(+/+)).</w>
( seizure</w>
( sd)</w>
( scopolamine</w>
( rtM204I</w>
( retention</w>
( responders)</w>
( relative</w>
( reference</w>
( rate</w>
( radioallergosorbent</w>
( rabbit</w>
( rTMS)</w>
( rHuEPO-beta).</w>
( r=0.81</w>
( purine</w>
( published</w>
( primarily</w>
( preinfusion:</w>
( pre-test),</w>
( poor</w>
( poison</w>
( plus</w>
( placebo,</w>
( placebo)</w>
( piroxicam)</w>
( perseveration</w>
( patients</w>
( overall</w>
( or</w>
( once</w>
( olanzapine,</w>
( octreotide)</w>
( number</w>
( noninnervated)</w>
( nonepisode</w>
( noncompliance</w>
( non-significantly)</w>
( neutrophil</w>
( nausea</w>
( mixed</w>
( memory</w>
( maximum</w>
( magnitude:</w>
( mToR)</w>
( mGluR5)</w>
( low</w>
( loss</w>
( losartan),</w>
( locomotor</w>
( lithium</w>
( lindane)</w>
( life</w>
( lamina</w>
( irCRF)</w>
( ip,</w>
( interclass</w>
( initial</w>
( inhibition),</w>
( infusion</w>
( increased</w>
( incidence</w>
( inactivated</w>
( in-</w>
( if</w>
( i.p.)</w>
( i.p.).</w>
( i.p.))</w>
( i.c.v.)</w>
( hyoscine)</w>
( hours</w>
( high-dose)</w>
( halothane)</w>
( haloperidol)</w>
( good</w>
( glutamate,</w>
( glomerular</w>
( gamma</w>
( gamma-HCH),</w>
( gamma-GT)</w>
( fusion</w>
( fourth</w>
( folic</w>
( first,</w>
( except</w>
( evident</w>
( evaluation</w>
( evaluable</w>
( estradiol-</w>
( estimated</w>
( episode</w>
( epinephrine</w>
( epinephrine),</w>
( elevated</w>
( electroconvulsive</w>
( either</w>
( eight</w>
( eGFP)</w>
( dynamic)</w>
( dose</w>
( dopamine</w>
( diltiazem,</w>
( dex-HT).</w>
( dex),</w>
( delta</w>
( delirium)</w>
( definite</w>
( dP/dtejc)</w>
( cyclosporine,</w>
( control</w>
( control,</w>
( completely,</w>
( clozapine</w>
( cholestatic</w>
( characterized</w>
( central</w>
( bridging</w>
( bipolar</w>
( betaxolol)</w>
( beta=0.49,</w>
( beta4</w>
( beta-CCM),</w>
( based</w>
( b</w>
( average</w>
( approximately</w>
( antiepileptogenic</w>
( anticonvulsant</w>
( angiodegeneration</w>
( amifostine)</w>
( alpha2ABC-/-).</w>
( alpha,beta-meATP)</w>
( alkylating</w>
( aggressive)</w>
( ages</w>
( age</w>
( adjusted</w>
( ad</w>
( across</w>
( acetaminophen)</w>
( [Na]o</w>
( Zyban)</w>
( ZDV)-induced</w>
( YMDD)</w>
( XO),</w>
( World</w>
( WSP)</w>
( WR242511).</w>
( UKPDRG)</w>
( UGT)</w>
( UDCA)</w>
( U-II)</w>
( TR(-))</w>
( TIMPs)</w>
( T</w>
( QTLs)</w>
( QS/QT)</w>
( PAI-1)</w>
( PA)</w>
( MRP2)</w>
( MRI)</w>
( MR)</w>
( MPT),</w>
( METH)</w>
( MD)</w>
( Li)-induced</w>
( LTP)</w>
( L-alpha-GFC)</w>
( L-NOArg;</w>
( L-NIL;</w>
( International</w>
( INWEST)</w>
( IIEF),</w>
( HOE</w>
( HCN)</w>
( HCFCs)</w>
( GABA(A))</w>
( FK</w>
( FANFT)</w>
( FAN)</w>
( ET-1),</w>
( BCHE)</w>
( BAEPs)</w>
( A</w>
( 9</w>
( 800</w>
( 7</w>
( 6.7</w>
( 6-OHDA)</w>
( 5-hydroxytriptamine,</w>
( 5-AzC)</w>
( 5%</w>
( 100%)</w>
( 0</w>
( 0.05,</w>
( 0,</w>
( 0%).</w>
' non-nephrotoxic</w>
' conscious</w>
' carbamylcholin';</w>
' atypical'</w>
' alpha</w>
" steal"</w>
" sham"</w>
" serious"</w>
" real"</w>
" prefrontal"</w>
" normality,"</w>
" natural</w>
" late"</w>
" jitteriness"</w>
" flash"</w>
" calibrating"</w>
" acute</w>
" acute"</w>
" Polfa")</w>
" 3-week</w>
